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1 Summary 
1.1 Abstract 
The Drosophila Lethal (3) malignant brain tumour (dL(3)mbt) protein  is the founding 
member of the family of MBT domain proteins. The MBT domain is a ‘chromatin 
reader’, a module that specifically recognises mono- and di-methylated lysines within 
histone tails. In vitro studies suggest that these domains compact nucleosomes to form 
higher order chromatin structures. Importantly, MBT domain-containing proteins were 
previously shown to have critical functions in developmental processes, maintenance of 
transcriptional repression and tumour suppression. Accordingly, mutation of the gene 
that encodes the dL(3)mbt protein leads to the development of a malignant and invasive 
tumour in the brain of third instar larvae.  
Data from both Drosophila melanogaster and human implicate that MBT domain 
proteins cooperate with or are part of multi-subunit protein complexes. Therefore, the 
goal of this thesis was to identify novel interaction partners and protein complexes of 
dL(3)mbt. 
In the first part of this thesis, dL(3)mbt has been shown to associate with enzymatic 
histone deacetylase activity. dRpd3 was identified as a histone deacetylase specifically 
associating with dL(3)mbt. Interestingly, the three MBT domains were sufficient to 
mediate interaction with dRpd3. This dL(3)mbt-dRpd3 complex has been linked to the 
maturation of newly synthesised chromatin.  
In the second part of this study, the multi-subunit complex LINT, consisting of 
dL(3)mbt, the co-repressor protein dCoREST and the novel protein dLint-1, was 
isolated by FLAG immunoaffinity purification and classical biochemical chromato-
graphy. These factors interacted stably with each other in extracts from cell lines, 
embryos and larval brain. On polytene chromosomes the two LINT subunits dL(3)mbt 
and dLint-1 co-localised extensively at many binding sites. Subsequent microarray 
analysis led to the identification of hundreds of genes that were co-regulated by 
dL(3)mbt and dLint-1. Among these target genes was a subset of germline-specific 
genes that were stably repressed by all three LINT complex components. Strikingly, 
there is a significant overlap with genes that have been demonstrated to drive tumour 
growth in l(3)mbt mutant brains. Moreover, this study confirmed that the LINT complex 
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bound directly to promoter regions of these target genes to repress transcription. A 
reporter gene assay revealed that the recruitment of dL(3)mbt and dLint-1 to the 
promoter of a luciferase gene was sufficient to repress its transcription and that maximal 
repression was dependent of the presence on all LINT subunits.  
The upregulation of LINT target genes was accompanied by changes in histone 
modifications, namely an increase in active and a loss of repressive histone 
modifications. However, since the LINT complex itself does not contain histone-
modifying enzymes these changes are likely to occur co-transcriptionally.  
Collectively, the results of this thesis lead to a model, in which the LINT complex 
maintains transcriptional repression of germ cell-specific target genes by hindering 
access of RNA Polymerase II and other activating transcription factors to their 
promoters. 
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1.2 Zusammenfassung 
Das Drosophila Protein Lethal (3) malignant brain tumour (dL(3)mbt) war das 
Gründungsmitglied der Familie der MBT-Domänen Proteine. Die MBT-Domäne ist ein 
sogenannter “Chromatin-Leser“, ein Modul, das spezifisch an mono- und di-methylierte 
Lysine, die in Histon-Schwänzen lokalisiert sind, bindet. In vitro Studien legen nahe, 
dass diese Domänen Nukleosomen kompaktieren, um dichter gepacktes Chromatin zu 
erzeugen. Bedeutenderweise wurde im Vorfeld gezeigt, dass MBT-Domänen 
enthaltende Proteine  entscheidende Funktionen in Entwicklungsprozessen, der 
Erhaltung von transkriptioneller Repression und Tumorsuppression übernehmen. 
Dementsprechend führt die Mutation des Gens, das für dL(3)mbt kodiert, zur 
Entwicklung eines malignen und invasiven Tumors im Larvengehirn des dritten 
Larvenstadiums. 
Daten sowohl aus Drosophila melanogaster als auch dem humanen System implizieren, 
dass MBT-Domänen Proteine im Allgemeinen Proteinkomplexen, die mehrere Unter-
einheiten enthalten, angehören oder mit ihnen zusammenwirken. Daher war das Ziel 
dieser Arbeit neue Interaktionspartner und Proteinkomplexe von dL(3)mbt zu 
identifizieren. 
Im ersten Teil dieser Arbeit wurde gezeigt, dass dL(3)mbt mit enzymatischer Histon-
deacetylaseaktivität assoziiert. dRpd3 wurde als eine Histondeacetylase identifiziert, die 
spezifisch mit dL(3)mbt interagiert. Interessanterweise waren die drei MBT-Domänen 
ausreichend, um die Bindung mit dRpd3 zu vermitteln. Die Funktion dieses dL(3)mbt-
dRpd3-Komplexes wurde in Zusammenhang gebracht mit der „Reifung“ von neu 
synthetisiertem Chromatin.  
Im zweiten Teil dieser Studie wurde der Proteinkomplex LINT, der aus dL(3)mbt, dem 
Korepressor dCoREST und einem neu identifizierten Protein namens dLint-1 besteht, 
mittels FLAG-Immunoaffinitäts-Aufreinigung und klassischer Chromatographie 
isoliert. Diese Faktoren interagieren stabil miteinander in Extrakten, die von Zelllinien, 
Embryonen und larvalen Gehirnen gewonnen wurden. Auf Polytän-Chromosomen 
kolokalisierten die beiden LINT-Untereinheiten dL(3)mbt und dLint-1 in hohem 
Umfang an vielen Bindungsstellen. Anschließende Microarray-Analyse führte zur 
Identifizierung Hunderter Gene, die von dL(3)mbt und dLint-1 koreguliert wurden. 
Innerhalb dieser Zielgene war eine Untergruppe von Keimbahn-spezifischen Genen, die 
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stabil von allen drei LINT-Komponenten reprimiert wurden. Auffallend ist, dass es 
einen signifikanten Überlapp mit Genen gibt, die das Tumorwachstum in l(3)mbt 
mutanten Gehirnen fördern. Weiterhin, bestätigte diese Arbeit, dass der LINT-Komplex 
direkt an die Promotoren dieser Zielgene bindet, um die Transkription zu unterbinden. 
Die Untersuchung eines Reportergen-Systems machte deutlich, dass die Rekrutierung 
von dL(3)mbt und dLint-1 an den Promotor eines Luciferasegens ausreicht, um dessen 
Transkription zu reprimieren und dass die maximale Repression abhängig ist von der 
Anwesenheit aller LINT-Untereinheiten. 
The Hochregulierung von LINT-Zielgenen wurde von Veränderungen von Histon-
modifikationen begleitet, nämlich dem Anstieg von aktiven und dem Verlust von 
repressiven Histonmodifikationen. Allerdings ist es, da der LINT-Komplex keine 
Histon-modifizierenden Enzyme enthält, wahrscheinlich, dass diese Veränderungen 
kotranskriptionell auftreten. 
Zusammengefasst, führen die Resultate dieser Arbeit zu einem Modell, in welchem der 
LINT-Komplex die Repression von Keimzell-spezifischen Zielgenen aufrechterhält, 
indem er den Zugriff von RNA Polymerase II und anderen aktivierenden Trans-
kriptionsfaktoren auf ihre Promotoren behindert. 
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2 Introduction 
 
2.1 Regulation of chromatin 
2.1.1 Chromatin structure 
In all eukaryotes the genetic information is encoded by DNA and packaged into 
chromatin, in a way that allows cellular processes, such as transcription, replication and 
DNA repair, to take place. The fundamental unit of chromatin is the nucleosome, which 
is composed of 146 base pairs (bp) of superhelical DNA wrapped around a protein 
octamer. This protein complex consists of the four core histones (each in two copies) 
H3, H4, H2A and H2B (Figure 2.1). The core histones are predominantly globular with 
the exception of the unstructured N-terminal ‘tails’, which stick out of the nucleosome 
(Luger et al., 1997). 
 
 
Figure 2.1: Crystal structure of the nucleosome core particle. Histone octamer core 
consisting of H3 (blue), H4 (green), H2A (blue) and H2B (red) (each two copies) and a 146 bp 
DNA superhelix (turquoise and purple). Left panel: View down the DNA superhelix. Right 
panel: View perpendicular to the DNA superhelix. The figure was generated using PyMOL 
software from the pdb file [1AOI] (Luger et al., 1997), available at the RSCB protein data base 
(http://www.rcsb.org/pdb/home/home.do). 
 
The repeating nucleosome core particles are separated from each other by a stretch of 
linker DNA and therefore occur on average every 200 bp throughout the eukaryotic 
genome (Kornberg, 1977). Under non-physiological conditions, nucleosome arrays 
including the linker DNA can form an approximately 10 nm fibre, referred to as ‘beads-
on-a-string’ structure (Thoma et al., 1979). In the nucleus, however, chromatin is 
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progressively compacted into higher-order chromatin structures, such as the 30 nm 
fibre. The assembly of higher-order structures is stabilised by the linker histone H1, 
which is attached to the nucleosome core where the DNA enters and leaves the histone 
octamer. In addition a multitude of non-histone proteins participate in the formation 
of higher-order chromatin structures, such as the heterochromatin protein 1 (HP1) 
(Eissenberg et al., 1990; James and Elgin, 1986).  
Dependent on the degree of compaction, chromatin can be divided into two general 
types, euchromatin and heterochromatin (Huisinga et al., 2006). Whereas hetero-
chromatin is typically highly condensed, relatively gene-poor and transcriptionally inert, 
euchromatin is less condensed, gene-rich and generally associated with higher 
transcriptional activity. 
Aside from the overall level of compaction the activity of chromatin is determined by 
various parameters, which play important roles during distinct cellular processes:  
First, the spacing between nucleosomes can vary and thereby influence nucleosome 
occupancy and positioning, which is for instance implicated in the regulation of gene 
expression by allowing or inhibiting the access of sequence-specific regulatory factors 
(Schnitzler, 2008). A genome-wide analysis in yeast revealed that most transcription 
factor binding sites are depleted of nucleosomes (Yuan et al., 2005). In general, the 
nucleosome architecture can be altered by chromatin remodeler factors, which utilise 
the energy of ATP-hydrolysis to loosen DNA-histone interactions (Varga-Weisz and 
Becker, 1998).  
Second, in addition to canonical histones, different variants exist that have evolved 
specialised functions in biological pathways. For instance, an alternative form of H3 is 
the histone variant H3.3 that is structurally very close to canonical H3 since they differ 
only in four amino acid residues (McKittrick et al., 2004). Despite this similarity, the 
histone variant H3.3 has been found to be specifically enriched in transcriptionally 
active chromatin and is the key substrate of replication-independent nucleosome 
assembly (Ahmad and Henikoff, 2002; McKittrick et al., 2004). The deposition of H3.3 
appears to be coupled to transcription (Schwartz and Ahmad, 2005).  
Third, DNA can be methylated on cytosines (m5C) within CpG dinucleotides, which is 
the major target for DNA methylation in eukaryotes (Bird, 2002). An exception is 
Drosophila melanogaster (D. melanogaster), where DNA methylation was found 
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mostly on CpTs in early embryos (Lyko et al., 2000). In general DNA methylation is 
associated with chromatin silencing (Bird et al., 2002).  
Finally, also histone proteins are targets for modifications that have roles both in 
activation and repression of transcription (for more details see 2.1.2). 
 
2.1.2 Histone modifications 
A remarkable feature of histones is their large number of residues that can be post-
translationally modified. These modifications include acetylation, methylation, 
phosphorylation, ubiquitylation, sumoylation, ADP-ribosylation, deimination, proline-
isomerisation (Kouzarides, 2007), propionylation, butyrylation (Zhang et al., 2009) and 
glycosylation (Sakabe et al., 2010). While some modification types, such as acetylation, 
methylation, phosphorylation and ubiquitylation (Figure 2.2), have been more 
intensively studied (see below), the biological nature of other post-translational histone 
modificaions (PTMs), such as propionylation, butyrylation and glycosylation, remains 
to be determined. In general, histone modifications have been shown to be important in 
many chromatin associated cellular processes, such as gene regulation, DNA 
replication, DNA repair, and chromosome condensation (Kouzarides, 2007). Just 
recently, a direct role of histone modifications in the regulation of alternative splicing 
has been demonstrated (Luco et al., 2010).  
The role of distinct histone modifications will be discussed below, with a special focus 
on their function in gene regulation. The mode of action of histone modifications is 
thought to rely on two basic mechanisms. Firstly, they act indirectly by recruiting non-
histone proteins, which in turn regulate corresponding processes through their 
chromatin-associated activities. Secondly, they act directly by influencing inter- or 
intranucleosomal DNA-histone contacts and thereby impacting higher-order chromatin 
structure (Kouzarides, 2007). 
The latter mechanism is documented best for histone acetylation, which occurs on 
several lysine residues within all four core histones (Figure 2.2). The covalent 
attachment of an acetyl group to a lysine residue will neutralise the positive charge of 
the ε-amino group in the lysine side chain. In vitro assays have suggested that this 
neutralisation of histone tails by hyperacetylation prevents the formation of higher-order 
chromatin compaction and thereby can promote transcription (Annunziato et al., 1988; 
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Tse et al., 1998). Furthermore, it has been shown that acetylation of H4K16 alone can 
also cause defects in chromatin folding, substantiating that H4K16ac is a critical 
determinant of the degree of chromatin compaction (Shogren-Knaak et al., 2006; 
Shogren-Knaak and Peterson, 2006). Generally speaking, acetylation of histones is 
associated with gene activation, while deacetylated chromatin is linked to 
transcriptional repression (Shahbazian and Grunstein, 2007). 
 
 
Figure 2.2: Histone modifications: Acetylation, methylation, phosphorylation and 
ubiquitylation of H3, H4, H2A and H2B. Schematic illustration of PTMs on canonical 
histones. The majority of histone modifications occur in the N-terminal tails of histones. 
Exceptions from this rule are methylation of K56 and K79 in H3 and ubiquitylation of K119 
and K120 in H2A and H2B, respectively, as well as phosphorylation of T120 in H2A, which are 
located in the globular histone domains (modified from Bhaumik et al., 2007). 
 
Phosphorylation of several histone H3 residues (such as S10: Wei et al., 1998; T11: 
Preuss et al., 2003; S28: Goto et al., 1999) has a well established role in chromosome 
condensation during mitosis (Nowak and Corces, 2004). Therefore it is striking that 
histone phosphorylation occurring during interphase has also been linked to 
transcriptional activation, which is thought to require an open chromatin state (Nowak 
and Corces, 2004; Pérez-Cadahía et al., 2009).  
Unlike acetylation, which in general is associated with actively transcribed genes, 
histone lysine methylation is associated with either active or repressive transcription, 
depending on the chromatin context and the residue it occurs on (Li et al., 2007a; 
Kouzarides, 2007). The complexity of this modification is further enhanced by the 
existence of three methylation states: mono- (me1), di- (me2) and tri-methylation (me3). 
In H3 several lysines have been found to be methylated, four of them are located in the 
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N-terminus (K4, K9, K27, K36), while K79 resides within the globular domain. In 
histone H4 only K20 is known to be targeted by lysine methylation. Whereas 
methylation on H3K9, H3K27 and H4K20 has been implicated in chromatin silencing, 
H3K4 and H3K36 methylation has been associated with actively transcribed chromatin. 
A genome-wide analysis in yeast revealed that specific histone methylation marks, 
associated with actively transcribed genes, exhibit specific patterns relative to the gene 
body (Pokholok et al., 2005). Thus, H3K4me3 peaks at the promoter-proximal regions, 
whereas H3K36me3 is enriched throughout the transcribed region with highest levels at 
the 3’ end. 
In addition to lysines, arginines are also targets for methylation and are modified either 
by mono- or di-methylation (Di Lorenzo and Bedford, 2010). The latter can be either 
symmetric or asymmetric with one methyl group on each terminal nitrogen or both 
methyl groups on one terminal nitrogen, respectively. Histone arginine methylation can 
be associated with both transcriptional activation and repression. 
The dynamics of histone modifications is dependent on enzymes catalysing the covalent 
attachment of PTMs, so called ‘writers’, and their removal, so called ‘erasers’ (see 
2.1.4) (Figure 2.3; Gardner et al., 2011). Furthermore, there are ‘readers’, also referred 
to as effector proteins, that specifically recognise histone modifications and accordingly 
associate with chromatin via specific binding modules (see 2.1.3). 
 
 
Figure 2.3: Activities of chromatin factors associated with histone modifications. Writers 
attach PTMs (asterisk) covalently to histones (left panel), while erasers remove them (middle 
panel), and readers (also termed effectors) bind to specific modifications (right panel) (modified 
from Gardner et al., 2011). 
 
The discovery of a large number and variety of histone modifications in recent years, 
also led to the finding that distinct histone modifications can influence each other, 
either synergistically or antagonistically (Suganuma and Workman, 2008). This kind of 
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communication between PTMs is called ‘cross-talk’ and can occur at different levels. 
For example, lysine residues can be modified by different PTMs, such as acetylation 
and methylation (compare H3K9, Figure 2.2), which is why these modifications are 
mutually exclusive. Whereas acetylation of H3K9 is associated with transcriptional 
activation (Liang et al., 2004; Roh et al., 2005), H3K9 methylation, a specific binding 
site for HP1, is a marker of silenced genes and heterochromatic regions (Bannister et al., 
2001; Stewart et al., 2005). Moreover, the binding of factors to specific histone marks 
can be either inhibited or enhanced by an additional modification of an adjacent residue. 
An example that illustrates inhibition is the disruption of HP1 binding to methylated 
H3K9 during M-phase of the cell cycle by phosphorylation of H3S10 (Fischle et al., 
2005). On the other hand, H3S10 phosphorylation can also promote K14 acetylation by 
the Gcn5 enzyme to activate transcription (Clements et al., 2003).  
As a model of how histone modifications can regulate diverse processes associated with 
chromatin, the ‘histone code hypothesis’ has been put forward (Strahl and Allis, 2000; 
Jenuwein and Allis, 2001). Thus, a histone code is established by the combinatorial 
nature of distinct histone modifications that are read by effector proteins to bring about 
a corresponding downstream biological event.  
 
2.1.3 Histone modification readers 
The histone code is becoming continuously more elaborate due to the discovery of 
novel histone modifications and ‘cross-talks’ between various modifications (Winter 
and Fischle, 2010). Although the exact mechanisms of how this code is deciphered in 
the cell remains to be investigated in more detail, the binding of reader proteins (or 
effector proteins) that interpret histone modifications and translate them into a proper 
downstream event, is one favoured model (Strahl and Allis, 2000). In order to 
specifically bind to distinct histone modifications, reader proteins harbour histone 
binding modules (Figure 2.4). In the past decade, a large number of crystal structures of 
histone binding modules, either in the free form or bound to their histone peptide 
substrate, and in vitro binding studies have contributed to the mechanistic understanding 
of specific recognition of PTMs by these domains (Taverna et al., 2007). Some of these 
insights into specific readout mechanisms will be discussed in the following. 
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Figure 2.4: Histone modification binding modules. Domains that specifically bind to 
methylated lysines, acetylated lysines or phosphorylated serines/threonines (modified from 
Kouzarides, 2007 and complemented with novel binding modules: Brent and Marmorstein, 
2008; Han et al., 2006; Kelly et al., 2010; Liu et al., 2010; Sofueva et al., 2010; Wang et al., 
2009; Zeng et al., 2010).  
 
The Bromo domain 
The Bromo domain, originally identified in the Drosophila protein Brahma (Tamkun 
et al., 1992), is a module known to bind to acetylated lysines. This highly conserved 
domain is found in many chromatin-associated proteins, such as chromatin remodelling 
factors, as well as in most histone acetyl transferases (Jeanmougin et al., 1997). Detailed 
insight into the mechanism of acetyl-lysine recognition was first gained from the 
solution of an NMR structure of the Bromo domain of HAT co-activator p300/CBP-
associated factor (P/CAF) and from a high-resolution crystal structure of the 
Saccharomyces cerevisiae (S. cerevisiae) acetyl-transferase Gcn5 Bromo domain 
complexed with H4K16ac (aa 15-29) (Dhalluin et al., 1999; Owen et al., 2000). Bromo 
domains adopt a conserved structural fold that is composed of a left-handed anti-parallel 
bundle of four helices (Z, A, B and C) with inter-helical loops ZA and BC. These loops 
accommodate a hydrophobic binding pocket, in which the acetyl-lysine inserts. In 
addition to hydrophobic interactions, acetyl-lysine forms a specific H-bond between the 
oxygen of the acetyl carbonyl group and the amide nitrogen of a conserved asparagine. 
Further contacts with the binding pocket derive from a network of water-mediated H-
bonds between the protein backbone carbonyl groups and acetyl-lysine.  
The ‘Royal family’ of histone binding domains 
The methylation state of lysines can be recognised by various binding modules 
(Figure 2.4). Among them are Tudor, Chromo, PWWP and MBT domains, which all 
belong to the so-called ‘Royal family’ and share a β-stranded core region (Maurer-
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Stroh et al., 2003). Members of the Royal family can read out both higher (Kme2, 
Kme3) and lower (Kme1, Kme2) lysine methylation states. A common mechanism of 
these domains is the formation of hydrophobic cavities or cages for the specific 
recognition of differentially methylated lysine residues (Taverna et al., 2007). 
Typically, Chromo domains belong to the group of modules that bind higher 
methylation states of lysines. In this context, the Chromo domain of HP1 binds 
preferentially to di- and tri-methylated H3K9, while the Chromo domain of Polycomb 
(Pc) specifically binds to H3K27me3 (Fischle et al., 2003). Interestingly, Tudor 
domains can target both higher and lower methylation states. While the tandem Tudor 
domain of human JMJD2A was found to bind to H3K4me3 (Huang et al., 2006), the 
tandem Tudor domain of 53BP1 recognises H4K20me1 and -me2 (Botuyan et al., 
2006). The binding specificity and structural mechanism of malignant brain tumour 
(MBT) domains as low methylation histone lysine readers will be described in detail 
below (see 2.2.1). 
The PHD finger domain 
Another domain able to bind histone lysines is the plant homeo domain (PHD), which 
was first described in the Arabidopsis homeo domain protein HAT3.1 (Schindler et al., 
1993), but is also conserved in many other eukaryotic chromatin-related proteins with 
roles in transcription regulation (Aasland et al., 1995). Characteristic for canonical PHD 
fingers, spanning 50 to 80 amino acids on average, is a Cys4HisCys3 (C4HC3) 
signature that coordinates two zinc ions (Pascual et al., 2000; Capili et al., 2001).  
On the one hand, PHD fingers exhibit nucleosome-binding activity. This was 
demonstrated for the PHD finger of the acetyltransferase p300 that cooperates with the 
adjacent Bromo domain to bind to hyperacetylated nucleosomes in a robust manner 
(Ragvin et al., 2004). Moreover, it was reported that the two PHD fingers of Drosophila 
ATP-dependent chromatin assembly factor 1 (Acf1) can bind to the central domains of 
core histones and thereby increase the efficiency of nucleosome mobilisation activity of 
the ATPase ISWI (Eberharter et al., 2004).  
On the other hand, PHD domains were shown to function as specific histone 
modification binding modules, recognising lysines of different methylation states. Thus, 
the PHD finger of human BPTF, the largest subunit of the chromatin remodelling 
complex NURF, binds to tri-methylated H3K4 (Li et al., 2006; Wysocka et al., 2006), 
whereas the PHD domain of human BHC80, a LSD1 complex component (Shi et al., 
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2005), targets the unmethylated H3 tail (Lan et al., 2007b). In both cases, the histone H3 
peptide binds to the surface of the PHD finger by extending the PHD anti-parallel β-
sheet by an additional strand. In the BPTF PHD finger the tri-methyl group of 
H3K4me3 is positioned within a cage of four aromatic residues. Furthermore, the 
specific binding of BPTF to H3K4me3 results from the simultaneous binding of H3R2 
in a second binding channel (Li et al., 2006). The BHC80 PHD domain lacks an 
aromatic cage. Instead, recognition of the unmethylated K4 residue through a pair of H-
bonds with the ε-ammonium group and steric exclusion of methyl groups contribute to 
its specificity (Lan et al., 2007b). Recently, PHD fingers have been shown to be an 
alternative module to bromo domains to bind to acetylated lysines. Thus, the tandem 
PHD finger of human DPF3b, which cooperates with the BAF chromatin remodelling 
complex, specifically recognises the H3K14ac modification (Zeng et al., 2010). 
Remarkably, histone binding modules, such as Bromo, Chromo, Tudor, MBT and PHD 
domains frequently occur in multiple repeats or in combination within the same protein 
or a protein complex (Ruthenburg et al., 2007). This observation supports the idea that 
many chromatin factors bind to multiple histone modifications in a multivalent fashion 
(Figure 2.5). 
 
 
Figure 2.5: Modes of intranucleosomal binding to multiple histone modifications. Left 
panel: A chromatin protein binds to two histone modifications within the same histone tail (cis-
histone). Middle panel: A protein interacts with two histone modifications located in different 
histone tails (trans-histone). Right panel: Two distinct proteins as part of a complex associate 
with two histone modifications located in different histone tails (trans-histone) (modified from 
Ruthenburg et al., 2007). 
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2.1.4 Histone modification writers and erasers 
Histone modifications are thought to be dynamic, since for most modifications writers, 
which specifically set the mark, and erasers, which catalyse selective removal, exist.  
The extent of histone acetylation is regulated by histone acetyltransferases (HATs) and 
histone deacetylases (HDACs) (Shahbazian and Grunstein, 2007).  
Most histone lysine methyltransferases (HKMTs) belong to a class of proteins 
containing a catalytic SET domain (named after the Drosophila proteins Su(var)3-9, 
E(z) and Trx), which possesses a selective substrate specificity (Upadhyay and Cheng, 
2011). An HKMT that lacks the SET domain is Dot1, which specifically methylates 
H3K79 (Feng et al., 2002). The removal of lysine methylation is carried out either by 
lysine specific demethylase (LSD) enzymes (Shi et al., 2004; Karytinos et al., 2009) via 
a flavin-dependent amine oxidation reaction or members of the Jumonji C (JmjC) 
domain-containing dioxygenases in a Fe2+- and α-ketoglutarate-dependent reaction 
(Tsukada and Zhang, 2006). 
The methylation of arginines is catalysed by protein arginine methyltransferases 
(PRMTs), a family of enzymes that transfer a methyl-group of S-adenosylmethionine 
(SAM) to a guanidino nitrogen of arginines (Di Lorenzo and Bedford, 2010). There are 
two major classes of PRMTs, namely type I and II. Both produce mono-methylation as 
an intermediate towards di-methylation. Type I and II PRMTs further catalyse the 
formation of asymmetric and symmetric di-methylation, respectively. To date, it is 
unclear, whether arginine demethylases exist. Previously, human JMJD6 has been 
reported to be the first identified arginine demethylase (Chang et al., 2007). However, a 
study from Webby and co-workers (2009), as well as a structural analysis (Mantri et al., 
2010), suggest that the dominant catalytic activity of JMJD6 is lysyl-hydroxylation. 
Besides, a modification that can block arginine methylation is the conversion of 
arginine to citrulline by peptidylarginine deiminases (PADIs) (Cuthbert et al., 2004).  
The role of enzymatic activities of writers and erasers will be exemplified by the two 
opposing histone lysine methylation marks H3K27 (repressive) and H3K4 (active), 
mainly focusing on the Drosophila system. Among the enzymes that regulate these two 
histone modifications are Polycomb group (PcG) and trithorax group (trxG) proteins, 
which are required for the proper maintenance of restricted homeotic gene (Hox) 
expression patterns during metazoan development (Kennison, 1995), whereby trxG and 
PcG proteins maintain the active or silent chromatin state of Hox genes, respectively. 
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The expression of Hox genes in turn is essential for the specification of the anterior-
posterior body axis and segment identity. The system of PcG and trxG proteins has been 
studied in the past extensively and the investigation in D. melanogaster as a model 
organism has contributed to a great extent to our current understanding. 
 
2.1.4.1 Dynamics of H3K27 methylation 
Methylation of H3K27 
Tri-Methylation of H3K27 is a hallmark of Polycomb silenced chromatin and is 
catalysed by the PcG member Enhancer of zeste (E(z)) (Czermin et al., 2002; Müller 
et al., 2002). The SET-domain HKMT E(z) is a subunit of the Polycomb repressive 
complex 2 (PRC2), which further contains the proteins Extra sex combs (Esc) (or Esc-
like, Escl), Nucleosome remodelling factor 55 (Nurf-55, also termed chromatin 
assembly factor 1, Caf1), and Suppressor of zeste 12 (Su(z)12) as core subunits. A 
homologous PRC2 complex was also identified in human (Cao et al., 2002; Kuzmichev 
et al., 2002). Interestingly, biochemical analyses of E(z) reveal that the enzyme on its 
own is virtually inactive. To effectively methylate K27 within the histone H3 tail E(z) 
needs to associate with the three above-mentioned non-enzymatic subunits of the PRC2 
complex (Czermin et al., 2002; Ketel et al., 2005; Nekrasov et al., 2005). While Nurf-
55, Su(z)12 and Esc contribute to nucleosome binding, Esc is also crucial to boost the 
enzymatic HKMT activity of E(z) as part of the PRC2 complex (Nekrasov et al., 2005). 
A specific role of the human homologue of Esc, the WD40 domain protein EED, was 
identified recently. EED was demonstrated to bind specifically via an aromatic cage to 
tri-methylated lysines in histone tails associated with repressive functions, among them 
H3K27me3 (Margueron et al., 2009). In methylation assays the addition of H3K27me3 
histone tails increased the HKMT activity of PRC2 on unmodified nucleosomes 
significantly. It is noteworthy that these observations provide a mechanism of how the 
H3K27me3 mark could be propagated following DNA replication. Biochemical 
purification of Polycomb-like (Pcl) interacting proteins, led additionally to the 
identification of a PRC2 complex variant, Pcl-PRC2, which also catalyses mono-, di- 
and tri-methylation of H3K27 in vitro (Nekrasov et al., 2007). In vivo data in 
Drosophila mutants lacking Pcl suggest that Pcl-PRC2 is critical for the generation of 
high H3K27 tri-methylation levels at Polycomb target genes, but appears to be 
dispensable for genome-wide H3K27me1/2 levels.  
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Demethylation of H3K27 
The E(z) activity is counteracted by H3K27 specific demethylases. In human the two 
related JmjC-domain proteins JMJD3 and UTX have been identified to specifically 
demethylate H3K27me2/3 (Agger et al., 2007; De Santa et al., 2007; Lan et al., 2007a; 
Lee et al., 2007a). A role of UTX in the regulation of Hox genes was demonstrated upon 
differentiation of the pluripotent embryonal carcinoma cell line NT2/D1 with retinoic 
acid. UTX was shown to be recruited to the promoters of HOXA and B loci coinciding 
with the loss of H3K27me3 and gene activation (Agger et al., 2007; Lee et al., 2007a). 
The homologue H3K27me2/3 demethylase in Drosophila was termed dUTX (Smith 
et al., 2008). Consistent with a role of dUTX in gene activation, its co-localisation with 
the elongating form (C-terminal domain (CTD) phosphorylated at Ser2) of RNA 
polymerase II (Pol II) was observed. Using the heat shock gene Hsp70 as a model for 
inducible gene activation, dUTX was found to be recruited along with Pol II to the 
Hsp70 gene upon heat shock. Interestingly, the investigation of histone modification 
changes in Utx mutant clones revealed in addition to an increase in H3K27me3 a 
reduction of H3K4me1 levels (Herz et al., 2010). In this context it is important to note, 
that the human UTX demethylase was found to associate with H3K4 methyltransferases 
of the mixed-lineage leukemia (MLL) family (Cho et al., 2007; Issaeva et al., 2007; 
Lee et al., 2007a). 
 
2.1.4.2 Dynamics of H3K4 methylation 
Methylation of H3K4 
The methylation of H3K4, which antagonises PcG gene silencing in Drosophila, has 
been reported to be catalysed by the SET domain and trxG proteins Trithorax (Trx) and 
Absent, small or homeotic discs 1 (Ash1) (Breen and Harte, 1991; Klymenko and 
Müller, 2004; LaJeunesse and Shearn, 1995; Milne et al., 2002).  
However, the specificity of Ash1 as a methyltransferase is controversial. Initially, Ash1 
was shown to be a multi-catalytic HKMT methylating H3K4, H3K9 and H4K20 in vitro 
(Beisel et al., 2002). An independent study found that the SET domain of Ash1 
specifically methylates H3K4 in vitro and that H3K4 methylation is widely lost on 
polytene chromosomes of ash1 mutant Drosophila larvae in vivo, while H3K9 
methylation is only slightly reduced and H4K20 or H3K36 methylation is unaffected 
(Byrd and Shearn, 2003). Therefore, in the past the effect of Ash1 on Hox gene 
2 INTRODUCTION 
17 
 
expression has been discussed in light of its H3K4 methyltransferase activity. However, 
two research groups report that Drosophila and human Ash1 specifically methylate 
H3K36 and that pre-existing H3K36 methylation inhibits the enzymatic activity of 
PRC2 on nucleosomes (Tanaka et al., 2007; Yuan et al., 2011).  
Nevertheless, consistent with a role as trxG proteins, which are generally considered to 
function as transcriptional activators, expression of the Hox gene Ubx is lost in ash1 or 
trx mutant imaginal discs within its normal expression domain (Klymenko and Müller, 
2004). Surprisingly, the Ubx expression is restored in these mutants, when additionally 
PcG function is removed. Furthermore, such trxG and PcG double mutants display 
strong mis-expression of Hox genes comparable to observations made in PcG single 
mutant clones. These results led to a model, in which Trx and Ash1 HKMTs do not 
function as ‘co-activators’, but as ‘anti-repressors’ preventing PcG silencing of Hox 
genes in their normal expression domains. 
Demethylation of H3K4 
In Drosophila, demethylation of the active histone mark H3K4 is catalysed by dLsd1 
(also referred to as Su(var)3-3) (Di Stefano et al., 2007; Rudolph et al., 2007) and the 
JmjC-domain protein Little imaginal discs (Lid) (Eissenberg et al., 2007; Lee et al., 
2007b). dLsd1 specifically demethylates H3K4me1/2, whereas the substrate of Lid has 
been shown in vivo to be tri-methylated H3K4. Recently, dKDM2 has been identified as 
an additional potential H3K4me3 demethylase (Kavi and Birchler, 2009).  
Previously, mutant alleles of Su(var)3-3 have been reported to suppress positional-effect 
variegation (PEV) (Di Stefano et al., 2007; Rudolph et al., 2007). In D. melanogaster 
PEV is an experimental system to identify genes controlling higher-order chromatin 
formation. In PEV a euchromatic gene becomes subjected to transcriptional silencing as 
a result of its placement into the vicinity of heterochromatin by chromosomal 
rearrangements (Schotta et al., 2003). Therefore, the suppressor function of dLsd1 
suggested its requirement for heterochromatic gene silencing (Di Stefano et al., 2007; 
Rudolph et al., 2007). Upon mutation of Su(var)3-3 early embryos display elevated 
levels of H3K4me2 in somatic and germline precursor cells, resulting in a reduction of 
heterochromatic H3K9me2/3 (Rudolph et al., 2007). These results support a role of 
dLsd1 in controlling the boundaries between eu- and heterochromatin during early 
embryogenesis.  
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Opposite to what one would expect from an enzyme removing a histone modification 
correlated with transcriptional activation, lid was first identified as a member of the 
trxG of genes, since lid mutations enhanced the homeotic phenotypes caused by 
mutations in other trxG genes (Gildea et al., 2000). In line with Lid-mediated H3K4me3 
demethylation contributing to Hox gene activation, expression of Ubx in haltere discs 
upon lid mutation and in S2 cells upon Lid knockdown was reduced (Lee et al., 2007b; 
Lloret-Llinares et al., 2008). Moreover, heterozygous lid mutant flies show a strong 
enhancement of PEV indicating a role of Lid in antagonising heterochromatin-
dependent gene silencing (Lloret-Llinares et al., 2008).  
Although dLsd1 and Lid cooperatively increase global levels of H3K4 methylation, the 
opposing functions in regulating euchromatin-heterochromatin boundaries were 
confirmed in double mutant flies (Di Stefano et al., 2011). Nevertheless, both dLsd1 and 
Lid were also shown to be directly involved in the repression of euchromatic Notch 
target genes (E(spl)) in a synergistic manner, by modulating the H3K4 methylation 
levels (Di Stefano et al., 2011; Moshkin et al., 2009). 
Taken together, the findings above illustrate that there is a complex functional interplay 
between histone lysine methylases and demethylases in vivo and that the biological role 
of distinct chromatin-modifying enzymes depends very much on the chromatin context.  
 
2.2 MBT domain proteins 
2.2.1 MBT domains as histone modification readers 
The MBT domain was originally named after the D. melanogaster tumour suppressor 
gene lethal (3) malignant brain tumour (l(3)mbt). Upon the identification and cloning of 
the l(3)mbt gene sequence, Wismar et al. (1995) noticed that the 1477 aa long sequence 
of the predicted protein MBT163 (referred to as dL(3)mbt in the following), encoded by 
l(3)mbt, comprised three tandem repeats of a novel motif encompassing 100 aa in 
average. This motif was termed ‘mbt-repeat’. A decade later the MBT domains have 
been found to belong to a new class of methyl-lysine binding modules (Kim et al., 
2006), which has contributed to a growing interest in the functional analysis of MBT 
domains.  
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2.2.1.1 Structural basis of histone peptide binding by MBT domains 
The first crystal structure of MBT domains has been solved for human L3MBTL1, 
which like dL(3)mbt contains three MBT repeats (Wang et al., 2003). In addition, the 
MBT domains of L3MBTL1 have been crystallised in complex with two potential 
physiological ligands, the histone peptides H1.5K27me1/2 (aa 23-27) (Li et al., 2007b) 
and H4K20me2 (aa 15-25) (Min et al., 2007). Since then several other MBT domains 
have been crystallised and their structure solved at atomic resolution (Eryilmaz et al., 
2009; Grimm et al., 2007; Grimm et al., 2009; Guo et al., 2009; Santiveri et al., 2008; 
Sathyamurthy et al., 2003).  
The three-dimensional structure of the human three MBT (h3MBT) domains comprises 
three similar globular modules (Figure 2.6). Each MBT domain consists of a C-terminal 
globular β-subunit core with a barrel-like fold and a long N-terminal arm that forms 
extended contacts with the β-subunit core of the preceding neighbour. This architecture 
adopts a stable propeller-like structure with three leaves arranged around a central 
cavity (Wang et al., 2003) (Figure 2.6, left panel). The structural observation that the N-
terminal arm of each MBT domain interacts extensively with its neighbouring MBT 
core is a likely explanation for why these domains are commonly found in repeats of at 
least two domains (Bonasio et al., 2010; Sathyamurthy et al., 2003).  
The crystal structure of h3MBT uncovered potential binding pockets in all three 
structural equivalent β-subunit cores, which were occupied by the morpholino ring of 
MES (2-(N-morpholino)ethane sulfonic acid; a component of the crystallisation buffer) 
(Wang et al., 2003). Strikingly, crystal structures of h3MBT bound to H4K20me2 
(Min et al., 2007) and H1.5K27me2 (Li et al., 2007b) revealed that only one of the 
MBT domains, namely the second, accommodates di-methylated lysine. A fact that 
interestingly also applies to modules with two (Grimm et al., 2007; Santiveri et al., 
2008) or four MBT domains (Grimm et al., 2009; Guo et al., 2009).  
The binding pocket of the second MBT domain of h3MBT that accommodates the di-
methyl-lysine (Kme2) is formed by residues Phe379, Trp382, Tyr386, Leu361, Thr411 
and Asp355 (Figure 2.6, right panel). The first four residues form an ‘aromatic cage’, 
with the side chains of Phe379, Trp382 and Tyr386 orientated approximately 
perpendicular to one another. This aromatic cage interacts with Kme2 via van-der-
Waals and cation-pi interactions (Min et al., 2007). Moreover, the negatively charged 
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Asp355 residue stabilises the Kme2 binding through formation of a salt bridge and a 
hydrogen bond to the di-methylammonium group.  
 
 
Figure 2.6: Crystal structure of the three MBT domains of human L3MBTL1. Left panel: 
Propeller-like structure of the three MBT domains MBT1 (red), MBT2 (green) and MBT3 
(blue). The labelling of the β-subunit core and the N-terminal arm refers to MBT2. N: N-
terminus; C: C-terminus. Right panel: Binding of di-methylated lysine K20 of H4 peptide (aa 
17-25) to the binding pocket of MBT2. Residues forming the lysine-binding pocket and the 
K20me2 are shown as stick models (in yellow and gray, respectively). The figure was generated 
using PyMOL software from the pdb file [2PQW] (Min et al., 2007), available at the RSCB 
Protein data base. 
 
An explanation for the exclusive peptide binding of the second MBT domain was found 
by superimposition of the three MBT modules: In the first and the third MBT domain 
the relatively small side chain of Cys363 inside of the binding site is substituted by a 
long or bulky side-chain of arginine or phenylalanine, respectively. Hence, steric 
hindrance prevents the binding of methyl-lysine to the binding pockets.  
Although peptide association is only observed for one domain of the MBT repeats, all 
MBT domains seem to have the structural potential to bind ligands, which remain to be 
identified. In h3MBT the first MBT domain was found to coordinate the proline of an 
adjacent MBT molecule (Min et al., 2007). Whether this interaction is important under 
physiological conditions needs to be further analysed.  
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2.2.1.2 Specificity of histone peptide binding 
Qualitative peptide pulldown assays and quantitative methods, such as isothermal 
titration calorimetry (ITC) and fluorescence polarisation measurements, demonstrated a 
preferential binding of MBT domains to mono- and di-methylated lysines within histone 
tails, including H4K20, H1.4K26, H3K9, H3K27, H3K4 and H3K36 methylation marks 
(Bonasio et al., 2010; Kalakonda et al., 2008; Li et al., 2007b). While the three MBT 
domains of L3MBTL1 bind equally well to mono- and di-methyl states in some cases 
(H4K20, H1.4K26), in others the binding affinity for mono-methyl-lysine is greater by a 
factor of two (H3K9, H3K27, H3K36) or even by an order of magnitude (H3K4) (Li 
et al., 2007b). Despite the low selectivity concerning the sequence context surrounding 
the lysines, a higher specificity in the in vivo context seems to be likely. For 
instance, PR-SET7-mediated H4K20 mono-methylation, but not G9a-catalysed H3K9 
methylation, is involved in the recruitment of L3MBTL1 to the cyclin E promoter 
(Kalakonda et al., 2008).  
Discrimination between differentially methylated lysines 
The discrimination of MBT domains between Kme1/2 and Kme0/3 is based on the 
chemical nature of the different methylation states of lysine. Thus, weaker van-der-
Waals and cation-pi interactions of the aromatic cage with unmethylated lysine are likely 
to account for favoured binding of higher methylation states (Min et al., 2007). In case 
of the tri-methyl modification, loss of the hydrogen bond with Asp355 and a weakening 
of ionic interactions between Kme3 and Asp355, as well as steric hindrance of the bulky 
tri-methyl-lysine, provide an explanation for the exclusion from the binding pocket. 
An exception concerning the peptide specificity of MBT domains mentioned above is 
the module of the four MBT domains of the C. elegans protein LIN-61. In in vitro 
assays LIN-61 shows a strong preference for histone peptides containing di- and tri-
methylated H3K9 over other peptides with methylated lysines, including H4K20, 
H3K27, H3K4 and H3K36 (Koester-Eiserfunke and Fischle, 2011). Furthermore, 
mutagenesis of conserved residues, known to be important for histone peptide binding 
(see above), implies a binding mode that differs from other MBT modules.  
Methylation-dependent chromatin compaction 
Another striking feature of the MBT domains, shown for the three MBT domains of 
human L3MBTL1 in vitro, is their ability to compact oligo-nucleosomal arrays in an 
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H4K20me1/2- and H1bK26me1/2-dependent manner (Trojer et al., 2007). In agreement 
with structural data (Li et al., 2007b; Min et al., 2007) mutation of residues critical for 
histone peptide recognition confirmed that the second MBT domain was essential for 
binding of methylated H4K20 or H1bK26 (Trojer et al., 2007). Trojer et al. provide two 
models of how MBT domains could compact chromatin in a monomeric or dimeric 
form by bringing nucleosomes into closer vicinity through binding to the respective 
histone modifications. However, the mechanism of how MBT domains compact 
chromatin exactly and the physiological relevance of this activity in vivo remain to be 
determined. 
 
2.2.2 MBT domain proteins in Drosophila melanogaster 
The dL(3)mbt tumour suppressor protein 
The founding member of the MBT domain protein family is dL(3)mbt (Wismar et al., 
1995). The corresponding l(3)mbt gene, mapping to the right arm of chromosome 3, 
was first identified in a genetic screen for mutant alleles causing malignant 
transformations in the developing fly (Gateff et al., 1993). A recessive-lethal and 
temperature sensitive (ts) mutation of l(3)mbt (l(3)mbtts1), induced by the mutagen ethyl 
methane sulfonate (EMS), resulted in the malignant transformation of adult optic 
neuroblasts and ganglion mother cells in the larval brain at the restrictive temperature of 
29°C. In addition to the malignant phenotype in the larval brain, a (non-malignant) 
epithelial overgrowth of the imaginal discs was observed. The penetrance of the mutant 
allele is 100% and larvae die at the end of the third instar stage without giving rise to 
adult flies. The malignant cells were shown to grow in an autonomous, invasive and 
lethal fashion after transplantation into wild-type adult hosts. The time period, in which 
l(3)mbt gene activity was sensitive to the restrictive temperature and led to 100% brain 
tumour growth (but normal imaginal disc development), spanned the first six hours of 
embryonic development. At the permissive temperature of 22°C mutant flies developed 
normally without any apparent phenotype.  
Additional l(3)mbt alleles were recovered in a maternal-effect screen with the objective 
to identify genes involved in pole/germ cell formation in the early embryo (Yohn et al., 
2003). As a result, mutations in l(3)mbt were demonstrated to result in a reduced 
number of germ cells. There are two critical processes during the development of germ 
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cells in the Drosophila embryo: 1. The assembly of the germ plasm, characterised by 
special components, such as oskar-mRNA, at the posterior end of the egg. 2. The 
migration of nuclei into the germ plasm prior to pole cell formation. In embryos laid by 
females mutant for l(3)mbt a disruption of the synchrony of nuclear divisions in the 
early embryo was observed, which very likely accounts for the defect in germ cell 
development. Interestingly, by sequencing l(3)mbt mutant alleles, displaying defects in 
mitotic divisions, Yohn et al. (2003) could show that four out of five mutations 
(Missense mutations: GM79, ts1; Nonsense mutations: GM76, E2) map to the MBT 
domains, supporting their importance for dL(3)mbt function. 
In line with a role of MBT domain proteins during cytokinesis, the human homologue 
L3MBTL1 was found to be associated with condensed chromosomes in mitotic cells 
(Koga et al., 1999). Overexpression of L3MBTL1 caused defects in proper chromosome 
segregation and cytokinesis, resulting in multi-nucleated U251MG cells. 
The Polycomb proteins Scm and Sfmbt 
In addition to dL(3)mbt, D. melanogaster contains two other MBT domain containing 
proteins: Sex comb on midleg (Scm) and Scm-related gene containing four mbt 
domains (Sfmbt) (Figure 2.7; see also 2.2.4). Both belong to the PcG group of proteins 
(Simon et al., 1992; Klymenko et al., 2006). In Drosophila many PcG genes were 
identified because of segmental transformation phenotypes produced by their mutation 
or mis-expression. For instance, in Scm-/- embryos, which lack both maternal and 
zygotic Scm product, all body segments from T1 (thoracic) to A7 (abdominal) were 
shown to be transformed into copies of segment A8 (Breen and Duncan, 1986). Sfmbt1 
(knockout allele) homozygous animals die as larvae (Klymenko et al., 2006), but mis-
expression of the Hox gene products Ubx and Scr could be observed in induced Sfmbt1 
homozygous cell clones in imaginal discs of otherwise heterozygous animals. 
It is worth noting that dL(3)mbt, Scm and Sfmbt protein sequences do not only share 
MBT domains as a structural motif, but also Zn fingers of the C2C2 type and the SPM 
domain (Bornemann et al., 1996) (Figure 2.7). The latter Scm, Ph and MBT homology 
(SPM) domain belongs to the superfamily of sterile alpha motif (SAM) domains (Kim 
and Bowie, 2003; Ponting, 1995) and might have a role in homo- and hetero-
dimerisation/oligomerisation (Kim et al., 2002; Kim et al., 2005; Peterson et al., 1997). 
In this context, the SPM domains of Scm and Polyhomeotic (Ph) can mediate direct 
binding of the two proteins in vitro (Peterson et al., 1997). Genetic rescue experiments 
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in vivo revealed that mutations within the SPM domain of Scm that disrupt protein 
interactions in vitro correlate with a loss of Scm function (Peterson et al., 2004). 
Moreover, overexpression of the isolated wild-type SPM domain causes PcG loss-of-
function homeotic transformation phenotypes in flies, supporting the idea that the SPM 
interaction module can efficiently compete with endogenous Scm for binding to other 
PcG partners in vivo. 
 
 
Figure 2.7: Schematic depiction of protein domain structures of Drosophila MBT proteins. 
Functional domains of dL(3)mbt, Scm and Sfmbt (transcript B) are displayed: MBT domains 
(red), SPM domains (blue) and putative Zn-fingers of the C2C2-type (orange). The positions of 
the domains are indicated below (MBT, SPM) or on top (C2C2). Protein lengths are indicated on 
the right. 
 
2.2.3 MBT domain proteins in other species 
The discovery of dL(3)mbt in the fly led to the identification of homologues from 
Caenorhabditis elegans (C. elegans) to man.  
MBT domain proteins in C. elegans 
In C. elegans three genes encode MBT domain containing proteins: lin-61, mbtr-1 
(Harrison et al., 2007) and sor-3 (Yang et al., 2007). The LIN-61 and MBTR-1 proteins 
have a similar protein domain structure, being composed almost exclusively of four 
MBT domains and lacking other functional domains (Harrison et al., 2007). Mutational 
studies identified lin-61 as a class B synthetic multivulva (synMuv) gene. In C. elegans 
vulval development is negatively regulated by the redundant functions of the synMuv 
genes, which are subdivided into three classes, namely A, B and C. The multivulva 
phenotype is caused by the mutation of at least two alleles from two different classes 
(Fay and Yochem, 2007). Several of the class B synMuv proteins act together in either 
one of the two protein complexes, DRM (DP, RB, MuvB) or NuRD-like (nucleosome 
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remodelling and histone deacetylase) (Harrison et al., 2006). However, LIN-61 was 
found to interact with neither of them (Harrison et al., 2007). Furthermore, despite their 
similar domain structure, MBTR-1 was not found to be involved in vulval development 
and its biological function remains unknown. Compared to other MBT domain 
containing proteins the Sor-3 protein in C. elegans is unique as it possesses only a 
single MBT domain (Yang et al., 2007). The corresponding sor-3 gene was identified 
because of its role in regulating the specification of neuronal identities, including 
neurotransmitter patterning and axon pathfinding. In the same study, sor-3 was shown 
to function as a PcG-like gene in maintaining the repression of the Hox gene egl-5 
outside of the restricted expression domain. 
MBT domain proteins in the mammalian system 
In mammals, at least nine MBT domain containing proteins exist (Bonasio et al., 2010). 
Two resemble Drosophila Scm, possessing two MBT domains: SCMH1 (Berger et al, 
1999) and SCML2 (Montini et al., 1999). Three contain three MBT domains, like 
dL(3)mbt: L3MBTL1 (also known as L3MBTL) (Koga et al., 1999), L3MBTL3 
(previously named MBT-1) (Arai and Miyazaki, 2005) and L3MBTL4 (Addou-Klouche 
et al., 2010). Four proteins are homologous to Sfmbt harbouring four MBT domains: 
L3MBTL2 (Wismar, 2001), SFMBT1 (Usui et al., 2000), SFMBT2 (Kuzmin et al., 
2008) and MBTD1 (Eryilmaz et al., 2009). It is worth mentioning that L3MBTL2, 
unlike most other MBT domain proteins, does not contain an SPM domain. 
 
Table 2.1: Homologous MBT domain proteins in D. melanogaster, human and C. elegans. 
For evolutionary relationship and domain organisation see Bonasio et al., 2010. 
Number of 
MBT domains D. melanogaster Human C. elegans 
1 - - SOR-3 
2 Scm SCMH1 SCML2 - 
3 dL(3)mbt 
L3MBTL1 
L3MBTL3 
L3MBTL4 
- 
4 Sfmbt 
L3MBTL2 
SFMBT1 
SFMBT2 
MBTD1 
LIN-61 
MBTR-1 
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MBT domain proteins and diseases  
The fact that mutation of the Drosophila l(3)mbt gene leads to a strong tumourigenic 
phenotype awoke interest in the potential tumour suppressor function of homologous 
human genes. Strikingly, the l3mbtl1 gene maps to chromosome 20q12, a region that is 
commonly deleted (del(20q12)) in hematopoietic malignancies, such as myelo-
proliferative disorders (MPD), like polycythaemia vera (PV), myelodysplastic 
syndromes (MDS) and acute myeloid leukemia (AML) (Bench et al., 2004; MacGrogan 
et al., 2004). In addition, L3MBTL1 is expressed in CD34+ hematopoietic stem 
progenitor cells (HSPCs), which enclose the hematopoietic progenitor cells from which 
myeloid disorders arise (MacGrogan et al., 2004). Therefore, l3mbtl1 has been assumed 
to be a good candidate tumour suppressor gene within this region, whose inactivation or 
haploinsufficiency could account for the pathogenesis of these disorders (Perna et al., 
2010). However, two mutation analyses of a limited number of myeloid leukemia cell 
lines and samples from MPD and MDS patients did not identify any significant 
mutations (Bench et al., 2004; MacGrogan et al., 2004). Furthermore, the l3mbtl1 gene 
has been previously identified as an imprinted gene locus in normal hematopoietic cells, 
in which monoallelic methylation of CpG islands is associated with transcriptional 
silencing. However, the analysis of methylation patterns revealed that the 20q12 
deletion does not correlate with the preferential loss of one specific allele and retention 
of the methylated allele did not correlate with reduction in l3mbtl1 mRNA levels 
(Bench et al., 2004; Li et al., 2004). Nevertheless, MacGrogan et al. (2004) found that 
eight leukemia cell lines (from 35 tested) showed significantly lower l3mbtl1 expression 
(at least 3-fold; mRNA was not detectable in five cell lines) and two samples from 
AML patients (from 15 tested) exhibited aberrant expression (significantly lower and 
higher compared to normal cell population). This might indicate a relevance of 
L3MBTL1 expression in some cases of myeloid leukemia.  
Recently, Perna et al. (2010) investigated the role of the L3MBTL1 protein in normal 
hematopoiesis in more detail by knockdown and overexpression experiments in CD34+ 
cells. Thus, the knockdown of L3MBTL1 resulted in an accelerated differentiation of 
hematopoietic progenitor cells towards the erythroid lineage, whereas overexpression of 
L3MBTL1 impaired erythroid differentiation. Additionally, L3MBTL1 depleted cells 
showed an increased activation of the STAT5, AKT/FOXO and MAPK signalling 
pathways, even in the absence of erythropoietin (Epo), which is characteristic of myelo-
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proliferative disorders, in particular polycythaemia vera. These results supported the 
idea that L3MBTL1 is critical for normal hematopoiesis.  
A study investigating the role of L3MBTL1 during the cell cycle revealed that its 
chromatin association is most prominent during S-phase and mirrors the appearance of 
the H4K20 mono-methylation mark, suggesting a possible role of L3MBTL1 related to 
DNA replication (Koga et al., 1999). Following this up, Gurvich et al. (2010) found that 
cell proliferation is inhibited in L3MBTL1 depleted U2OS cells, which arrest in G2/M 
phase. Moreover, knockdown of L3MBTL1 in these cells caused double strand breaks 
(DSBs), activation of the DNA damage response (DDR) pathway and genomic 
instability. In agreement with a function of L3MBTL1 during DNA replication, the 
protein was demonstrated to interact with various components of the DNA replication 
machinery and to be required for proper replication fork progression. The involvement 
of L3MBTL1 in DNA replication and maintenance of genomic stability might provide 
another mechanism for the role of l3mbtl1 as a tumour suppressor. However, given the 
non-redundant defects upon L3MBTL1 depletion in cell lines described above, it was 
somewhat surprising that L3MBTL1-/- mice developed normally and did not display any 
apparent phenotype (Qin et al., 2010). This might be attributed to a difference between 
an acute loss of L3MBTL1 upon knockdown versus a chronic absence in knockout 
mice, where functional compensation by another MBT family member could take place 
(Gurvich et al., 2010). 
In addition to L3MBTL1 also other MBT domain proteins have been linked to cancer in 
human. For instance, focal homozygous and hemizygous deletions of l3mbtl3, l3mbtl2 
and scml2 genes were identified in a subset of medulloblastomas (Northcott et al., 
2009). Furthermore, l3mbtl4 is a candidate tumour suppressor gene in breast cancer 
(Addou-Klouche et al., 2010) and AML (Veigaard et al., 2011). Loss of the 18p11 
region that l3mbtl4 maps to was found in approximately 20% of breast cancer tumours 
and 40% of breast cancer cell lines (Addou-Klouche et al., 2010). The l3mbtl4 gene was 
shown to be targeted by deletion, breakage and mutations and its mRNA was down-
regulated in a significant number of breast tumours. In addition, the 18p11 region was 
identified as a common deleted region in a subset of AML patients, characterised by a 
complex aberrant karyotype and poor prognosis (Veigaard et al., 2011). 
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2.2.4 MBT domain proteins in transcriptional repression 
2.2.4.1 Transcriptional silencing by Polycomb group proteins 
The two Drosophila MBT proteins Scm and Sfmbt act in concert with other PcG family 
members to maintain transcriptional repression of Hox genes (Simon et al., 1992; 
Klymenko et al., 2006). Since the discovery of PcG factors and their role in Hox gene 
regulation, genome-wide studies have greatly increased the number of target genes 
beyond Hox genes, both in D. melanogaster (Oktaba et al., 2008; Schwartz et al., 2006) 
and mammalian cells (Boyer et al., 2006; Lee et al., 2006b). In the fruit fly, several PcG 
protein complexes have been identified, among them PRC1 and PRC2, as well as the 
Pho-repressive complex (PhoRC) (Müller and Verrijzer, 2009). PcG proteins have been 
found to be associated with so called cis-regulatory Polycomb responsive elements 
(PREs) that are required for silencing (Müller and Kassis, 2006).  
Scm and the PRC1 complex 
Biochemical studies have established Pc, Ph, Posterior sex combs (Psc) and Sex combs 
extra (Sce)/Ring1 as core subunits of PRC1 (Francis et al., 2001; Saurin et al., 2001; 
Shao et al., 1999). The PRC1 complex combines writer and reader activities through 
Ring1 and Pc: The enzymatic activity of Ring1 facilitates H2A ubiquitylation, while the 
Chromo domain of Pc was reported to specifically bind to tri-methylated H3K27 
(Fischle et al., 2003; Min et al., 2003), which is catalysed by E(z) and is a hallmark of 
PcG-silenced chromatin (Cao et al., 2002; Müller et al., 2002). Additional biochemical 
activities of PRC1 in vitro comprise chromatin compaction (Francis et al., 2004) and 
inhibition of chromatin remodelling (Francis et al., 2001; Shao et al., 1999). The nature 
of the Scm association with PRC1 (Figure 2.8), initially suggested by in vitro 
interaction assays between the SPM domains of Scm and Ph (Peterson et al., 1997), is 
controversial. In vivo reporter gene assays demonstrate the repressor function of Scm, 
when tethered to DNA, that requires functional Ph (Roseman et al., 2001). Further 
evidence derives from biochemical purifications that consistently detect sub-
stoichiometric amounts of Scm in PRC1 complexes in both fly and human (Saurin 
et al., 2001; Levine et al., 2002). However, co-immunoprecipitations detect little or no 
association between Scm and PRC1 components (Klymenko et al., 2006; Peterson et al., 
2004). Additionally, although Scm can stably assemble into a reconstituted PRC1 
complex upon baculoviral co-expression, in gel filtration analysis the bulk of Scm in fly 
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embryo extract elutes in a peak that separates from Ph containing fractions (Peterson 
et al., 2004).  
 
 
Figure 2.8: Drosophila MBT domain proteins in multi-subunit complexes: Left panel.: 
dL(3)mbt and the Myb-MuvB complex. Middle panel: Scm and the PRC1 complex. Right 
panel: Sfmbt within the PhoRC complex. dL(3)mbt and Scm are associated with the 
corresponding complexes in sub-stoichiometric amounts. See text for more detail. 
 
Targeting of Polycomb complexes 
Recently, in order to functionally characterise the relationships between Scm and the 
three PcG complexes, PRC1, PRC2 and PhoRC, in the context of chromatin, ChIP 
studies of distinct PcG components have been carried out upon RNAi in S2 cells and 
larval imaginal discs (Wang et al., 2010). In this study, Scm was found to co-occupy a 
PRE upstream of Ubx together with PRC1, PRC2 and PhoRC. However, Scm 
association was retained upon knockdown of Pho (PhoRC), E(z) (PRC2) or Pc (PRC1). 
In contrast, knockdown or mutation of Scm did not affect Pho binding, but dislodged 
PRC1 and PRC2 subunits. Similarly, upon Sfmbt knockdown, Scm remained bound, 
whereas PRC1 and PRC2 levels were reduced. These results are in agreement with 
biochemical studies suggesting that Scm is not a core subunit of PRC1 (see above), 
although it might be involved in the recruitment of PRC1 and PRC2. Questions that 
remain to be answered are how Scm itself is recruited, since it lacks a DNA-specific 
binding motif, and how it executes its repressor function. 
Another recent study identified conjugation of Small ubiquitin-like modifier (SUMO) as 
a negative regulation mechanism of Scm and PcG-mediated silencing (Smith et al., 
2011). The Scm protein was found to be a novel substrate for SUMO modification, 
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whereby decreased SUMOylation correlated with elevated levels of Scm at the bxd 
PRE. In agreement with this, SUMO knockdown resulted in lower expression levels of 
Ubx in S2 cells and partial haltere-to-wing transformation phenotypes in flies. 
The only known PcG proteins with specific DNA-binding activity are the redundant 
factors Pleiohomeotic (Pho; Brown et al., 1998) and Pho-like (Brown et al., 2003), 
which are required for anchoring the complexes PRC1 and PRC2 at PRE sequences 
(Wang et al., 2004). However, Pho is not a subunit of either PRC1 or PRC2, but was 
found to exist together with Sfmbt in a distinct complex, named PhoRC (Klymenko 
et al., 2006) (Figure 2.8). Analysis of genome-wide distribution of Pho and Sfmbt in 
embryos and larvae revealed that PhoRC associates with PREs of a large number of 
target genes, including key developmental regulators, many of which are co-occupied 
by PRC1 and PRC2 (Oktaba et al., 2008).  
Repressive activities of Scm and Sfmbt  
With regard to a role in silencing, transcriptional repressive activity of Sfmbt was 
demonstrated in embryos carrying an UASGAL4-Ubx-LacZ reporter gene, when tethering 
Sfmbt to DNA by fusion to GAL4 (Klymenko et al., 2006). As reported for other MBT 
domains protein, the MBT repeats of Scm (Grimm et al., 2007) and Sfmbt (Grimm 
et al., 2009) bind specifically to mono- and di-methylated lysines of various histone 
peptides, respectively. To study the importance of the MBT domains in Hox gene 
repression, Scm (∆MBT or D324A) and Sfmbt (E947A/Y948F/D917A) transgenes with 
mutations in their MBT domains, that abolish histone peptide binding in vitro, were 
tested for their capacity to rescue Hox gene repression (Ubx) in homozygous null-
mutant imaginal discs (Grimm et al., 2007; Grimm et al., 2009). In case of Scm, MBT 
mutant transgenes showed impaired functionality in the rescue experiment compared to 
wild-type protein. But surprisingly, Scm∆MBT and ScmD324A were able to rescue 
repression of Ubx in a fraction of cell clones. Similar results were obtained testing 
the SfmbtE947A/Y948F/D917 mutant in a homozygous Sfmbt null-background. These 
observations raised the question, whether Scm and Sfmbt function in a partially 
redundant fashion in Hox gene silencing, even though biochemical purifications suggest 
that they are present in distinct complexes (Grimm et al., 2009). In line with this 
hypothesis, Scm and Sfmbt co-occupied several PREs at common target genes. 
Furthermore, the functional redundancy between Scm and Sfmbt was tested by 
investigating the mis-expression of PcG target genes in clones lacking wild-type Scm 
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and Sfmbt function, but expressing ScmD324A instead. Interestingly, in these double 
mutant clones a strong synergistic effect between Scm and Sfmbt for the two target 
genes Abd-B and en was observed, suggesting that the two proteins cooperate to 
maintain PcG repression. Although Scm and Sfmbt were purified in different PcG 
complexes, co-expression in Sf9 cells revealed a potential physical association in 
addition to the known genetic interaction (Grimm et al., 2009). The relevance of this 
association in vivo and the role of histone modification binding by MBT domains in the 
Polycomb system are so far unclear. 
 
2.2.4.2 Transcriptional repression by dL(3)mbt and homologous proteins 
Repression mechanism of human MBT domain proteins 
Similar to Scm (Roseman et al., 2001) and Sfmbt (Klymenko et al., 2006), human 
L3MBTL1 (Boccuni et al., 2003), L3MBTL2 (Yoo et al., 2010) and SFMBT1 (Wu 
et al., 2007) were shown to function as transcriptional repressors, when tethered to 
DNA using UAS/GAL4 luciferase reporter assays. Analysis of different deletion 
mutants of L3MBTL1 revealed that the MBT repeats are required for full repressive 
activity, whereas the SPM domain and the Zn finger motif were dispensable (Boccuni 
et al., 2003). In accordance with this, a construct spanning only the four MBT domains 
of SFMBT1 was sufficient to mediate transcriptional repression (Wu et al., 2007). In 
contrast to L3MBTL1, whose transcriptional repression seemed to be independent of 
HDAC activity (Boccuni et al., 2003), L3MBTL2-mediated repression was inhibited by 
TSA treatment (Yoo et al., 2010). Involvement of HDAC activity in transcriptional 
repression by L3MBTL2 is also supported by demonstration of a physical and selective 
interaction between HDAC3 and L3MBTL2 (Yoo et al., 2010). Knockdown of HDAC3, 
but not other class I HDACs, significantly relieved transcriptional repression mediated 
by L3MBTL2, suggesting that HDAC3 is a key-modulator in the repression mechanism.  
Like Sfmbt, L3MBTL1 was found to associate with a DNA sequence-specific 
transcription factor, providing a potential recruitment mechanism for L3MBTL1 to 
target genes (Boccuni et al., 2003). Thus, L3MBTL1 was reported to interact in vivo 
with TEL, also known as ETV6, which belongs to the ETS family of transcription 
factors. Deletion of either the SPM domain of L3MBTL1 or the SAM domain of TEL 
completely abrogated the interaction between the two proteins. Therefore, this is 
another example of SPM/SAM domains mediating protein-protein interactions (see 
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2.2.2). The ability of TEL to repress a luciferase reporter gene under the control of a 
TEL-responsive promoter was enhanced upon co-expression of L3MBTL1. This 
supports the idea that in fact L3MBTL1 is recruited to the promoter of target genes in a 
TEL-dependent manner. 
Another human transcription factor that was reported to recruit MBT domain proteins as 
co-repressors is Sp3. Aiming at identifying SUMO-dependent regulators of Sp3, 
Stielow et al. (2008a) made use of a genome-wide RNA interference (RNAi) screen in 
D. melanogaster Kc167 cells and identified Sfmbt as a corepressor of Sp3 acting 
downstream of SUMO conjugation. In line with a SUMO-specific regulation 
mechanism, Sfmbt has been shown to be capable of binding to SUMOylated Sp3 and to 
be recruited to a luciferase reporter gene carrying Sp3 binding motifs in a 
SUMOylation-dependent manner (Stielow et al., 2008a). In agreement with the 
assumption that the co-repressor function of MBT domain proteins is conserved in the 
human system, L3MBTL1 and L3MBTL2 were recruited to a luciferase reporter gene 
by GAL4-Sp3-WT, but not a SUMOylation-deficient GAL4-Sp3-KEEm mutant 
(Stielow et al., 2008b). In addition to MBT proteins, Mi-2, HP1 proteins and methyl-
transferases SETDB1 and SUV4-20H were recruited in a SUMO-dependent manner, 
together with the silencing histone marks H3K9me3 and H4K20me3, leading to a model 
in which SUMOylated Sp3 represses target genes by establishing a local hetero-
chromatic environment.  
MBT domain proteins and the E2F/pRB system 
Interestingly, several studies suggest the involvement of MBT domain proteins in the 
E2F/pRB pathway to repress E2F target genes. The pocket proteins, such as the tumour 
suppressor protein pRB, and heterodimeric E2F/DP transcription factors cooperate in 
the regulation of cell cycle, but also differentiation (Blais and Dynlacht, 2007; Frolov 
and Dyson, 2004; Korenjak and Brehm, 2005). In G0/G1 pRB-family members interact 
with E2F transcription factors to repress genes required for S-phase entry and cell cycle 
progression through S-phase. Phosphorylation of pRB-family members induced by 
Cycline-dependent kinases (CDKs) causes the release of E2F repressor complexes from 
occupied promoters and results in binding of activator E2Fs and the expression of E2F 
target genes. The modulation of chromatin structure is thought to play an important role 
underlying pRB-mediated repression. Aside from core histones and the linker histone 
H1B, Trojer et al. (2007) identified HP1γ and the retinoblastoma protein (pRB) as 
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proteins interacting with L3MBTL1 using α-FLAG affinity purification. In agreement 
with pRB-association, L3MBTL1 is bound to proximal promoter regions of E2F target 
genes c-myc and cyclin E1 (Trojer et al., 2007). At the cyclin E1 promoter mono-
methylation of H4K20 has been shown to contribute to association of L3MBTL1 to 
chromatin (Kalakonda et al., 2008). In addition to L3MBTL1, L3MBTL2 has been co-
purified with an E2F-6 complex (E2F6.com-1), including the E2F6 heterodimeric 
partner DP-1, the heterodimeric transcription factors Mga/Max, the PcG proteins 
RING1/2 and HP1γ (Ogawa et al., 2002). Subunits of the E2F6.com-1 were found to 
bind to E2F-responsive target genes in G0 rather than G1. Since the MBT domains of 
L3MBTL1/2 have the capability to compact nucleosomal arrays (Trojer et al., 2007; 
Trojer et al., 2011; Trojer and Reinberg, 2008) and human L3MBTL1/2 have been 
demonstrated to associate or co-localise with HP1 proteins (Ogawa et al., 2002; 
Stielow et al., 2008b; Trojer et al., 2007), a model has been put forward, in which MBT 
domain proteins repress target genes by chromatin compaction and local 
heterochromatin formation. 
In Drosophila, there is data as well linking the action of MBT domain proteins with 
E2F transcription factors. During the isolation of the Myb-MuvB complex dL(3)mbt, 
just like the HDAC dRpd3, were co-purified, however, both in sub-stoichiometric 
amounts compared with the core components of the complex (Lewis et al., 2004). The 
Myb-MuvB core complex contains beside the heterodimeric transcription factor 
dE2F2/dDP, one of the two pocket proteins RBF1 and RBF2, members of the 
retinoblastoma protein family, p55/Caf1, a second transcription factor, called dMyb, 
and the dMyb-interacting proteins Mip120, Mip130 and Mip40, (Figure 2.8). An 
independent purification of the identical core complex, termed dREAM (Drosophila 
RBF, dE2F2, and dMyb-interacting proteins) complex, failed to recover dL(3)mbt, as 
well as dRpd3, as stable interaction partners (Korenjak et al., 2004). Moreover, in 
C. elegans even though the MBT domain protein LIN-61 acts as a class B synMuv gene 
in the same genetic pathway as the worm homologues of pRB and E2F, LIN-35 and 
EFL-1, which assemble together into the DRM complex, no physical interaction 
between LIN-61 and subunits of the DRM complex was detected (Harrison et al., 2006; 
Harrison et al., 2007).  
However, in line with a functional interaction dL(3)mbt co-represses a significant 
number of E2F target genes with roles in developmental processes (Georlette et al., 
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2007; Lewis et al., 2004). Additionally, dL(3)mbt and Sfmbt were identified to act as 
negative regulators of E2F in a reporter-based genome-wide RNAi screen in Drosophila 
cells (Lu et al., 2007).  
 
2.3 Objectives 
Past research on MBT domain-containing proteins has revealed that they are associated 
with chromatin and play critical roles in transcriptional repression, regulation of 
development and tumour suppression (see 2.2).  
The presence of a limited number of homologous MBT proteins in the fly (dL(3)mbt, 
Scm and Sfmbt, see 2.2.2), results in a lower potential of redundancy within this family 
of proteins compared to mammals, which have at least nine homologous MBT proteins 
(Bonasio et al., 2010). Therefore, D. melanogaster is a valuable model organism for 
biochemical and functional investigation of these chromatin-related factors.  
Previously, biochemical analyses have identified several MBT proteins associated with 
or as part of multi-subunit complexes (see 2.2.4). For dL(3)mbt an association with the 
Myb-MuvB complex has been reported (Lewis et al., 2004). However, the interaction 
between dL(3)mbt and the Myb-MuvB complex was only sub-stoichiometric. This 
raised the question, whether stoichiometric dL(3)mbt-specific protein complexes exist 
in the fly. Accordingly, one of the major goals of this PhD thesis was to address this 
question by identification and isolation of putative dL(3)mbt-specific protein complexes 
using gel filtration chromatography and α-FLAG immunoaffinity purification. 
In the past, MBT proteins were shown to contribute to transcriptional repression in both 
human and fly. Thus, an additional objective of this study was to determine the impact 
of potential dL(3)mbt complexes on transcriptional regulation by identifying target 
genes on a genome-wide level using a combined RNA interference (RNAi) and 
microarray approach. Moreover, this study aimed at finding direct target genes of 
dL(3)mbt complexes by chromatin immunoprecipitation (ChIP) analysis and further 
unravelling the consequences of transcriptional control by dL(3)mbt and its interaction 
partners on the chromatin level. 
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3 Material and Methods 
3.1 Material 
3.1.1 Material sources 
If not mentioned otherwise, all common chemicals and reagents as well as equipment 
and consumables used in this study were from the following companies and trademarks: 
Abcam plc, Abgene Ltd., Aesculap AG, Agilent Technologies Inc., Amersham 
Biosciences, AppliChem GmbH, Bayer AG, B. Braun Melsungen AG, Beckman 
Coulter Inc., Biometra, Bio-Rad Laboratories Inc., Biozym Scientific GmbH, 
Boehringer Ingelheim, Calbiochem, Covance Inc., Diagenode, Eppendorf, Fermentas, 
Gilson Inc., GE Healthcare, G. Kisker, Greiner Bio-one, Heraeus, HMC Europe GmbH, 
Intas Pharmaceutical Inc., Invitrogen, Julabo Labortechnik GmbH, Otto E. Kobe AG, 
Kodak, Labnet International, Lauda Dr. R. Wobser GmbH & Co.KG, Leica Micro-
systems GmbH, Life Technologies Corporation, Merck Chemicals, Millipore, MWG 
Biotech, New England Biolabs, PAA Laboratories GmbH, Peqlab Biotechnologie 
GmbH, Perbio, Pierce, Promega, Qiagen, Roche, Roth, Santa Cruz Biotechnology, 
Sarstedt AG & Co., Sartorius AG, Scientific Industries, Serva GmbH, Sigma-Aldrich, 
Sorenson BioScience, Thermo Fisher Scientific Inc., Upstate, VWR International, 
Whatman and Zeiss. 
 
3.1.1.1 Enzymes 
Calf intestine alkaline phosphatase Fermentas 
DNase I (RNase-free) Peqlab 
Fast AP Thermosensitive Alkaline  
Phosphatase Fermentas 
M-MLV Reverse Transcriptase  Invitrogen 
Proteinase K Roth 
Restriction endonucleases Fermentas, New England BioLabs 
RNase A (DNase-free)  Qiagen  
Taq DNA Polymerase  Fermentas 
T4 DNA ligase  Fermentas 
 
3.1.1.2 Enzyme inhibitors 
Aprotinin  Roth 
Leupeptin  Roth 
Pepstatin  Roth 
PMSF (phenyl-methane-sulfonyl-fluoride) Roth 
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RNasin Ribonuclease Inhibitor Promega 
RiboLock RNase Inhibitor  Fermentas 
 
3.1.1.3 Chromatography and affinity purification  
ÄKTApurifier system  GE Healthcare 
ANTI-FLAG M2 Agarose   Sigma-Aldrich 
Dialysis membranes  Spectra/Por 
Glutathione Sepharose 4 Fast Flow   GE Healthcare  
GSTrap FF column   GE Healthcare 
HiTrap SP HP column   GE Healthcare  
HiTrap Q Sepharose FF column  GE Healthcare 
Mono Q 5/50 GL column  GE Healthcare 
Protein A Sepharose 4 FF  GE Healthcare 
Protein G Sepharose 4 FF  GE Healthcare 
StrataClean Resin  Stratagene 
SulfoLink Coupling Gel  Pierce 
Superose 6 HR 10/30 gel filtration column  GE Healthcare 
 
3.1.1.4 SDS-PAGE and Western blotting  
APS (ammonium persulfate) Serva 
Rotiphorese Gel 30  
(Acrylamide-Bisacrylamide 37,5:1) Roth  
Immobilon Western Chemiluminescent  
HRP Substrate  Millipore 
PageBlue  Fermentas 
PageRuler Prestained Protein Ladder  Fermentas 
Protein Assay (Bradford solution)  Bio-Rad 
Roti-Load 1  Roth 
Roti-PVDF membrane  Roth 
SuperRX Fuji Medical X-ray film  Fujifilm 
TEMED (tetramethyl-ethylene-diamine)  Roth 
Whatman-3MM paper  Whatman 
 
 
3.1.1.5 Agarose gel electrophoresis 
6x DNA Loading Dye Fermentas 
GeneRuler 1 kb DNA Ladder Plus Fermentas 
EtBr (ethidium bromide) AppliChem 
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3.1.1.6 Kits 
Table 3.1: Kits with corresponding application and supplier. 
Kit Application Supplier 
ABsolute SYBR Green Mix qPCR Thermo-
Scientific 
Attractene Reagent Transient transfection of 
Drosophila cells 
Qiagen 
 
Bac-N-Blue Transfection Kit  SF9 cell transfection for 
baculovirus generation 
Invitrogen 
Colloidal Blue Staining Kit Colloidal coomassie staining 
of SDS-PAGE gels 
Invitrogen 
Dual-Luciferase Reporter Assay 
System 
Measurement of Firefly and 
Renilla luciferase enzymatic 
activities 
Promega 
Effectene Transfection Reagent Transient transfection of 
Drosophila cells 
Qiagen 
 
Expand High FidelityPLUS PCR 
System 
PCR  Roche 
HiSpeed Plasmid Maxi Kit DNA isolation for cell 
transfection 
Qiagen 
 
Immobilon Western 
Chemiluminescent HRP Substrate 
Detection of Western blot  
signals 
Millipore 
MEGAscript T7 Kit In vitro transcription Ambion 
Nanofect Reagent Transient transfection of 
Drosophila cells 
Qiagen 
 
peqGOLD Cycle-Pure Kit  DNA isolation after ChIP Peqlab 
peqGOLD Total RNA Kit RNA isolation from 
Drosophila cells and larvae 
Peqlab 
QIAGEN Plasmid Midi Kit DNA isolation for cell 
transfection and cloning 
Qiagen 
QIAquick Gel Extraction Kit  Extraction of DNA from 
agarose gels  
Qiagen 
 
TNT T3/SP6 Quick Coupled 
Reticulocyte Transcription-
Translation System 
Coupled in vitro transcription 
and translation 
Promega 
 
Additional sources and suppliers are mentioned in the individual subsections of section 
3.2. Methods. 
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3.1.2 Standard solutions 
The most common solutions and buffers are listed below. Buffer preparation was 
carried out according to standard procedures. Additional buffers are described in the 
individual subsections of section 3.2. Methods. 
 
Phosphate Buffered Saline (PBS) 140 mM NaCl 
 2.7 mM KCl 
 8.1 mM Na2HPO4 
 1.5 mM K2PO4 
 
pH adjusted to 7.4 with HCl 
 
TE buffer 10 mM Tris-HCl, pH 8.0  
 1 mM EDTA, pH 8.0  
 
TAE buffer 40 mM Tris-acetate, pH 8.0 
 1 mM EDTA, pH 8.0 
 
TBE buffer 90 mM Tris-borate 
 2 mM EDTA 
 
3.1.3 Bacteria strains and culture media 
The Escherichia coli (E. coli) XL1-Blue strain was used for cloning and the propagation 
of plasmid DNA. The E. coli BL21 strain was used specifically for recombinant protein 
expression of GST fusion proteins.  
Transformed bacteria were selected, depending on the resistance gene encoded on the 
plasmid, with 100 µg/ml ampicillin (Ratiopharm) or 30 µg/ml kanamycin (AppliChem). 
 
Lysogeny Broth (LB) medium  1% (w/v) Peptone 
 0.5% (w/v) Yeast extract 
 1% (w/v) NaCl 
 
Agar plates 1.5% (w/v) Agar-agar  
 in LB medium 
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3.1.4 Cell lines and tissue culture media 
3.1.4.1 Insect cell lines 
Kc167: A female diploid D. melanogaster cell line, derived from 6 to 12 hr old 
Drosophila embryos (Echalier and Ohanessian, 1970). 
S2: A male aneuploid D. melanogaster cell line, derived from a primary culture of 20 to 
24 hr old Drosophila embryos (Schneider, 1972; Zhang et al., 2010). 
Sf9: A cell line established from pupal tissue of Spodoptera frugiperda. Sf9 cells were 
used for the expression of recombinant proteins using the baculovirus system (Vaughn 
et al., 1977). 
 
3.1.4.2 Stably transfected S2 cell lines 
Below is a description of the two stable S2 cell lines established in this study (for 
generation, see 3.2.1.4). 
S2 pPacHAFLAG-dL(3)mbt (puromycin resistant): S2 cells were co-transfected 
with the plasmids pPacHAFLAG-dL(3)mbt and pBS-Puro. pPacHAFLAG-dL(3)mbt 
encodes the full length N-terminally HA-/FLAG-tagged dL(3)mbt protein under the 
control of the constitutive actin 5C promoter.  
S2 pPac-dLint-1-FLAG (puromycin resistant): S2 cells were co-transfected with the 
vectors pPac-dLint-1-FLAG and pBS-Puro. pPac-dLint-1-FLAG encodes the full length 
C-terminally FLAG-tagged dLint-1 protein under the control of the constitutive 
actin 5C promoter.  
The pBS-Puro vector carries a resistance gene against the antibiotic puromycin. 
Therefore, stably transfected S2 cell lines were selected and maintained by the addition 
of 5-10 µg/ml puromycin (PAA) into the medium. 
 
3.1.4.3 Tissue culture media 
Schneider’s Drosophila Medium: Tissue culture medium for Drosophila cell lines, 
used for both Kc167 and S2 cell lines.  
The medium was supplemented with 10% (v/v) fetal bovine serum (FBS; purchased 
from Gibco or HyClone) and 1% (v/v) Penicillin-Streptomycin (10 mg/ml; PAA). 
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Sf-900 II SFM: Tissue culture medium for Sf9 cells that was supplemented with 10% 
(v/v) FBS and 0.1% (v/v) Gentamycin (10 mg/ml; PAA). 
 
3.1.5 Fly strains 
Fly stocks were generally maintained at room temperature (RT), while fly crosses were 
kept at 26°C in a fly incubator. Fly stocks and crosses were cultured on standard food as 
described previously (Kunert and Brehm, 2008). 
Table 3.2: Fly strains used in this study. 
Fly strain Description Source 
OrR Oregon R wild-type fly strain P. Becker 
w[1118] isogenic w1118 isogenic fly strain, isogenised 
chromosomes 1, 2 and 3. 
Bloomington 
(BL#5905) 
da-GAL4  P{da-GAL4}; GAL4 driver strain, 
expresses GAL4 in a daughterless pattern.  
R. Renkawitz-
Pohl 
sgs-58AB-GAL4  GAL4 driver strain, expresses GAL4 in 
salivary glands. 
R. Renkawitz-
Pohl 
UAS-dL(3)mbt RNAi  Transgenic line carrying a UAS-RNAi 
construct directed against dL(3)mbt, 
inserted at the 2nd chromosome. 
VDRC library 
(ID #104563)  
UAS-dLint-1 RNAi Transgenic line carrying a UAS-RNAi 
construct directed against dLint-1, inserted 
at the 2nd chromosome. 
VDRC library 
(ID #105932) 
UAS-HA-FLAG-
dL(3)mbt  
Transgenic line carrying UAS-HA-FLAG-
dL(3)mbt, inserted at the 3rd chromosome. 
This study 
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3.1.6 Plasmids 
Table 3.3: Plasmids used in this study. 
Plasmid name Description Source/Reference 
LD05287 cDNA encoding for full length dL(3)mbt 
in the pBluescript_SK(-) vector. 
DGC gold BDGP 
collection 
RE35228 cDNA encoding for full length 
CG1908/dLint-1 in the pFLC-I vector. 
DGC gold BDGP 
collection 
pPac-HA-FLAG Vector for expression of N-terminal HA-
FLAG-tagged proteins under the control 
of the constitutive actin 5C promoter in 
Drosophila cells. 
G. Suske  
(Braun et al., 2001)  
pPac-FLAG-
BACK 
Vector for expression of C-terminal 
FLAG-tagged proteins under the control 
of the constitutive actin 5C promoter in 
Drosophila cells. 
I. Vetter 
pVL1392 Baculovirus transfer vector for 
recombinant protein expression in 
Sf9 cells. 
Invitrogen 
pGex4T1 Vector for IPTG-inducible (isopropyl-
beta-D-thiogalactopyranoside) expression 
of GST-tagged proteins in E. coli. 
GE Healthcare 
pGex5X3-3MBT Vector for IPTG-inducible expression of 
a GST fusion of the 3MBT domains of 
L3MBTL1 in E. coli. 
G. Suske; 
Generated by the 
Reinberg lab 
(Trojer et al., 2007) 
pBS-Puro Expression vector for Drosophila cells: 
encodes a resistance gene against 
puromycin under the control of the 
Drosophila heat shock promoter. 
(Benting et al., 
2000) 
pING14A Vector for in vitro transcription 
containing a SP6 promoter. 
(Hagemeier et al., 
1993) 
pUASTattB Integration vector for UAS/GAL4-
mediated expression of transgenes. The 
plasmid contains an attB element that is 
recognised by the φC31 integrase, which 
can integrate the construct into a 
transgenic fly genome at an attP landing 
site. The vector carries a white+ marker 
gene for selection of transgenic flies. 
H. Jäckle; 
Generated by the 
Basler lab (Bischof 
et al., 2007)  
pAc 5.1-LexA Expression vector for Drosophila cells, 
which encodes the DNA binding domain 
of LexA under the control of a 
constitutive actin promoter. 
B. Thompson 
(Thompson and 
Travers, 2008) 
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pAc 5.1-LexA-
dL(3)mbt 
Encodes full length dL(3)mbt, C-
terminally fused to the DNA binding 
domain of LexA. For constitutive 
expression in Drosophila cells, driven by 
a constitutive actin promoter. 
D. Pagliarini 
pAc 5.1-LexA- 
dLint-1 
Encodes full length dLint-1, C-terminally 
fused to the DNA binding domain of 
LexA. For constitutive expression in 
Drosophila cells, driven by a constitutive 
actin promoter. 
L. M. Reuter 
pGL2-hse/lexA Reporter gene vector for Drosophila 
cells, which encodes Firefly Luciferase. 
The luciferase reporter gene is under the 
control of the Hsp70 promoter. Upstream 
of the promoter reside 4 repeats of a 
LexA-specific recognition motif and a 
heat shock element. 
B. Thompson 
(Thompson and 
Travers, 2008) 
pPacRNLuc Expression vector for Drosophila cells, 
which encodes Renilla Luciferase under 
the control of a constitutive actin 
promoter. 
G. Suske 
Continuation of Table 3.3. 
 
Table 3.4: Plasmids generated in this study. 
Plasmid name Description 
pPac-HA-FLAG-
dL(3)mbt 
Encodes full length dL(3)mbt, tagged N-terminally with an 
HA-/FLAG-tag, for constitutive expression in Drosophila 
cells, cloned with XbaI and BamHI using oligos: l3mbt-5-fw 
and l3mbt-6-rv. 
pPac-dLint-1-FLAG Encodes full length dLint-1, tagged C-terminally with a 
FLAG-tag, for constitutive expression in Drosophila cells, 
cloned with NotI and XhoI, using oligos: CG1908-3-fw and 
CG1908-4-rv. 
pVL1392-HA-FLAG-
dL(3)mbt 
Encodes full length dL(3)mbt, N-terminally HA-/FLAG-
tagged, for generation of recombinant baculovirus, subcloned 
from pPac-HA-FLAG-dL(3)mbt with BglII and BamHI. 
pVL1392-dL(3)mbt-
FLAG 
Encodes full length dL(3)mbt, C-terminally FLAG-tagged, 
for generation of recombinant baculovirus, cloned with EcoRI 
and BamHI using oligos: l3mbt-9-fw and Flag-l3mbt-10-rv. 
pVL1392-FLAG-N-
term-dL(3)mbt 
Encodes the N-terminus (aa 2-786) of dL(3)mbt, N-terminally 
FLAG-tagged, for generation of recombinant baculovirus, 
cloned with EcoRI and BamHI using oligos: del-l3mbt-
Nterm-fw and del-l3mbt-Nterm-rv. 
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pVL1392-FLAG-
3MBT-dL(3)mbt 
Encodes the 3MBT domains (aa 787-1171) of dL(3)mbt, N-
terminally FLAG-tagged, for generation of recombinant 
baculovirus, cloned with EcoRI and BamHI using oligos: del-
l3mbt-MBTreg-fw and del-l3mbt-MBTreg-rv. 
pVL1392-FLAG-C-
term-dL(3)mbt 
Encodes the C-terminus (aa 1172-1477) of dL(3)mbt, N-
terminally FLAG-tagged, for generation of recombinant 
baculovirus, cloned with EcoRI and BamHI using oligos: del-
l3mbt-Cterm-fw and del-l3mbt-Cterm-rv. 
pVL1392-dLint-1 Encodes full length dLint-1 for generation of recombinant 
baculovirus, cloned with BglII and XbaI, using oligos: 
CG1908-5-fw and CG1908-6-rv. 
pGex4T1-3MBT-
dL(3)mbt 
Contains GST fusion of 3MBT domains (aa 811-1140) of 
dL(3)mbt for IPTG-inducible expression in E. coli, cloned 
with EcoRI and SalI using oligos: 3MBT-prim1-fw and 
3MBT-prim2-rv. 
pGex4T1-dLint-1 Contains GST fusion of full length dLint-1 for IPTG-
inducible expression in E. coli, cloned with SalI and NotI 
using oligos: CG1908-8-fw and CG1908-Cterm-rv. 
pGex4T1-Nterm-
dLint-1 
Contains GST fusion of N-terminus (aa 1-301) of dLint-1 for 
IPTG-inducible expression in E. coli, cloned with SalI and 
NotI using oligos: CG1908-Nterm-fw and CG1908-Nterm-rv. 
pGex4T1-Cterm-
dLint-1 
Encodes GST fusion of C-terminus (aa 302-602) of dLint-1 
for IPTG-inducible expression in E. coli, cloned with SalI and 
NotI using oligos: CG1908-Cterm-fw and CG1908-Cterm-rv. 
pGex4T1-PHDlike-
dLint-1 
Encodes GST fusion of PHD-like domain (aa 515-602) of 
Lint-1 for IPTG-inducible expression in E. coli, cloned with 
SalI and NotI using oligos: CG1908-9-fw and CG1908-
Cterm-rv. 
pING14A-dLint-1 Encodes full length dLint-1 under the control of a SP6 
promoter for in vitro transcription, cloned with XbaI using 
oligos: CG1908-1-fw and CG1908-1-rv. 
pUASattB-HA-
FLAG-dL(3)mbt 
Full length dL(3)mbt N-terminally HA-/FLAG-tagged for 
UAS/GAL4-mediated expression of recombinant dL(3)mbt in 
transgenic flies, subcloned from pPac-HA-FLAG-dL(3)mbt 
with BamHI into BglII cut pUASattB. 
Continuation of Table 3.4. 
 
Oligonucleotides that were used for PCR-cloning are listed in Table 3.5. PCR-cloned 
fragments were sequenced after cloning at LGC Genomics.  
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3.1.7 Oligonucleotides  
Unmodified DNA oligonucleotides were purchased from Eurofins MWG Operon, 
diluted for stock solutions at a concentration of 100 pmol/µl in double distilled water 
(ddH2O) and stored at -20°C. 
 
3.1.7.1 Primers for PCR cloning  
Table 3.5: Primers used for PCR cloning. Recognition sites of restriction endonucleases are 
underlined and FLAG-tag sequences are depicted in bold.  
Primer name Sequence 
l3mbt-5-fw CGCTCTAGACCTGCCATTGTCGATGGCCAG 
l3mbt-6-rv CGCGGATCCCTAAGAGGACGTGCGCAAGG 
l3mbt-9-fw GGCCGAATTCATGCTGCCATTGTCGATGGC 
Flag-l3mbt-10-rv 
 
TTAAGGATCCCTATTTATCGTCATCGTCTTTGTAG
TCAGAGGACGTGCGCAAGGG 
del-l3mbt-Nterm-fw TTAAGAATTCATGGACTACAAAGACGATGACGATA
AACTGCCATTGTCGATGGC 
del-l3mbt-Nterm-rv 
 
GGCCGGATCCCTATCTAGACAAATCTGGCGCTGTTC
C 
del-l3mbt-MBTreg-fw TTAAGAATTCATGGACTACAAAGACGATGACGATA
AACCACAAAAGCGGCAAACC 
del-l3mbt-MBTreg-rv GGCCGGATCCCTACGGCGCATACGGACAGC 
del-l3mbt-Cterm-fw TAAGAATTCATGGACTACAAAGACGATGACGATAA
ATCTAGAGAAAATTGGCGTCAGTGG 
del-l3mbt-Cterm-rv GGGCCGGATCCCTAAGAGGACGTGCGCAA 
3MBT-prim1-fw GGCCGAATTCCAAAAGGATAAGCCCAGAAAGCC 
3MBT-prim2-rv AATTGTCGACTTACATCACGGACTTGGGCTGAAG 
CG1908-1-fw CCGGTCTAGAAGCAAGTACCATAAGGAGCGCA 
CG1908-1-rv CCGGTCTAGACTACTTCTCCAACTTATCTTTTTC 
CG1908-3-fw TTAAGCGGCCGCAGCAAGTACCATAAGGAGCGC 
CG1908-4-rv GGCCCTCGAGGTCTTCTCCAACTTATCTTTTTCGC 
CG1908-5-fw GGCCAGATCTATGAGCAAGTACCATAAGGAGC 
CG1908-6-rv GGCCTCTAGACTACTTCTCCAACTTATCTTTTTC 
CG1908-8-fw GGTTGTCGACTCATGAGCAAGTACCATAAGGAGC 
CG1908-9-fw  AATTGTCGACTCAGCAGCGCAGGAGGAGGAT 
CG1908-Nterm-fw GGCCGTCGACTCAGCAAGTACCATAAGGAGCGC 
CG1908-Nterm-rv TTAAGCGGCCGCCTAGATCTCCAGGTCCTCCTCGT  
CG1908-Cterm-fw GGCCGTCGACTCACCAGTTTGCAGAACGATCGC  
CG1908-Cterm-rv TTAAGCGGCCGCCTACTTCTCCAACTTATCTTTTTC  
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3.1.7.2 Primers for sequencing 
The inserts of all newly cloned constructs were sequenced before usage. Sequencing 
reactions were conducted by LGC Genomics.  
 
Table 3.6: Primers used for sequencing.  
Primer name Sequence 
l3mbt-seq-1-rv TCAACGGTCAGGCTGTTCTTG 
l3mbt-seq-2-fw TGTGTGCGAGTACATAGAGCG 
l3mbt-seq-3-fw TGGTGCCATCGCCCAGTAATC 
l3mbt-seq-4-rv CAGAATCAGGGAGTAGAGCTTC 
l3mbt-seq-5-fw CAGTGGCGCCAGTTGTTACATC 
l3mbt-seq-6-rv GTTTCCAGTTCGTGCGAGGTGG 
l3mbt-seq-7-fw CATCATCAAGGCGGAATCTCTG 
CG1908-seq-5-rv GCGACCCTTTCATCAGCTTCG 
CG1908-seq-6-fw GGATTGGGTCAGCAGATCGC 
CG1908-seq-7-fw TCC GGCAGCTCCGATGATTC 
GEX-fw CTTTGCAGGGCTGGCAAG 
GEX-rv GAGCTGCATGTGTCAGAGG 
 
3.1.7.3 Primers for generation of dsRNA by in vitro transcription 
Primers that were used to generate gene-specific dsRNAs by in vitro transcription 
contained a T7 promoter at the 5’ end. dsRNA probes were used for RNA interference 
(RNAi) experiments to knockdown specific proteins in Drosophila cell lines. RNAi 
probes were designed according to the GenomeRNAi database of the German Cancer 
Research Center (DKFZ) (http://www.dkfz.de/signaling2/rnai/) and the Gene Lookup 
tool of the Drosophila RNAi Screening Center (DRSC) (http://www.flyrnai.org/). 
 
Table 3.7: Primers for dsRNA synthesis by in vitro transcription: The sequence of the T7 
promoter is depicted in lowercase letters, whereas the gene-specific DNA sequence is shown in 
uppercase letters. 
Primer name Sequence ID/Reference 
EGFP-RNAi-fw  
 
gaattaatacgactcactatagggaGAGCTGGACGGC
GACGTAA 
(Stielow et al., 
2008a) 
EGFP-RNAi-rv  
 
gaattaatacgactcactatagggagACTTGTACAGCT
CGTCCATG 
dL(3)mbt-RNAi-
BKN20998-fw 
taatacgactcactatagggGTTGGTTTGGGTGCTG
TCTT 
BKN20998 
dL(3)mbt-RNAi-
BKN20998-rv 
taatacgactcactatagggGCGTCTAAAGTTCAGC
CAGG 
dLint-1-RNAi-
HFA19822-fw 
taatacgactcactatagggATGAAAGGGTCGCTG
GATT 
HFA19822 
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dLint-1-RNAi-
HFA19822-rv 
taatacgactcactatagggGCTCGGCACTGGAAT
CAT 
dRpd3- RNAi-(2)-
fw  
taatacgactcactatagggCGACGGCGTCTAATA
CCAAT 
(Stielow et al., 
2008a) 
dRpd3- RNAi-(2)-
rv  
taatacgactcactatagggCCGCCCACTGATTACT
GATT 
dCoREST-RNAi-
fw  
taatacgactcactatagggCATTCGCTCAGTTTTC
TGACG 
(Dallman 
et al., 2004) 
dCoREST-RNAi-
rv  
taatacgactcactatagggCCACCGAAATGTACTC
CTCC 
dLsd1-RNAi-fw taatacgactcactatagggAAAGAAACGTCAATC
ACCCG 
DRSC24846 
dLsd1-RNAi-rv taatacgactcactatagggCCTCTTCGTTGGGTGT
CATT 
E(z)-RNAi-fw taatacgactcactatagggTCTCCAGCGGTTCTTC
AGTT 
DRSC29388 
E(z)-RNAi-rv taatacgactcactatagggTCCTCGATAAGGATG
GCAA 
dPR-Set7-RNAi-fw taatacgactcactatagggATGGTCTCCAAGTACG
CCAC 
DRSC27118 
dPR-Set7-RNAi-rv taatacgactcactatagggCCAAAAACCAGTTTA
GCCCA 
G9a-RNAi-fw 
 
taatacgactcactatagggAAACCAAGTGTTACTT
TGAGAG 
DRSC18619 
G9a-RNAi-rv 
 
taatacgactcactatagggTGTACAAAATATGCC
ACATCCT 
Pc-RNAi-fw 
 
taatacgactcactatagggGAAGCCATAAACACA
ACGCC 
DRSC24966 
Pc-RNAi-rv taatacgactcactatagggACATTTGTTTGGGTCG
AAGC 
Continuation of Table 3.7. 
 
3.1.7.4 Primers for gene expression analysis by RT-qPCR  
Oligonucleotides that were used for RT-qPCR were designed either by the Universal 
ProbeLibrary Assay Design Center (Roche) or using Primer3 as a tool. The Oligo-dT 
primer that was used to reversely transcribe polyadenylated mRNAs into cDNA 
contained 17 dT nucleotides. 
Universal ProbeLibrary Assay Design Center:  
(http://www.roche-applied-science.com/sis/rtpcr/upl/index.jsp?id=UP030000) 
Primer3: (http://frodo.wi.mit.edu/primer3/) 
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Table 3.8: Primers for RT-qPCR gene expression analysis. 
Primer name Sequence Reference 
Gapdh1-fw GAGCAAGGACTAAACTAGCCAAA (Kunert et al., 
2009) Gapdh1-rv CAACAGTGATTCCCGACCA 
l(3)mbt-RT-7-fw TTTCTGGCACCACATTTCTG This study 
l(3)mbt-RT-8-rv CTCTCCTTCTGCGTACTCTGC This study 
lint-1-RT-fw GCAGGAGCAGCAAAGACG This study 
lint-1-RT-rv CTCAAAGAGGCCGAGGAAC This study 
piwi-RT-fw CAGAAGTACAAGGCCGGATAA This study 
piwi-RT-rv TTTGCCAATCAGCGTTTTCT This study 
nos-RT-fw GCGCGATCCTTGAAAATCT This study 
nos-RT-rv GCGAACTCCTGCATCACAT This study 
swa-RT-fw GCTGATGGCAGCGGTAGT This study 
swa-RT-rv GGCTGGTTTCCGAGTTGTT This study 
ea-RT-fw CGAAAATGCTAAAGCCATCG This study 
ea-RT-rv CGTTGGGGAAGTAGAACTGG This study 
tor-RT-fw GCCTGCAGAACTTTTTACGTG This study 
tor-RT-rv TGTCCACGTTCTGTTCAAGG This study 
bam-RT-fw GAGCAATGCGGACAAGTTC This study 
bam-RT-rv TAGCGGTGCTCCAGATCC This study 
zpg-RT-fw CGTCTTCTGCGAAATACTCAATTT This study 
zpg-RT-rv CACTGGTTATAGTCGCCATTGT This study 
spnE-RT-fw CCATATTTCCGATGCACTCA This study 
spnE-RT-rv ATGGGGTAAAGTGCCTTCG This study 
tud-RT-fw AAGAAGCCTTTGCTGCTTTG This study 
tud-RT-rv CCTCGTTCGGCTGAGTAGTT This study 
G9a-RT-fw  AACGATGACTTGGAGCGTGTA This study 
G9a-RT-rv GGGAGTCAGCACGTTGAAGT This study 
Pc-RT-fw TCCAAAAGCGCGTTAAGAAG This study 
Pc-RT-rv  TCGTTTGTTCGTAGATGTCGAT This study 
 
3.1.7.5 Primers for ChIP-qPCR analysis  
Oligonucleotides that were used for ChIP analysis were designed using Primer3 as a 
tool. 
 
Table 3.9: Primers for ChIP analysis by qPCR. 
Primer Sequence Reference 
swa-a-fw CGAAGTCCTGGAACTCGAAG This study 
swa-a-rv AGTCTCAGCACACGGAACG This study 
swa-b-fw TTTCGCCAAAGGCAATAGATG This study 
swa-b-rv GGCGAGATCGAGGAGTATG This study 
swa-c-fw TGCAGAGAAGCAATTTCACG This study 
swa-c-rv CAATTAAATATGGCAGCGAATTG This study 
swa-d-fw GTTAGCACCGAAGCTGATGG This study 
3 MATERIAL AND METHODS 
48 
 
swa-d-rv GCTGGTTTCCGAGTTGTTGG This study 
swa-e-fw ATCATGTGGACACCTCATCC This study 
swa-e-rv GCAAACGCTTCTGACTATCG This study 
swa-f-fw AAGTGGTTGCTTGTCGGTTG This study 
swa-f-rv TGACGACGCTGATATTGAGG This study 
piwi-a-fw CTGGTTGACCAACGATTGC This study 
piwi-a-rv CGATAACTGCAACCTGATCG This study 
piwi-b-fw CTTACCAATGCTTGGATCGAC This study 
piwi-b-rv GGAACCAATCCGAGGAGCTG This study 
piwi-c-fw TAAGGCTCTTGCAACGATTG This study 
piwi-c-rv TTTTTTGGTACTTCGAGCTTTG This study 
piwi-d-fw CCGTGGGGTGACCAATATG This study 
piwi-d-rv GATCCCAGAAGGTTAGCATG This study 
tok-b-fw GCGACGCTTGGTGAGAATC’ This study 
tok-b-rv GCAGAAAACTCTGCCGTAG This study 
tok-c-fw TTTGGGAAATTTGCCTTACG This study 
tok-c-rv AACCCTGGCACAAACGTATC This study 
tok-d-fw TCTGATTTCGCTTTGTGTCG This study 
tok-d-rv GGCCAGACAAGATGAGTTGG This study 
nos-b-fw GTCATCGTTTCCGAAAGCTC This study 
nos-b-rv AGGTATGGAGCTGCACAAGG This study 
nos-c-fw CATGTGATGTTGTCACAGTGC This study 
nos-c-rv ACTTGCTAAGAATATGTGCCAC This study 
nos-d-fw ATGTCCTACGGGAGTGCTC This study 
nos-d-rv CACACGTTGTTCAGATGCTC This study 
crb-b-fw CTAAGCGCCCAATGCTACTC This study 
crb-b-rv TTTTACCAGCCAGGAATTGG This study 
crb-c-fw TGCTGCTTGCAGTTCAAAAG This study 
crb-c-rv GCACGCGACACTTTCTAGC This study 
crb-d-fw CCTCATTTGTCTGCATTTTCA This study 
crb-d-rv CACAATCCGTTGGAAAAAGG This study 
ea-b-fw GAATGAAGGCATTGCGACTC This study 
ea-b-rv CCCACGGAATACGGGATAC This study 
ea-c-fw AGGCGGGGATTAAATAATGG This study 
ea-c-rv TGGCGAGTCTCCAAATCAG This study 
ea-d-fw GTGCCAGAACGTCTACAGC This study 
ea-d-rv GGAGTCGGTCCAAATGACAC This study 
spn-E-b-fw TCTGTTTCTAATAACTGACCAGCAA This study 
spnE-b-rv TTCCACGTTGTATTCGACAGA This study 
spnE-c-fw GCTGGGTTTCTTTCGATTACC This study 
spnE-c-rv TTTTTCTCACAGTCTTTCTGGATT This study 
spnE-d-fw TTCTGCATCAAGGCACTCTG This study 
spnE-d-rv GCTCTAGATCTGCGCAAGGA This study 
tud-b-fw TTAACGAATGGCTTTCCTCCT This study 
tud-b-rv CGGATTTCAGTAGCGTCCTC This study 
tud-c-fw CACGGCGACGTACCTAAAAT This study 
tud-c-rv TTCCACAAGACAACGAAACG This study 
Continuation of Table 3.9. 
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tud-d-fw TGGAAGGATAATCCGCAGTC This study 
tud-d-rv CGGCAGATGTTTAGGCGTAT This study 
actin5C-ORF-fw ACCGGTATCGTTCTGGACTC M.Murawska 
actin5C-ORF-rv CGGTCAGGATCTTCATCAGG M.Murawska 
interg-2R-fw TGCTGACTGCCATCAAATTC This study 
interg-2R-rv TACTTGCTGTGACGGCTTTG This study 
Continuation of Table 3.9. 
 
3.1.8 Antibodies and antisera 
3.1.8.1 Primary antibodies 
The dL(3)mbt- and dLint-1-specific antibodies were established and tested in the course 
of this study. More details concerning these antibodies can be found in section 3.2.5. 
 
Table 3.10: Antibodies and antisera used in this study. Antibodies are specified with their 
name, including clone number (if available) or order number (for commercial antibodies). 
Corresponding dilutions or amounts (in µg or µl) depending on the type of experiment are 
stated. WB: Western blot; IP: immunoprecipitation; ChIP: chromatin immunoprecipitation; 
IF: immunofluorescence; DSHB: Developmental Studies Hybridoma Bank. 
Antibody Host origin Experiment Dilution or 
amount 
Source/Reference 
α-FLAG  
M2 (F3165) 
Mouse, 
monoclonal 
WB 1:4000 Sigma-Aldrich 
α-FLAG 
(F7425) 
Rabbit, 
polyclonal 
WB 
ChIP 
1:2000 
1 µg 
Sigma-Aldrich 
α-GST  
R-6G9 
Mouse, 
monoclonal 
WB 
IP 
1:100 
100 µl 
E. Kremmer  
α-LexA Mouse, 
monoclonal 
WB 1:200 Santa Cruz 
Biotechnology 
α-dL(3)mbt #3 Rabbit, 
polyclonal 
WB 1:1000 Peptide Specialty 
Laboratories 
α-dL(3)mbt  
P1 6E6 
Rat, 
monoclonal 
IP 
IF 
50µl 
1:2 (conc.) 
E. Kremmer 
α-dL(3)mbt  
P3 8F10   
Rat, 
monoclonal 
IP 50µl E. Kremmer 
α-dLint-1 #1 Rabbit, 
polyclonal 
WB 
ChIP 
IF 
1:5000 
8 µl 
1:50 
Peptide Specialty 
Laboratories 
α-dLint-1 #2 Rabbit, 
polyclonal 
WB 
ChIP 
1:5000 
7 µl 
Peptide Specialty 
Laboratories 
Pre-immune #1 - WB 
ChIP 
1:5000 
6 µl 
Peptide Specialty 
Laboratories 
Pre-immune #2 - WB 
ChIP 
1:5000 
6.5 µl 
Peptide Specialty 
Laboratories 
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α-Rpd3 Rabbit, 
polyclonal 
WB 
 
1:5000 J. Müller 
(Brehm et al., 2000) 
α-dCoREST Rabbit, 
polyclonal 
WB 
 
1:5000 G. Mandel  
(Dallman et al., 2004) 
α-dLsd1  
(α-Su(var)3-3) 
Rabbit, 
polyclonal 
WB 
 
1:2000 T. Rudolph  
(Rudolph et al., 2007) 
α-dHDAC3 Rabbit, 
polyclonal 
WB 
 
1:1000 B. Turner 
α-dMi2 
(N-term) 
Rabbit, 
Polyclonal 
WB 
 
1:10000 (Kehle et al., 1998) 
α-dMi2 4D8 Rat, 
monoclonal 
IP 100 µl (Murawska et al., 
2008) 
α-RBF2 DR6 Rat, 
monoclonal 
WB 
 
1:10 N. Dyson 
α-HP1 C1A9 Mouse, 
monoclonal 
WB 
 
1:50 DSHB  
α-dPR-Set7 Rabbit, 
polyclonal 
WB 
 
1:1000 A. Imhof 
α-E(z)  Mouse, 
monoclonal 
WB 
 
1:50 A. Imhof 
α-E(z) TAF Rabbit, 
polyclonal 
WB 
IP 
1:1000 
2 µl 
J. Müller 
α-E(z) TAD Rabbit, 
polyclonal 
WB 
ChIP 
1:1000 
4 µl 
J. Müller 
α-Tubulin beta 
KMX-1 
Mouse, 
monoclonal 
WB 1:15000 Millipore 
α-Lamin C 
LC28.26 
Mouse, 
monoclonal 
WB 1:1000 DSHB  
α-H3  
(ab1791) 
Rabbit, 
polyclonal 
WB 
ChIP 
1:5000 
1 µg 
Abcam 
α-H4K20me1 
(ab9051) 
Rabbit, 
polyclonal 
WB 
ChIP 
1:1000 
3 µg 
Abcam 
α-H4K20me1 
(17-651) 
Rabbit, 
polyclonal 
ChIP 0.25 µg Millipore 
α-H4K20me2 
(39173) 
Rabbit, 
polyclonal 
ChIP 10 µl Active Motif 
α-H4ac  
(06-598) 
Rabbit, 
polyclonal 
ChIP 7.5 µg Millipore 
α-H3K4me2 
CMA303  
(05-1338) 
Mouse, 
monoclonal 
ChIP 3 µg Millipore 
α-H3K27me3 
(ab6002) 
Mouse, 
monoclonal 
WB 
 
1:1000 
 
Abcam 
α-H3K27me3  
(07-449) 
Rabbit, 
polyclonal 
ChIP 3 µg Millipore 
α-H3K27me3 
C36B11 (#9733) 
Rabbit, 
polyclonal 
ChIP 5 µg Cell Signaling 
Continuation of Table 3.10. 
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3.1.8.2 Secondary antibodies 
Table 3.11: Secondary antibodies used for Western blot analysis and immunofluorescence. 
WB: Western blot; IF: immunofluorescence;  
Antibody  Host origin Experiment Dilution Source  
ECL α-Rabbit  Donkey, 
polyclonal 
WB 1:30000 GE Healthcare 
ECL α-Mouse  Sheep, 
polyclonal 
WB 1:30000 GE Healthcare 
ECL α-Rat  Goat, 
polyclonal 
WB 1:30000 Jackson Immuno-
Research 
α-rabbit 
Alexa488 
Goat, 
polyclonal 
IF 1:200 Invitrogen 
α-rat  
Alexa546 
Goat, 
polyclonal 
IF 1:200 Invitrogen 
 
3.2 Methods 
If not stated otherwise reactions were performed at RT. 
3.2.1 Cell biological methods 
3.2.1.1 Standard cell culture procedures 
D. melanogaster S2 and Kc167 cells were propagated at 26°C in Schneider’s insect 
medium, supplemented with FBS and Penicillin-Streptomycin (3.1.4.3). Sf9 cells were 
cultured at 26°C in Sf-900 II SFM medium, supplemented with FBS and Gentamycin 
(3.1.4.3). For splitting, S2 and Kc167 cells were shaken off the flask and re-seeded in a 
cell density of 1.5-2·106 cells/ml every 3-4 days. Cell densities were determined using a 
hemacytometer. The adherent Sf9 cells were removed from the flask surface using a cell 
scraper when they had reached confluency, and splitted in a 1:3 to 1:4 ratio. Cells were 
typically spun down at 1000 rpm for 5 min at RT (Heraeus Megafuge 1.0). 
 
3.2.1.2 Freezing and thawing of cells 
For freezing, cells from one dense 75 cm2 flask were resuspended in 0.5 ml freezing 
medium A and 0.5 ml freezing medium B was added dropwise. 1 ml of cell suspension 
was aliquoted into a cryovial and frozen in a container with isopropanol at -80°C for 48-
72 hr, before stored at -80°C or in liquid nitrogen. 
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Freezing medium A Schneider’s insect or Sf-900 II SFM medium 
 40% (v/v) FBS 
 1% (v/v) Penicillin-Streptomycin or  
 0.1% (v/v) Gentamycin 
 
Freezing medium B  Schneider’s insect or Sf-900 II SFM medium 
 20% (v/v) dimethyl-sulfoxide (DMSO) 
 1% (v/v) Penicillin-Streptomycin or  
 0.1% (v/v) Gentamycin 
 
For thawing, cell aliquots were thawed at RT and resuspended in 12 ml of Schneider’s 
insect medium or Sf-900 II SFM medium. S2 and Kc167 cells were centrifuged to 
remove DMSO, diluted in fresh medium and transferred to a tissue culture flask. Sf9 
cells were directly seeded into a flask and medium was exchanged after 15-30 min, after 
cells had attached to the flask surface. 
 
3.2.1.3 Transient transfection 
To test for the expression of recombinant FLAG-tagged dL(3)mbt and dLint-1, S2 or 
Kc167 cells were transiently transfected with the corresponding pPac expression vector. 
For this, Nanofect transfection reagent (Qiagen) was used. 6-10·106 cells were seeded 
into 10 cm dishes 6-24 hr prior to transfection in 10 ml of supplemented medium. 
According to the manufacturer’s instruction manual, 7 ?g of plasmid DNA was diluted 
to a total volume of 300 µl with medium lacking supplements. 10 ?l of Nanofect 
transfection reagent were added and mixed by pipetting up and down. This was 
followed by an incubation for 10-15 min to allow transfection complex formation. 
Thereafter, cells were incubated with the transfection mix for 48 hr, harvested and 
assayed for expression by analysing nuclear extract samples (3.2.3.5) by Western blot 
(3.2.3.4).  
 
3.2.1.4 Stable transfection 
For the generation of monoclonal cell lines stably expressing recombinant proteins, S2 
cells are more suited than Kc167 cells, because S2 cells adhere to the culture dish more 
tightly, which leads to the formation of cell clones after selection with antibiotic. 
For this purpose, cells were transfected using the calcium phosphate method (Graham 
and van der Eb, 1973a/b). 8·106 S2 cells were seeded into a 10 cm dish in 10 ml of 
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supplemented medium. 24 hr later cells were co-transfected with 20 µg of the 
corresponding pPac expression vector (pPac-HA-FLAG-dL(3)mbt or pPac-dLint-1-
FLAG) and 1 µg of pBS-Puro. The plasmid DNA was diluted in 500 µl CaCl2 solution 
and added dropwise to 500 µl of 2x HeBS buffer while vortexing. After an incubation 
of 30 min the transfection mixture including precipitates was added dropwise onto the 
cells. Plates were swirled and incubated at 26°C. Two days post-transfection cells were 
selected for 4-6 weeks with 5-10 µg/ml puromycin (PAA). Clones were picked and 
expanded until finally tested for expression of recombinant protein by Western blot 
(3.2.3.4).  
 
CaCl2 solution HeBS buffer (2x) 
250 mM CaCl2  16 g NaCl 
1 mM Hepes/KOH, pH 7.1 0.7 g KCl 
sterile filtered
 
0.5 g Na2HPO4 
 2 g D-Glucose 
  10 g Hepes 
 pH adjusted to 7.1 with NaOH  
 up to 1 l with ddH2O 
 sterile filtered 
 
3.2.1.5 Luciferase reporter gene assay 
The plasmid-based luciferase reporter gene system (Thompson and Travers, 2008), used 
in this study, allows measuring the influence of a potential transcriptional regulator on 
transcription. Proteins of interest were fused to the DNA binding domain of LexA and 
tethered to specific LexA binding sites upstream of a reporter gene encoding the Firefly 
luciferase protein.  
1.6·106 Kc167 cells in 2 ml of supplemented cell culture medium were transfected 
simultaneously with three plasmids:  
1. 10 to 1000 ng of pAc5.1-LexA, pAc5.1-LexA-dL(3)mbt or pAc5.1-LexA- 
    dLint-1 
2. 250 ng of pGL2-hse/lexA 
3. 100 ng of pPacRNLuc  
As controls transfections without plasmid and with only 250 ng pGL2-hse/lexA or 
100 ng pPacRNLuc vector were included. pAc5.1 vectors were used to express the 
DNA binding domain of LexA (LexA) alone or dL(3)mbt and dLint-1 fused to LexA, 
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respectively. The expression of LexA or LexA fusion proteins was driven by a 
constitutive actin promoter. pGL2-hse/lexA was the vector carrying the luciferase 
reporter gene encoding for Firefly luciferase. This reporter gene was under the control 
of the Hsp70 promoter and a TATA box, located directly upstream of the transcription 
start site. Further upstream were multiple copies of specific recognition motifs for the 
LexA domain, tethering the LexA proteins in close proximity to the luciferase reporter 
gene promoter. The third plasmid, pPacRNLuc, was used to drive constitutive 
expression of Renilla luciferase (controlled by an actin promoter). The activity of the 
Renilla luciferase was needed for nomalisation to account for differences in transfection 
efficiencies.  
Transient transfections were carried out using Attractene Reagent (Qiagen). 4.5 µl of 
Attractene were added to each plasmid mixture and filled up to 100 µl with cell culture 
medium without supplements. The transfection mixture was incubated for 10-15 min at 
RT. Then the transfection mixture was added dropwise to the cells and incubated at 
26°C for 48 hr. In cases when the luciferase reporter gene assay was combined with 
RNAi, 0.8·106 cells were treated with 15 µg of dsRNA, as described elsewhere 
(3.2.2.4), incubated at 26°C and transfected 48 hr after RNAi treatment as described 
above. After 48 hr of transfection, cells were lysed to measure luciferase activities (see 
below), to extract protein for Western blot analysis (3.2.3.4) or to isolate RNA for RT-
qPCR (3.2.2.6). 
To measure the enzymatic activities of Firefly and Renilla luciferases in the cell lysates 
of transfected cells the Dual-Luciferase Reporter Assay System (Promega) was used 
according to manufacturer’s instructions. In brief, cells were harvested, washed twice 
with 1 ml of PBS and lysed in 250 µl of 1x Passive Lysis Buffer for 15 min while 
shaking. Then 20 µl of cell lysate were transferred into 5 ml polystyrene tubes (Sarstedt) 
in triplicates and Firefly and Renilla luciferase activities were determined using a 
Luminometer (AutoLumat PLUS LB953, Berthold Technologies). First, 100 µl of 
LAR II reagent were dispensed and Firefly luciferase activity was measured. Second, 
100 µl Stop & Glo reagent were added, which inhibits the activity of Firefly luciferase 
and allows the measurement of Renilla luciferase activity.  
For each sample the mean from the triplicate measurements of Firefly and Renilla 
luciferase enzymatic activities and the standard deviation was determined. To calculate 
the repressive activity of LexA fusion proteins, the mean values of the Firefly luciferase 
activities (aF) were normalised against the Renilla luciferase activities (aR) (equation 1) 
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and referred to the activities of samples transfected with an equal amount of expression 
vector encoding LexA alone (equation 2). 
(1)    b = (????)??                       (2)    ?-???? ?????????? =  (????? ?????? ???????????? ????? ) 
The calculation of errors for the fold repression was calculated according to the 
Gaussian error propagation law (equation 3). 
(3)    ?(??,??,… ) =  ?( ????? ∙ ∆?? )? + ( ????? ∙ ∆?? )? + ⋯    
 
3.2.2 Molecular biological methods 
Standard procedures in molecular biology, including transformation of DNA into 
chemically-competent bacteria, amplification of plasmid DNA in bacteria, restriction 
enzyme digestion, dephosphorylation of DNA fragments, ligation of DNA fragments, 
determination of DNA concentration and analysis of DNA on TAE- or TBE-agarose 
gels were carried out according to standard protocols (Sambrook and Russell, 2001). 
Plasmid DNA was prepared on a large scale using QIAGEN Plasmid Midi Kit (Qiagen). 
For small-scale preparation of plasmid DNA buffers P1 to P3 of the QIAGEN Plasmid 
Midi Kit were used and DNA was precipitated from the supernatant using isopropanol 
due to standard procedures. Furthermore, isolation of PCR products or other DNA 
fragments from agarose gels was conducted using QIAquick Gel Extraction Kit and 
purification of digested PCR products or other DNA fragments was carried out using 
QIAquick PCR Purification Kit.  
 
3.2.2.1 Total RNA isolation 
When working with RNA precautions were taken to provide an RNase-free 
environment. Pipette tips and reaction tubes were autoclaved before usage. In addition 
benches and pipettes were wiped with the decontamination solution RNaseZap 
(Ambion). Nuclease-free H2O from Ambion was used to solubilise or dilute RNA 
samples. 
Total RNA was purified from Kc167 cells or from 3rd instar larvae upon RNAi 
knockdown to examine changes in mRNA levels of target genes by RT-qPCR. RNA 
was purified using the peqGOLD Total RNA Kit (S-Line; Peqlab). For this purpose, 
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cells from one well (6-well plate) were lysed in 400 µl RNA Lysis Buffer T. In case of 
larvae, 15-20 animals, washed in PBS, were collected into a 1.5 ml reaction tube and 
frozen in liquid nitrogen. After removal from the liquid nitrogen 400 µl lysis buffer 
were directly added and larvae were homogenised with a pestle. After applying the 
lysate onto the DNA Removing Column RNA was isolated following the 
manufacturer’s instructions, including an on-column digest with DNase using the 
peqGOLD DNase I Digest Kit (Peqlab).  
 
3.2.2.2 Complementary DNA (cDNA) synthesis 
To quantify changes in transcription levels upon RNAi, the mRNA contained in the 
total RNA preparation (3.2.2.1) was reversely transcribed into first-strand cDNA. 
cDNA was synthesised using the M-MLV Reverse Transcriptase (Invitrogen), 
according to the manual’s instructions, using 1-1.5 µg of total RNA as template. dNTPs 
were purchased from Fermentas, nuclease-free H2O from Ambion and oligo (dT)17 
primer from MWG Biotech. cDNA was used as template for RT-qPCR (3.2.2.6) or for 
the generation of in vitro transcription (ivT) template by PCR (3.2.2.5).  
 
3.2.2.3 Synthesis of double-stranded RNA (dsRNA) by in vitro transcription 
(ivT) 
For the synthesis of dsRNA, first a template for ivT was generated by PCR (3.2.2.5) 
using gene-specific oligos amplifying a product, usually 300-600 bp in length, from a 
plasmid, cDNA or genomic DNA, containing the gene of interest. The forward and 
reverse primers used (Table 3.7), enclosed a minimal T7 polymerase promoter 
(TAATACGACTCACTATAGGG) situated at the 5’ end.  
To synthesise a sense and an anti-sense RNA strand from the gene-specific PCR 
product an ivT reaction was performed using the MEGAscript T7 Kit (Ambion) 
following the instructions of the manual with minor changes. In short, 500-1000 ng of 
PCR product (purified by gel extraction) were incubated with 2 µl of each rNTP and 
2 µl of enzyme mix in 1x reaction buffer for 16 hr at 37°C, followed by a 15 min 
incubation with 1 µl of TURBO DNase at 37°C. Upon addition of stop solution (5 M 
ammonium acetate; 100 mM EDTA) in a 1:1 ratio, the RNA was precipitated with 
2.5 volumes of absolute ethanol at -20°C for at least 30 min. The probe was centrifuged 
for 15 min at 13000 rpm (Heraeus BIOFUGE pico). The RNA pellet was washed with 
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70% ethanol and centrifuged again for 5 min. After removal of the supernatant the RNA 
pellet was dried using a vacuum centrifuge. For solubilisation, the RNA was 
resuspended in 40 µl of nuclease-free water. To obtain properly aligned dsRNA the 
samples were first incubated at 37°C for 60 min in a thermoshaker (G. Kisker TS-100, 
400 rpm), afterwards denatured at 65°C without shaking and then renatured by turning 
off the thermoshaker, to achieve a slow temperature decrease down to RT. The RNA 
concentration was determined by measuring the absorption at 260 nm and integrity was 
judged by agarose gel electrophoresis on a 1.5% TBE-gel.  
 
3.2.2.4 Knockdown by RNA interference (RNAi) 
RNAi is a valuable tool to knockdown protein expression in eukaryotic cells (Fire et al., 
1998). For Drosophila cells, dsRNA molecules with a size of around 500 bp can be 
transfected directly into the cells (Clemens et al., 2000). Inside of the cells the dsRNA is 
processed into small RNA molecules that bind specifically to the messenger RNA 
(mRNA), thereby leading to mRNA cleavage and suppression of protein expression. 
The synthesis of dsRNA for RNAi in cells is described in subsection 3.2.2.3. 
 
RNAi in cell culture 
For knockdown of a specific gene 0.8-1.2·106 S2 or Kc167 cells were transfected with 
15 µg of the corresponding dsRNA in a well of a 6-well plate. For this purpose, dsRNA 
was pre-pipetted into the well and cells were added in 1 ml of medium lacking 
supplements. After incubation for 40 min at 26°C 1 ml of medium containing 20% (v/v) 
FBS, 2% (v/v) Pen/Strep was added. To increase the efficiency of dsRNA uptake 
Effectene transfection reagent (Qiagen) was used. According to the manufacturer’s 
instructions, 50 µl of EC buffer were mixed briefly with 1.6 µl of Enhancer and 
incubated for 5 min. Thereafter, 5 µl of Effectene were added, vortexed for 10 sec and 
incubated for another 10 min. Upon addition of the transfection mix, cells were 
incubated for 6 d at 26°C. Knockdown efficiency of proteins in the nuclear extract 
fraction (3.2.3.5) was confirmed by Western blot (3.2.3.4) and changes in mRNA levels 
of target genes were quantified by RT-qPCR (3.2.2.6). 
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RNAi in flies 
Knockdown experiments in flies were conducted using stocks from the phiC31 RNAi 
Library (KK) of the Vienna Drosophila RNAi Center (VDRC) (Dietzl et al., 2007). 
UAS-RNAi flies were crossed with corresponding GAL4-driver strains and knockdown 
efficiencies were verified by measuring the mRNA levels in 3rd instar larvae by RT-
qPCR (3.2.2.6) or protein level in brain extracts (3.2.3.7) in case of dLint-1. As control, 
GAL4-driver strains were crossed with the w1118 host strain which the RNAi library was 
injected into. Expression changes of target genes at the mRNA level in 3rd instar larvae 
were quantified by RT-qPCR.  
 
3.2.2.5 Polymerase chain reaction (PCR) 
PCR is a method to amplify a specific DNA sequence exponentially from a template 
DNA using sequence-specific primer pairs (Saiki et al., 1988). DNA fragments required 
for cloning or as template for ivT were generated using Expand High FidelityPLUS PCR 
System (Roche). Plasmid DNA containing the corresponding DNA sequence or cDNA 
from Kc167 was used as PCR template. According to the manufacturer’s instructions 
PCR reactions were set up as follows: 
 
10 µl Expand HiFiPLUS Reaction Buffer  (5x) 
1 µl dNTP mix (10 mM) 
2 µl Forward primer (10 pmol/µl) 
2 µl Reverse primer (10 pmol/µl) 
x µl Template DNA (50 ng plasmid or 2 µl cDNA) 
0.5 µl Expand HiFiPLUS enzyme (5 U/µl) 
x µl ddH2O (up to 50 µl) (up to 50 µl) 
 
The PCR was performed in a T3000 Thermocycler (Biometra) following the scheme 
below. The annealing temperature was dependent on the primers used and the 
elongation time was chosen corresponding to the length of the DNA sequence that had 
to be amplified. For PCR products up to 3 kb the elongation temperature was 72°C, 
whereas for products larger than 3 kb it was 68°C. 
 
Initial denaturation 94°C 2 min  
Denaturation 94°C 20 sec  
Annealing 55-60°C 30 sec 35 cycles 
Elongation 68 or 72°C 1 min/1 kb   
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Final elongation 68 or 72°C 7 min  
Cooling 4°C ∞  
 
3.2.2.6 Quantitative PCR (qPCR) 
The qPCR technique combines the amplification of a certain DNA sequence by 
common PCR with the sensitive detection of a fluorescent dye, incorporated into the 
DNA, after each round of amplification. The dye used was SYBR Green, which 
specifically intercalates into dsDNA.  
As template, 6 µl of 1:10 diluted cDNA (3.2.2.2) or 6 µl of 1:6 diluted genomic DNA 
(eluted after ChIP; 3.2.3.11) were pipetted into a Thermo-Fast 96 non-skirted PCR plate 
(Thermo-Scientific). Template DNA was diluted with injection-grade H2O (Serum-
werk). Subsequently, 19 µl of PCR mix were added and the PCR plate was sealed with 
an Adhesive PCR Film (Thermo-Scientific). The samples were mixed briefly by 
vortexing and collected by brief centrifugation. 
 
PCR mix 1 µl  Primerpair (1:1 mix of forward and reverse primers 
in 1:10 dilution) 
 12 µl  ABsolute SYBR Green Mix (Thermo-Scientific) 
 8 µl  injection-grade H2O 
 
The PCR reactions were carried out in an Mx3000P cycler from Agilent Technologies 
using the PCR program below: 
 
Initial denaturation 95°C 15 min  
    
Denaturation 95°C 15 sec  
Annealing 60°C 30 sec 40 cycles 
Elongation 72°C 20 sec   
    
Denaturation 95°C 1 min  
 
Dissociation curve 
 
55°C 30 sec  
55°C → 95°C gradually  
95°C 30 sec  
 
The MxPro software automatically calculates the Cycle threshold (Ct) value for each 
reaction. The Ct is defined as the number of cycles required for the fluorescent signal to 
cross a certain set threshold which exceeds the background level. 
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For gene expression analysis, the relative amount of cDNA in two samples (i.e. EGFP 
control and dL(3)mbt RNAi) was compared, after both samples had been normalised to 
a reference gene (Gapdh1). A ∆Ct value was calculated for both samples:  
reference1 sample1 sample CC = Ct −∆                            reference2 sample2 sample CC = Ct −∆  
The subtraction of the two ∆Ct values results in a ∆∆Ct value: 
sample21 sample CC =Ct ∆−∆∆∆  
Since the fluorescent signal per amplification cycle increases in an exponential manner, 
the difference in expression is calculated as: Ct-2 = ∆∆x  
To show relative changes in expression levels of genes, the control (i.e. EGFP RNAi) 
was set to 1 and all other samples (i.e. dL(3)mbt RNAi) were displayed normalised to 
the control.  
All samples were measured in triplicates, which resulted in a standard deviation s for 
each sample, used to calculate a standard deviation s∆Ct of ∆Ct: 
2
sample
2
reference?Ct s  s = s +  
and therefrom a standard deviation snorm for the normalised fold expression: 
22))2ln(( = Ctnormnorm sxs ∆⋅⋅  
For chromatin immunoprecipitation (ChIP; 3.2.3.11), all samples were normalised to 
the corresponding ChIP-input sample ( sampleinputsample CC = Ct −∆ ) and displayed as a 
percentage of input: sample?Ct2 =input %  
A standard deviation s%input, considering the standard deviations from triplicate 
measurements, was determined as follows: 
2
sample
2
inputinput s  sinput %ln(2) = s +⋅⋅
 
In case of histone modifications, the results were normalised against % input values of 
H3 ChIPs to account for differences in the nucleosome density between different 
chromatin regions. The errors were calculated as described in 3.2.1.5 according to 
equation 3. 
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3.2.2.7 Microarray analysis 
RNAi in Kc167 cells to deplete dL(3)mbt and dLint-1 was conducted in three biological 
replicates as described above (3.2.2.4). Transfection of dsRNA directed against 
enhanced green fluorescent protein (EGFP) was included as a control. After 5 d of 
incubation, total RNA was extracted from RNAi-treated cells as described in subsection 
3.2.2.1. Samples were prepared according to standard Affymetrix protocols using the 
GeneChip® Fluidics Station 450 (protocol FS450_0002) and hybridised to the 
Affymetrix GeneChip® Drosophila Genome 2.0 Array. Scans were carried out on an 
Affymetrix GeneChip Scanner GSC3000_7G and the fluorescence intensities were 
analysed with Affymetrix GCOS Software 1.4. The quality of the total RNA, as well as 
of cRNA samples, which were synthesised during the Affymetrix protocol, was 
analysed using Agilent 2100 Bioanalyzer and RNA Nano LabChips from Agilent 
Technologies. 
Statistical analysis was conducted by Florian Finkernagel. Raw data were normalised 
with the gcrma package of Bioconductor (http://www.bioconductor.org) and gene lists 
were filtered with the following thresholds: fold change ≥ 1.5, adj. p ≤ 0.05.  
 
3.2.3 Biochemical methods 
Generally, proteins were kept on ice, in the presence of protease inhibitors (Leupeptin, 
Pepstatin, Aprotinin, each 1 ?g/ml and 0.2 mM PMSF) and the reducing agent DTT 
(1 mM). Protease inhibitors and DTT were added freshly to buffers. 
 
3.2.3.1 Determination of protein concentration 
Protein concentration was determined using the Bio-Rad Protein Assay (Bio-Rad), 
which is based on the colorimetric method described by Bradford (1976), according to 
manufacturer`s instructions. The concentration of purified GST proteins was estimated 
according to protein standards with a known concentration (such as BSA) in SDS-
PAGE (3.2.3.2) and subsequent Coomassie blue staining (3.2.3.3). 
 
3.2.3.2 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Discontinuous SDS-polyacrylamide gel preparation and electrophoresis were carried 
out  using disposable gel cassettes and the XCell SureLock Mini-Cell system from 
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Invitrogen. Resolving and stacking gels were prepared according to standard protocols 
using a ready-to-use acrylamide/bisacrylamide mixture from Roth (Rotiphoresegel 30; 
37.5:1). The resolving gel contained 7.5-15% and the stacking gel 4% of polyacryl-
amide. Prior to loading, protein samples were supplemented with 1x SDS-PAGE 
loading buffer and boiled for 5 min at 95°C. As molecular weight standard PageRuler 
Prestained Protein Ladder (Fermentas) was loaded in addition. The electrophoresis was 
carried out in SDS-PAGE running buffer at a constant voltage of 100 V in the stacking 
gel and at 150-180 V in the resolving gel. After electrophoresis, gels were either 
subjected to Western blotting (3.2.3.4) or stained with Coomassie Blue or silver staining 
(3.2.3.3).  
 
SDS-PAGE running buffer SDS-PAGE loading buffer (5x) 
25 mM Tris 250 mM Tris-HCl, pH 6.8 
192 mM glycine 10% (w/v) SDS 
0.1% SDS (w/v) 50% (v/v) glycerol 
 0.5% (w/v) bromophenol blue 
 0.5 M DTT 
 
3.2.3.3 Staining of SDS-polyacrylamide gels 
Coomassie Blue staining 
To visualise purified recombinant proteins after gel electrophoresis, gels were stained 
with PageBlue Protein Staining Solution (Fermentas), which is based on the Coomassie 
Brilliant Blue G-250 dye. For that purpose, the gel was washed in ddH2O for at least 
10 min, typically incubated overnight in the staining solution and destained with ddH2O 
until the difference in intensity between protein bands and background was as 
requested. 
Colloidal Coomassie Blue staining 
This staining technique is a very sensitive detection method for proteins and is highly 
compatible with subsequent mass spectrometry analysis. Protein gels were stained using 
the Colloidal Blue Staining Kit from Invitrogen according to the manufacturer’s 
instructions, with the maximum staining time of 12 hr.  
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Silverstaining 
The staining of protein gels with silver nitrate solution was carried out based on the 
method of Blum (1987). The gel was fixed in 50% ethanol/10% acetic acid overnight 
and washed three times for 20 min each in 30% ethanol. Afterwards, the gel was 
incubated for 1 min in 0.02% Na2S2O3, washed three times with ddH2O (20 sec each) 
and stained in 0.2% AgNO3 solution for 1 hr. Subsequently, the gel was washed with 
ddH2O again (three times, 20 sec each) and developed for 5 to 10 min with developing 
solution (3% Na2CO3, 0.05% H2CO and 0.0004% Na2S2O3) until the protein bands had 
the desired intensity. After a brief wash with ddH2O (1 min) the reaction was stopped 
by incubating the gel in 0.5% (w/v) glycine for 5 min and finally washed in ddH2O for 
at least 30 min. 
 
3.2.3.4 Western blotting 
For Western blot analysis, proteins were separated by SDS-PAGE (3.2.3.2) and 
transferred onto a polyvinylidene fluoride (PVDF) membrane (Roth) using the Bio-Rad 
‘Wet Blot’ Module. The PVDF membrane was activated for some seconds in methanol, 
before being placed onto the gel and surrounded by gel-sized sponges and Whatman 
paper soaked in transfer buffer. The transfer was then carried out for 1.5 hr at 400 mA 
constant current. The transfer chamber was cooled by the addition of a block of ice 
inside of the chamber and kept on ice. After the transfer, the membrane was incubated 
for 45 min in blocking solution (5% dried milk in PBST) at RT or overnight at 4°C to 
reduce non-specific background.  
 
PBST PBS with 0.1% Tween-20 
Transfer buffer 25 mM Tris 
 192 mM glycine 
 20% (v/v) methanol 
 0.02% (v/v) SDS 
 
Incubations with antibodies, as well as washing steps, were carried out on a rocking 
platform. Blocking was followed by incubation with a primary antibody directed against 
the protein of interest in an appropriate dilution (Table 3.10) with blocking solution. 
Depending on the antibody this incubation lasted for 1-2 hr at RT or overnight at 4°C. 
Afterwards, the membrane was washed three times with PBST (5-10 min each) and 
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subsequently incubated with the appropriate HRP-coupled secondary antibody (Table 
3.11) for 1 hr at RT. After three washes with PBST (see above), the antigen-antibody 
complexes were detected by chemiluminescence using the Immobilon Western 
Chemiluminescent HRP Substrate Kit (Millipore) and SuperRX Fuji Medical X-ray 
films. In order to re-probe membranes with another primary antibody they were 
‘stripped’. For stripping, membranes were incubated in 50 ml of stripping buffer for 
30 min at 50°C in a water bath and then washed three times with PBST for 10 min each. 
Afterwards membranes could be blocked and immunoblotted as described above. 
 
Stripping buffer 62.5 mM Tris/HCl, pH 6.8 
 10% (v/v) β-mercaptoethanol 
 2% (w/v) SDS 
 
3.2.3.5 Nuclear extract preparation 
For preparation of nuclear extract, Kc167 or S2 cells were harvested, washed twice with 
ice cold PBS and resuspended in low salt buffer (6 well plate: 100 µl; 10 cm plate: 
500 µl; 75cm2 flask: 1000 µl). The cells were incubated on ice for 10 min and collected 
at 13000 rpm for 1 min at 4°C. The cytosolic fraction was removed, nuclei were 
resuspended in high salt buffer (at least in 1.5x nuclei pellet volume), incubated for 
20 min on ice and centrifuged at 13000 rpm for 10 min at 4°C. The supernatant (nuclear 
extract) was subjected to Western blot (3.2.3.4), immunoprecipitation (3.2.3.10) or 
frozen in liquid nitrogen and stored at -80°C. All centrifugations were carried out in 
BIOFUGE pico centrifuge from Heraeus. 
 
Low salt buffer  High salt buffer 
10 mM Hepes/KOH, pH 7.6 20 mM Hepes/KOH, pH 7.6 
1.5 mM MgCl2 1.5 mM MgCl2 
10 mM KCl 420 mM NaCl 
DTT, protease inhibitors 0.2 mM EDTA 
 25 % glycerol 
 DTT, protease inhibitors 
 
Nuclear extract from 0-12 hr old embryos were prepared as previously described by 
Kunert and Brehm (2008) and kindly provided by N. Kunert. 
 
3 MATERIAL AND METHODS 
65 
 
3.2.3.6 Acid extraction of histones  
For extraction of histones the insoluble nuclear pellet (after the preparation of nuclear 
extract; 3.2.3.5) was resuspended in 0.4 M HCl (at least 2x pellet volume) and 
incubated overnight at 4°C with shaking (1000 rpm). After centrifugation (at 4°C, 
15 min, 13000 rpm) extracted histones were present in the supernatant and could be 
used for Western blotting (3.2.3.4). 
 
3.2.3.7 Tissue extracts from third instar larvae 
For direct Western blot analysis (3.2.3.4) 20 brains or salivary glands were dissected 
from third instar larvae in PBS under a stereomicroscope (Askania GSZ 2T) and 
transferred into 20 µl collection buffer (20 mM Tris, pH 8.0, 150 mM NaCl, 10 mM 
EDTA and 1 mM EGTA). The organs were squashed using a pestle and boiled for 
5 min at 95°C after the addition of Roti-Load 1 (Roth), before loaded onto an SDS-
PAGE gel for Western blot analysis.  
For Immunoprecipitation (3.2.3.10) 200 brains were dissected from third instar larvae in 
PBS. 40 brains were collected in 20 µl PBS at a time and frozen in liquid nitrogen and 
stored at -80°C. After thawing, PBS supernatants were removed (and kept on ice) and 
each brain aliquot was squashed in 100 µl LNB I buffer using a pestle and incubated for 
10 min on ice. Then samples were centrifuged at 5000 rpm for 5 min at 4°C (Heraeus 
BIOFUGE pico) and the supernatants (‘cytosolic fraction’) were taken off and 
combined. Afterwards, pellets were resuspended in 25 µl LNB II, incubated for 30 min 
on ice and centrifuged at 13000 rpm for 10 min at 4°C. The supernatants were pooled 
(‘nuclear fraction’).  
 
LNB I buffer LNB II buffer 
15 mM Hepes/KOH, pH 7.6 15 mM Hepes/KOH, pH 7.6 
10 mM KCl 385 mM KCl 
5 mM MgCl2 5 mM MgCl2 
0.1 mM EDTA, pH 8.0 0.1 mM EDTA, pH 8.0 
350 mM sucrose 0.1% Tween 20 
DTT, protease inhibitors 10% glycerol 
 DTT, protease inhibitors 
 
The protein concentration of the PBS supernatant, as well as the extracts obtained with 
LNB I and LNB II buffer, were measured in a Bradford Assay and 10 µg of the total 
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protein amount were analysed by Western blot (3.2.3.4). Immunoblotting revealed that 
all three samples contained β-tubulin and the nuclear proteins dL(3)mbt and dLint-1 
(Figure 3.1). This was not the case when dissected brains were directly subjected to 
extract preparation (data not shown). Probably, the freezing/thawing procedure led to an 
at least partial lysis of the tissue/cells. For this reason the PBS supernatants and all 
LNB I/II extracts were pooled and used for immunoprecipitations. 
 
 
Figure 3.1: Extract preparation from larval 
brains. 10 µg of protein extracted with PBS, 
LNB I or LNB II buffer as indicated on top 
were analysed by Western blot using the 
corresponding antibodies as depicted on the 
right. 
 
 
3.2.3.8 Whole cell extract preparation from Sf9 cells 
To obtain whole cell extracts from Sf9 cells upon baculovirus infection (3.2.3.12), cells 
were harvested, washed in ice cold PBS and resuspended in 2 ml of LyBu-200 buffer 
per 15 cm dish. Cells were lysed by three repetitive freeze-thaw cycles in liquid 
nitrogen and subsequent sonication (2x15 sec, 25% output). Lysates were spun down at 
13000 rpm for 15 min at 4°C (Heraeus BIOFUGE pico). The obtained whole cell 
extracts were used for various interaction assays.  
 
LyBu-x buffer  20 mM Hepes/KOH, pH 7.6  
 x mM KCl 
 10 % glycerol  
 0.1 % NP-40 
 DTT, protease inhibitors 
 
3.2.3.9 FLAG affinity purification  
For FLAG affinity purification of FLAG-dL(3)mbt and dLint-1-FLAG associated 
proteins, nuclear extracts from stable S2 cell lines (3.1.4.2) were prepared, as described 
before (3.2.3.5). 70 mg (total protein) of FLAG-dL(3)mbt extract and 150 mg (total 
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protein) of dLint-1-FLAG extract, as well as an equal amount of S2 mock extract, were 
incubated with 60 or 120 µl α-FLAG M2 agarose (FLAG beads; from Sigma-Aldrich; 
equilibrated in D-125), respectively, in D-125 buffer at 4°C for 3 hr with rotation. 
FLAG-beads were washed once with buffer D-125, three times with D-300 and once 
with D-125. Each wash was carried out with 10 ml of buffer at 4°C for 10 min on a 
rotating wheel. Bound proteins were eluted with 0.4 mg/ml FLAG-peptide (Sigma-
Aldrich) in D-125 buffer. The beads were diluted 1:1 in elution buffer and elution was 
carried out for 2 hr on ice with regular resuspension of the slurry. Additionally, an 
elution was performed overnight at 4°C on a shaker. Eluates were combined, 
precipitated using StrataClean resin (Stratagene), subjected to SDS-PAGE and 
visualised by silver or Colloidal Coomassie Blue (Invitrogen) staining (3.2.3.2 and 
3.2.3.3). In general, 10% of the eluates were visualised by silver staining, whereas 90% 
were loaded onto a gel for Colloidal Coomassie Blue staining. Protein bands were 
excised from Colloidal Coomassie Blue stained gels and analysed by peptide mass 
fingerprinting (Zentrum für Proteinanalytik, Munich, Germany). 
 
D-x buffer 20 mM Hepes/KOH, pH 7.6 
 x mM mM KCl  
 2 mM MgCl2 
 0.2 mM EDTA 
 0.05% NP-40  
 10% glycerol 
 protease inhibitors 
 
3.2.3.10 Immunoprecipitation 
750 to 1000 µg of nuclear extract from Drosophila cells or 12 hr old embryos were 
incubated with an appropriate amount of the respective antibody (Table 3.10) diluted 
with IP buffer to a final salt concentration of 200 mM, and incubated for 2 hr at 4°C 
with rotation. 5 µl of Protein G or A beads (GE Healthcare) were added and incubation 
was continued for 1 hr. Beads were washed three times with IP buffer, before 
immunoprecipitates were subjected to Western blot (3.2.3.4) or HDAC assay (0).  
α-FLAG-immunoprecipitations were carried out with S2 nuclear extracts (750 µg total 
protein) and 5 µl FLAG beads, diluted with IP buffer to a final salt concentration of 
200 mM. Incubation was performed for 3 hr at 4°C on a rotating wheel. Beads were 
washed three times with IP buffer and analysed by Western blotting or HDAC assay. 
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For HDAC assays (0) nuclear extracts were optionally incubated with 50 µg/µl EtBr for 
30 min on ice and centrifuged for 5 min at 13000 rpm (Heraeus BIOFUGE pico) to 
remove potential precipitates prior to IP. The supernatant was used for IP. EtBr was also 
present during washing steps. 
For the interaction assays between recombinant proteins in Sf9 cells upon baculoviral 
co-infection, 200 µl of whole cell extract were incubated in 800 µl IP buffer with 10 µl 
FLAG beads for 3 hr at 4°C with rotation. Then, beads were washed three times in IP 
buffer and subjected to Western blotting (3.2.3.4). 
 
IP buffer 25 mM Hepes/KOH, pH 7.6 
 150 mM NaCl  
 12.5 mM MgCl2 
 0.1 mM EDTA, pH 8.0 
 10 % glycerol 
 0.1 % NP-40 
 
3.2.3.11 Chromatin immunoprecipitation (ChIP) 
The ChIP technique was applied to investigate the direct association of proteins or 
histone modifications with a specific genomic region. The protocol was based on the 
Upstate Biotechnology ChIP assay protocol. In summary, 100·106 Kc167 cells were 
fixed with 1% formaldehyde (10% stock, methanol free from Polyscience) in culture 
medium for 10 min at RT. Fixation was stopped by the addition of 240 mM glycine 
(end concentration). Cells were harvested, washed in 20 ml ice cold PBS, resuspended 
in 1 ml SDS-lysis buffer and incubated for 10 min on ice. Lysates were sonicated using 
a Bioruptor (Diagenode) to obtain an average fragment length of 0.5 kb and centrifuged 
at 4°C for 15 min, 13000 rpm (Heraeus BIOFUGE pico). The supernatant (chromatin) 
was subjected to ChIP analysis. 140 µl of chromatin were used per ChIP, diluted 10x 
with ChIP buffer and pre-cleared with 40 µl of ProtG or ProtA beads (GE Healthcare) 
for 30 min with rotation. Prior to this, ProtG/A beads had been pre-blocked with 
1 mg/ml BSA in TE buffer for at least 6 hr at 4°C. From the pre-cleared chromatin 14 µl 
were taken as an input sample and stored at 4°C. After adding antibody directed against 
the protein or histone modification of interest (Table 3.10) to the pre-cleared chromatin, 
samples were incubated overnight with rotation, prior to incubation with 35 µl of 1:1 
ProtG/ProtA slurry for 2 hr at 4°C. As controls, ChIPs were performed without antibody 
(beads control), using pre-immune serum or a IgG control antibody. Precipitates were 
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washed successively for each 10 min on a rotating wheel at 4°C: three times with low 
salt wash buffer, three times with high salt wash buffer, once with LiCl wash buffer and 
twice with TE buffer. The last TE wash served to transfer beads into fresh reaction 
tubes for elution. All centrifugation steps to collect ProtG/ProtA beads were done with 
2000 rpm for 4 min at 4°C (Heraeus BIOFUGE pico). Immunoprecipitates were eluted 
twice with 250 µl elution buffer (1% SDS, 0.1 M NaHCO3) for each 15 min at RT. 
500 µl of elution buffer were also added to input samples, which were then treated 
identically. Cross-links were reversed by addition of 20 ?l 5 M NaCl and incubation at 
65°C overnight. After addition of 10 ?l 0.5 M EDTA, 20 ?l 1 M Tris/HCl, pH 6.5 and 
2 ?l 10 mg/ml Proteinase K (Roth), samples were incubated for 1 hr at 45°C. DNA was 
purified with the peqGOLD Cycle-Pure Kit (Peqlab) and subjected to gene-specific 
qPCR (3.2.2.6).  
 
SDS-lysis buffer  ChIP buffer 
50 mM Tris/HCl, pH 8.0 16.7 mM Tris/HCl, pH 8.0 
10 mM EDTA 16.7 mM NaCl 
1% SDS 1.2 mM EDTA 
protease inhibitors 0.01% SDS 
 1.1% Triton X-100 
 protease inhibitors 
 
Low/high salt wash buffer  LiCl wash buffer 
20 mM Tris/HCl, pH 8.0  10 mM Tris/HCl pH 8.0 
150 mM/500 mM NaCl  250 mM LiCl 
2 mM EDTA  1 mM EDTA 
0.1% SDS  1% NP-40 
1% Triton-X-100  1% sodium deoxycholate 
 
3.2.3.12 Recombinant protein expression using the baculovirus system 
The baculovirus system is an attractive tool to express proteins recombinantly in 
eukaryotic Sf9 cells. To generate recombinant viruses, coding sequences of the 
according proteins were cloned into the pVL1392 vector. pVL1392 constructs (Table 
3.4) were transfected into Sf9 cells using the Bac-N-Blue Linear Transfection Kit 
(Invitrogen). For this purpose, 106 Sf9 cells were plated into a 6 cm dish and incubated 
for 15 min at 26°C until cells attached to the dish surface. In the meantime, the 
transfection mix was prepared: 4 µg of plasmid DNA, 1 ml of Sf-900 II SFM medium 
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(without supplements) and at last 20 µl of Cellfectin Reagent were added to 0.5 µg of 
Bac-N-Blue DNA, mixed for 10 sec and incubated for 15 min. Meanwhile the medium 
was removed from the cells after settling and exchanged against 2 ml of medium 
without supplements. The transfection mix was added dropwise onto the Sf9 cells and 
incubated for 4 hr at RT on a rocking platform with moderate speed. After addition of 
1 ml supplemented Sf9 medium, transfected cells were kept for 7 d at 26°C.  
To amplify the virus titre, another two rounds of Sf9 infections were carried out. The 
supernatant was collected from the cells and centrifuged for 5 min at 1000 rpm to 
remove cell debris (Heraeus Megafuge 1.0). First, 7.5·106 Sf9 cells were plated into a 
10 cm dish and incubated for 1 hr on a rocking platform with 1 ml of the first 
supernatant in 2.5 ml of supplemented medium. After addition of 10 ml of 
supplemented medium, infected Sf9 cells were incubated for 7 d at 26°C. Second, 
12·106 Sf9 cells were plated into a 15 cm dish and incubated for 1 hr on a rocking 
platform with 1 ml of the second supernatant in 5 ml of supplemented medium. 15 ml of 
supplemented medium were added and infected Sf9 cells were incubated for 5-7 d at 
26°C.  
For protein expression the supernatant of the second amplification was used to infect 
Sf9 cells, described as above for the second amplification. But in contrast, cells were 
harvested after 48 hr and whole cell extract was prepared as specified in section 3.2.3.8. 
For protein expression a maximum amount of 1 ml of supernatant was used. In order to 
investigate interactions between proteins (FLAG-dL(3)mbt and dRpd3; dL(3)mbt and 
dLint-1-FLAG) volumes of baculoviruses to co-infect Sf9 cells had to be titrated (Table 
3.12) to achieve optimal expression levels for both proteins. 
 
Table 3.12: Volumes of baculoviruses used for co-infection of Sf9 cells. All baculoviruses in 
this table, except for His6-Rpd3 (provided by A. J. Courey; Chen et al., 1999), were generated 
in the course of this study. 
Baculovirus Volume Baculovirus Volume 
dL(3)mbt-dRpd3 interaction assay 
HA-FLAG-dL(3)mbt 400 µl His6-dRpd3 200 µl 
FLAG-N-term-dL(3)mbt 400 µl His6-dRpd3 200 µl 
FLAG-3MBT-dL(3)mbt 200 µl His6-dRpd3 200 µl 
FLAG-C-term-dL(3)mbt 200 µl His6-dRpd3 200 µl 
dL(3)mbt-dLint-1 interaction assay 
dL(3)mbt-FLAG 900 µl dLint-1 100 µl 
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3.2.3.13 Histone deacetylase (HDAC) assay 
As samples for measuring HDAC activity, immunoprecipitates of endogenous or 
recombinant FLAG-tagged proteins bound to ProtG or FLAG beads (3.2.3.10), were 
used. In case of FLAG-tagged protein, FLAG immunprecipitations from nuclear extract 
of mock S2 cells were used as negative controls. In case of endogenous proteins, control 
precipitations using α-GST antibody or no antibody (beads control) were carried out.  
The sample volume was adjusted to 30 µl with HDAC buffer in siliconised reaction 
tubes and 3H-labelled chicken core histones (20000-50000 cpm; kindly provided by 
A. Imhof) were added. For HDAC inhibition 500 nM TSA were added. The samples 
were incubated for 90 min at 30°C and beads were resuspended every 15 min. After 
incubation, 200 µl H2O and 65 µl 1 M HCl/0.16 M HAc were added and mixed briefly. 
To extract radioactively labelled acetyl groups, which were set free by HDAC activity, 
the samples were mixed with 700 µl of ethyl acetate for 15 min by vortexing and 
centrifuged for 2 min at 13000 rpm (Heraeus BIOFUGE pico). 500 µl of the upper 
organic phase were transferred into a scintillation vial containing 5 ml of scintillation 
cocktail (PerkinElmer), mixed for 10 sec by vortexing and counted in a scintillation 
counter. A control with only histone substrate was included, which was then subtracted 
from all samples.  
 
HDAC buffer 10 mM Tris/HCl, pH 8.0 
 1 mM MgCl2 
 0.1 µg/µl BSA (added freshly) 
 
3.2.3.14 Coupled in vitro transcription and translation  
For the synthesis of 35S-labelled dLint-1 the TNT Quick Coupled Reticulocyte 
Transcription/Translation System (Promega) was used, following the manufacturer’s 
instructions. Radioactively labelled 35S-methionine was purchased from Amersham. In 
brief, a reaction was assembled on ice, as below. The reaction was kept at 30°C for 
90 min. Aliquots were taken and analysed by autoradiography. Samples were separated 
by SDS-PAGE and the gel was treated with Amplify (Amersham) according to 
manufacturer’s instructions, to increase signal intensity. After drying the gel, 
radioactively labelled proteins were visualised on a SuperRX Fuji Medical X-ray film. 
Residual protein was stored at -20°C. 
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12.5 µl Rabbit reticulocyte lysate  
1 µl  Reaction buffer  
0.5 µl  TNT RNA Polymerase SP6 or T3 
0.5 µl  Amino acid mixture without Met 1 mM 
1 µl [35S] methionine >1000 Ci/mmol at 10 mCi/ml 
0.5 µl  RNasin Ribonuclease Inhibitor 40 U/µl 
2 µl DNA template 0.5 µg/µl  
7 µl Nuclease-free ddH2O (up to 25 µl) 
 
For in vitro transcription/translation of dLint-1, the ORF was cloned into the pING-14A 
vector under the control of a SP6 RNA polymerase-specific promoter. A control DNA 
encoding a luciferase gene under the control of a T3 RNA polymerase promoter served 
as a positive control for the reaction. The generated Luciferase protein was used in the 
following as a negative control for interaction studies (3.2.3.15).  
 
3.2.3.15 Interaction assay of 35S-dLint-1 and FLAG-dL(3)mbt 
To investigate the interaction between 35S-dLint-1 (3.2.3.14) and recombinant FLAG-
dL(3)mbt, 12 ml of Sf9 extract, either mock or expressing FLAG-dL(3)mbt (3.2.3.12), 
were bound to 60 µl of α-FLAG M2 agarose. Beads were washed extensively, twice 
with 10 ml LyBu-200 and once with 5 ml LyBu-500 buffer (buffer composition, see 
3.2.3.8) for each 5 min. Afterwards, 10 µl FLAG beads were equilibrated with IP buffer 
(3.2.3.10), blocked for 30 min with 0.2 µg/µl BSA in IP buffer and incubated with 8 µl 
of 35S-dLint-1 or 6 µl of 35S-Luciferase (similar protein amounts, estimated by signal 
strength on an X-Ray film) for 3 hr at 4°C in IP buffer. After extensive washing (four 
times 5 min with 1 ml IP buffer) samples were separated by SDS-PAGE and detected 
by autoradiography (3.2.3.14). All incubation and washing steps were carried out with 
rotation.  
 
3.2.3.16 GST protein expression 
Recombinant GST fusion proteins were expressed according to standard procedures. 
Generally, GST fusion proteins were expressed in E. coli BL21 (0.2-1 l total culture 
volume) for 2 hr at 37°C or overnight at 18°C after induction with 0.2-0.4 mM IPTG at 
OD600 of 0.7-0.8. The bacteria were resuspended in 10-20 ml of PBS/1% Triton-X-100 
(AppliChem) supplemented with protease inhibitors. After sonication (10 x 12 sec, 25% 
output), the suspension was centrifuged for 20 min at 15000 rpm at 4°C (Sorvall RC-
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5B, SS34 rotor) to remove cell debris from the supernatant. GST proteins were bound to 
Glutathione Sepharose 4 Fast Flow (200-400 µl; GE Healthcare) and washed three 
times with PBS/1% Triton-X-100 and two times with PBS (each with 5-10 ml for 5 min 
at 4°C with rotation). If necessary GST proteins were eluted with 0.2-0.4 mM reduced 
glutathione in PBS and stored at -80°C. 
 
3.2.3.17 GST protein pulldown 
GST fusion proteins were expressed and bound to Glutathione Sepharose as described 
above (3.2.3.16). If required GST proteins bound to Glutathione Sepharose beads were 
stored at -20°C in PBS/40% glycerol. Protein concentrations on beads were estimated 
after SDS-PAGE and Coomassie staining in comparison to a standard protein (such as 
BSA). For GST pulldown assays, beads with bound GST proteins (2-4 µg) were 
equilibrated in GST pulldown buffer and incubated with 200 µl of dL(3)mbt-FLAG 
containing Sf9 extract for 4 hr at 4°C with rotation in GST pulldown buffer. After 
extensive washing four times with 1 ml of GST pulldown buffer for 5 min at 4°C, 
samples were analysed by Western blotting and Ponceau staining. 
 
GST pulldown buffer 25 mM Hepes/KOH, pH 7.6 
 150 mM KCl 
 12.5 mM MgCl2 
 20% glycerol 
 0.1% NP-40 
 DTT, protease inhibitors 
 
3.2.3.18 Histone peptide pulldown assay 
Histone H4 peptides comprising amino acids 16-25 with lysine 20 either unmodified, 
mono-, di- or tri-methylated (purchased from Peptide Specialty Laboratories), were 
coupled to SulfoLink Coupling Gel (Pierce) via a C-terminal cysteine according to the 
manufacturer’s protocol with minor changes. Instead of using columns, the batch 
method was applied. All centrifugations were carried out at 4000 rpm for 2 min 
(Heraeus BIOFUGE pico).  
For the pulldown, immobilised peptides (0.5 µg each) were pre-blocked with 1 µg/µl 
BSA in binding buffer for 1 hr at 4°C. Recombinant FLAG-d3MBT, GST-d3MBT or 
GST-h3MBT was incubated with pre-blocked immobilised peptides for 2 hr at 4°C in 
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binding buffer with agitation. After extensive washing with binding buffer (4x with 
1 ml for 5 min at 4°C with rotation), peptide-bound protein was analysed by Western 
blotting.  
 
Peptide pulldown binding buffer  25 mM Tris, pH 8.0  
 150 mM NaCl  
 2 mM EDTA 
 0.5% NP-40 
 
3.2.3.19 GST protein purification for antibody generation 
The recombinant GST fusion protein of dLint-1-Cterm (aa 302-602) was expressed in 
E. coli BL21 for 2 hr at 37°C after induction with 0.4 mM IPTG at OD600 of 0.7-0.8. 
The bacteria of a 1 l culture were resuspended in 20 ml of PBS/1% Triton-X-100 
(AppliChem) supplemented with protease inhibitors and 1 mM DTT. After sonication 
and centrifugation (see 3.2.3.16) the GST fusion protein was purified from the 
supernatant via affinity chromatography using a GSTrap FF column and the Äkta 
purifier system (GE Healthcare). Before loading the column, the bacterial lysate was 
filtered through a 0.2 µM filter. The GST fusion protein was eluted with elution buffer 
(40 mM reduced glutathione in 50 mM Tris-HCl, pH 8.5, 200 mM NaCl). Fractions 
containing the GST fusion protein were pooled and further purified via cation exchange 
chromatography using a HiTrap SP HP column (GE Healthcare). The protein was 
bound to the column in IEX-C-100 buffer and eluted with a salt gradient of 100 to 
500 mM KCl in IEX-C-x buffer. Prior to injection, the purified GST-dLint-1-Cterm 
protein was diluted to a final salt concentration of 150 mM salt.  
 
IEX-C-x buffer 25 mM Hepes/KOH, pH 7.0 
 x mM KCl 
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3.2.4 Chromatographic fractionation of Drosophila cell nuclear extract  
3.2.4.1 Gel filtration analysis 
Gel filtration is a chromatographic technique to separate proteins and protein complexes 
on the basis of size. Generally, gel filtration was carried out in the presence of 300 mM 
salt, to eliminate or at least minimise the detection of protein complexes mediated by 
weak protein-protein interactions. Nuclear extract from Kc167 or S2 cells was loaded 
onto a Superose 6 HR 10/30 gel filtration column (GE Healthcare) and resolved in 
EX300 buffer on an Äkta purifier system and collected with a fraction collector Frac-
950 according to the manufacturer’s instructions. Upon sample injection 500 µl 
fractions were collected, precipitated using StrataClean resin (Stratagene) and subjected 
to Western blot analysis (3.2.3.4). 
 
EX300 gel filtration buffer 10 mM Hepes/KOH, pH 7.6 
 300 mM KCl 
 1.5 mM MgCl2  
 0.5 mM EGTA  
 10% glycerol 
 DTT, PMSF 
 
3.2.4.2 Ion exchange chromatography 
Ion exchange chromatography was carried out according to standard procedures on an 
Äkta purifier system with a Frac-950 fraction collector using columns supplied by GE 
Healthcare according to the manufacturer’s instructions. In general, samples were 
applied at slow flow rates of 250-500 µl/min, while washing and elution steps were 
carried out at flow rates of 1-2 ml/min, always considering the maximum back pressure 
of the corresponding columns.  
In summary, 3.5 ml of Kc167 nuclear extract (6.0 µg/µl protein conc.) were diluted 4.2x 
with IEX-A-0 buffer to adjust the NaCl concentration of the sample to 100 mM. 
Subsequently, the sample was bound to a HiTrap Q Sepharose FF column (5 ml 
volume) that was prior to this equilibrated with IEX-A-100 buffer. The flow through 
was loaded once more to ensure efficient binding of proteins. Then the column was 
washed with 10-20 ml of IEX-A-100 buffer or until no protein (measured by absorption 
at 280 nm) appeared in the effluent.  
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IEX-A-x buffer  20 mM Tris/HCl pH 7.5 
 x mM NaCl  
 DTT, PMSF 
 
Elution was performed in two steps: First, applying IEX-A-500 buffer and second, 
applying IEX-A-1000 buffer. Peak fractions of the eluates were collected and tested 
together with the flow through by Western blotting. Next, the eluate (500 mM peak 
fraction), containing the proteins of interest, was diluted 5x with IEX-A-0 buffer. The 
sample was then bound to a Mono Q 5/50 GL column (GE Healthcare) and after the 
sample application the column was washed with 5-10 ml of IEX-A-100 buffer or until 
no protein was present in the effluent. For elution a continuous salt gradient was used, 
going from 100 mM up to 500 mM NaCl in IEX-A buffer, applied at a flow rate of 
1 ml/min, collecting 50 fractions of 0.5 ml volume each. Finally, residual protein was 
eluted in one step with IEX-A-1000 buffer. 500 µl fractions were collected, precipitated 
using StrataClean resin (Stratagene) and subjected to Western blot analysis (3.2.3.4).  
 
3.2.5 Antibody generation 
3.2.5.1 dL(3)mbt-specific antibodies 
The polyclonal α-dL(3)mbt (#3) antibody was raised against three dL(3)mbt-specific 
peptides (P1: PSGEDKTRSTQKNNKQNTSASC; P2: YFERPLYDRPGRRPSAC; 
P3:CLPEQSQTNGYKTDHDQELS). These peptides were synthesised and injected into 
rabbit by the Peptide Specialty Laboratories (Heidelberg).  
The monoclonal α-dL(3)mbt antibodies (clones P1 6E6 and P3 8F10) were generously 
generated by E. Kremmer (Helmholtz Zentrum München). In short, Lou/C rats were 
immunised with dL(3)mbt-specific peptides (P1 and P3, see above) coupled to KLH 
(Keyhole Limpet Hemocyanin). After a series of immunisations, a final boost was given 
three days before fusion of the rat spleen cells with the murine myeloma cell line 
P3X63-Ag8.653. Subsequently, hybridoma supernatants were tested in ELISA using the 
corresponding peptides coupled to ovalbumin. 
The specificity of the α-dL(3)mbt #3 antibody was tested by expressing a recombinant 
FLAG-tagged full-length protein of dL(3)mbt in S2 cells. The FLAG-tagged protein 
was immunoprecipitated using α-FLAG M2 agarose, subjected to Western blotting and 
detected using the α-dL(3)mbt #3 antibody (Figure 4.1 A). Moreover, the specificity 
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was confirmed by RNAi experiments in Kc167 cells and subsequent Western blot 
analysis (Figure 4.22 A). α-dL(3)mbt monoclonal P1 6E6 and P3 8F10 antibodies were 
used exclusively for immunoprecipitation and immunofluorescence. The specificity of 
the immunoprecipitate was tested in Western blot, using the α-dL(3)mbt #3 as primary 
antibody, which resulted in a band at the expected molecular weight of 170 kDa (Figure 
4.2 C). Specificity in immunofluorescent stainings of polytene chromosomes was 
demonstrated by recognition of ectopically expressed recombinant dL(3)mbt (Figure 
4.20 B). 
 
3.2.5.2 dLint-1-specific antibodies 
The α-dLint-1 antibodies (#1 and #2) were raised against the C-terminal half of dLint-1 
(aa 302-602), expressed and purified as a GST fusion protein (for purification, see 
3.2.3.19). The injection of protein (0.5 mg/rabbit) and further antibody production was 
conducted by the Peptide Specialty Laboratories (Heidelberg). 
To verify the specificity of these antibodies dLint-1 was depleted in Kc167 cells and the 
nuclear extracts were tested by Western blot (Figure 4.8 C). Both antibodies recognised 
a protein band between the molecular weight standards for 72 and 95 kDa that 
significantly decreased in intensity upon knockdown by RNAi.  
 
3.2.5.3 Antibody concentration 
The cell culture supernatant, containing dL(3)mbt-specific rat antibody P1 6E6, was 
concentrated on Protein G Sepharose FF beads (ProtG beads) before being used in 
immunofluorescent staining of polytene chromosomes. 0.5 ml of ProtG beads were 
equilibrated in 100 mM Tris/HCl, pH 8.0. The pH of 8 ml of cell culture supernatant 
was adjusted to 8.0 by the addition of 1 M Tris/HCl, pH 8.0. Afterwards, the cell culture 
supernatant was incubated with the equilibrated ProtG beads on a rotating wheel for 
2 hr at 4°C. Then ProtG beads were loaded into a 2 ml gravity flow column (Bio-Rad) 
and washed once with 5 ml of 100 mM Tris/HCl, pH 8.0 and once with 5 ml of 10 mM 
Tris/HCl, pH 8.0. Stepwise elution of the antibodies from the ProtG beads was carried 
out using 50 mM glycine, pH 3.0. 10 fractions of 500 µl volume were collected and 
neutralised immediately with 50 µl of 1 M Tris/HCl, pH 8.0. Eluates were separated on 
a 10-12.5% SDS-polyacrylamide gel and analysed by Coomassie staining. Fractions 
containing the bulk of antibodies were pooled and stored at 4°C.  
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3.2.6 Generation of a UAS-dL(3)mbt transgenic fly line 
For fly transgenesis an integration system (Bischof et al., 2007) was used that is based 
on the ectopic expression of the φC31 integrase in the germline. φC31 integrase 
mediates the site-specific integration of a transgene encoded on the integration vector 
flanked by a bacterial attachment site (attB) into the transgenic fly genome at a phage 
landing site (attP) via recombination. The integration vector further contains a white+ 
marker gene that can be functionally expressed upon correct integration. The 
pUASattB-HA-FLAG-dL(3)mbt plasmid (Table 3.4) was injected into the J5 strain 
(attP-zh86Fb/vas-phi-zh102D), which possesses an attP element inserted on the 3rd 
chromosome and showed the highest frequency of transgenesis (Bischof et al., 2007). 
Injection into embryos was performed in collaboration with the laboratory of Prof. R. 
Renkawitz-Pohl. 
After injection, flies of the F0 generation were crossed to the w1118 isogenic strain and 
the F1 generation was screened for flies with ‘orange’ eyes. Flies with ‘orange’ eyes 
were then crossed against each other to gain homozygous transgenic flies with red eyes, 
carrying the UAS-construct. Site-specific integration of the transgene was confirmed by 
PCR using genomic DNA as template (Figure 3.2). To isolate genomic DNA single flies 
(male and female) from the transgenic F2 generation were put into 50 µl of squashing 
buffer complemented by the addition of 1 µl ProteinaseK (10 mg/ml) and squashed with 
the aid of a 200 µl tip. Thereafter, the suspension was incubated for 30 min at 37°C and 
10 min at 85°C. After a brief centrifugation 2 µl of the supernatant were used as DNA 
template for PCR (3.2.2.5). As negative controls identical PCR reactions were set up 
using genomic DNA, isolated from the J5 injection strain (attP-zh86Fb/vas-phi-
zh102D) and w1118 control flies, as template.  
 
Squashing buffer  10 mM Tris/HCl, pH 8.0 
 25 mM NaCl 
 1 mM EDTA, pH 8.0 
 
To check the correct insertion of the UAS-dL(3)mbt construct via PCR a forward 
primer specific to the coding sequence of dL(3)mbt (l3mbt-insert-1-fw) and a reverse 
primer specific to the 3’ end of the attP landing site (attPzh86Fb_rv) were used. A 
specific amplicon with a size above 2000 bp was present only in UAS-HA-FLAG-
dL(3)mbt transgenic flies (Figure 3.2, lanes 1 and 2), but not in control flies (lanes 3, 4, 
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5 and 6). Furthermore, overexpression of recombinant dL(3)mbt in salivary glands was 
verified by Western blot and polytene stainings (Figure 4.20). 
 
l3mbt-insert-1-fw GGACTCCCAACAAGAGATTGTC 
attPzh86Fb_rv  GCCGAACGAAATTAAAAATTGA 
 
 
Figure 3.2: Site-specific integration of the UAS-HA-FLAG-dL(3)mbt construct in the attP 
landing site. Genomic DNA was isolated from single male and female flies (depicted on top) 
from transgenic flies carrying the UAS-HA-FLAG-dL(3)mbt (lanes 1 and 2), from the J5 
injection strain (attP-zh86Fb; lanes 3 and 4) and from w1118 control flies (lanes 5 and 6), as 
specified below. PCRs were carried out using the primer pair, l3mbt-insert-1-fw and 
attPzh86Fb_rv. PCR amplicons were analysed by agarose gel electrophoresis.  
 
3.2.7 Immunofluorescent staining of polytene chromosomes 
Drosophila larvae were raised under standard culturing conditions at 26°C. Third instar 
wandering larvae were washed and salivary glands were dissected in PBS under a 
stereomicroscope (Askania GSZ 2T). Dissected salivary glands (2 pairs at a time) were 
fixed in a drop of Polytene fixation buffer for 5 min on a siliconised cover slip (treated 
with dimethylchlorosilane solution). Then the cover slip was taken up by a glass 
microscope slide. In order to break up the glands, facilitate cell lysis and spreading of 
the polytene chromosomes, the tip of a pencil was used to gently tap onto the cover slip, 
while slightly moving it back and forth. Success of the squashing was verified quickly 
under a phase contrast microscope (Zeiss Primo Star) at 40x magnification. Squashed 
chromosomes were flattened by applying strong pressure on the cover slip by pressing 
the thumb onto the back side of the glass microscope slide. Subsequently, each glass 
slide was frozen in liquid nitrogen, the cover slip was removed using a scalpel and the 
glass slides were collected in PBS in a Coplin jar. Collected glass slides were washed 
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with PBS for 10 min while gently shaking. Subsequently glass slides were blocked in 
blocking solution (5% milk in PBS) for 30 min, while shaking was continued. After 
rinsing the slides with PBS again, they were placed in a humid chamber. Polytene 
chromosomes were covered with 40 µl of primary antibodies diluted in blocking 
solution and 2% normal goat serum (NGS; Sigma Aldrich) and fresh cover slips 
(concentrated rat α-dL(3)mbt P1 6E6: 1:2; rabbit α-dLint-1 #1: 1:50). Incubation with 
primary antibodies was carried out overnight at 4°C. After removal of the cover slips, 
glass slides were rinsed with PBS and washed three times with blocking solution. 
Chromosome squashes were incubated with the appropriate secondary antibodies (Table 
3.10) diluted in blocking solution and 2% NGS for 1 hr at RT in the dark. Then the 
glass slides were washed once with wash buffer A and once with wash buffer B, each 
for 10 min in the dark, rinsed with PBS and DNA was stained with DAPI solution 
(0.2 µg/ml DAPI from Invitrogen in PBS) for 4-5 min. Slides were washed with PBS 
for 10 min in the dark, mounted with Fluoromount (SouthernBiotech), sealed with nail 
polish and stored at 4°C in the dark. Polytene chromosome stainings were analysed with 
a Zeiss fluorescence microscope (Axioplan). 
 
Polytene fixation buffer  45% acetic acid 
1% formaldehyde (10% stock, methanol-
free from Polyscience) 
  
Wash buffer A PBS 
 300 mM NaCl 
 0.2% NP-40 
 0.2% Tween 20 
 
Wash buffer B  PBS 
 400 mM NaCl 
 0.2% NP-40 
 0.2% Tween 20 
 
Overlays of dL(3)mbt and dLint-1 stained polytene chromosomes were assembled using 
Adobe Photoshop. Quantitative analysis of dL(3)mbt and dLint-1 binding sites was 
accomplished by visual inspection and counting was done with the aid of the Image J 
software (http://rsbweb.nih.gov/ij/). 
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4 Results 
 
4.1 Purification of novel dL(3)mbt complexes  
MBT domain-containing proteins have been previously reported to be part of or 
associate with multi-subunit complexes. In the model organism D. melanogaster, three 
MBT proteins have been identified, two of which are the PcG proteins Scm and Sfmbt. 
Although Scm can interact with the PRC1 complex, it is not a core component 
(Peterson et al., 2004), while Sfmbt is a stoichiometric subunit of the PhoRC complex 
(Klymenko et al., 2006). Both are involved in the maintenance of homeotic gene 
repression. Furthermore, dL(3)mbt as the third MBT protein in Drosophila, has been 
reported to be associated in sub-stoichiometric amounts with the Myb-MuvB complex 
(Lewis et al., 2004). However, an independent purification of the same core complex 
(dREAM) has failed to recover dL(3)mbt (Korenjak et al., 2004). In order to better 
understand the role of dL(3)mbt in the cell, this study aimed to investigate, whether 
dL(3)mbt is present in novel multi-protein complexes. 
 
4.1.1 The dL(3)mbt repressor protein interacts with a histone deacetylase 
4.1.1.1 dL(3)mbt is associated with HDAC activity 
At first to aid biochemical analysis of dL(3)mbt a polyclonal antibody (α-dL(3)mbt #3) 
was established. The specificity of this polyclonal antibody was confirmed by depleting 
the dL(3)mbt protein in Kc167 cells. After 5 d of RNAi, nuclear extracts of cells treated 
with double-stranded RNA (dsRNA) directed against dL(3)mbt and EGFP were 
analysed by Western blotting. A protein band with an apparent molecular weight of 
170 kDa was detected that was no longer visible upon dL(3)mbt RNAi compared to 
cells treated with EGFP dsRNA (Figure 4.22 A, upper panel, compare lanes 1 and 2). 
This identified the antibody reactive band above 170 kDa as dL(3)mbt, which runs 
slower than expected from its theoretical molecular weight (163 kDa). Detection of β-
tubulin around 55 kDa served as a loading control, to ensure that equal protein amounts 
have been applied. 
In the past, numerous studies investigating the modulation of chromatin to regulate gene 
transcription have established that HDAC enzymes and their ability to deacetylate 
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histone tails are often required as co-repressive activities to shut down gene expression. 
In accordance with this, HDACs are important components of numerous transcriptional 
co-repressor complexes (Nagy et al., 1997; Shi et al., 2005; Xue et al., 1998). Moreover 
the activity of deacetylases is thought to play an important role to facilitate the 
formation of higher-order chromatin structures (Shahbazian and Grunstein, 2007; 
Shogren-Knaak et al., 2006; Shogren-Knaak and Peterson, 2006). Likewise, members of 
the MBT domain protein family have been implicated in chromatin compaction and 
transcriptional repression of genes. Therefore, the involvement of MBT and HDAC 
proteins in similar biological processes raised the question whether dL(3)mbt might 
interact with a histone deacetylase in Drosophila. 
To address this question, first it was tested if dL(3)mbt associates with enzymatic 
HDAC activity. For this purpose, an expression vector for FLAG-tagged dL(3)mbt was 
generated, which drives the efficient expression of FLAG-dL(3)mbt, when transfected 
into S2 cells. To increase the chances that recombinant FLAG-tagged dL(3)mbt 
becomes incorporated into protein complexes, a stable monoclonal S2 cell line carrying 
the expression vector was established. The successful integration of the construct and 
expression of the recombinant protein in this S2 cell line was confirmed by FLAG 
immunoprecipitation and Western blot analysis using the α-dL(3)mbt #3 antibody 
(Figure 4.1 A, compare lanes 1 and 2 with 3 and 4). Overexpression of FLAG-dL(3)mbt 
was reflected in the input signals (compare lanes 1 and 3). Due to the high molecular 
weight of dL(3)mbt, addition of a comparatively small tag, such as in this case the HA-
FLAG-epitope, did not result in a slower migration of the recombinant protein 
compared to endogenous dL(3)mbt in SDS-PAGE. 
The enzymatic activity of HDACs can be measured using as a substrate core histones 
that were radioactively labelled with acetyl groups containing 3H isotope (Brehm 
et al., 1998). In this set up HDAC activity corresponds to the radioactivity that is 
released upon incubation of a protein sample with the histone substrate. To test for the 
association of dL(3)mbt with HDAC activity, this assay was performed with FLAG 
immunoprecipitates of FLAG-dL(3)mbt, stably expressed in S2 cells (Figure 4.1 B). 
FLAG immunoprecipitations from control extract, lacking FLAG-tagged dL(3)mbt 
(mock), served as controls. Ethidium bromide (EtBr) was included in some assays to 
prevent unspecific interaction with HDAC activity mediated by DNA (Lai and Herr, 
1992). The precipitation of FLAG-dL(3)mbt led to an enrichment of HDAC activity of 
about 30-fold, compared to controls. The interaction with HDAC activity, however, was 
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not affected by the addition of EtBr to the immunoprecipitation. To verify that the 
release of radioactivity relies on enzymatic HDAC activity, the class I- and II-specific 
HDAC inhibitor trichostatin A (TSA) (Yoshida et al., 1990) was added to the HDAC 
reaction, resulting in a 15-fold drop of the released radioactivity (Figure 4.1 B). Taken 
together, the FLAG-tagged dL(3)mbt protein precipitated HDAC activity and this 
association appeared to be mediated by protein-protein interactions. Moreover, the 
dL(3)mbt associated HDAC activity was sensitive to treatment with TSA, suggesting 
that the responsible enzyme belongs to HDAC classes I or II. 
 
 
Figure 4.1: Recombinant and endogenous dL(3)mbt are associated with HDAC activity. 
(A) Stable expression of FLAG-tagged dL(3)mbt in S2 cells. Nuclear extracts from control S2 
cells (mock, lanes 1 and 2) and cells stably expressing FLAG-tagged dL(3)mbt (lanes 3 and 4) 
were immunoprecipitated with α-FLAG M2 agarose (FLAG beads; lanes 2 and 4). Immuno-
precipitates were analysed by Western blot using dL(3)mbt-specific antibody as indicated. 5% 
input (lanes 1 and 3). (B) HDAC assays were carried out with FLAG immunoprecipitates from 
nuclear extracts from control S2 cells (mock) and S2 cells stably expressing FLAG-tagged 
dL(3)mbt (FLAG-dL(3)mbt). Immunoprecipitations (IP) were carried out in the absence (-) or 
presence (+) of ethidium bromide (EtBr) and HDAC reactions were performed with (+) or 
without (-) the HDAC inhibitor trichostatin A (TSA), as indicated above. Data are means of 
triplicate experiments. (C) and (D) HDAC assays were carried out with α-dMi-2 (#4D8) and α-
dL(3)mbt (#P1-6E6 and #P3-8F10, ratio 1:1) immunoprecipitates from S2 nuclear extract. 
Controls with α-GST (#R 6G9) antibody or no antibody (beads control) were included. Data are 
means of triplicate experiments. (B) and (C): Published in Scharf et al. (2009).  
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To ensure the significance of this interaction it was important to verify that also 
endogenous dL(3)mbt interacts with HDAC activity. However, despite its applicability 
in Western blot the α-dL(3)mbt #3 antibody did not work in immunoprecipitation. 
Hence, two monoclonal antibodies against dL(3)mbt were raised. When used in a 1:1 
ratio these antibodies precipitated a significant proportion of dL(3)mbt that was detected 
by the polyclonal dL(3)mbt antibody in Western blot (Figure 4.2 C, upper panel, 
compare lanes 1 and 2). When using these dL(3)mbt-specific antibodies for immuno-
precipitation, robust HDAC activity was indeed precipitated from S2 nuclear extract, 
corresponding to 4.6- and 12.5-fold more compared to precipitations using a control 
antibody or no antibody (beads control), respectively (Figure 4.1 C).  
In order to assess, whether the amount of HDAC activity that was associated with 
dL(3)mbt was significant, an immunoprecipitation of the dMi-2 chromatin remodeler 
protein was carried out to serve as a positive control. As established previously, dMi-2 
is the ATPase subunit of the stable Drosophila Nucleosome Remodelling and De-
acetylation complex (dNuRD) that comprises among other proteins the HDAC dRpd3 
(Kunert et al., 2009; Reddy et al., 2010). As expected, dMi-2 immunoprecipitates 
displayed a strong HDAC activity, when compared to precipitations using GST control 
antibody (10.7-fold more) or no antibody (beads control; 6.0-fold more) (Figure 4.1 D). 
Interestingly, the HDAC activity measured with dL(3)mbt precipitates, which were 
processed in parallel, was only 25% less than the activity interacting with dMi-2. Even 
though, the absolute values of HDAC activity levels precipitated by dL(3)mbt and dMi-
2 antibodies are not directly comparable, since the antibodies might differ in their 
precipitation efficiencies, these results strengthen the idea, that endogenous dL(3)mbt 
interacts with one or more HDAC enzymes in vivo.  
 
4.1.1.2 dL(3)mbt and the histone deacetylase dRpd3 interact in vivo 
HDAC assays revealed that dL(3)mbt is associated with enzymatic HDAC activity. This 
HDAC activity was sensitive to treatment with TSA, an inhibitor that targets class I and 
II HDACs. In Drosophila, there are two class I (dRpd3 and dHDAC3) and two class II 
histone deacetylases (HDAC6, isoforms S/L, and HDAC4). Of these, dRpd3, dHDAC3, 
HDAC4 and the isoform S of HDAC6 have been shown to be highly sensitive to TSA 
(Cho et al., 2005). Generally, dRpd3 is considered to be one of the most abundant 
HDACs, which is conserved from yeast (Rundlett et al., 1996) to human (Taunton et al., 
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1996). To examine, whether dL(3)mbt was associated with dRpd3, immunoprecipitates 
of FLAG-tagged dL(3)mbt stably expressed in S2 cells were subjected to Western blot 
analysis (Figure 4.2 A).  
 
 
Figure 4.2: Recombinant and endogenous dL(3)mbt are associated with the histone 
deacetylase dRpd3. (A) Nuclear extracts from control S2 cells (mock, lanes 1, 2 and 3) and 
cells stably expressing FLAG-tagged dL(3)mbt (lanes 4, 5 and 6) were immunoprecipitated with 
FLAG beads (lanes 2, 3, 5 and 6). Immunoprecipitations were carried out in the absence (-) or 
presence (+) of ethidium bromide (EtBr). Immunoprecipitates (IP) were analysed by Western 
blotting using dL(3)mbt- (#3) and dRpd3-specific antibodies as indicated. Input: 5% of nuclear 
extracts (lanes 1 and 4). (B) Nuclear extracts from control S2 cells (mock, lanes 1 and 2) and 
cells stably expressing FLAG-dL(3)mbt (lanes 3 and 4) were immunoprecipitated with FLAG 
beads (lanes 2 and 4). Immunoprecipitates were analysed by Western blotting using dL(3)mbt 
(#3) and dHDAC3 antibodies as indicated. Input: 5% of nuclear extracts (lanes 1 and 3). (C) 
Nuclear extract from S2 cells was precipitated using a mixture of monoclonal dL(3)mbt 
antibodies (at a ratio of 1:1) or no antibody (lane 4, beads control). Immunoprecipitations were 
subjected to Western blot using dL(3)mbt (#3) and dRpd3 antibodies. Lane 3: Ab control using 
dL(3)mbt-specific antibody without extract. Input: 5% of nuclear extract (lane 1). Published in 
Scharf et al. (2009). 
 
FLAG immunoprecipitation showed that dRpd3 co-precipitated with recombinant 
dL(3)mbt in an efficient manner in comparison with control precipitations conducted 
with extracts from cells lacking FLAG-dL(3)mbt expression vector (mock) (Figure 4.2 
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A, compare lanes 5 and 6 with 2 and 3). In agreement with the observations made in 
HDAC assays, the presence of EtBr did not interfere with the efficiency of dRpd3 co-
precipitation (Figure 4.2 A, compare lanes 5 and 6). 
In contrast to dRpd3, FLAG-dL(3)mbt did not bind the second class I histone 
deacetylase dHDAC3 (Figure 4.2 B, lower panel), even though a significant amount of 
recombinant FLAG-tagged dL(3)mbt was precipitated compared to the input 
(Figure 4.2 B upper panel, compare lanes 3 and 4 with 1 and 2). Unfortunately, 
antibodies against dHDAC4 and dHDAC6 were not available and a possible interaction 
with dL(3)mbt could not be investigated. Since the interaction with dRpd3 was detected 
using extracts from the S2 cell line stably expressing FLAG-dL(3)mbt, it was 
conceivable that this was only an observation seen upon overexpression of a 
recombinant protein. To exclude this possibility, endogenous dL(3)mbt was precipitated 
from S2 nuclear extract using monoclonal antibodies (Figure 4.2 C) and immuno-
precipitates were assayed for endogenous dRpd3 in Western blot. In accordance with 
data obtained with FLAG-tagged dL(3)mbt, dRpd3 was clearly detected in immuno-
precipitates of endogenous dL(3)mbt, suggesting that these proteins interact in a robust 
manner under physiological conditions.  
Taken together, dL(3)mbt interacts with one or more enzymatically active HDACs 
belonging to either class I or II of this enzyme family. While association of dL(3)mbt 
with HDAC4 and HDAC6 could not be tested, no interaction with dHDAC3 was 
detected in Western blot (Figure 4.2 B). Nevertheless, it is likely that most of the 
HDAC activity that was shown to be associated with dL(3)mbt (Figure 4.1) is 
contributed by the robust interaction with dRpd3 (Figure 4.2).  
 
4.1.1.3 The three MBT domains of dL(3)mbt are sufficient for dRpd3 binding 
As co-immunoprecipitations established that dL(3)mbt specifically interacts with the 
HDAC dRpd3, it was of interest to map the corresponding interaction module within 
dL(3)mbt. The amino acid sequence of dL(3)mbt exhibits three known protein domains, 
the 3MBT region, the SPM domain and a zinc finger motif (Figure 4.3 A, upper panel), 
which are all located in the C-terminal half of the protein. In contrast, the N-terminal 
half of the protein does not contain any established motifs. To map the region within 
dL(3)mbt that is important for binding of dRpd3, both proteins were expressed 
recombinantly in Sf9 insect cells via baculovirus infections and interaction studies were 
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carried out using FLAG immunoprecipitation. First, full length dL(3)mbt, which was N-
terminally tagged with a FLAG epitope tag (Figure 4.3 A, upper panel), was co-
expressed in cells together with full length dRpd3 (Figure 4.3 B, compare lanes 1 
and 7). As controls, Sf9 cells were infected with no baculovirus or individual 
baculoviruses, encoding FLAG-dL(3)mbt or dRpd3, respectively (Figure 4.3 B, 
compare lanes 3, 5 and 7). FLAG affinity purification of FLAG-tagged dL(3)mbt 
reveals a robust co-precipitation of dRpd3 from Sf9 whole cell extracts compared to 
precipitations from extracts containing no or only one of the two recombinant proteins 
(Figure 4.3 B, compare lane 2 with lanes 4, 6 and 8).  
 
 
Figure 4.3: The major dRpd3 interaction domain in dL(3)mbt maps to the MBT domains. 
(A) Schematic representation of FLAG-tagged dL(3)mbt constructs used for baculoviral 
expression. Protein domains of dL(3)mbt are indicated on top: The Zn finger (C2C2-type) is 
depicted in light grey, the 3MBT domains in black, the SPM domain in dark grey and the 
remaining dL(3)mbt protein in white. (B) Sf9 cells were co-infected with baculoviruses 
expressing full length FLAG-dL(3)mbt or dRpd3 or as indicated on top. Extracts from infected 
cells were immunoprecipitated with FLAG beads (lanes 2, 4, 6 and 8). Immunoprecipitates were 
subjected to Western blot using α-FLAG (rabbit) and α-Rpd3 antibodies. Input: 5% of extracts 
(lanes 1, 3, 5 and 7). (C) Cells were co-infected with baculoviruses expressing one of the three 
FLAG-tagged dL(3)mbt deletion mutants, depicted in (A), or dRpd3 as indicated on top. 
Extracts from infected cells were immunoprecipitated with FLAG beads (lanes 4, 5 and 6). 
Immunoprecipitates were subjected to Western blot using α-FLAG (rabbit) and α-Rpd3 
antibody. Input: 5% of extracts (lanes 1, 2 and 3). IP: Immunoprecipitation. 
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To determine which domain of dL(3)mbt is involved in the dRpd3 interaction, three 
FLAG-tagged dL(3)mbt mutants (depicted in Figure 4.3 A) were co-expressed with 
dRpd3. The three mutants tested in the interaction assay comprised: 1. most of the N-
terminus including the zinc finger motif, 2. the three MBT domains and 3. the C-
terminus of dL(3)mbt including the SPM domain. Western blot analysis using FLAG 
antibody verified that the different deletion mutants were produced with similar 
expression levels (Figure 4.3 C, upper panel, lanes 1, 2 and 3) and precipitated with 
comparable efficiencies upon FLAG affinity purification (Figure 4.3, upper panel, lanes 
4, 5 and 6). Intriguingly, immunoblotting revealed strong binding of dRpd3 to the 
3MBT domains and weaker binding to the N-terminal part of dL(3)mbt. In contrast, no 
interaction was observed between the C-terminus of dL(3)mbt and dRpd3. 
In conclusion, both the N-terminus half, as well as the 3MBT motif of dL(3)mbt, 
contribute to dRpd3 association. However, the 3MBT region seemed to be the major 
dRpd3 interaction domain in dL(3)mbt. A construct including only the three MBT 
modules (aa 787-1171) was sufficient to bind dRpd3.  
 
4.1.2 dL(3)mbt is part of a novel multi-subunit complex 
4.1.2.1  The bulk of dL(3)mbt is separated from RBF2 in Drosophila cells 
Interestingly, HDAC assays and immunoprecipitations revealed that dL(3)mbt is 
associated with dRpd3, a very abundant histone deacetylase that also interacts with 
many other transcriptional regulators, as for instance Groucho (Chen et al., 1999) and is 
a subunit of multiple chromatin-associated complexes, like dNuRD (Kunert et al., 
2009), the SIN3–RPD3 complex (Pile and Wassarman, 2000) or RLAF (Moshkin et al., 
2009). Therefore it was conceivable that the dL(3)mbt-dRpd3 interaction was part of an 
association of dL(3)mbt with a larger complex. An alternative possibility was that 
dL(3)mbt was a subunit of other protein complexes independent of the interaction with 
dRpd3.  
In order to assess the existence and distribution of dL(3)mbt protein in complexes 
nuclear extract from Kc167 cells was fractionated over a Superose 6 gel filtration 
column (Figure 4.4). Fractions were probed in Western blot with specific antibodies 
directed against dL(3)mbt and Retinoblastoma-family protein 2 (RBF2). The latter is 
one of the two retinoblastoma protein homologues in Drosophila and a specific subunit 
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of the Myb-MuvB/dREAM complex (Lewis et al., 2004; Korenjak et al., 2004). The 
bulk of dL(3)mbt was detected in fractions 16 to 20 (Figure 4.4, upper panel) with an 
apparent molecular weight of close to 2 MDa. By contrast, the major RBF2 peak eluted 
in fractions 20 to 24 close to an apparent molecular weight of 670 kDa (Figure 4.4, 
lower panel), which is consistent with previously published data on the size of the Myb-
MuvB/dREAM complex (Korenjak et al., 2004). Hence, in this fractionation the bulk of 
dL(3)mbt is separated from the Myb-MuvB complex. Strikingly, it elutes in one major 
peak, with a higher apparent molecular weight than Myb-MuvB. Nevertheless, 
dL(3)mbt Western blot signals are also observed in RBF2-containing fractions, in 
agreement with a sub-stoichiometric association of dL(3)mbt with Myb-MuvB, as 
suggested by Lewis and co-workers. 
 
 
Figure 4.4: The bulk of dL(3)mbt exists in a high molecular weight complex distinct from 
Myb-MuvB. Nuclear extract from Kc167 cells was fractionated over a Superose 6 gel filtration 
column. Eluted fractions were analysed by Western blot for the presence of dL(3)mbt and RBF2 
using antibodies as indicated. Fraction numbers and gel filtration molecular weight standards 
are denoted on top. Input: 5% of nuclear extract loaded on the column. 
 
In summary, this supports the idea that dL(3)mbt is present in a so far uncharacterised 
high molecular weight complex, which is distinct from the Myb-MuvB complex.  
 
4.1.2.2 Recombinant FLAG-tagged dL(3)mbt incorporates into high molecular 
weight complexes 
An unbiased approach to purify interaction partners of a protein of interest is to epitope-
tag the polypeptide, express it in an appropriate cell/model system and subject it to 
immunoaffinity purification. To facilitate identification of unknown dL(3)mbt 
interacting proteins, the expression vector encoding N-terminally FLAG-tagged 
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dL(3)mbt under the control of the constitutive actin 5C promoter was used for stable 
expression in S2 cells (see Figure 4.1 A). Initially, to investigate the incorporation of 
recombinant FLAG-tagged dL(3)mbt into high molecular weight complexes, FLAG-
dL(3)mbt was expressed by transient transfection into S2 cells and nuclear extract was 
fractionated over a Superose 6 gel filtration column (Figure 4.5). As a control, nuclear 
extract from untransfected cells, not expressing the FLAG-tagged protein, was also 
analysed by gel filtration.  
 
 
Figure 4.5: Recombinant Flag-tagged dL(3)mbt integrates into high molecular weight 
complexes in S2 cells. pPac-HA-FLAG-dL(3)mbt was transiently transfected into S2 cells. 
Nuclear extracts from S2 FLAG-dL(3)mbt (lower panel) and untransfected (mock, upper and 
middle panels) cells were fractionated over a Superose 6 gel filtration column. Eluted fractions 
were analysed by Western blot for the presence of endogenous dL(3)mbt (upper panel) and 
recombinant FLAG-tagged dL(3)mbt (middle and lower panels) using antibodies as indicated. 
Fraction numbers and gel filtration molecular weight standards are denoted on top. Input: 5% of 
nuclear extract loaded on the column. Cross-reacting proteins, detected by the FLAG antibody 
(mouse) are depicted with an asterisk.  
 
Western blot analysis of the fractions using the dL(3)mbt antibody revealed that 
endogenous dL(3)mbt in S2 cells elutes in one major peak (Figure 4.5, upper panel, 
fractions 15 to 20) close to an apparent molecular weight of 2 MDa, in line with data 
obtained with Kc167 cell nuclear extract (Figure 4.4). Moreover, FLAG-tagged 
dL(3)mbt co-eluted in the same fractions as endogenous dL(3)mbt. Gel filtration 
analysis of FLAG-dL(3)mbt revealed a second peak in fraction 21, which is not 
apparent with endogenous protein. This could result from overexpression of FLAG-
dL(3)mbt, upon which not all recombinant protein was incorporated into the major 
dL(3)mbt complex. 
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In conclusion, the gel filtration analysis suggests that recombinant FLAG-tagged 
dL(3)mbt incorporated into the same high molecular weight complex as endogenous 
dL(3)mbt. Therefore the cell line expressing FLAG-tagged dL(3)mbt (Figure 4.1 A) 
was a suitable tool to identify dL(3)mbt interacting partners. 
 
4.1.2.3 Identification of Drosophila L(3)mbt interacting protein 1 (dLint-1) as a 
novel interaction partner of dL(3)mbt 
To scale up expression of FLAG-tagged dL(3)mbt for purification, the stable S2 cell 
line expressing FLAG-tagged dL(3)mbt was expanded (see Figure 4.1 A). Next, nuclear 
extract, obtained from this cell line, was subjected to FLAG affinity purification. In 
parallel, nuclear extract from cells not expressing FLAG-tagged dL(3)mbt, was 
processed as well. Aliquots of eluates obtained by FLAG-peptide competition were 
visualised by silver staining of an SDS-PAGE gel (Figure 4.6).  
 
 
Figure 4.6: dLint-1 (CG1908) co-purifies 
with FLAG-dL(3)mbt in FLAG affinity 
purification. Nuclear extracts from control 
S2 cells (mock, lanes 1 and 3) and cells 
stably expressing FLAG-tagged dL(3)mbt 
(lanes 2 and 4) were subjected to FLAG 
affinity purification, elution with FLAG 
peptide (lanes 3 and 4), SDS-PAGE and 
silver staining. Input: 2 µg of nuclear 
extract (lanes 1 and 2). Proteins identified 
by mass spectrometry are denoted on the 
right (Table 4.1). IP: Immunoprecipitation.  
 
 
 
Many polypeptides were recovered in both purifications (compare lanes 3 and 4), some 
of which appeared to be stained more intensively in the FLAG-dL(3)mbt purification. It 
seems likely, that a slightly higher input of FLAG-dL(3)mbt nuclear extract could 
account for this observation (compare lanes 1 and 2). Nevertheless, all polypeptides, 
which were present in both purifications (mock and FLAG-dL(3)mbt) were considered 
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to be contaminants, resulting from unspecific binding of proteins to α-FLAG agarose. 
This complication of unspecific binding was attributed to low expression levels of the 
recombinant FLAG-tagged protein. 
Despite the high background caused by unspecific binding, two polypeptides were 
specifically enriched in the purification from FLAG-dL(3)mbt expressing cells, one 
with an apparent molecular weight higher than 170 kDa and one with approximately 
85 kDa (Figure 4.6, compare lanes 3 and 4, polypeptides (I) and (II)). These poly-
peptides were excised from the gel and analysed by peptide mass fingerprinting. The 
larger polypeptide was identified as dL(3)mbt (see Figure 4.6 and Table 4.1). The 
85 kDa polypeptide was identified as the gene product of CG1908, a protein of so far 
unknown function. In the following, the protein will be referred to as Drosophila 
L(3)mbt interacting protein 1 (dLint-1).  
 
Table 4.1: Peptide mass fingerprinting results from FLAG affinity purification of FLAG-
dL(3)mbt. Roman numerals denoting polypeptide bands refer to Figure 4.6. Mass spectrometry 
data are expressed as probability based molecular weight search (Mowse) scores, including the 
number of peptides, which matched the identified protein. Scores, greater than 60, are 
significant (p<0.05). Identified polypeptides are given with the according GI number in NCBI, 
the protein name, if available, the CG gene number, including the isoform and the 
corresponding organism. MW: molecular weight. 
Label Probability based 
Mowse score 
Number of peptides 
matched 
Polypeptide identified MW 
[kDa] 
(I) 184 26 
gi|24650589, lethal (3) 
malignant brain tumour, 
CG5954-PA 
[Drosophila melanogaster] 
163.0 
(II) 75 10 gi|18859817, CG1908-PA [Drosophila melanogaster] 67.9 
 
BLAST search identified homologues of dLint-1 in other Drosophila species, but not 
outside of the genus. Furthermore, conventional protein domain search tools failed to 
find conserved motifs within the dLint-1 amino acid sequence. Nevertheless, the C-
terminus (amino acids 542 to 602) of dLint-1 is characterised by a cysteine/histidine-
rich region, which contains a motif with similarity to the plant homeo domain (PHD) 
(R. Aasland, personal communication) (Figure 4.7).  
Interestingly, PHD fingers are commonly found in nuclear proteins that play a role in 
chromatin regulation (Aasland et al., 1995). This PHD-like domain in dLint-1 has the 
typical Cys4HisCys3 (C4HC3) signature and the length (about 60 amino acids) in 
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common with canonical PHD fingers (Aasland et al., 1995; R. Aasland, personal 
communication). However, an aromatic residue, such as tryptophan, preceding the last 
cysteine pair that is conserved in classical PHD motifs (Bienz 2006) is missing. 
Moreover, the N-terminal part of the PHD-like domain contains a high density of 
charged residues, which is not typical for canonical PHD fingers. In summary, dLint-1 
contains a domain that, despite some special features, shares significant similarities with 
PHD-fingers. 
 
 
Figure 4.7: Alignment of PHD-like motifs in Drosophila dLint-1 homologues. Multiple 
sequence alignment of dLint-1 (CG1908) Drosophila homologues, generated with ClustalW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) program. Drosophila species are denoted on the 
left. The C4HC3 PHD-like motif is written in bold and depicted below the alignment. Cys and 
His residues are colour-coded in yellow and green. Basic residues (Arg and Lys) are illustrated 
in red and acidic residues (Asp and Glu) in blue. Positions of amino acid residues (referring to 
the full length protein) of D. melanogaster and other D. species, are depicted on the right, 
respectively. Conservation of residues is displayed below the multiple alignment as follows: ‘*’: 
Identical residues; ‘:’: conserved substitutions; ‘.’: semi-conserved substitutions.  
 
4.1.2.4 dL(3)mbt and dLint-1 interact in a robust manner 
To verify the data of the α-FLAG affinity chromatography, in which dLint-1 was 
identified as a novel dL(3)mbt associating protein, the protein-protein interaction was 
assayed using several different approaches.  
First, N-terminally FLAG-tagged dL(3)mbt, expressed in Sf9 insect cells using a 
recombinant baculovirus, was immobilised on α-FLAG agarose and incubated with 
in vitro translated, 35S-labelled dLint-1 (Figure 4.8 A). Autoradiography revealed that 
FLAG-dL(3)mbt bound dLint-1 very efficiently (upper panel), compared to the 
background resulting from unspecific binding of dLint-1 to the α-FLAG agarose (beads 
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control). In contrast, FLAG-dL(3)mbt failed to interact with in vitro translated Firefly-
Luciferase confirming the specificity of the assay (lower panel).  
 
 
Figure 4.8: dL(3)mbt and dLint-1 interact in a robust manner. (A) In vitro translated, 35S-
labelled dLint-1 (upper panel) or Luciferase (lower panel) were incubated with FLAG beads 
(beads control, lane 3) or FLAG beads loaded with baculoviral-expressed FLAG-dL(3)mbt 
(lane 2). Bound proteins were separated by SDS-PAGE and detected by auto-radiography. 
Input: 1% of in vitro translations (lanes 1). (B) Sf9 cells were co-infected with baculo-viruses 
expressing dL(3)mbt-FLAG or dLint-1 as indicated on top. Extracts from infected cells were 
immunoprecipitated with FLAG beads. Immunoprecipitates were subjected to Western blot 
using α-FLAG (rabbit) and α-Lint-1 antibody #1 (lanes 2, 4 and 6). Input: 5% of extracts (lanes 
1, 3 and 5). (C) Specificity of dLint-1 antibodies. Nuclear extracts from cells treated with 
dsRNA directed against EGFP (lanes 1 and 3) and dLint-1 (lanes 2 and 4) were subjected to 
Western blot using dLint-1 #1 (left upper panel), dLint-1 #2 (right upper panel) and β-tubulin 
antibody (lower panels) as indicated. Detection of β-tubulin served as a loading control. (D) 
Nuclear extract from Kc167 cells was precipitated with ProtG beads loaded with dL(3)mbt 
antibody (lane 2), with dLint-1 antibody #2 (lane 6) or no antibody (beads control, lane 3). 
Immunoprecipitates were analysed by Western blot as indicated on the right. Ab control: 
dL(3)mbt- (lane 4) or dLint-1-specific (lane 7) antibody without extract. Input: 5% of nuclear 
extracts (lanes 1 and 5). 
 
Next, Sf9 cells were co-infected with recombinant baculoviruses expressing C-
terminally FLAG-tagged dL(3)mbt and untagged dLint-1. α-FLAG immunoaffinity 
purification of Sf9 whole cell extracts and Western blot analysis, demonstrated a strong 
interaction between both proteins (Figure 4.8 B, lane 6). As a control, dL(3)mbt-FLAG 
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and dLint-1 were also expressed individually and subjected to FLAG immuno-
precipitation. However, in both controls no protein recognised by the dLint-1-specific 
antibody was recovered (compare lanes 2 and 4).  
Up to that point, all binding assays were performed with overexpressed proteins. To rule 
out the possibility, that the interaction was driven by overexpression of proteins, it was 
indispensable to test for the interaction between endogenous dL(3)mbt and dLint-1.  
For this purpose, two dLint-1-specific antibodies were generated. The specificity of 
these polyclonal antibodies was confirmed in Western blot, analysing nuclear extracts 
from Kc167 cells that were treated for 6 d with dsRNA directed against dLint-1 or 
EGFP as control (Figure 4.8 C). In line with the size of the 85 kDa band, which was 
identified as dLint-1 in peptide mass fingerprinting, both antibodies detected a protein 
between 72 and 95 kDa. Consistent with this protein being dLint-1, a strong decrease in 
signal intensity was observed after dLint-1 RNAi treatment (compare lanes 2 and 4 with 
lanes 1 and 3). Next, nuclear extract derived from Kc167 cells was immunoprecipitated 
both with dL(3)mbt- and dLint-1-specific antisera, respectively (Figure 4.8 D). In both 
cases endogenous dL(3)mbt and dLint-1 co-precipitated (compare lanes 2 and 6), 
whereas no dL(3)mbt and dLint-1 signals were detected in controls omitting either 
antibody (beads control, lane 3) or nuclear extract (antibody control, lanes 4 and 7). 
This result confirms that endogenous dL(3)mbt and dLint-1 interact in vivo. 
To map the dLint-1 region required for binding to dL(3)mbt, immobilised GST-fusion 
proteins of full length dLint-1 and three deletion constructs (depicted in Figure 4.9 B) 
were incubated with recombinant baculoviral expressed dL(3)mbt-FLAG (Figure 
4.9 A). This showed that the first N-terminal 301 residues of dLint-1 were required for 
binding to dL(3)mbt, whereas the C-terminal half of the protein (amino acids 302 to 
602), including the Cys/His-rich PHD-like domain, was dispensable. The protein 
amounts of dLint-1-GST-fusions were controlled by Ponceau staining of the Western 
blot membrane (Figure 4.9 A, lower panel), demonstrating that the N-terminal dLint-1 
construct was present in a lower protein concentration than the C-terminal constructs, 
but still capable of binding dL(3)mbt. 
Taken together, the protein binding data strongly argue for a stable and presumably 
direct interaction between dL(3)mbt and dLint-1. Moreover, the dL(3)mbt interaction 
domain resides in the N-terminal half of the dLint-1 protein. 
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Figure 4.9: The dL(3)mbt interaction domain of dLint-1 is located in the N-terminal half 
of the protein. (A) Upper panel: GST and GST fusion proteins (lane 2: 4 µg GST; lane 3: 4 µg 
GST-dLint-1 full length; lane 4 and 5: 1 µg and 2 µg GST-dLint-1-N-term, respectively; lane 6: 
4 µg GST-dLint-1-C-term; lane 7: 4 µg GST-dLint-1-PHD-like) as indicated on top were 
incubated with Sf9 extracts containing baculoviral expressed dL(3)mbt-FLAG. Bound proteins 
were analysed by Western blot using α-FLAG antibody. Input: 5% of Sf9 extract (lane 1). 
Lower panel: Ponceau-stained membrane of GST-dLint-1 fusion proteins used for binding 
experiment. (B) Scheme of GST-dLint-1 fusion proteins: The GST tag is depicted in grey, the 
PHD-like domain in black and the remaining dLint-1 protein in white. Numbers of amino acid 
residues are denoted below.  
 
 
Figure 4.10: dL(3)mbt and dLint-1 co-elute in gel filtration analysis. Nuclear extract from 
Kc167 cells was fractionated over a Superose 6 column. Fractions were analysed by Western 
blotting using antibodies as indicated. Fraction numbers and gel filtration molecular weight 
standards are denoted on top. Input: 5% of extract loaded on the column. 
 
Considering the robust association of dL(3)mbt and dLint-1, it seemed likely that dLint-
1 is part of the high molecular weight complex, in which the bulk of dL(3)mbt resides. 
In order to address this issue, Kc167 nuclear extract was separated on a Superose 6 gel 
filtration column (Figure 4.10). Western blot analysis of the fractions suggested that the 
majority of dL(3)mbt and dLint-1 are associated in a large complex. A minor peak of 
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dLint-1 was observed in a fraction corresponding to a molecular weight of 670 kDa, 
indicating that a small amount of dLint-1 might exist as a smaller molecular weight 
species. 
 
4.1.2.5 Identification of dCoREST, dLsd1 and dRpd3 as additional dLint-1 
associated proteins  
The high apparent molecular weight of the dL(3)mbt- and dLint-1-containing complex, 
raised the question, whether dL(3)mbt is associated with additional polypeptides. In the 
α-FLAG immunoaffinity purification of FLAG-tagged dL(3)mbt high background 
binding of unspecific polypeptides prevented the identification of further interaction 
partners (Figure 4.6). As an alternative strategy to purify dL(3)mbt/dLint-1 associated 
proteins two S2 cells lines stably expressing FLAG-tagged dLint-1 (dLint-1-FLAG) 
were established. The two stable S2 cell lines varied in their dLint-1-FLAG expression 
levels (Figure 4.12 A, compare lanes 3 and 4 with 5 and 6).  
To confirm the association of dLint-1-FLAG with high molecular weight complexes, 
nuclear extract from cell line #2 stably expressing recombinant dLint-1 was fractionated 
over a Superose 6 column (Figure 4.11). A proportion of FLAG-tagged dLint-1 was 
found to be present in high molecular weight fractions together with endogenous 
dL(3)mbt suggesting that the recombinant protein was incorporated into dL(3)mbt 
complexes. In addition, FLAG-tagged dLint-1 was also present in lower molecular 
weight fractions. dLint-1-FLAG, eluting in fractions with an apparent molecular weight 
smaller than 160 kDa (fractions 30 to 32), possibly corresponded to monomeric protein, 
which was not associated with complexes due to overexpression.  
In agreement with the incorporation of recombinant dLint-1-FLAG into dL(3)mbt 
complexes, FLAG immunoprecipitation of nuclear extracts derived from the two cell 
lines co-precipitated endogenous dL(3)mbt (Figure 4.12 A, upper panel, compare lanes 
4 and 6 with 2). Two chromatin-related proteins, the ATPase dMi-2 and the deacetylase 
dHDAC3, were not precipitated by FLAG immunoprecipitation (lower panels), 
demonstrating the specificity of the FLAG antibody and the dL(3)mbt-dLint-1 
interaction. 
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Taken together, both gel filtration analysis and co-precipitations indicated that dLint-1-
FLAG incorporated into dL(3)mbt complexes. Therefore the dLint-1-FLAG expressing 
cell line was a suitable tool to co-purify putative dLint-1/dL(3)mbt interacting proteins. 
 
 
Figure 4.11: Recombinant FLAG-tagged dLint-1 incorporates into high molecular weight 
complexes in S2 cells. FLAG-tagged dLint-1 (encoded on pPac-dLint-1-FLAG) was stably 
transfected into S2 cells. Nuclear extracts from control S2 cells (mock, upper panel) and S2 
dLint-1-FLAG cells (middle and lower panels) were fractionated over a Superose 6 gel filtration 
column. Eluted fractions were analysed by Western blot for the presence of endogenous 
dL(3)mbt (middle panel) and recombinant FLAG-tagged dLint-1 (upper and lower panels) using 
antibodies as indicated on the right. Fraction numbers and gel filtration molecular weight 
standards are denoted on top. Input: 5% of nuclear extract loaded.  
 
To identify additional dLint-1/dL(3)mbt associated polypeptides, an FLAG immuno-
affinity purification of FLAG-tagged dLint-1 from nuclear extract of the stable S2 cell 
line #2, characterised by a high expression level of the recombinant protein, was carried 
out (Figure 4.12 B). Several polypeptide bands were detected by silver staining that 
specifically co-purified with dLint-1-FLAG bound to α-FLAG resin, but not to resin 
incubated with mock nuclear extract (compare lanes 3 and 4). Input samples confirmed 
that equal amounts of both nuclear extracts have been applied (compare lanes 1 and 2).  
In order to identify the corresponding proteins that co-purified with dLint-1-FLAG, 
bands were excised and subjected to peptide mass fingerprinting as before (compare 
Figure 4.12 and Table 4.2). For comparison, corresponding gel slices excised from the 
mock lane were analysed in parallel (data not shown).  
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Figure 4.12: Identification of dLint-1-FLAG associated proteins by FLAG affinity 
purification. (A) Stable expression of FLAG-tagged dLint-1 in S2 cells. Nuclear extracts from 
control S2 cells (mock, lanes 1 and 2) and two S2 cell lines #1 and #2 stably expressing FLAG-
tagged dLint-1 (lanes 3, 4, 5 and 6) were immunoprecipitated with α-FLAG agarose (lanes 2, 4 
and 6). Immunoprecipitates were analysed by Western blotting with antibodies as indicated. 
Input: 5% of nuclear extracts (lanes 1, 2 and 3). (B) FLAG affinity purification. Nuclear extracts 
from control S2 cells (mock, lanes 1 and 3) and S2 cells stably expressing FLAG-tagged dLint-
1 (cell line #2) (lanes 2 and 4) were subjected to FLAG affinity purification, elution with FLAG 
peptide (lanes 3 and 4), SDS-PAGE and silver staining. Input: 2 µg of nuclear extracts (lanes 1 
and 2). Proteins identified by mass spectrometry are denoted on the right (see Table 4.2). The 
asterisk marks unspecifically bound protein. IP: immunoprecipitation. 
 
Besides dLint-1 (V), polypeptides I and II were identified as dL(3)mbt (Figure 4.12 and 
Table 4.2). One is likely to correspond to the full length protein and the second one 
possibly originated from degradation, which occurred during the purification procedure. 
In addition, the histone deacetylase dRpd3 (VI), the corepressor dCoREST (III), and the 
histone demethylase dLsd1 (IV), were identified as dLint-1 associated polypeptides. 
Notably, the latter two were identified from the same gel slice as the top two specific 
hits in mass spectrometry. The intensively stained polypeptide band with a size between 
43 kDa and 55 kDa was identified as the translation initiation factor eIF-4B, which was 
also bound to the resin of the mock FLAG purification, albeit at lower levels. 
Translation elongation and initiation factors belong to a class of proteins that commonly 
bind non-specifically to Sepharose/agarose beads (Trinkle-Mulcahy et al., 2008). Thus, 
eIF-4B was considered to be a cytoplasmic contaminant and not further investigated. 
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Table 4.2: Peptide mass fingerprinting results from α-FLAG affinity purification of dLint-
1-FLAG. Roman numerals denoting the polypeptide bands refer to Figure 4.12 B. Mass 
spectrometry data are expressed as probability based molecular weight search (Mowse) scores, 
including the number of peptides, which matched the identified protein. Scores, greater than 32, 
are significant (p<0.05). Identified polypeptides are stated with the according GI number in 
NCBI, the protein name, the CG gene number, including the isoform and the corresponding 
organism. MW: molecular weight. 
Label Probability based 
Mowse score 
Number of peptides 
matched 
   Polypeptide identified MW 
[kDa] 
(I) 6437 374 gi|3421009, tumour supressor [Drosophila melanogaster] 163.0 
(II) 3061 229 gi|3421009, tumour supressor [Drosophila melanogaster] 163.0 
(III) 3847 214 
gi|62473829, CoREST, 
CG33525-PF  
[Drosophila melanogaster] 
62.7 
(IV) 814 78 
gi|21356479, Histone 
demethylase, CG17149-PA 
[Drosophila melanogaster] 
98.4 
(V) 8391 466 
gi|18859817, CG1908, 
CG1908-PA  
[Drosophila melanogaster] 
67.9 
(VI) 4831 356 
gi|24657891, Rpd3,  
CG7471-PA  
[Drosophila melanogaster] 
58.3 
 
4.1.2.6 dLint-1 associated proteins co-immunoprecipitate both in Drosophila 
embryonic cell lines and embryos 
The FLAG immunoaffinity purification of dLint-1-FLAG led to the identification of 
three additional polypeptides that are associated with dLint-1 apart from dL(3)mbt. To 
validate the data obtained by mass spectrometry and to verify the complex composition, 
specific antibodies directed against dCoREST (Dallman et al., 2004) and dLsd1 (also 
referred to as Su(var)3-3) (Rudolph et al., 2007) were obtained. dL(3)mbt (this study, 
Scharf et al., 2009), dRpd3 (Brehm et al., 2000) and dLint-1 antibodies (this study) were 
available in the lab. 
First, FLAG immunoprecipitations were carried out from nuclear extract derived from 
the stable S2 cell line (#2) expressing dLint-1-FLAG and subjected to Western blot 
(Figure 4.13). In agreement with mass spectrometry results, dL(3)mbt, dCoREST, 
dLsd1 and dRpd3 were detected in precipitates from FLAG-tagged dLint-1, but not 
from control extract (mock, compare lane 4 with lane 2). As an additional control for 
the specificity of this experiment FLAG immunoprecipitates were subjected to Western 
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blot using an HP1α-specific antibody and as a result no co-precipitation with dLint-1-
FLAG was observed. The dCoREST protein exists in three splice variants, a small (S), a 
medium-sized (M) and a large (L) isoform, which will be referred to as dCoREST-S, 
dCoREST-M and dCoREST-L from hereon. The antibody used in this study recognises 
two of them, namely dCoREST-M and dCoREST-L, which exhibit the same domain 
composition, but differ in the length of the domain separating the two SANT domains 
(Dallman et al., 2004). The Western blot analysis clearly revealed that FLAG-tagged 
dLint-1 preferentially co-precipitated dCoREST-M (Figure 4.13), which was also the 
isoform identified by mass spectrometry. Moreover, Western blot analysis illustrated 
that the dCoREST-M splice variant and dLsd1 migrate, despite their different predicted 
molecular weights, at the same height upon SDS-PAGE. This is consistent with the fact 
that dLsd1 and dCoREST were identified by mass spectrometry from the same gel slice 
(compare Figure 4.12 and Table 4.2). 
 
 
Figure 4.13: Recombinant dLint-1-FLAG 
co-immunoprecipitated in addition to 
dL(3)mbt, dCoREST, dLsd1 and dRpd3. 
Nuclear extracts from control S2 cells 
(mock, lanes 1 and 2) and S2 cells stably 
expressing FLAG-tagged dLint-1 (lanes 3 
and 4) were precipitated with α-FLAG 
agarose. Immuno-precipitates were analysed 
by Western blot using antibodies as 
indicated on the right (lanes 2 and 4). Input: 
5% of nuclear extracts (lanes 1 and 3).  
 
 
In conclusion, the results obtained by FLAG affinity purification and subsequent 
peptide mass fingerprinting could be evidently confirmed by Western blot analysis, 
showing that immunoprecipitation of FLAG-tagged dLint-1 co-precipitated apart from 
dL(3)mbt also specifically dRpd3, dCoREST and dLsd1. 
The association of dCoREST, dLsd1 and dRpd3 with dLint-1 was found after 
overexpression of a FLAG-tagged version of recombinant dLint-1 protein. To ensure 
that also the endogenous proteins interact with each other, nuclear extracts from Kc167 
4 RESULTS 
102 
 
cells (Figure 4.14 A) and 0-12 hr old Drosophila embryos (Figure 4.14 B) were 
precipitated with dLint-1 and dCoREST-specific antisera.  
 
 
Figure 4.14: Endogenous dLint-1 and dCoREST interact and co-immunoprecipitate 
dL(3)mbt, dRpd3 as well as dLsd1 in Kc167 cells and Drosophila embryos. Nuclear extracts 
from Kc167 cells (A) and 0-12 hr old Drosophila embryos (B) were precipitated with ProtG 
beads loaded with dLint-1 antibody (lanes 2), with dCoREST antibody (lanes 6) or no antibody 
(beads control, lanes 3 and 7). Immunoprecipitates were analysed by Western blot as indicated 
on the right. Ab controls: contained dLint-1- (lanes 4) or dCoREST-specific (lanes 8) antibody, 
respectively. Input: 5% (lanes 1 and 5) of nuclear extracts. The asterisks mark signals that 
derive from unspecific antibody cross-reactions. 
 
Indeed, both dLint-1- and dCoREST-specific antibodies co-precipitated all five proteins 
efficiently (Figure 4.14, compare lanes 2 and 6), compared to control precipitations, 
omitting either antibody (beads controls, lanes 3 and 7) or nuclear extract (antibody 
controls, lanes 4 and 8). This was the case not only for extract from embryonic Kc167 
cells (Figure 4.14 A), but also for extract obtained from 0-12 hr old embryos (Figure 
4.14 B), supporting the existence of these protein interactions in vivo in the Drosophila 
embryo. 
The unrelated, highly abundant chromatin remodeler dMi-2 did not bind to either dLint-
1 or dCoREST antibody, demonstrating the specificity of co-immunoprecipitations. In 
line with results obtained by FLAG immunoprecipitation (Figure 4.13), dLint-1 
precipitated preferentially the dCoREST-M splice variant (lanes 2). In dLint-1 immuno-
precipitations only a small percentage of dLsd1 appeared to precipitate (lanes 2). In 
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contrast, the dCoREST antibody, which recognised both splice variants (M and L), 
precipitated significantly more dLsd1 (lanes 6), while the dLint-1 signal was equal 
(Figure 4.14 A, lane 6) or even weaker (Figure 4.14 B, lane 6) compared with dLint-1 
precipitates (lanes 2). This observation might imply the interaction of dCoREST and 
dLsd1 in other complexes independent of dLint-1/dL(3)mbt.  
Taken together, immunoprecipitations clearly showed that all five proteins, which were 
identified in FLAG affinity immunopurification, co-precipitated with either dLint-1 or 
dCoREST on an endogenous level. This and the fact that all dLint-1 co-purifying 
proteins were identified with very high Mowse scores by mass spectrometry analysis 
(Table 4.2) strongly suggest that these proteins form stable protein complexes in 
Drosophila.  
 
4.1.2.7 dLint-1 interacting proteins co-elute in gel filtration analysis 
The interaction of dLint-1 with dL(3)mbt, dCoREST, dLsd1 and dRpd3, documented 
extensively by immunoprecipitation experiments (Figures 4.13 and 4.14), supported the 
idea that these proteins are present in stable protein complexes. This hypothesis predicts 
that complex subunits co-elute during gel filtration. To test this hypothesis, nuclear 
extract from Kc167 cells was fractionated by gel filtration on a Superose 6 column 
(Figure 4.15) to separate protein complexes according to their molecular weight and 
shape and analysed by Western blot.  
In line with previous results (Figure 4.10), the bulk of dL(3)mbt and dLint-1 eluted in a 
common peak, close to 2 MDa. However, a minor fraction of dLint-1 eluted at 670 kDa 
and below, indicating the association with other complexes aside from dL(3)mbt-
containing ones. On the contrary to dL(3)mbt and dLint-1, Western blot analysis of gel 
filtration fractions using antibodies directed against dCoREST, dLsd1 and dRpd3 
displayed more complex elution profiles, suggesting their presence in several 
independent complexes. Consistent with this observation dRpd3 has been shown to be 
part of multiple other chromatin-associated protein complexes, such as dNuRD 
(Kunert et al., 2009), SIN3–RPD3 (Pile and Wassarman, 2000) and ESC (Tie et al., 
2001). In addition, gel filtration analysis of Drosophila embryo extract indicated, that 
dLsd1 also exists in numerous complexes (T. Rudolph, personal communication). 
Nevertheless, all three proteins were present in dL(3)mbt- and dLint-1-containing 
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fractions (compare fractions 15 to 19). However, while the peak fraction of dL(3)mbt 
and dLint-1 appeared to be in fraction 17, dLsd1 revealed a peak in fraction 15 and 
signal intensity decreased severely in fraction 17, arguing against their presence in the 
same complex. In case of dRpd3 no strong conclusions can be drawn, since the histone 
deacetylase was present in equal amounts in fractions 15 to 21. In contrast to this the 
dCoREST-M isoform, which was shown to preferentially bind to dLint-1 (Figures 4.13 
and 4.14), co-eluted in fractions 15 to 19 with an identical profile as dL(3)mbt and 
dLint-1. By contrast these fractions contained only a small proportion of the dCoREST-
L isoform present in the nuclear extract, which reveals rather a peak in the first protein-
containing fraction similar to dLsd1 (fraction 17). These results provide further 
evidence that at least dL(3)mbt, dLint-1 and dCoREST are present in a common multi-
subunit complex. 
 
 
Figure 4.15: dLint-1 interacting partners co-elute during gel filtration. Nuclear extract from 
Kc167 cells was fractionated over a Superose 6 column. Fractions were analysed by Western 
blot as indicated on the right. Fraction numbers and molecular weight standards are denoted on 
top. Input: 5% of extract loaded on the column. 
 
In order to assess more directly if dCoREST and dLsd1 are specifically associated with 
dL(3)mbt and dLint-1, Kc167 nuclear extract depleted of dL(3)mbt and dLint-1 by 
dL(3)mbt RNAi (see Figure 4.22 A) was separated by gel filtration (Figure 4.16).  
Comparison of the input signals of dCoREST (panels 5 and 6) and dLsd1 (panels 7 
and 8) protein in EGFP and dL(3)mbt RNAi-treated cells, revealed that protein levels 
were not affected by co-depletion of dL(3)mbt (compare panels 1 and 2) and dLint-1 
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(compare panels 3 and 4). However, the knockdown of dL(3)mbt and dLint-1 resulted 
in a pronounced shift of the dCoREST-M isoform peak (fraction 17, panel 5) from high 
molecular weight fractions to lower molecular weight fractions (compare panels 5 and 
6, fractions 15 to 19). On the contrary, the dCoREST-L splice variant was still 
detectable in high molecular weight fractions after dL(3)mbt/dLint-1 co-depletion. 
Moreover the elution profile of dLsd1 remained unchanged upon RNAi treatment 
directed against dL(3)mbt compared to the EGFP control (compare panels 7 and 8). On 
first inspection the profiles of dRpd3 seemed to largely overlap in the presence and 
absence of dL(3)mbt/dLint-1 (compare panels 9 and 10). A closer look though revealed 
a shift of a dRpd3 portion to lower molecular weight fractions. While the peak of dRpd3 
in EGFP dsRNA treated Kc167 cells in high molecular weight fractions resided in 
fraction 17 along with dL(3)mbt and dLint-1, the peak fraction in dL(3)mbt dsRNA 
treated cells is in fraction 19. This might indicate that dL(3)mbt/dLint-1-associated 
dRpd3 is incorporated in other complexes with lower molecular weight. Additionally as 
a control the analysis of an independent chromatin-related protein dMi-2 did not show a 
change in its elution profile (compare panels 11 and 12).  
Taken together, these results support the idea that the dCoREST-M isoform, present in 
high molecular weight fractions, is stably associated with the dL(3)mbt/dLint-1 
complex and that this complex disassembles upon dL(3)mbt and dLint-1 depletion. 
However, gel filtration analyses suggest that dLsd1 is not stably interacting with the 
dL(3)mbt/dLint-1 complex or that only sub-stoichiometric amounts are associated with 
the complex, which co-elute with other high molecular weight dLsd1 complexes in 
fractions 15 to 19. The results concerning dRpd3 are consistent with its presence in a 
dL(3)mbt/dLint-1 complex. However, to draw a substantive conclusion from gel 
filtration experiments is difficult, since dRpd3 is existent in numerous other multi-
subunit complexes.  
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Figure 4.16: Depletion of dL(3)mbt and dLint-1 results in a loss of dCoREST protein from 
high molecular weight fractions. Nuclear extracts from Kc167 cells, treated with dsRNA 
directed against EGFP (panels 1, 3, 5, 7, 9 and 11) or dL(3)mbt (panels 2, 4, 6, 8, 10 and 12) 
were separated over a Superose 6 column and fractions were analysed by Western blot using 
dL(3)mbt (panels 1 and 2), dLint-1 (panels 3 and 4), dCoREST (panels 5 and 6), dLsd1 (panels 
7 and 8), dRpd3 (panels 9 and 10) and dMi-2 (panels 11 and 12) antibodies as denoted on the 
right. Fraction numbers and molecular weight standards are shown on top. Input: 5% of extract 
loaded on the column. This experiment was designed by me and carried out under my 
supervision by M. Groh during an internship in the lab of Prof. A. Brehm. 
 
4.1.2.8 LINT is distinct from other dLint-1-, dCoREST- and dLsd1-containing 
complexes 
Although dLsd1 co-immunoprecipitates with recombinant FLAG-tagged, as well as 
with endogenous Lint-1, gel filtration analyses of Kc167 nuclear extract imply that 
dLsd1 might not be stably associated with the dL(3)mbt-dLint-1-dCoREST complex. 
This is somewhat surprising, since in human CoREST and LSD1 have been found to co-
exist in protein complexes in several purifications (Hakimi et al., 2003; Lee et al., 2005; 
Shi et al., 2005; You et al., 2001). 
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To gain a deeper insight into the composition of dL(3)mbt and dLint-1-containing 
complexes, Kc167 nuclear extract was subjected to classical sequential ion exchange 
chromatography (Figure 4.17 A).  
 
 
Figure 4.17: The LINT core subunits dL(3)mbt, dLint-1 and dCoREST co-fractionate 
during ion exchange chromatography. (A) Purification scheme: Nuclear extract from Kc167 
cells was applied to sequential ion exchange chromatography. Extract was bound to a Q 
Sepharose anion exchange column in the presence of 100 mM salt (NaCl) and eluted stepwise 
with 500 mM and 1 M NaCl. The 500 mM salt eluate was applied to anion exchange chromato-
graphy using a Mono Q column and eluted gradually with 100 to 500 mM NaCl (fractions 1 to 
50). Q Sepharose (B) and Mono Q (C) fractions were analysed by Western blot as indicated on 
the right. Salt concentrations (B) and fraction numbers (C) are denoted on top, respectively.  
 
First, the nuclear extract was pre-fractionated in a first step using the anion exchange 
column Q Sepharose. As revealed by Western blot analysis (Figure 4.17 B) the proteins 
of interest eluted all at 500 mM NaCl and were therefore separated from proteins in the 
flow trough (100 mM) and from proteins eluting at 1 M NaCl. Moreover, this procedure 
removes nucleic acids present in the nuclear extract, since they bind strongly to the 
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anion exchange column due to their negative charge and are only eluted with 1 M salt. 
Second, the 500 mM Q Sepharose peak was fractionated over a Mono Q anion 
exchange column, which provides protein separation with a high resolution. For elution 
a salt gradient ranging from 100 to 500 mM (fractions 1 to 50) was applied. Signals 
specific for dL(3)mbt, dLint-1, dCoREST, dLsd1 and dRpd3 were only detected in 
fractions above 250 mM (Figure 4.17 C and data not shown). As judged by Western 
blot analysis, dL(3)mbt eluted in a single peak in fraction 32 together with dLint-1 and 
the dCoREST-M isoform at approximately 360 mM salt. The dRpd3 profile, however, 
is not informative. Although fraction 32 contained dRpd3 the signal did not coincide 
with a peak of dRpd3. Interestingly, the bulk of dLsd1 was separated from dL(3)mbt, 
eluting in fractions 22 to 24 along with a minor fraction of dLint-1, both splice variants 
of dCoREST (-M and -L) and dRpd3.  
In summary, gel filtration and ion exchange chromatography experiments identified at 
least two dLint-1 complexes, one of which contains dCoREST and the bulk of 
dL(3)mbt. This novel three subunit complex will be referred to as the LINT complex 
from hereon (Figure 4.18). Moreover, ion exchange chromatography analysis along 
with results from immunoprecipitations suggests that dLint-1 resides in other complexes 
together with the histone demethylase dLsd1 and the histone deacetylase dRpd3. 
 
 
Figure 4.18: LINT core complex composition. Left panel: Schematic depiction of the LINT 
complex. Right panel: Schematic representation of the LINT subunits, depicting their domain 
structure. Top-down: dL(3)mbt, dLint-1, dCoREST-M. Protein sizes, in terms of amino acid 
residues, are denoted below the corresponding proteins. 
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4.1.2.9 The LINT complex exists in the Drosophila larval brain 
Up to this point biochemical data, identifying the LINT complex, had been obtained 
using extracts from Drosophila cell lines as a source, except for immunoprecipitations 
(α-dLint-1 and α-dCoREST) of endogenous proteins that have been also confirmed 
using Drosophila embryo extracts. Thus, it was important to further ensure that the 
LINT complex exists in vivo in the developing fly. A loss of function mutation of the 
l(3)mbt gene leads to the development of a malignant tumour in the brain of Drosophila 
larvae (Gateff et al., 1993; Wismar et al., 1995; Janic et al., 2010), uncovering the larval 
brain as a biological relevant tissue of dL(3)mbt protein function. Therefore, protein 
extracts were prepared from whole brains that were dissected from third instar larvae 
(Figure 4.19).  
 
 
Figure 4.19: The LINT core subunits 
dL(3)mbt, dLint-1 and dCoREST interact 
in third instar larval brain tissue. Protein 
extracts from larval brains were precipitated 
with ProtG beads loaded with dLint-1 antibody 
(lane 2) or no antibody (beads control, lane 3). 
Ab control: contained dLint-1 antibody (lane 
4). Immunoprecipitates were analysed by 
Western blot as indicated on the right. Input: 
10% of brain extract (lane 1). The asterisk 
denotes a signal that derives from an un-
specific antibody cross-reaction. 
 
The extracts were imunoprecipitated using dLint-1 antibody and tested for co-
immunoprecipitation of dL(3)mbt, dCoREST, dRpd3 and dLsd1 (Figure 4.19). In 
agreement with the LINT complex existing in the larval brain both dL(3)mbt and 
dCoREST co-precipitated with dLint-1 (lane 2). In contrast, dLsd1 and dRpd3 are not 
detected in the α-dLint-1 precipitate, despite robust input signals for both proteins, 
demonstrating that they are expressed in this tissue (compare lanes 1 and 2). In 
conclusion, the LINT complex exists in larval brain tissue and comprises the three core 
subunits dL(3)mbt, dLint-1 and dCoREST.  
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4.2 Identification of LINT complex target genes 
Remarkably, the LINT complex contains with dL(3)mbt and dCoREST two known 
chromatin-regulating proteins, both exhibiting motifs, MBT and SANT domains, 
respectively, that have the potential to bind to histone tails (Bonasio et al., 2010; 
de la Cruz et al., 2004). In addition dL(3)mbt and dCoREST have known functions in 
transcriptional repression (Dallman et al., 2004; Lewis et al., 2004; Georlette et al., 
2007). Therefore it was prompting to investigate the chromatin-associated role of the 
LINT complex in regulation of transcription. 
 
4.2.1 dL(3)mbt and dLint-1 co-localise on many sites in the Drosophila 
genome 
A special tool that is available in Drosophila third instar larvae, in order to investigate 
the localisation of chromatin binding proteins in vivo on a genome-wide level, is 
indirect immunofluorescent labelling of polytene chromosomes (Schwartz et al., 2004). 
During the third instar larval stage the genome of salivary gland cells undergoes 
repeated  rounds of DNA replication without cell division (called endoreplication). 
A consequence of this is the production of giant polytene chromosomes that consist of 
up to thousand sister chromatids that remain synapsed. The centromeric regions of all 
chromosomes stay bundled together and form the so called chromocentre. 
As a first step towards understanding whether the LINT complex that was purified from 
soluble Kc167 nuclear extract associates with chromatin in vivo, polytene chromosomes 
from w1118 larvae were stained with dL(3)mbt and dLint-1 antibodies. However, no 
signals for endogenous dL(3)mbt above background levels could be detected with the 
available antibodies (Figure 4.20 B, upper panels). 
Nevertheless, to investigate dL(3)mbt binding to chromatin despite this, a transgenic fly 
carrying an inducible UAS-dL(3)mbt transgene was generated using a germline-specific 
ϕC31 integrase-based integration system (Bischof et al., 2007). In this system, the 
expression of the transgene is regulated by an upstream activating sequence (UAS) 
element containing GAL4 binding sites. To induce transgene expression, flies carrying 
the UAS-transgene are mated to flies, which express the GAL4 transcription factor in a 
specific pattern (GAL4-driver strain) (Duffy, 2002). The progeny from these crosses 
express the UAS-dependent transgene in a transcriptional pattern that corresponds to the 
GAL4 expression pattern of the respective driver strain.  
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Figure 4.20: Ectopically expressed recombinant dL(3)mbt reveals binding to multiple sites 
in the Drosophila genome. (A) Verification of ectopic overexpression of the dL(3)mbt 
transgene in salivary gland extracts of third instar larvae by Western blot using dL(3)mbt (#3) 
and β-tubulin antibodies. w1118 control flies and flies carrying a dL(3)mbt transgene under the 
control of UAS were crossed with a da-GAL4 driver strain. Western blot against β-tubulin 
served as a loading control. (B) w1118 control flies (I, II) and flies carrying a UAS-dL(3)mbt 
transgene (III, IV) were crossed with an sgs-58AB-GAL4 driver strain. Polytene chromosomes 
were stained with DAPI (blue; left panels) and dL(3)mbt antibody (#P1 6E6) (red; right panels).  
 
To verify the proper expression of the dL(3)mbt transgene upon site-specific insertion 
into the genome the resulting transgenic flies were crossed to a daughterless-GAL4 (da-
GAL4) driver strain, which expresses GAL4 in an ubiquitous pattern. Western blot 
analysis of whole cell extracts from larval salivary glands using a dL(3)mbt-specific 
antibody confirmed the strong ectopic overexpression of dL(3)mbt in the progeny of 
these crosses (Figure 4.20 A, upper panel, compare lanes 1 and 2). In agreement with 
undetectable endogenous dL(3)mbt in immunostainings of polytene chromosomes 
(Figure 4.20 B, compare upper panels), no or little dL(3)mbt was detected by Western 
blot analysis in extracts obtained from control crosses (Figure 4.20, compare lane 1). 
In order to get an insight into the ability of dL(3)mbt to bind to chromatin on a genome-
wide level, flies carrying the UAS-dL(3)mbt transgene were crossed to the sgs-58AB-
GAL4 driver strain, which expresses GAL4 in a salivary gland-specific expression 
pattern. Immunostaining of polytene chromosomes with a dL(3)mbt-specific antibody 
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highlighted numerous distinct bands occupied by recombinant dL(3)mbt (Figure 4.20 B, 
compare panels IV and II).  
Next, to determine whether recombinant dL(3)mbt co-localises with LINT complex 
subunits polytene chromosomes were co-stained with dL(3)mbt and dLint-1 antibodies 
(Figure 4.21).  
 
 
Figure 4.21: Recombinant dL(3)mbt and endogenous dLint-1 co-localise on polytene 
chromosomes. The sgs-58AB-GAL4 driver strain was crossed with UAS-dL(3)mbt transgenic 
flies. Upper panels: Polytene chromosomes were stained with DAPI (blue; panel I), dL(3)mbt 
(red; panel II) and dLint-1 (green; panel III) antibodies. An overlay of dL(3)mbt and dLint-1 
signals is shown in panel IV. Lower panels: Close-up views of polytene stainings. White and 
grey arrowheads denote selected prominent bands of dL(3)mbt and dLint-1 co-localisation 
(white) or exclusive dLint-1 binding (grey).  
 
Co-stainings revealed extensive co-localisation between the two proteins (Figure 4.21, 
compare panels II and III with panel IV). 466 bands were identified for dL(3)mbt and/or 
dLint-1 binding by visual inspection of immunofluorescence signals. 83% (386 bands) 
were stained by both dL(3)mbt and dLint-1 antibodies, 12% (55 bands) displayed dLint-
1 but no or only very weak dL(3)mbt binding and 5% (25 bands) seemed to be occupied 
by dL(3)mbt alone. These results support the idea, gained by biochemical studies 
before, that the LINT subunits act in concert with each other and can bind together to 
many discrete genomic loci. 
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4.2.2 Expression profiling upon dL(3)mbt and dLint-1 depletion  
Given that dL(3)mbt and dLint-1 co-occupy numerous chromosomal locations on 
polytene chromosomes it seemed very likely that the proteins of the LINT complex 
work in concert to co-regulate genes on the level of transcription.  
To identify LINT regulated genes on a genome-wide level microarray expression 
analysis following the removal of complex subunits by RNAi in Kc167 cells was employed. 
Gel filtration analysis of the individual LINT subunits had suggested (Figures 4.10 and 
4.15) that the bulk of dL(3)mbt and dLint-1 was present in the LINT complex, whereas 
dCoREST exists in other protein complexes. Therefore, to identify LINT complex-
specific target genes, the two LINT-unique subunits dL(3)mbt and dLint-1 were 
depleted in Kc167 cells, respectively, by treating the cells with dsRNA targeting either 
dL(3)mbt or dLint-1 (Figure 4.22). For comparison, cells were treated with dsRNA 
directed against EGFP in parallel.  
 
 
Figure 4.22: Depletion of dL(3)mbt and dLint-1 in Kc167 cells. Kc167 cells were treated 
with dsRNA directed against EGFP, dL(3)mbt or dLint-1 as indicated. (A) Protein levels of 
dL(3)mbt (upper panel) and dLint-1 (middle panel): Nuclear extracts from RNAi-treated cells 
were analysed by Western blot using antibodies as indicated on the right. Western blot against 
β-tubulin served as a loading control. (B) mRNA levels of l(3)mbt (left panel) and lint-1 (right 
panel): mRNA isolated from RNAi treated cells was analysed by RT-qPCR. mRNA levels in 
EGFP dsRNA-treated cells were set to 1. 
 
Efficiencies of RNAi-mediated knockdowns were controlled by Western blot (Figure 
4.22 A). Detection of β-tubulin served as a loading control, to ensure that equal amounts 
of extract have been applied. Depletion of both dL(3)mbt and dLint-1 was efficient and 
resulted in strong decreases in protein level. Interestingly, dL(3)mbt knockdown 
resulted in co-depletion of dLint-1 but not vice versa. Quantification of mRNA levels 
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by RT-qPCR (Figure 4.22 B), however, revealed that dL(3)mbt depletion did not affect 
lint-1 mRNA levels. This suggests that dLint-1 protein is destabilised by the loss of 
dL(3)mbt as a stable binding partner. 
For microarray analysis knockdown experiments were conducted in biological 
triplicates and total RNA was prepared from dL(3)mbt, dLint-1 and EGFP RNAi-
treated cells in each experiment. In cooperation with Gunther Doehlemann (MPI for 
Terrestrial Microbiology, Marburg) the total RNA was processed and hybridised to 
Affymetrix GeneChip Drosophila Genome 2.0 Arrays. Statistical analysis of the micro-
array results was conducted by Florian Finkernagel (IMT, Marburg). Genes with a fold 
change of at least 1.5 (adjusted p-value ≤ 0.05) were considered to be deregulated 
(Figure 4.23).  
 
 
Figure 4.23: Venn-diagrams displaying dL(3)mbt and dLint-1 regulated genes. (A) Venn-
diagrams representing all genes that were deregulated more than 1.5 fold (adj. p ≤ 0.05) upon 
dL(3)mbt or dLint-1 knockdown in Kc167 cells (blue). Deregulated genes were subdivided into 
(B) up-regulated (red) and (C) down-regulated (green) genes. 
 
In dLint-1 depleted cells, 1017 genes were deregulated. From these 697 were up- and 
320 were down-regulated. dL(3)mbt knockdown resulted in a deregulation of 760 
genes, from these 561 genes were up-regulated, while 199 were down-regulated. 
Therefore, in both dL(3)mbt and dLint-1 depleted cells, approximately 2-fold more 
genes were up-regulated than down-regulated. Surprisingly, in dL(3)mbt RNAi-treated 
cells, less genes were deregulated overall compared to dLint-1 RNAi-treated cells, 
although co-depletion of dLint-1 in cells treated with dL(3)mbt-dsRNA seemed as 
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efficient as the loss of dLint-1 in cells treated with dLint-1 dsRNA (Figure 4.22, 
compare lanes 2 and 3). 
Genes whose expression was changed in the same direction in both dL(3)mbt and dLint-
1 depleted cells were considered as potential LINT complex target genes. For both 
dL(3)mbt and dLint-1 the majority of deregulated genes (74% and 53%, respectively) 
were found in both data sets. From these 563 coregulated genes 460 were up-regulated 
and 103 were down-regulated. The ratio between the numbers of up- and down-
regulated genes (4.5 : 1) suggests a predominant role of LINT in transcriptional 
repression.  
 
4.2.3 LINT represses ovary- and testis-specific genes 
To gain insight into the type of target genes that were repressed by the LINT complex, 
genes strongly up-regulated upon dL(3)mbt and dLint-1 depletion were analysed. 
Interestingly, closer inspection of the top 50 genes derepressed upon dLint-1 RNAi 
using the FlyAtlas (http://flyatlas.org), a microarray-based atlas of gene expression in 
multiple adult tissues, revealed that 40% of the genes were expressed specifically in 
ovary or testis in the adult fly (Table 4.3). With the exception of eight, these genes were 
also among the top 50 up-regulated genes upon dL(3)mbt knockdown.  
Among these were genes with established roles during germline development, such as 
piwi (Cox et al., 1998), swallow (swa) (Stephenson et al., 1988) and nanos (nos) 
(Lehmann and Nüsslein-Volhard, 1991), as well as in meiosis, such as crossover 
suppressor on 2 of Manheim (c(2)M) (Manheim and McKim, 2003). In contrast, a 
multitude of the top 50 deregulated genes displaying ovary- and testis-specific 
expression was annotated with unknown molecular function (i.e. CG14516 and skpB). 
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Table 4.3: Top 50 dLint-1 up-regulated genes. Expression changes of genes upon knockdown 
of either dLint-1 or dL(3)mbt are expressed as log2 fold changes (FC). Genes were ranked 
according to decreasing FC. Genes are stated with their gene symbol and name. Specific 
expression of genes in ovary and/or testis is indicated. 
dLint-1 
rank  
dLint-1 
log2 
FC 
dL(3)mbt 
rank 
 
dL(3)mbt 
log2 
FC 
Gene 
symbol 
 
Gene 
name 
Ovary/Testis-
specific 
expression 
1 7.9 3 7.6 CG14516 CG14516 Ovary 
2 7.2 2 8.8 CG30296 CG30296  
3 6.5 4 7.6 piwi P-element 
induced 
wimpy testis 
Ovary 
4 6.4 1 8.9 CG11052 CG11052 Testis 
5 6.0 9 8.8 CG17207 CG17207 Testis 
6 5.9 6 7.1 CG5731 CG5731  
7 5.9 10 6.7 CG8589/tej tejas/anon-
fast-evolving-
1D11 
Ovary 
8 5.7 5 7.1 mthl14 methuselah- 
like 14 
 
9 5.7 19 5.9 hdm hold'em  
10 5.7 14 6.1 eIF4E-6 eIF4E-6  
11 5.7 18 5.9 Acer Angiotensin-
converting 
enzyme-related 
 
12 5.6 24 5.4 CG1623 CG1623  
13 5.4 16 5.9 CG32313 CG32313 Testis 
14 5.4 20 5,9 Rh4 Rhodopsin 4  
15 5.2 17 5.9 CG9875 CG9875 Testis 
16 5.1 25 5.3 CG8008 CG8008  
17 5.0 13 6.3 skpB skpB Testis 
18 5.0 32 5.1 Asph Aspartyl β-
hydroxylase 
 
19 5.0 27 5.3 CG11638 CG11638  
20 4.9 8 6.9 CG30380 CG30380  
21 4.9 23 5.4 CG5715 CG5715  
22 4.9 28 5.3 GNBP3 Gram-neg. 
bacteria binding 
protein 3 
 
23 4.7 31 5.1 osm-6 osm-6 Testis 
24 4.7 36 5.0 CG15737 CG15737 Ovary 
25 4.7 30 5.2 Cyp6g1 Cyp6g1  
26 4.6 40 4.8 Gbeta5 Gbeta5  
27 4.6 12 6.3 dpr19 dpr19  
28 4.5 26 5.3 TM4SF Transmembrane 
4 superfamily 
 
29 4.5 38 4.9 tok tolkin  
30 4.5 7 7.0 CG4596 CG4596  
31 4.4 46 4.5 CG32436 CG32436 Testis 
32 4.4 11 6.4 RpS5b Ribosomal 
protein S5b 
Ovary 
Testis 
33 4.4 39 4.8 CG34232 CG34232  
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34 4.4 15 6.0 Ef1α100E Elongation 
factor 1α100E 
 
35 4.3 41 4.8 swa swallow Ovary 
36 4.3 6 4.0 CG9542 CG9542  
37 4.3 45 4.5 CG12698 CG12698 Testis 
38 4.3 51 4.3 Hsp67Bc Heat shock 
gene 67Bc 
 
39 4.1 43 4.8 CG8046 CG8046  
40 4.1 79 3.8 CG9961 CG9961 Testis 
41 4.1 52 4.3 CG9427 CG9427  
42 4.0 47 4.5 CG2887 CG2887 Testis 
43 4.0 84 3.7 CG17625 CG17625 Testis 
44 3.9 22 5.6 nos nanos Ovary 
45 3.9 42 4.8 CG40303 CG40303  
46 3.9 90 3.5 CG32187 CG32187  
47 3.8 21 5.7 c(2)M crossover 
suppressor on 
2 of Manheim 
Ovary 
48 3.8 33 5.1 CG34355 CG34355  
49 3.7 71 3.9 CG17032 CG17032  
50 3.7 97 3.3 CG6737 CG6737 Testis 
Continuation of Table 4.3.  
 
For validation of the microarray results, nine genes with established roles during 
gametogenesis and axis formation of the oocyte or early embryo were selected. In 
microarray analysis, seven of these genes, piwi, nanos (nos), swallow (swa), easter (ea), 
torso (tor), zero population growth (zpg) and bag of marbles (bam), exhibited a 
significant derepression upon dL(3)mbt and dLint-1 knockdown, whereas the 
expression levels of tudor (tud) and SpindleE (SpnE) did not change. For verification, 
mRNA levels of these genes were determined in dL(3)mbt- and dLint-1-depleted cells 
by RT-qPCR in comparison to EGFP RNAi-treated cells (Figure 4.24; for knockdowns 
see Figure 4.22). Knockdown of dL(3)mbt and dLint-1 resulted in a derepression of 
piwi, nos, swa, ea, tor, zpg and bam, but had no significant effect on the expression of 
tud and SpnE, in agreement with microarray data. The magnitude of derepression 
ranged from 2.5-fold (bam expression in dLint-1 RNAi-treated cells) to 40-fold (nos 
expression in dL(3)mbt RNAi-treated cells).  
In conclusion, these data support the idea that the LINT complex subunits contribute to 
the stable repression of germ cell-specific genes in Kc167 cells. 
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Figure 4.24: Validation of dL(3)mbt and dLint-1 target genes by RT-qPCR. Kc167 cells 
were treated with dsRNA directed against EGFP, dL(3)mbt or dLint-1 as indicated. Expression 
of piwi, nanos (nos), swallow (swa), easter (ea), torso (tor), zero population growth (zpg), bag 
of marbles (bam), tudor (tud) and spindleE (SpnE) were determined by RT-qPCR. mRNA levels 
in EGFP RNAi-treated cells were set to 1.  
 
4.2.4 LINT represses germline-specific genes during fly development 
The expression profiling by microarray analysis and the validation of candidate target 
genes had been performed in cell culture upon depletion of dL(3)mbt and dLint-1 by 
RNAi. To investigate whether LINT was also required for repression of germline-
specific genes in the developing fly, RNAi fly lines of the Vienna Drosophila RNAi 
Center (VDRC) were used. These fly lines carry RNAi transgenes under the control of 
the upstream activating sequence (UAS) that can be conditionally expressed by crossing 
them to a GAL4-driver strain (Dietzl et al., 2007). This binary UAS-GAL4 system 
allowed the expression of RNAi transgenes to target l(3)mbt and lint-1, respectively. 
RNAi transgene transcription was driven by crossing in a driver strain expressing GAL4 
under the control of the daughterless (da) gene. This should result in ubiquitous 
expression of the RNAi transgenes from early embryogenesis on in the pattern of the da 
gene (Cronmiller et al., 1988).  
To quantify the knockdown efficiencies in third instar larvae of da-GAL4/UAS-RNAi 
crosses, expression levels of l(3)mbt and lint-1 mRNA were determined by RT-qPCR 
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(Figure 4.25 A, left panels). As control, UAS-RNAi lines were crossed to the isogenic 
host strain of the RNAi library w1118. Whereas, RNAi directed against dL(3)mbt led 
only to a mild reduction of dL(3)mbt mRNA (of about 40%), dLint-1 RNAi resulted in 
a robust reduction of dLint-1 mRNA levels (greater than 90%). In contrast to the 
situation in Kc167 cells (Figure 4.22 B), dLint-1 mRNA was also decreased (to 20%) 
upon dL(3)mbt depletion. Despite the robust effect on mRNA level, Western blot 
analysis of extract obtained from brains of third instar larvae revealed that dLint-1 
protein levels were not strongly affected by dL(3)mbt RNAi (Figure 4.25 B). 
 
 
Figure 4.25: Knockdown of dL(3)mbt and dLint-1 in the developing fly derepresses 
transcription of germline-specific genes. RNAi depletion was achieved by crossing the da-
GAL4 driver strain to w1118 (as control), UAS-l(3)mbt RNAi and UAS-lint-1 RNAi strains, 
respectively. (A) Expression of genes in third instar larvae was determined by RT-qPCR: 
l(3)mbt, lint-1 (left panel) and germline-specific target genes (right panels), piwi, nos, swa, ea, 
tor and tud (control). mRNA levels in w1118 crosses were set to 1. (B) Western blot 
demonstrating depletion of dLint-1 protein in the brain of third instar larvae. Western blot 
against β-tubulin served as a loading control.  
 
Upon depletion of either dL(3)mbt or dLint-1 the transcription of piwi, nos, swa, ea and 
tor was derepressed in RNAi larvae, which is in good agreement with data obtained 
with Kc167 cells (Figure 4.25 B). In contrast, tud expression was not up-regulated. The 
magnitude of up-regulation ranged from 2.2-fold (ea transcription in dL(3)mbt RNAi 
larvae) to 22-fold (swa transcription in dL(3)mbt RNAi larvae). 
Taken together these results strongly argue for an important role of LINT in the stable 
repression of germline-specific genes, both in Drosophila cell lines and in the 
developing fly. 
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4.2.5 LINT localises to promoter regions of target genes 
The involvement of the LINT complex in repression of germ cell-specific genes raised 
the question, whether LINT binds directly to its target genes. Therefore, swallow, which 
was highly up-regulated upon dL(3)mbt and dLint-1 depletion, both in Kc167 cells and 
Drosophila larvae, was chosen as a model gene. To gain insight into the potential 
binding profile of LINT to specific chromatin regions, amplicons within the genomic 
swallow locus ranging from 3 kb upstream to 5.3 kb downstream of the transcription 
start site (TSS) were selected for qPCR analysis (Figure 4.26 A).  
 
 
Figure 4.26: dLint-1 binds to the promoter region of the swallow gene. (A) Schematic 
representation of the genomic swa locus on chromosome [X]. The sequence location in bp is 
indicated below in squared brackets. 5’ and 3’ untranslated regions are shown in white, coding 
regions of swa and neighbouring genes are depicted in red and grey, respectively. Regions 
selected for amplification are indicated by framed letters (a to f). They have the following 
approximate distances from the TSS: a, 3 kb upstream; b, 1.5 kb upstream; c, 0-0.15 kb 
upstream (putative promoter); d, 1.5 kb downstream; e, 3.8 kb downstream; f, 5.3 kb down-
stream. (B) Chromatin was isolated from Kc167 cells. ChIP was performed with antisera 
indicated below. Immunoprecipitated DNA was quantified by qPCR using primers against 
regions as indicated (compare (A)). Mean values are expressed as percentage of input (% input). 
 
Next, chromatin immunoprecipitations (ChIP) were carried out, using the dLint-1-
specific antibody #1, to identify chromatin regions bound by LINT. The dL(3)mbt-
specific antibodies could not be used, because they did not precipitate dL(3)mbt 
efficiently under ChIP conditions. Analysis of the immunoprecipitated DNA by qPCR, 
revealed that the dLint-1-specific antibody #1 precipitated generally higher levels of 
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DNA than the pre-immune serum control. This observation was independent of the 
chromatin region that was analysed (Figures 4.26 and 4.28). Nevertheless, a distinct 
peak of dLint-1 was detected by ChIP analysis at the putative promoter region of swa 
directly upstream of the TSS (region c). Compared with neighbouring regions (regions 
a, b, d, e and f) the immunoprecipitated DNA of the promoter region (c) was enriched 
by approximately 4-fold. This argues for a specific binding of dLint-1 to the promoter 
region of the swa gene. 
To further support the specificity of the dLint-1 ChIP result, chromatin was also 
immunoprecipitated using the second dLint-1-specific antibody #2 and the 
corresponding pre-immune serum as control (Figure 4.27 B). Consistent with data 
obtained using the α-dLint-1 #1 antibody, the promoter region was at least 3-fold 
enriched, compared to amplicons localised 1.5 kb up- and downstream of the TSS.  
Additionally, to ensure that the detected peak was indeed a result of dLint-1 protein as 
part of the LINT complex localising to the promoter region, ChIPs were carried out 
after co-depletion of dL(3)mbt/dLint-1 by RNAi directed against dL(3)mbt (see Figure 
4.22 A). As control dLint-1 ChIPs were also done from chromatin of EGFP dsRNA-
treated cells. In agreement with the idea that dLint-1 associates with the swa promoter, 
the corresponding dLint-1 peak decreased strongly (about 3-fold) upon co-depletion of 
dL(3)mbt and dLint-1, compared to the EGFP control. In addition, a decline of 2-fold 
was observed for the amplicon 1.5 kb downstream, indicating that also a proportion of 
ChIP signal in this region resulted from immunoprecipitation of dLint-1. On the 
contrary, analysis of an unrelated intergenic region revealed that the amount of 
immunoprecipitated DNA did not differ between EGFP and dL(3)mbt RNAi-treated 
cells, suggesting that this was the background level of DNA recovered by the dLint-1 
antiserum. 
In conclusion, the LINT subunit dLint-1 binds specifically to the putative promoter 
region of the swa gene directly upstream of the TSS.  
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Figure 4.27: Validation of dLint-1 ChIP results. (A) Schematic representation of the 
amplified regions relative to the TSS. (B) Chromatin was prepared from Kc167 cells. ChIPs 
were carried out with antisera indicated below. (C) Chromatin was isolated from Kc167 cells 
treated with dsRNA directed against EGFP and dL(3)mbt. ChIPs were done using dLint-1-
specific antibody #1. (B) and (C) Mean values are expressed as % input. Immunoprecipitated 
DNA was quantified by qPCR using primers against regions as indicated. Intergenic refers to an 
unrelated intergenic region on chromosome arm 2R.  
 
To investigate if dLint-1 binds also to the promoter regions of other regulated genes, 
several putative LINT target genes were analysed by ChIP (Figure 4.28). Distinct peaks 
were detected over the promoters of swa, nos, tolkin (tok) and crumbs (crb) compared to 
regions 1.5 kb up- and downstream. In case of piwi elevated ChIP signals were detected 
at the putative promoter region directly upstream of the TSS and 1.5 kb upstream 
compared to 3 kb upstream and 1.5 kb downstream. As a second LINT subunit, 
association of dCoREST with these genes was tested. ChIP signals, obtained with the 
dCoREST-specific antibody, were generally lower than signals obtained using the α-
dLint-1 antibody. Nevertheless, distinct dCoREST peaks were observed at the 
promoters of swa, nos, tok  and crb. These results indicate that several target genes, 
which were identified by their derepression upon dL(3)mbt or dLint-1 knockdown, are 
directly bound by LINT complex subunits.  
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Figure 4.28: dLint-1 and dCoREST bind to promoter regions of LINT target genes. ChIPs 
were performed with antibodies indicated on the right. Genes analysed are denoted below the 
diagram. Regions selected for amplification are indicated by framed letters (a to d). They had 
the following approximate distances from the TSS: a, 3 kb upstream; b, 1.5 kb upstream; c, 0-
0.15 kb upstream (putative promoter); d, 1.5 kb downstream. Derepression of transcription 
following RNAi-mediated depletion of dLint-1 and dL(3)mbt is shown as log2 FC (fold change) 
below the panel. Expression values for dLint-1 and dL(3)mbt RNAi are taken from microarray 
analysis.  
 
4.3 Mechanism of gene repression by LINT 
4.3.1 LINT occupied promoters display reduced nucleosome levels 
It has been reported previously that the MBT domains of human L3MBTL1 can induce 
the compaction of nucleosomal arrays in vitro dependent on H4K20 or H1K26 mono- 
and di-methylation (Trojer et al., 2007). Therefore, the generation of compacted 
chromatin has been favoured as a mechanism for transcriptional repression by MBT 
domain-containing proteins. A prediction from this model is that the density of 
nucleosomes would be higher in the proximity of MBT protein-bound regions.  
To determine if this applies to LINT target genes H3 occupancy as a parameter of 
nucleosome occupancy, was determined (Figure 4.29). In fact, ChIP results revealed 
that H3 ChIP signals are noticeably reduced at promoters of LINT target genes (swa, 
piwi, nos) (Figure 4.29 A) compared to regions up- and downstream (Figure 4.29 B, 
compare relative distances of amplicons). Hence, a negative correlation between LINT 
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binding to promoters and nucleosome density was observed. In case of the swa gene, 
not only regions 1.5 kb up- (b) and downstream (d), but also 3.0 kb up- (a), 3.8 kb 
down- (e) and 5.3 kb downstream (f) were analysed. Amplicons a, b and f were located 
in neighbouring genes Marf and kdn, respectively, which are actively transcribed in 
Kc167 cells, according to RNA-Seq data, obtained from the ModENCODE project 
(http://www.modencode.org/). These regions displayed similar nucleosome densities as 
detected in region b, situated in the body of the repressed swa gene. In summary, these 
data indicate that LINT regulated genes are not necessarily embedded into a highly 
compacted chromatin structure. In order to elucidate if dL(3)mbt plays a role in 
nucleosome positioning on LINT target genes, a thorough mapping analysis of 
nucleosomes remains to be done before and after dL(3)mbt RNAi. 
 
 
Figure 4.29: LINT target gene promoters display reduced levels of H3. (A) Chromatin from 
Kc167 cells was immunoprecipitated with α-H3 and α-FLAG (control) antibody. Immuno-
precipitated DNA was quantified by qPCR using primers against regions a to f, as depicted in 
(B). Mean values are expressed as % input. (B) Schematic depiction of the approximate 
amplicon distances relative to the transcription start site (TSS; +1).  
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4.3.2 Depletion of dPR-Set7-mediated H4K20 mono-methylation does not 
affect LINT target gene repression 
Previous publications have demonstrated that the MBT domains of the human dL(3)mbt 
homologue L3MBTL1 bind specifically to mono- and di-methylated H4K20 in vitro 
(Trojer et al., 2007). In this context, mono-methylation of H4K20, catalysed by PR-
SET7 (Nishioka et al., 2002), was sufficient to mediate 3MBT domain-dependent 
compaction of oligo-nucleosomal arrays (Trojer et al., 2007). Moreover, it has been 
reported that L3MBTL1 and PR-SET7 can interact directly and that PR-SET7 promotes 
the repressive activity of L3MBTL1 in reporter assays. Furthermore, L3MBTL1 
chromatin occupancy was decreased upon knockdown of PR-SET7 (Kalakonda 
et al., 2008).  
In contrast to the situation in human, no interaction between dL(3)mbt and dPR-Set7 
was detected in co-immunoprecipitations (Figure 4.31 A). Nevertheless, it was possible 
that binding of dL(3)mbt to methylated H4K20 could have an impact on the repressive 
function of LINT. Therefore, to verify that the MBT domains of dL(3)mbt indeed have 
the capability to bind to methylated H4 tails, their binding affinity to differentially 
methylated H4 peptides, comprising amino acids 16 to 25, was tested in in vitro peptide 
pulldown assays (Figure 4.30). As a positive control, immobilised H4 peptides were 
incubated with a recombinant GST fusion protein of the 3MBT domains of human 
L3MBTL1 (GST-h3MBT). 
 
 
Figure 4.30: The three MBT domains of dL(3)mbt bind preferentially to mono- and di-
methylated H4K20 peptides. Immobilised H4 peptides (aa 16-25), with unmodified (unmod), 
mono- (me1), di- (me2) or tri-methylated (me3) K20, were incubated with purified recombinant 
GST-h3MBT (A), GST-d3MBT (B, upper panel) or Sf9 extract containing FLAG-d3MBT (B, 
lower panel). Binding of GST-fusion or FLAG-tagged 3MBT proteins was analysed by Western 
blotting using α-FLAG or α-GST antibody, respectively. Input: 10% of GST fusion protein or 
Sf9 extract; beads: control without peptide. (B) Published in Scharf et al., 2009. 
4 RESULTS 
126 
 
In agreement with published data (Trojer et al., 2007), the MBT domains of L3MBTL1 
displayed a strong preference for H4 peptide mono- and di-methylated at lysine 20 
(Figure 4.30 A). On the contrary, the MBT domains of dL(3)mbt (GST-d3MBT) bind to 
unmodified H4 peptide and showed increased binding to all three methylation states of 
H4K20 (Figure 4.30 B, upper panel). To preclude that incorrect protein folding or the 
lack of a post-translational modification, caused by expression of the GST fusion 
protein in bacteria, had any influence on the binding affinities, a FLAG-tagged 
construct of the MBT domains (FLAG-d3MBT) was expressed using the baculovirus 
system. In this case the histone peptides were incubated with Sf9 extract containing 
overexpressed FLAG-d3MBT. This FLAG-d3MBT construct recognised preferentially 
the mono- and di-methylated H4K20 peptide (Figure 4.30 B, lower panel), similarly to 
the human MBT domains. Collectively, the results from the peptide pulldown assays 
establish that the MBT domains of dL(3)mbt have the potential to bind to mono- and di-
methylated H4K20 in vitro. 
To further investigate whether dPR-Set7-mediated H4K20 mono-methylation has any 
impact on repression of LINT regulated genes dPR-Set7 was depleted by RNAi in 
Kc167 cells (Figure 4.31 B). The efficient knockdown of dPR-Set7 was controlled by 
analysing nuclear extract of dsRNA-treated cells by Western blot (Figure 4.31 B, upper 
panel). To monitor the effect of dPR-Set7 depletion on the global level of H4K20 
mono-methylation histones were acid-extracted from the insoluble nuclear fraction. 
Western blotting revealed that RNAi against dPR-Set7 resulted in a strong decrease of 
H4K20me1 levels, while histone H3 levels were constant (Figure 4.31 A, middle and 
lower panels). Despite the efficient global reduction of H4K20 mono-methylation, no 
significant derepression of LINT target genes could be detected (Figure 4.31 B).  
The observation that dPR-Set7 RNAi had no or little effect on LINT target gene 
expression, even though H4K20 mono-methylation levels were globally reduced, could 
have different reasons. There were two obvious possibilities to account for this: First, it 
was possible that the H4K20me1 mark was present at target genes, but the knockdown 
had no influence on repression by LINT. Second, it was equally conceivable, that this 
modification was not present at LINT target gene promoters.  
Therefore, H4K20me1 levels were assessed by ChIP-qPCR (Figure 4.32 A). The actin 
gene was used as a positive control region to verify the efficiency of the 
immunoprecipitation. Indeed, robust H4K20me1 levels were detected at the actin gene 
with two independent antibodies (Figure 4.32 A). In comparison to this, H4K20me1 
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signals at the promoters of swa and nos were approximately 20-fold lower, similarly to 
an intergenic region that served as a negative control. Furthermore, H4K20me1 signals 
at swa and nos target genes did not significantly differ from signals obtained with the 
IgG control antibody.  
 
 
Figure 4.31: dPR-Set7 does not contribute to repression of LINT target genes. (A) Nuclear 
extracts from control S2 cells (mock, lanes 1 and 2) and S2 cells stably expressing FLAG-
dL(3)mbt (lanes 3 and 4) were precipitated with FLAG agarose beads. Immunoprecipitates were 
analysed by Western blot using antibodies as indicated on the right (lanes 2 and 4). Input: 5% of 
nuclear extracts (lanes 1 and 3). dLint-1 served as a positive control. (B) and (C) Kc167 cells 
were treated with dsRNA directed against EGFP (control) or dPR-Set7. (B) Nuclear extracts or 
acid extracted histones were analysed by Western blot using antibodies as indicated on the right. 
Western blot against histone H3 served as a loading control. (C) Expression of LINT target 
genes was determined by RT-qPCR. Expression in EGFP RNAi-treated cells was set to 1. 
 
The depletion of dPR-Set7 by RNAi led to strong decrease of H4K20me1 levels at the 
actin gene (Figure 4.32: left panel: 70%; right panel: 40%), but did not affect H4K20 
mono-methylation signals at swa and nos.  
In summary, these results suggest that the H4K20me1 mark appears to be absent from 
LINT target gene promoters and that binding of dL(3)mbt to mono-methylated H4K20 
is not essential for the maintenance of stable repression of LINT target genes. 
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Figure 4.32: Kc167 cells were treated with RNAi directed against EGFP (control) or dPR-Set7. 
(A) Chromatin was precipitated with H4K20me1 (left panel: Abcam antibody; right panel: 
Millipore antibody) or IgG antibodies as indicated. (B) Chromatin was precipitated with 
H4K20me2 or IgG antibodies as indicated. (A) and (B) ChIP signals as % input are shown for 
swa and nos promoter regions, an intergenic region and the actin ORF as denoted below the 
panels. 
 
Since the MBT domains of dL(3)mbt are also capable of binding H4K20 in its di-
methylated state, ChIPs were also carried out to assess the levels of H4K20me2 at swa 
and nos promoters (Figure 4.32 B). It has been shown previously that H4K20me2 is the 
most abundant form of histone H4 in Drosophila as well as in mammals constituting 
85-90% of total H4 (Schotta et al., 2008; Yang et al., 2008). Correspondingly, H4K20-
me2-specific ChIPs showed robust signals for both swa and nos promoters and the two 
control regions relative to IgG signals (Figure 4.32 B). Knockdown of dPR-Set7 
resulted in a partial loss of H4K20me2 levels at all four genomic regions. By 
comparison H4K20me2 levels differed by a factor of less than 3 between swa, nos, 
actin and intergenic region and were lowest at LINT target genes.  
In conclusion, the H4K20me2 modification is detectable at target gene promoters. 
However, probably due to the abundance of this mark it is likely to be uniformely high 
along the genome and therefore H4K20me2 is also present at control regions that are 
not bound by LINT. 
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4.3.3 Derepression of LINT target genes is accompanied by changes in 
H3K4 methylation and H4 acetylation levels 
Nucleosome occupancy profiles on genomic loci of LINT target genes and dPR-Set7 
RNAi experiments demonstrated that chromatin compaction and dPR-Set7-dependent 
recruitment to H4K20me1 can be neglected as a major LINT repression mechanism.  
The LINT complex does not appear to contain histone-modifying enzymes as stable 
subunits. Even though dLsd1 co-precipitated with dLint-1, the histone demethylase did 
not co-fractionate with the LINT subunits upon ion exchange chromatography (Figures 
4.13, 4.14 and 4.17). The data about association of the histone deacetylase dRpd3 with 
LINT are more complex, since dRpd3 interacts efficiently with both dL(3)mbt and 
dLint-1 in immunoprecipitations carried out from S2, Kc167 or embryo nuclear extracts 
and is not clearly separated from the LINT subunits upon fractionation of Kc167 
nuclear extract (Figures 4.2, 4.13, 4.14 and 4.17). However, dRpd3, as well as dLsd1, 
did not co-precipitate with dLint-1 from larval brain extract (Figure 4.19), suggesting 
that dRpd3 might be associated with LINT in a tissue-specific manner.  
Although the LINT complex is devoid of histone modifier proteins, it was still 
conceivable that changes in histone modifications are involved in the regulation of 
LINT target genes. Therefore, changes of various histone marks were investigated by 
ChIP upon co-depletion of dL(3)mbt and dLint-1 in Kc167 cells by dL(3)mbt RNAi 
treatment (Figure 4.22), which leads to the disassembly of the complex (Figure 4.16) 
and a strong derepression of target genes (Figure 4.24). In the following, ChIP results 
are shown exemplary for swa as a direct target of LINT. Results obtained from analysis 
of the nos gene were comparable (not shown).  
In EGFP dsRNA-treated control cells, H3K4me2 and H4 acetylation (antibody specific 
for H4 peptide acetylated at K5, 8, 12 and 16) levels were higher in the swa promoter 
region, compared to a region 1.5 kb downstream of the swa TSS, overlapping with the 
swa ORF, and an unrelated intergenic region on chromosome arm 2R (Figure 4.33).  
Upon knockdown of dL(3)mbt, a strong increase in H3K4me2 levels both at the 
promoter and within the ORF was observed. Additionally, acetylation on H4 rose 
slightly at the promoter region, while it remained at low levels within the transcribed 
region. Both di-methylation of H3K4 and acetylation of H4 were not significantly 
changed upon dL(3)mbt depletion at the intergenic region, demonstrating the specificity 
of detected changes on the swa gene concomitant with derepression of transcription. 
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Figure 4.33: LINT coordinates H3K4 methylation and H4 acetylation levels. Kc167 cells 
were treated with dsRNA directed against EGFP (control) or dL(3)mbt. (A) ChIPs were carried 
out with α-H3K4me2 and α-H3 antibodies. (B) ChIPs were performed with α-H4ac and α-H3 
antibodies. (A) and (B): Ratio of H3K4me2 or H4ac and H3 ChIP signals (mean values of 
qPCR triplicates as % input) is shown for swa promoter (c), swa ORF region (d) and an 
unrelated intergenic region, as indicated. The positions of the amplified swa regions relative to 
the TSS are depicted schematically on the right.  
 
Taken together, derepression of LINT target genes is accompanied by elevated levels of 
histone marks associated with active transcription: A strong increase of H3K4me2 was 
observed, both at the promoter and within the ORF region. Additionally, H4 acetylation 
increased moderately in the promoter region of swa. These observations are in good 
agreement with LINT target genes being activated upon removal of the repressor 
complex.  
 
4.3.4 Derepression of LINT target genes is accompanied by a decrease in 
H3K27me3 levels 
The investigation of histone modification levels before and after derepression of LINT 
target genes in Kc167 cells did not only reveal a gain in active histone modifications 
(H3K4me2 and H4ac), but also a loss of the repressive histone mark H3K27me3 
(Figure 4.34). In control cells, H3K27me3 levels were elevated in the transcribed region 
of swa, compared to the swa promoter (Figure 4.34 A). While H3K27me3 remained 
unchanged at the promoter, the modification declined strongly within the ORF of swa. 
Similar results were obtained using two independent H3K27me3-specific antibodies 
(Figure 4.34 A, left and right panels).  
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The enzyme that catalyses tri-methylation of H3K27 is the PcG protein Enhancer of 
zeste (E(z)) (Czermin et al., 2002; Kuzmichev et al., 2002). Correspondingly, depletion 
of E(z), which was controlled by Western blot (Figure 4.36 A), resulted also in a 
reduction of H3K27me3 levels in the transcribed region of swa, confirming the 
specificity of the H3K27me3 ChIP results (Figure 4.34 A). Whereas depletion of the 
H3K27 methylase E(z) led to a strong reduction of the H3K27me3 signal in Western 
blot analysing acid-extracted histone samples, dL(3)mbt RNAi did not decrease H3K27 
tri-methylation levels in a global manner (Figure 4.34 B). 
 
 
Figure 4.34: Derepression of LINT target genes is accompanied by a decrease in H3K27 
methylation in the transcribed region. Kc167 cells were treated with dsRNA directed against 
EGFP (control), dL(3)mbt or E(z). (A) ChIPs were carried out with H3K27me3- and H3-
specific antibodies. α-H3K27me3 antibodies were from Millipore (left panel) or Cell Signaling 
(right panel). Ratios of H3K27me3 and H3 ChIP signals (mean values of qPCR triplicates as % 
input) are shown for swa promoter (c) and ORF (d) regions. The positions of the amplified swa 
regions relative to the TSS are illustrated schematically on the right. (B) Acid extracted histones 
were analysed by Western blot using antibodies as indicated on the right. Western blot against 
histone H3 served as a loading control.  
 
The reduction of H3K27me3 levels, mediated by dL(3)mbt/dLint-1 depletion and 
derepression of LINT regulated genes, raised the possibility that LINT interacts with the 
E(z) methylase. To address this hypothesis, nuclear extract from Kc167 cells was 
immunoprecipitated with dLint-1- (Figure 4.35 A) or E(z)-specific (Figure 4.35 B) 
antibodies. Although dLint-1 and dL(3)mbt were efficiently co-precipitated with the 
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dLint-1 antibody, no association of E(z) was detected (Figure 4.35 A, lane 2). Vice 
versa, E(z) antibody did not co-precipitate dL(3)mbt or dLint-1 above background 
levels (Figure 4.35 B, compare lanes 2 and 3). These results suggest that the effect of 
LINT depletion on H3K27me3 levels is not due to a direct interaction of LINT with 
E(z). 
 
 
Figure 4.35: LINT and E(z) do not co-immunoprecipitate in Kc167 cells: (A) Nuclear 
extract from Kc167 cells was precipitated with ProtG beads loaded with α-dLint-1 antibody (A, 
lane 2), with α-E(z) 3TAF antibody (B, lane 2) or with no antibody (beads control, lanes 3). 
Immunoprecipitates were analysed by Western blot as indicated on the right.. Ab control: 
Contained E(z)- or dLint-1-specific antibody (lanes 4). Input: 5% of nuclear extract (lanes 1). 
 
To confirm the presence of E(z) at LINT target genes, which was indicated by the 
H3K27me3 decrease upon E(z) depletion within the swa transcribed region, ChIP 
analysis was carried out using an E(z)-specific antibody (Figure 4.36). To demonstrate 
the specificity of the antibody used, E(z) was depleted in Kc167 cells using RNAi.  
Western blot analysis of RNAi-treated cells confirmed that E(z) protein was depleted 
significantly (Figure 4.36 A). According to elevated levels of H3K27me3 1.5 kb 
downstream of the TSS compared to the promoter region, the E(z) antibody also 
precipitated more DNA in the transcribed region than in the promoter (Figure 4.36 B). 
In line with E(z) being associated with LINT target genes, E(z) ChIP signals were 
reduced upon RNAi knockdown both in promoter and ORF regions. In contrast, the 
knockdown of E(z) did only affect H3K27me3 levels within the transcribed region 
(Figure 4.34). Surprisingly, however, in dL(3)mbt RNAi cells (Figure 4.36 A) E(z) 
levels did not decrease, although the dL(3)mbt knockdown resulted in a significant loss 
of H3K27me3 at the swa gene (Figure 4.34). 
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Figure 4.36: E(z) is present at the swa target gene even in the absence of LINT. Kc167 cells 
were treated with dsRNA directed against EGFP (control), dL(3)mbt or E(z). (A) Nuclear 
extracts were analysed by Western blot using antibodies as indicated. Western blot against 
Lamin C served as a loading control. (B) ChIPs were carried out using α-E(z) antibody (3TAD). 
Immunoprecipitated DNA was quantified by qPCR using primers against swa promoter and 
ORF regions. Mean values are expressed as % input. The positions of the amplified swa regions 
relative to the TSS are depicted schematically on the right.  
 
In summary, derepression of LINT target genes results in a reduction of the E(z)-
mediated repressive histone mark H3K27me3 in the transcribed region. Since E(z) 
binding is not affected by dL(3)mbt/dLint-1 co-depletion, there must be other 
mechanisms by which E(z) activity is inhibited or the balance of H3K27 methylation 
and demethylation is shifted towards the latter.  
 
4.3.5 Histone-modifying enzymes are dispensable for maintenance of 
stable repression of LINT target genes 
There is an ongoing debate in the chromatin field on whether histone modification 
changes are the cause of biological responses or rather the consequences of these 
processes, such as transcription or nucleosome remodelling (Henikoff and Shilatifard, 
2011).  
Therefore, the fact that LINT does not contain histone-modifying activities, however, 
the derepression of LINT target genes was accompanied by increased levels of 
activating (H3K4me2, H4ac) and a decrease in repressive (H3K27me3) histone 
modifications, raised the question if the loss of the corresponding enzymatic activities 
(dLsd1, dRpd3 and E(z), respectively) was sufficient to produce the observed changes 
in histone marks and transcription levels of LINT target genes. To address this issue, 
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first dLsd1 and E(z) were depleted by RNAi in Kc167 cells (Figure 4.36 A and 4.37 A, 
middle panels). To determine if dLsd1 depletion was affecting H3K4 methylation levels 
on LINT target genes, ChIPs targeting H3K4me2 were carried out after dLsd1 
knockdown in comparison to dL(3)mbt or EGFP RNAi-treated cells (Figure 4.37 B). 
Again dL(3)mbt RNAi led to a specific increase of H3K4 di-methylation both in the 
promoter and the transcribed regions of swa and nos. dLsd1 depletion, however, failed 
to increase H3K4me2 levels, even though the knockdown seemed very efficient, judged 
by Western blot analysis (Figure 4.37 A). In contrast, knockdown of E(z) resulted, as 
shown above, in a reduction of H3K27me3 levels in the swa transcribed region (Figure 
4.34).  
 
 
Figure 4.37: H3K4me2 levels of LINT target genes do not increase upon dLsd1 
knockdown. Kc167 cells were treated with dsRNA directed against EGFP (control), dL(3)mbt 
and dLsd1. (A) Nuclear extracts were analysed by Western blot using antibodies as indicated. 
Detection of β-tubulin served as a loading control. (B) ChIPs were carried out using H3K4me2- 
and H3-specific antibodies. Immunoprecipitated DNA was quantified in triplicate by qPCR. 
Ratios of H3K4me2 and H3 ChIP signals (mean values of qPCR triplicates as % input) are 
shown for promoter (c) and ORF (d) regions of swa and nos and an unrelated intergenic region, 
as indicated. The positions of the amplified promoter and ORF regions relative to the TSS are 
depicted schematically on the right.  
 
The opposite impacts of dLsd1 and E(z) depletion on their corresponding histone 
modifications, raised the question whether their knockdowns would have any 
consequences for the transcription of LINT target genes (Figure 4.38 and 4.39).  
Even though the knockdown of E(z) resulted in a global loss of H3K27me3 levels and 
the decrease of this mark on the swa gene was comparable to the effect of dL(3)mbt 
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RNAi (Figure 4.34), LINT target genes were only mildly derepressed. The modest 
upregulation ranged from approximately 1.5- (piwi, ea and tor) to 2.5-fold (swa). 
 
 
Figure 4.38: LINT target genes are mildly derepressed upon E(z) depletion: Kc167 cells 
were treated with dsRNA directed against EGFP (control) and E(z). Expression of LINT target 
genes was determined by RT-qPCR. Transcription in EGFP RNAi-treated cells was set to 1. For 
knockdown efficiency compare Western blots in Figure 4.36 A. 
 
Next, all factors that associated with dLint-1 in the FLAG affinity purification, 
including dCoREST, dRpd3 and dLsd1 (Figure 4.12), were depleted by RNAi in Kc167 
cells (Figure 4.39 A) to investigate which of them contribute to the repression of LINT 
target genes aside from dL(3)mbt and dLint-1. As shown before (Figure 4.24) dL(3)mbt 
and dLint-1 knockdown led in 6 out of 7 cases to a strong derepression of germline-
specific target genes (dL(3)mbt RNAi: 10-fold (zpg) to 40-fold (nos); dLint-1 RNAi: 5-
fold (tor) to 20-fold (piwi)) (Figure 4.39 B). In addition, the transcription of bam was 
up-regulated moderately, but significantly (dL(3)mbt RNAi: 3.5-fold; dLint-1 RNAi: 
2.5 fold). Even though the depletion of dCoREST resulted only in a minor decrease of 
dCoREST protein levels (Figure 4.39 A, lane 3), the majority of LINT target genes were 
severely derepressed (dCoREST RNAi: 10-fold (zpg) to 20-fold (piwi)) (Figure 4.39 B). 
Again, in agreement with the effects of dL(3)mbt and dLint-1 RNAi, bam expression 
levels were up-regulated only 3-fold upon dCoREST knockdown. Therefore in most 
cases fold changes of deregulation of LINT target genes upon dCoREST RNAi were 
comparable with fold changes upon dL(3)mbt or dLint-1 depletion. One exception was 
the ea gene that was upregulated 13- and 30- fold after dLint and dL(3)mbt RNAi, 
respectively, but only 3-fold after dCoREST knockdown. In summary, these results 
revealed that all three LINT subunits are required for effective target gene silencing.  
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Figure 4.39: LINT non-enzymatic subunits, but not the histone-modifying dLsd1 and 
dRpd3 enzymes, are required for repression of germline-specific target genes: Kc167 cells 
were treated with dsRNA directed against EGFP (control), dLsd1, dCoREST, dRpd3, dLint-1 
and dL(3)mbt. (A) Nuclear extracts were analysed by Western blot using antibodies as 
indicated. The detection of β-tubulin served as a loading control. (B) Expression of LINT target 
genes was determined by RT-qPCR. Analysis of tud served as a negative control. Transcription 
in EGFP RNAi-treated cells was set to 1.  
 
Despite the fact that depletion of dLsd1 and dRpd3 appeared to be efficient judged by 
Western blot analysis (Figure 4.39 A, lanes 2 and 4), neither of them led to an up-
regulation of LINT-specific target genes (Figure 4.39 B). 
Interestingly, upon dCoREST knockdown it was noticeable that protein levels of dLsd1 
were affected by a decrease that was comparable to the specific knockdown of dLsd1 
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itself (Figure 4.39, compare lanes 2 and 3). This is likely to be due to protein instability 
of dLsd1 upon loss of dCoREST. However, since dCoREST and dLsd1 do not co-exist 
in the LINT complex, this effect can be presumably attributed to the presence of these 
factors in other independent protein complexes that was already predicted from other 
experiments (see Figures 4.14, 4.15 and 4.17). By contrast, dL(3)mbt and dLint-1 
protein levels remained unaltered upon dCoREST RNAi (Figure 4.39 A, compare lane 
3).  
Taken together, these results suggest that only the non-enzymatic LINT subunits, 
dL(3)mbt, dLint-1 and dCoREST, but not the histone-modifying factors dLsd1 and 
dRpd3 are required for stable repression of germline-specific target genes. This further 
implies that the histone modification changes of H3K4 methylation and H4 acetylation 
are likely to be consequences of active transcription taking place. 
 
4.3.6 dL(3)mbt or dLint-1 promoter recruitment is sufficient for reporter 
gene silencing 
The repression of the germline-specific LINT target genes, tested in this study, is 
strictly dependent on the presence of the three subunits, dL(3)mbt, dLint-1 and 
dCoREST. In contrast, the histone-modifying activities of dPR-Set7, E(z), as well as 
dLsd1 and dRpd3, of which the latter two are associated with dLint-1 or dL(3)mbt, are 
not required to maintain stable repression of these genes. The core LINT complex itself 
does not display any chromatin-modifying activities, but shows a strong preference to 
bind to the promoter regions of regulated genes (Figure 4.28). These observations raised 
the possibility that LINT represses transcription by sterically restricting the access for 
RNA polymerase II and/or activating transcription factors to promoter sequences.  
To test this hypothesis, a LexA-dependent, plasmid-based reporter gene assay was used 
in order to recruit LINT subunits to a LexA binding site containing promoter upstream 
of a reporter gene encoding Firefly luciferase (Figure 4.40 A; Thompson and Travers, 
2008). In the presence of LexA DNA binding domain alone the luciferase reporter gene 
is expressed at basal levels from the Hsp70 promoter. To determine how dL(3)mbt and 
dLint-1 modulate transcription when tethered to the actively transcribed promoter of the 
reporter gene, both proteins were transiently expressed as LexA fusion proteins in 
Kc167 cells using increasing amounts of the pAc5.1 expression vectors (Figure 4.40 B). 
Immunoblotting with a LexA-specific antibody revealed that dL(3)mbt-LexA, as well as 
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dLint-1-LexA, were expressed at similar levels as LexA alone upon transfection of 500 
or 1000 ng expression vector (panels 5 and 6). When less vector was used, expression 
was hardly detectable by Western blot (panels 1 to 4). Recruitment of either dL(3)mbt-
LexA or dLint-1-LexA fusion protein to the reporter gene consistently resulted in a 
robust and dose-dependent repression of the luciferase gene (Figure 4.40 C) compared 
to LexA alone. The repressive activity of dL(3)mbt-LexA (upper panel) and dLint-1-
LexA (lower panel) ranged from 4- to 12- and 2- to 10-fold, respectively. Comparison 
of the repressive activities with expression levels showed that even protein amounts of 
dL(3)mbt and dLint-1 LexA-fusions close or below the detection limit of Western blot 
were capable of repressing the reporter gene (Figure 4.40 B and C).  
 
 
Figure 4.40: dL(3)mbt and dLint-1 repress a luciferase reporter gene in a dose-dependent 
manner. (A) Upper panel: LexA luciferase reporter gene assay (Thompson and Travers, 2008): 
The DNA binding domain of LexA (LexA DB) alone binds to sequence-specific recognition 
motifs (LexA motifs) upstream of the reporter gene. The luciferase gene, which is under the 
control of the Hsp70 promoter, is expressed by RNA polymerase at basal levels. Firefly 
Luciferase protein is synthesised and its enzymatic activity can be measured. Lower panel: 
When a transcriptional repressor is fused to LexA, the fusion protein is tethered to the LexA 
motifs and efficient transcription of the luciferase gene is hindered (lower panel). (B) LexA 
(upper panels), dL(3)mbt-LexA (middle panels) and dLint-1-LexA (lower panels) were 
expressed transiently in Kc167 cells. Expression levels in the nuclear fraction of Kc167 cells 
were monitored by Western blot as indicated on the right using a LexA-specific antibody. 
Detection of β-tubulin served as a loading control. (C) Repressor activities of dL(3)mbt-LexA 
(upper panel) and dLint-1-LexA (lower panel) on the transcription of the luciferase reporter 
gene relative to LexA only samples. (B) and (C) The amount of expression vector used for 
transfections is denoted on top.  
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4.3.7 Reporter gene repression by dL(3)mbt and dLint-1 depends on 
LINT subunits 
To unravel to which extent the integrity of the LINT complex plays a role for dL(3)mbt-
LexA and dLint-1-LexA to function as repressors, dL(3)mbt, dLint-1 and dCoREST 
were depleted by RNAi prior to the luciferase reporter gene assay (Figure 4.41). In 
addition to the knockdown of LINT complex subunits, cells were treated with dsRNA 
directed against dLsd1 and other subunits of histone-modifying complexes, such as the 
H3K9 methyltransferase G9a and the Polycomb group proteins Pc, dRING, E(z) and 
Suz(12) (Figure 4.41 A and data not shown). The efficiencies of knockdowns were 
controlled by Western blot as far as antibodies were available (Figure 4.41 B) or by RT-
qPCR (Figure 4.41 C).  
As expected, since dsRNA probes were directed against sequences in the coding 
regions, RNAi against dL(3)mbt or dLint-1 had the strongest effects on dL(3)mbt-LexA 
or dLint-1-LexA, respectively, in terms of derepression of the reporter gene (Figure 
4.41 A). The repressive activity of dL(3)mbt-LexA was reduced by a factor of at least 
32, compared to mock and EGFP RNAi-treated cells, while repression by dLint-1-LexA 
was diminished approximately 8-fold. This result served as a positive control to confirm 
that RNAi treatment was effective within the chosen time frame.  
In contrast to dL(3)mbt and dLint-1 knockdown, RNAi-mediated depletion of either 
G9a or Pc protein, both of which have an established function in transcriptional 
repression, did not abrogate repression of the reporter gene mediated by dL(3)mbt-
LexA or dLint-1-LexA. Similarly, knockdown of dLsd1 had no or only a minor effect 
on dLint-1-LexA- or dL(3)mbt-mediated repression.  
However, depletion of the LINT subunits dL(3)mbt and dCoREST led to a strong 
decrease of the repressive activity on the reporter by dLint-1-LexA of approximately 3-
fold compared to mock and EGFP controls (Figure 4.41 A, right panel). Vice versa 
RNAi treatment against dLint-1 and CoREST also resulted in a partial derepression of 
the reporter gene in the presence of dL(3)mbt-LexA (Figure 4.41 A, left panel), but to a 
lesser extent compared with the effect on dLint-1-LexA upon LINT depletion.  
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Figure 4.41: The repressor activities of dL(3)mbt and dLint-1 is dependent on residual 
LINT subunits in a luciferase reporter gene assay. (A) Kc167 cells were treated with dsRNA 
against various co-repressor proteins as indicated on the bottom. As negative controls cells were 
treated with no dsRNA (mock) or with dsRNA directed against EGFP. Luciferase reporter gene 
assays were carried out 48h after RNAi treatment. Repressor activity of dL(3)mbt-LexA (left 
panel) and dLint-1-LexA (right panel) on the luciferase reporter gene transcription compared to 
LexA only controls. (B) The knockdown efficiencies on endogenous dL(3)mbt, dLint-1, 
dCoREST and dLsd1 (as indicated on the right) in dsRNA treated cells (denoted below) were 
confirmed by Western blotting. (C) The knockdown efficiencies of G9a (upper panel) and Pc 
(lower panel) in RNAi-treated cells (denoted below) on the level of mRNA transcripts were 
monitored by RT-qPCR. The transcription level in untreated cell (mock) was set to 1.  
 
Quantification of the effects of RNAi against LINT revealed that the repressive activity 
of dL(3)mbt-LexA was reduced from 16- (mock treated) or 17-fold (EGFP RNAi) to 
10-fold (dLint-1 or dCoREST RNAi). In this context one might speculate that the 
dL(3)mbt-LexA fusion protein, which upon dLint-1 and dCoREST RNAi retains 
significant fold repression on the reporter, possesses an intrinsic activity to repress 
transcription that is independent on the LINT complex association. Furthermore, it is 
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noteworthy that the knockdown of dCoREST results additionally in decreased Lsd1 
protein levels (see Figure 4.39). However, since dLsd1 RNAi did not release repression 
of dL(3)mbt and dLint-1, it can be concluded that the effects seen upon RNAi are 
dCoREST-specific. Surprisingly, the effect of dCoREST RNAi on repression by 
dL(3)mbt-LexA and dLint-1-LexA was comparable to dLint-1 and dL(3)mbt depletion, 
respectively, even though the knockdown, especially of the dCoREST-M, isoform 
appeared to be relatively inefficient as judged by Western blot (Figure 4.41 B). 
In conclusion, both dL(3)mbt and dLint-1 displayed a robust and dose-dependent 
repressive activity on a luciferase reporter gene when tethered to its promoter in a 
LexA-dependent manner. Moreover, RNAi depletion experiments revealed that all three 
LINT subunits are required for maximal transcriptional repression when recruited to the 
promoter of a reporter gene, whereas dLsd1 and other repressive chromatin-associated 
proteins are dispensable for efficient repression.  
 
5 DISCUSSION 
142 
 
5 Discussion 
In this doctoral thesis, an interaction between dL(3)mbt and the HDAC dRpd3 has been 
identified that was found to play a role in the process of chromatin maturation (Scharf 
et al., 2009). 
Moreover, LINT, a novel dL(3)mbt complex, has been purified by affinity purification 
and classical biochemical chromatography. Microarray analysis identified LINT target 
genes on a genome-wide level, which revealed that a subset of LINT targets constitutes 
germline-specific genes. An analysis of these regulated genes determined important 
molecular features of the repression mechanism by LINT.  
 
5.1 dL(3)mbt is in a protein complex with dRpd3 
5.1.1 The MBT domains as a protein interaction module 
dL(3)mbt interacts with the deacetylase dRpd3 
Both histone deacetylases and members of the MBT domain protein family have been 
implicated in chromatin compaction and transcriptional repression of genes. The 
assumption that dL(3)mbt as a MBT domain protein could cooperate with HDAC 
activity, proved to be indeed true. Both recombinant and endogenous dL(3)mbt was 
associated with significant amounts of HDAC activity (Figure 4.1). In agreement with 
this, dL(3)mbt co-immunoprecipitated dRpd3 (Figure 4.2), which can target various 
acetylated histone lysines (Rundlett et al., 1996). However, dL(3)mbt did not interact 
with dHDAC3, another member of the HDAC enzyme family in Drosophila. 
Nevertheless, an additional association with dHDAC4 and dHDAC6 cannot be excluded 
at this point, since antibodies against these enzymes were not available to test for a 
possible interaction.  
The MBT domains as a protein-protein interaction domain 
In the past, the MBT domains have been studied mainly in terms of their ability to 
function as histone tail binding modules (see introduction 2.2.1). A specific recognition 
of methylated H4K20 histone peptides was also confirmed for the MBT domains of 
dL(3)mbt (Figure 4.30 B). Therefore it is intriguing that the major dRpd3 interaction 
domain in dL(3)mbt was mapped also to the module of the three MBT domains (Figure 
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4.3 C). A recent publication provided good evidence that the interaction between MBT 
domain proteins and HDACs is highly conserved from Drosophila to man. The human 
L3MBTL2 protein has been reported to specifically associate with HDAC3 (Yoo et al., 
2010). In accordance with the mapping data presented in this study, a construct 
containing only the four MBT domains of L3MBTL2 interacted with HDAC3.  
Until recently, the methyl binding specificity of the MBT domains has been only 
studied in terms of binding to histone tails. However, for L3MBTL1 two studies have 
suggested a mono-methylation-dependent interaction with p53 (West et al., 2010) and 
pRB (Saddic et al., 2010), respectively. In both proteins specific lysine residues (pRB-
K860 and p53-K382) have been identified that promote binding of L3MBTL1. The 
interaction of L3MBTL1 with methylated p53 appears to mediate repression of p53 
target genes (such as p21) in the absence of DNA damage (West et al., 2010). 
The specific interaction of the 3MBT region with dRpd3 and the fact that other 
interactions between a MBT domain protein and non-histone proteins are methylation-
dependent, raises the possibility that dL(3)mbt binds to a dRpd3 product that has been 
post-translationally modified by methylation. This hypothesis has to be elucidated in 
future experiments. To this end one could investigate whether the dL(3)mbt-dRpd3 
interaction still takes place upon treatment of cells with S-adenosyl-L-homocysteine 
(SAH). SAH is the product of all methyltransferases that use S-adenosyl-methionine 
(SAM) as a co-factor and acts as a competitive inhibitor for the methyl-transferase 
enzymatic activity.  
 
5.1.2 A potential role of dL(3)mbt during chromatin assembly 
Histone modification changes during chromatin maturation 
As cells divide the DNA content doubles in S-phase of each cell cycle. The process of 
DNA replication entails the propagation of the chromatin structure to the daughter cells. 
The progression of the replication machinery temporarily disassembles the nucleosomes 
in front of the replication fork (Jackson and Chalkley, 1985; Sogo et al., 1986). 
Following replication, parental histones, as well as newly synthesised histones are re-
assembled onto the two nascent DNA strands in a random manner, which requires the 
action of so called histone chaperones and chromatin remodelers (Avvakumov et al., 
2011). The newly synthesised histones carry a specific histone modification pattern that 
distinguishes them from the histones found in mature chromatin (Loyola et al., 2006). 
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For instance, newly synthesised H4 has been shown to be acetylated at positions K5 and 
K12 (Sobel et al., 1995). Rapidly after deposition this acetylation pattern on H4 is 
removed.  
The dynamics of histone modification changes during chromatin assembly were 
investigated by A. Scharf in the group of A. Imhof in an in vitro chromatin assembly 
assay (Scharf et al., 2009). This assay makes use of an extract obtained from Drosophila 
pre-blastoderm embryos that facilitates the efficient assembly of cloned DNA into 
chromatin (Becker and Wu, 1992). Immediately upon deposition of the histones, H4 
becomes mono-methylated at K20, which is necessary for efficient deacetylation of the 
two acetylation marks at K5 and K12 (Scharf et al., 2009).  
A potential role of dL(3)mbt and dRpd3 during chromatin maturation 
As dL(3)mbt harbours the MBT domains as a reader module for recognition of mono-
methylated K20 (this study and Scharf et al., 2009) dL(3)mbt was a candidate for the 
association with H4K20me1 and the recruitment of HDAC activity to newly assembled 
chromatin. In line with a possible role of the dL(3)mbt-dRpd3 complex (this study) 
during chromatin maturation, it gets efficiently recruited to newly assembled chromatin 
concomitant with H4K20 methylation and H4 deacetylation (Scharf et al., 2009). The 
association, however, is sensitive to the methyltransferase inhibitor SAH, suggesting 
that indeed association of dL(3)mbt-dRpd3 is dependent on H4K20 mono-methylation. 
Taken together, these data support a model, in which the mono-methylation of H4K20 
marks properly assembled nucleosomes and recruits dL(3)mbt and dRpd3 HDAC 
activity, thereby contributing to the efficient deacetylation of the H4 tail required for 
chromatin maturation (Scharf et al., 2009).  
The identification of the LINT complex raises the question, whether the dL(3)mbt-
dRpd3 interaction and recruitment to newly assembled nucleosomes is independent of 
other dL(3)mbt complexes. Even though the core complex consists of only dL(3)mbt, 
dLint-1 and dCoREST a partial association with dRpd3 cannot be completely excluded 
(see 5.2.1). Therefore in terms of a role in chromatin maturation, a detailed analysis of 
composition of dL(3)mbt complexes in early embryos would be of special interest. So 
far the investigation of dL(3)mbt association in multi-protein complexes in Drosophila 
embryos by gel filtration and classical ion exchange chromatography was precluded by 
a weak and ‘smeary’ dL(3)mbt input signal (Figure 4.14).  
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A role of MBT domain proteins in chromatin assembly 
In light of a possible role of dL(3)mbt in chromatin maturation, it is interesting that 
l(3)mbt mutant embryos display cell cycle defects, whereby the synchrony of nuclear 
divisions in the early embryo is disrupted (Yohn et al., 2003). Intriguingly, in mammals 
mono-methylation of H4K20 and the dL(3)mbt homologue L3MBTL1 have been 
implicated in the regulation of cell cycle. Thus, the depletion of PR-SET7, which causes 
a decrease in H4K20me1 levels, results in improper S-phase progression and replicative 
stress (Huen et al., 2008; Jørgensen et al., 2007; Tardat et al., 2007). The finding that 
PR-SET7 foci co-localise with sites of DNA synthesis supports a role of PR-SET7 and 
H4K20me1 directly at the replication fork (Tardat et al., 2007; Tardat et al., 2010). In 
line with an involvement of L3MBTL1 in DNA replication, L3MBTL1 was found to 
interact with several components of the DNA replication apparatus (Gurvich et al. 2010) 
and to be recruited to chromatin most prominently during S-phase (Koga et al., 1999). 
Just like PR-SET7, L3MBTL1 seems to be required for proper progression of the 
replication fork (Gurvich et al., 2010). 
 
5.2 LINT – a novel chromatin-related protein complex 
5.2.1 Identification of LINT as a high molecular weight complex 
The LINT complex is distinct from the Myb-MuvB/dREAM complex 
The gel filtration analysis of Kc167 nuclear extract (Figure 4.4) revealed that the bulk of 
dL(3)mbt is separated from the Myb-MuvB/dREAM complex-specific subunit RBF2 
(Lewis et al., 2004; Korenjak et al., 2004). Therefore the data of this study strongly 
support the idea that LINT, the major dL(3)mbt complex purified from Kc167 cells, is 
biochemically independent of the Myb-MuvB/dREAM complex. The major conclusion 
from the biochemical analyses of the complex composition is that the LINT complex 
consists of three core subunits, the MBT domain protein dL(3)mbt, the previously 
uncharacterised protein dLint-1 and dCoREST (Figure 4.18). The latter is a known co-
repressor protein, which assists Ttk88 to restrict expression of neuronal genes in non-
neuronal tissues (Dallman et al., 2004).  
However, the purification of dLint-1 using FLAG affinity purification co-purified in 
addition the H3K4me1/me2-specific demethylase dLsd1 (Rudolph et al., 2007; Shi et al, 
2004) and the histone deacetylase dRpd3 (De Rubertis et al., 1996). In addition dLsd1 
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also co-precipitated with endogenous dLint-1, but in a rather inefficient manner 
compared to the input signal (Figure 4.14). Moreover, the combination of gel filtration 
analysis and sequential ion exchange chromatography of Kc167 nuclear extract revealed 
that the histone demethylase did not co-fractionate with the LINT subunits (Figures 4.15 
and 4.17 C). In addition, the fractionation provides evidence that dLint-1 exists in at 
least one more protein complex, that is likely to contain dLsd1 but not dL(3)mbt (Figure 
4.17 C).  
Possible association of dRpd3 with the LINT complex 
The biochemical data about the interaction of dRpd3 with LINT are less clear. Firstly, 
dRpd3 co-precipitated with both dL(3)mbt and dLint-1 in an efficient manner 
(Figure 4.2, 4.13 and 4.14). Secondly, even though the LINT subunits dL(3)mbt, dLint-
1 and dCoREST got separated from several dRpd3 peaks (Figure 4.17 C, compare 
fractions 22, 28 and 36), the LINT-containing peak fraction was not devoid of dRpd3 
(Figure 4.17 C, compare fraction 32). However, dRpd3, as well as dLsd1, did not co-
precipitate with dLint-1 from larval brain extract, suggesting that LINT, at least in the 
larval brain, does not contain these histone-modifying proteins (Figure 4.19). 
Furthermore, although dRpd3 co-precipitated with dL(3)mbt and dLint-1 from nuclear 
extracts of cell lines, dRpd3 protein was dispensable for stable repression of LINT 
target genes (Figure 4.39). Nevertheless, it is conceivable that dRpd3 associates with 
LINT in a tissue-specific, developmental-specific or cell cycle-dependent manner. To 
test for this possibility it would be necessary to biochemically analyse the complex 
compositions of dL(3)mbt and dLint-1 complexes in different tissues, various 
developmental stages and in specific cell cycle stages.  
The size of the high molecular weight LINT complex 
The estimated molecular weight of the LINT complex, obtained by adding up the 
molecular weights of the single subunits dL(3)mbt (163 kDa), dLint-1, (67.9 kDa) and 
dCoREST (62.7 kDa), is approximately 300 kDa. Despite the theoretical molecular 
weight, however, LINT elutes from the gel filtration column sooner than expected, close 
to the void volume of 2 MDa (Figure 4.15).  
In general, two major parameters determine the fractionation of proteins by gel 
filtration: the actual molecular weight and the three-dimensional shape of a protein or 
protein complex. Therefore, one possible reason that the calculated molecular weight of 
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the LINT complex does not correlate with the fractionation on the column might be an 
influence by the shape of the LINT complex. An alternative explanation could be that 
the LINT peak observed upon gel filtration does not correspond to a monomeric 
complex, but a dimer or even an oligomer of the complex. In fact, dL(3)mbt contains in 
its C-terminus an SPM domain that has been reported to facilitate homo- and hetero-
dimerisation or oligomerisation (Kim et al., 2002; Kim et al., 2005; Peterson et al., 
1997). This observation raises the question whether the SPM domain of dL(3)mbt can 
mediate dimerisation or oligomerisation of the LINT complex. Indeed, investigation of 
the role of the dL(3)mbt SPM domain in LINT supports its importance in the formation 
of oligomeric complexes (M. Reuter, diploma thesis, 2011). In this context it would be 
of great value to reconstitute the LINT complex biochemically in vitro using for 
example the MultiBac system for recombinant protein expression in Sf9 cells 
(Fitzgerald et al., 2006). This would facilitate to analyse the size of the purified wild-
type complex, as well as an SPM deletion mutant, and compare it to the molecular 
weight of endogenous LINT in nuclear extract.  
 
5.2.2 LINT complex composition  
L(3)mbt and CoREST complexes in Drosophila and mammals 
LINT is the first dL(3)mbt multi-subunit complex purified from Drosophila. Many 
other chromatin-related protein complexes that exist in Drosophila are also conserved in 
human. Exemplary are the complexes PRC2 (Drosophila: Czermin et al., 2002; Müller 
et al., 2002; human: Cao et al., 2002; Kuzmichev et al., 2002), dNuRD (Drosophila: 
Kunert et al., 2009; Reddy et al., 2010; human: Xue et al., 1998; Zhang et al., 1999) and 
dREAM (Drosophila: Korenjak et al., 2004; Lewis et al., 2004; human: Schmit et al., 
2007). 
However, the subunit compositions of the LINT complex and mammalian L3MBTL 
and CoREST protein complexes differ dramatically. On the one hand, L3MBTL1 co-
precipitated pRB, HP1γ, H1B and core histones in a FLAG affinity purification (Trojer 
et al., 2007; Figure 5.1). None of these factors has been detected as dL(3)mbt or dLint-1 
interacting proteins in the corresponding FLAG immunoaffinity purifications (Figures 
4.6 and 4.12). On the other hand, all known CoREST complexes in the mammalian 
system that have been isolated from human cell lines contain LSD1 (also known as 
p110b or BHC110) as an integral subunit (You et al., 2001; Hakimi et al., 2003; 
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Lee et al., 2005; Shi et al., 2005). These purifications suggest that a core complex exists 
that is composed of CoREST, LSD1, HDAC1/2 and BHC80 (Figure 5.1). Additional 
proteins associated with this core include CtBP, BRAF35 and Zn-finger proteins (e.g. 
ZnF217, ZnF198). In Drosophila, an affinity purification of dLsd1 from nuclear extract 
of early (0-3 hr old) embryos identified the heterochromatin-associated factors HP1 and 
the H3K9 methyltransferase Su(var)3-9, as well as dRpd3 as interaction partners 
(Rudolph et al., 2007). However, also an interaction of dCoREST with dLsd1 and 
dRpd3 has been shown to be conserved in Drosophila previously (Dallman et al., 2004).  
 
 
Figure 5.1: L(3)mbt and CoREST complexes in Drosophila melanogaster and mammals. 
Schematic representation of complex compositions of mammalian L3MBTL1 (left; Trojer et al., 
2007), Drosophila LINT (middle) and mammalian LSD1/CoREST (right; Lee et al., 2005; Shi 
et al., 2005) complexes. Only core subunits are shown. Shared homologous subunits are 
indicated by color (red: L(3)mbt, blue: CoREST). Proposed repression mechanisms for each 
complex are indicated below. 
 
dLint-1 and dCoREST complexes in Drosophila aside from LINT 
This study provides further evidence that there are dCoREST complexes other than 
LINT. First, gel filtration analysis revealed that LINT only accounts for a fraction of 
dCoREST in nuclear extract of Kc167 cells (Figure 4.15). Second, a substantial amount 
of dCoREST-M and in fact the bulk of dCoREST-L splice variants are separated from 
LINT in extract fractionation by ion exchange chromatography (Figure 4.17). Thus, the 
majority of dCoREST protein was separated from LINT subunits dLint-1 and dL(3)mbt 
in both gel filtration and ion exchange chromatography. Intriguingly, the biochemical 
fractionations of Kc167 nuclear extract further disclosed that, while dL(3)mbt was 
apparently present only in a single peak together with the residual LINT subunits, 
dLint-1 eluted in a second broader peak that contained dLsd1, dRpd3 and again 
dCoREST (Figure 4.17 and data not shown, fractions 21-25). To unravel the exact 
distribution and composition of these additional dLint-1, dCoREST and dLsd1 
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complexes in Drosophila, further experiments are needed. One possible approach could 
be to establish another purification scheme using more or other types of ion exchange 
columns to figure out how many distinct complexes are indeed present in this second 
peak. Aside from this, additional immunoprecipitations of dLint-1, dCoREST or dLsd1, 
from single fractions after complex purification, analysed by Western blot or mass 
spectrometry, could shed light on the existence of other multi-subunit complexes. 
In Drosophila, dCoREST exists in three splice variants (Dallman et al., 2004). The 
antibody, used in this study, recognises the dCoREST-M and -L isoforms, which exhibit 
the same domain composition, but differ in the length of the domain separating the two 
SANT domains (inter-SANT region) (Dallman et al., 2004). In co-immunoprecipitation 
experiments both FLAG-tagged dL(3)mbt (data not shown) and dLint-1 (Figure 4.13) 
preferentially bound the dCoREST-M isoform. Moreover, gel filtration analysis upon 
dL(3)mbt and dLint-1 co-depletion confirmed the specific association of the dCoREST-
M variant with the LINT complex (Figure 4.16). It is tempting to speculate that the 
shorter inter-SANT region in dCoREST-M harbours a specific protein-protein 
interaction motif that mediates binding to the LINT complex. However an overall 
change in the structure of dCoREST by a variable length of the inter-SANT region 
could also be responsible for the specific interaction of LINT with the dCoREST-M 
splice variant.  
Taken together, the novel LINT complex is exceptional in regards to its composition, 
since so far MBT and CoREST family members have not been found together in multi-
subunit complexes (Figure 5.1).  
 
5.2.3 dLint-1 – a novel PHD-like finger protein 
The PHD finger motif in dLint-1 
The LINT subunit dLint-1 is a novel protein containing a PHD-like domain in its C-
terminus. The identification of the PHD-like domain was based on the discovery of a 
PHD finger-typical C4HC3 signature with the appropriate distances between the 
individual Cys/His residues (Aasland et al., 1995; see Figure 4.7) that is very likely to 
adopt a PHD finger fold (R. Aasland, personal communication).  
The HHpred server (http://toolkit.tuebingen.mpg.de/hhpred) is a bioinformatical tool 
that was developed to detect even remote protein homologies and predict, based on 
published protein structures, secondary structures (Söding et al., 2005). In agreement 
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with the presence of a C4HC3 PHD signature, HHpred predicted the C-terminal region 
of dLint-1 (aa 501 to 602) to adopt with high probabilities similar structures as 
established PHD domains, among them the PHD fingers of the demethylase JARID1D, 
the co-repressor KAP-1, the ATP-remodeler CHD4 and BHC80 (also known as PHD 
finger protein 21A) (data not shown). The definite evidence for this would certainly be a 
structural analysis of the dLint-1 PHD-like domain using either nuclear magnetic 
resonance (NMR) or X-ray crystallography.  
PHD finger proteins in CoREST complexes 
As mentioned above, immunoprecipitations and fractionation of Kc167 nuclear extract 
revealed that dLint-1 is present in at least two distinct complexes, LINT and another 
that is likely to contain dLsd1 and dCoREST (Figures 4.13 and 4.17). Interestingly, 
BHC80, one of the PHD finger proteins that was identified by HHpred, is a subunit of 
mammalian CoREST/LSD1/HDAC complexes (Hakimi et al., 2002; Shi et al., 2005). 
However, an apparent homologous protein of the PHD-finger protein BHC80 is absent 
in Drosophila based on BLAST (Basic Local Alignment Search Tool) analysis. Vice 
versa, dLint-1 lacks an apparent homologue in mammals. In light of both BHC80 and 
dLint-1 containing a PHD and PHD-like domain, respectively, it is tempting to 
speculate that, although these proteins are not related based on their amino acid 
sequence, they possess a similar molecular function. Even though PHD fingers 
generally share a common topology, with two short β-strands bridging two Zn-binding 
motifs, which coordinate the Cys/His residues (Taverna et al., 2007), they exhibit 
flexibility in their histone peptide binding properties. Whereas the PHD fingers of 
human BPTF and inhibitor of growth family 2 (ING2) bind tri-methylated H3K4 (Shi 
et al., 2006; Wysocka et al., 2006), the BHC80 PHD domain was shown to specifically 
recognise unmethylated K4 within histone H3, the reaction product of LSD1 enzymatic 
activity, and discriminates higher methylated states of H3K4 (Lan et al., 2007b; Shi 
et al., 2004). Depletion of BHC80 led to the derepression of LSD1 target genes and the 
repression could be rescued by the re-introduction of wild-type BHC80, but not a PHD-
finger mutant that was unable to bind H3 (Lan et al., 2007b).  
Potential chromatin-related roles PHD finger proteins  
On the basis of the primary sequence, it seems difficult to predict, whether an individual 
PHD finger functions as a histone-binding module and whether it recognises 
unmodified or methylated lysines, although a recent study made efforts to determine 
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sub-families of PHD fingers based on sequence alignments providing functional 
information (Slama and Geman, 2011). To investigate, whether the dLint-1 PHD-like 
domain belongs to the group of histone binding modules, GST-tagged or EGFP-tagged 
constructs of this domain were expressed in bacteria or HEK293 cells, respectively. A 
potential specificity for various histone lysine residues, including H3K4, H3K9, H3K27 
and H4K20 in different methylation states, was tested in histone peptide binding assays 
(data not shown). However, reproducible and specific binding of the PHD-like domain 
to isolated histone tails could not be observed in these experiments. The failure in 
histone peptide binding could have several different reasons.  
It is possible that either the histone substrate or/and the PHD-like binding module were 
not correctly chosen. The PHD-like domain might not be able to recognise free histone 
tails, but require additionally contacts to the globular domains of histones or to 
nucleosomes for efficient binding. Moreover, it is conceivable that the isolated PHD-
like module was not sufficient for specific binding. The latter could be due to the lack of 
protein sequences within dLint-1 or dLint-1 interacting proteins that are required to 
stabilise or mediate histone peptide interaction.  
However, the PHD-like domain does not necessarily need to belong to the group of 
histone readers. Instead, PHD fingers have been previously reported to have 
nucleosome-binding activity in human p300 (Ragvin et al., 2004) and Drosophila Acf1 
(Eberharter et al., 2004). In both cases the PHD fingers seemed to cooperate with an 
adjacent Bromo domain. Therefore, it would be interesting to investigate whether PHD 
or PHD-like domains that are not linked to Bromo domains, such as the one of dLint-1, 
can also function as nucleosome-binding modules.  
Furthermore, PHD fingers were also found to function as protein-protein interaction 
domains for non-histone proteins (O’Connell et al., 2001; Townsley et al., 2004). For 
instance, in Drosophila the PHD fingers of Polycomb-like (Pcl) mediate the interaction 
with E(z) (O’Connell et al., 2001). In case of dLint-1, the dL(3)mbt interaction domain 
resides in the N-terminal half of the protein, lacking the PHD-like domain (Figure 4.9). 
However, this does not exclude that the PHD-like domain can mediate interaction with 
the third LINT subunit dCoREST. To test this hypothesis, the dCoREST interaction 
domain(s) within dLint-1 or dL(3)mbt need(s) to be mapped in future experiments. 
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5.3 LINT as a repressor complex of genes driving brain tumour 
growth in Drosophila 
5.3.1 dL(3)mbt as a tumour suppressor in the larval brain 
dL(3)mbt - a tumour suppressor protein 
Originally, brain tumour suppressor screens identified l(3)mbt, as a tumour suppressor 
gene in Drosophila melanogaster, since a temperature-sensitive mutation of the l(3)mbt 
gene (l(3)mbtts) led to the development of malignant tumour growth in the larval brain 
(Gateff et al., 1993; Wismar et al., 1995) (see introduction, 2.2.2). In this context it is 
noteworthy that most tissues in the Drosophila larva contain endo- or post-mitotic cells, 
and therefore only a limited number of actively dividing cells are in fact capable of 
neoplastic transformation, including adult optic neuroblasts and ganglion mother cells in 
the larval brain, imaginal disc and blood cells (Gateff, 1978). Thus, the malignant 
transformation caused by l(3)mbt mutation uncovered the larval brain as a biological 
relevant tissue of dL(3)mbt protein function, but this does not necessarily allow the 
conclusion that dL(3)mbt has a unique role in the brain.  
In the course of this doctoral thesis two publications (Janic et al., 2010; Richter et al., 
2011) contributed to our understanding of how dL(3)mbt acts as a tumour suppressor 
and identified two groups of target genes that are able to drive tumour growth in the 
Drosophila larval brain. The findings of these studies will be summarised in the 
following and discussed later in context of dL(3)mbt as a LINT subunit (see 5.3.2). 
In order to get a deeper insight into the role of dL(3)mbt as a tumour suppressor Richter 
and co-workers (2011) characterised the origin of malignant overgrowth in l(3)mbt 
mutant larval brains in more detail. Before elucidating the results of these experiments I 
will give a short overview of the brain structure in the Drosophila larva. 
The nervous system of the Drosophila larval brain 
In Drosophila, all neurons of the central nervous system (CNS) originate from 
neuroblasts, which possess stem cell-like features (Neumüller and Knoblich, 2009). In 
the larva, these cells are subdivided in central brain (CB), optic lobe (OL) and ventral 
nerve cord (VNC) neuroblasts, dependent on their affiliation to one of these three main 
neurogenic regions (Figure 5.2 A). One important characteristic of neuroblasts is that 
they undergo multiple rounds of asymmetric cell divisions during larval stages, giving 
rise to two daughter cells. One of them remains a neuroblast, while the other 
differentiates further into a ganglion mother cell to ultimately generate two neurones 
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(Figure 5.2 B). While embryonic neuroblasts give rise to the neuroblasts of the CB and 
VNC, OL neuroblasts develop during larval stages from OL neuroepithelial cells. 
One mechanism for the malignant transformation in Drosophila larval brain is believed 
to be the loss of cell polarity in neuroblasts leading to an increase in the neuroblast cell 
pool and the development of stem cell-derived tumours (Caussinus and Gonzalez, 
2005). Defects in asymmetric cell divisions and loss of cell polarity are also found in 
human cancers and tightly correlate with the ability of tumours to invade and 
metastasise (Wodarz and Näthke, 2007). In contrast to human, where a multitude of 
mutations in genes that are required for essential cellular pathways needs to accumulate 
for the formation of tumours, in Drosophila mutations of single tumour suppressors, 
such as asymmetric cell division regulators, can initiate malignant transformation in the 
brain (Caussinus and Gonzalez, 2005). 
 
 
Figure 5.2: The Drosophila larval brain. (A) Schematic scheme of the Drosophila third instar 
larval brain (lateral view), which consists of three main neurogenic regions: The optic lobes 
(OL) are situated at the lateral surface of the two brain hemispheres. The central brain (CB) is 
located medially of the OL and descends into the ventral nerve cord (VNC) on the posterior side 
of the brain. (B) Asymmetric division of Type I, II and OL neuroblasts (NBs). Type I 
neuroblasts, which constitute the majority of NBs in the CB and VNC, divide asymmetrically 
into another NB and a mother ganglion cell (GMC) that terminally gives rise to two neurons. 
Type II NBs, which are located on the medial posterior surface of the brain lobes, generate 
transiently amplifying intermediate neural progenitor (INP) cells that produce in another 
asymmetric division GMCs. The NBs of the OL originate from OL neuroepithelial (NE) cells. 
Modified from Neumüller and Knoblich, 2009.  
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The tumour phenotype of l(3)mbt mutant larval brains 
Using the neuroblast marker Deadpan to identify neural stem cells Richter et al. (2011) 
show that the number of Deadpan-positively stained cells is strongly increased in 
l(3)mbt mutant larval brains compared to wild-type causing an abnormal enlargement of 
the brain, in particular of the optic lobes. This expansion of the optic lobes appeared to 
result from an over-proliferation of the neuroepithelial cells of the inner and outer optic 
anlagen, which in late larval stages led to an elevated number in OL neuroblasts. In 
contrast to other mutants, exhibiting a tumour phenotype (such as brat and lgl mutants) 
(Betschinger et al., 2006; Lee et al., 2006a), l(3)mbt mutant brains did not reveal defects 
in the asymmetric segregation of determinants (Richter et al., 2011).  
dL(3)mbt target genes that drive tumour progression 
Using a candidate screen Richter and co-workers identified genes of the Salvador-
Warts-Hippo (SWH) pathway (ban, CycA, CycB, CycE, E2f, diap1, fj, ex, Mer, wg, 
Ser), which was known to play a role in the regulation of proliferation and organ size 
(Harvey and Tapon, 2007; Zeng and Hong, 2008), to be important for tumour growth in 
l(3)mbt mutant larvae. As overexpression of Expanded or mutation of ban or yki could 
rescue the tumour phenotype, deregulation of target genes of the SWH pathway appears 
to be essential for the development of tumours (Richter et al., 2011). Out of eleven 
SWH pathway genes seven were identified as direct targets of dL(3)mbt binding, 
suggesting that derepression of SWH genes upon loss of dL(3)mbt function, leads to 
tumourigenesis.  
Prior to the study by Richter et al. (2011) another set of genes, termed MBT signature 
(MBTS) genes, was already revealed to be required for tumour growth in l(3)mbt 
mutant larval brains by Janic et al. (2010). In an unbiased approach to identify mis-
regulated genes that could be involved in the tumour growth genome-wide gene 
expression profiling was performed, comparing expression levels in l(3)mbt mutant 
larval brains at the restrictive temperature (29°C) to w1118 control and l(3)mbt mutant 
larval brains at the permissive temperature (17°C). Intriguingly, from 102 genes, that 
were observed to be significantly up-regulated in l(3)mbt brain tumours, 26 are required 
in the germline, among them were also swa, nos and piwi. To investigate the 
contribution of mis-expression of germline genes to tumourigenesis Janic et al. (2010) 
quantified brain overgrowth in larvae that were mutant for l(3)mbtts alone or double 
mutant for l(3)mbtts and one of the germline-specific genes. The average brain size, 
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measured in total protein content, was approximately 7-fold larger in l(3)mbtts mutants 
compared to w1118 controls. Remarkably, the additional mutation of piwi, nos, vasa (vas) 
or aubergine (aub) prevented overgrowth, which resulted in normal sized brains in 
double mutant larvae, whereas mutation of other germline genes (e.g. zpg, Pxt) did not 
significantly reduce the brain size. These data revealed a striking correlation between 
the ectopic expression of some germline-specific genes and the l(3)mbt-mediated 
tumour growth in Drosophila.  
Taking the data of the two studies of Richter et al. (2011) and Janic et al. (2010) into 
account, the most surprising result might be that the manipulation of single dL(3)mbt 
targets from both gene clusters (of SWH and MBTS genes), even though acting in 
completely different biological pathways, is able to rescue the tumourigenic phenotype 
in l(3)mbt mutant larvae. However, in none of the two publications, mentioned above, 
the authors address the question, whether dL(3)mbt as a repressor protein and tumour 
suppressor functions as a single protein or in context of a protein complex. 
 
5.3.2 LINT and the regulation of genes driving brain tumour growth  
LINT represses MBTS genes 
Given that this study shows that LINT is the major dL(3)mbt complex in Kc167 cell 
nuclear extract and exists in the developing fly in embryos as well as in larval brain, it is 
likely that dL(3)mbt represses tumour-relevant genes in the context of the LINT 
complex. Supporting this idea RNA interference against dL(3)mbt or dLint-1 in Kc167 
cells combined with gene expression profiling revealed that the majority of dL(3)mbt 
(74%) and dLint-1 (53%) deregulated genes overlapped between the two data sets 
(Figure 4.23). Intriguingly, 15 out of 32 germline-specific MBTS genes, which were up-
regulated in tumourigenic l(3)mbt mutant larval brains (Janic et al., 2010), were also 
derepressed in Kc167 cells that were depleted of dL(3)mbt or dLint-1 (see Table 7.1 in 
the appendix). In addition, the MBTS genes piwi, tej, hdm, CG32313, RpS5b, swa and 
nos were among the top 50 genes that were most strongly up-regulated upon both 
dL(3)mbt and dLint-1 depletion (see Table 4.3). Among these, piwi and nos have been 
reported to contribute to malignant brain tumour growth (Janic et al., 2010). Moreover, 
20 of the top 50 genes encode proteins that are expressed in an ovary- or testis-specific 
expression pattern (see Table 4.3).  
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By contrast, none of the SWH pathway genes that have been recently shown to be 
dL(3)mbt targets in l(3)mbt mutant brains (Richter et al., 2011) were found in 
microarrays to be up-regulated in dL(3)mbt and dLint-1 RNAi-treated cells. 
Discrepancies between the data presented in this study and the reports by Janic et al. 
(2010) and Richter et al. (2011) on dL(3)mbt target genes may arise from different 
reasons. It is possible that the depletion of dL(3)mbt or dLint-1 by RNAi, as opposed to 
a non-functional dL(3)mbt mutant protein, was not sufficient to derepress certain target 
genes under these conditions. The knockdown efficiencies were generally monitored in 
soluble nuclear extract, but not in the chromatin-bound fraction. It is therefore 
conceivable that even in case of an efficient depletion a protein fraction remains stably 
associated with chromatin. In addition, genes of the SWH pathway might be differently 
regulated in Drosophila larval brain compared to cell lines. 
In line with the LINT complex regulating germ cell-specific target genes the expression 
of a selected subset of MBTS genes was strongly derepressed, not only upon dL(3)mbt 
and dLint-1, but also dCoREST knockdown (Figure 4.39). ChIP analysis, showing 
dLint-1 and dCoREST binding to promoter regions of the corresponding target genes 
confirmed that LINT represses them by a direct mechanism (Figure 4.28). A drawback 
of the dL(3)mbt-specific antibodies, which were raised in the course of this study, was 
that none of them worked in ChIP. Therefore the association of dL(3)mbt, the only 
subunit which appears to be specific for LINT (Figure 4.17), with target genes could not 
be tested. However, Richter and co-workers (2011) published a genome-wide ChIP-Seq 
analysis of dL(3)mbt binding sites using an independent antibody. In accordance with 
the LINT complex regulating germ cell-specific target genes, promoters that were 
bound by dLint-1 and dCoREST (Figure 4.28), also revealed peaks for dL(3)mbt 
association in the region upstream of the transcriptional start sites (ChIP-Seq data from 
Richter et al., 2011).  
Genome-wide binding of LINT subunits to chromatin 
Co-localisation studies on polytene chromosomes, preceding the identification of target 
genes, had already suggested that dL(3)mbt and dLint-1 binding sites overlap to a high 
extent, namely 83% of all bands were co-stained by both dL(3)mbt and dLint-1 
antibodies (Figure 4.21). However, it was interesting to map global binding sites of 
LINT that are common to dL(3)mbt and dLint-1. To this end dLint-1 binding sites were 
determined in our lab using ChIP-Seq: Chromatin immunoprecipitations of dLint-1 
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were carried out by Eve-Lyne Mathieu in our lab, isolated DNA was subjected to 
Illumina sequencing by Maren Scharfe (Helmholtz Center for Infection Research, 
Braunschweig) and data were statistically analysed by Florian Finkernagel (IMT, 
Marburg). To gain insight into the co-localisation, dLint-1 (E. Mathieu, data not shown) 
and dL(3)mbt (Richter et al., 2011) ChIP-Seq results were compared. In good 
agreement with immunofluorescent polytene stainings, 80% of the dL(3)mbt peaks 
(2902 in number) overlapped with dLint-1 peaks. To gain a deeper insight in the 
distribution of LINT and other dLint-1 containing complexes on a genome-wide level it 
would be interesting to carry out dCoREST and dLsd1 ChIP-Seq analyses to be 
compared with existing dL(3)mbt (Richter et al., 2011) and dLint-1 (E. Mathieu, 
unpublished data) data sets. This has been so far precluded by the lack of adequate 
antibodies.  
Taken together, the results presented in this work strongly support the idea that 
dL(3)mbt as part of the LINT complex directly silences germline-specific genes, whose 
ectopic expression contributes to the progression of tumour growth in the brain of larvae 
(Janic et al., 2010). This underlines furthermore the biological relevance of this novel 
protein complex. Since dLint-1 knockdown, similar to dL(3)mbt depletion, results in a 
strong derepression of germline-specific target genes, at least in the systems tested so 
far (Figures 4.24 and 4.25), it would be very interesting to investigate, whether mutation 
of the lint-1 gene or ectopic depletion of dLint-1 protein by RNAi interference in the 
brain causes a similar tumourigenic phenotype.  
Germline-specific genes and tumourigenesis 
Interestingly, in human the aberrant expression of cancer-testis (CT) or cancer-germline 
(CG) genes, whose expression is normally restricted to gametes and trophoblasts, has 
been found in a range of tumour types (Simpson et al., 2005). Based on this study it is 
conceivable, that in human L3MBTL and CoREST proteins play a role in the silencing 
of CT and CG genes. Although the mechanism of how germline genes could induce 
tumourigenesis is poorly understood, a theory evolved that partial re-activation of the 
gametogenic gene-expression program equips somatic cells with germ cell-specific 
features contributing to immortality, invasiveness and metastatic capacity. In this 
context, a correlation between germ cell characteristics and lifespan was reported in the 
worm (Curran et al., 2009). C. elegans mutants with an increased longevity have been 
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shown to exhibit a soma-to-germline transformation, describing the mis-expression of 
germline-specific genes in somatic tissues.  
A germline-specific defect in L(3)mbt mutant embryos 
As many germ cell-specific genes are among the top LINT-regulated genes, it is worth 
noting that mutation of l(3)mbt in the fly has been reported to cause, aside from the 
malignant brain tumour phenotype, a defect in germline development (Yohn et al., 
2003). However, it is difficult to judge how this relates to the silencing of germline-
specific cells in somatic tissues. Embryos with a mutation in l(3)mbt had a decreased 
number of germline precursor pole cells (Yohn et al., 2003). These embryos already 
display defects in the synchrony of nuclear divisions at the onset of embryonic 
development. Thus it seems likely that defects in nuclear migration and hence germ cell 
formation are a direct consequence of disturbed nuclear divisions. Investigating the 
distribution of l(3)mbt mRNA by in situ hybridisation, Wismar et al. (1995) found that 
l(3)mbt mRNA is expressed throughout embryonic development in most tissues, but 
that pole cells were devoid of a hybridisation signal. This would support the idea that 
the abnormalities in the number of primordial germ cells (Yohn et al., 2003) is not due 
to a lack of dL(3)mbt in these cells, but through an indirect mechanism.  
 
Although a high proportion of strongly up-regulated LINT target genes evidently 
display testis- or ovary-specific expression patterns, it is clear that the LINT complex is 
involved in the regulation of a large suite of genes functioning in diverse biological 
processes, which remains to be further investigated.  
 
5.4 The role of MBT domains in transcriptional repression by LINT 
Several in vitro binding studies have found that MBT domains specifically bind to 
mono- and di-methylated lysines within histone tails exhibiting a relatively low 
selectivity concerning the sequence context (Bonasio et al., 2010; Kalakonda et al., 
2008; Li et al., 2007b; see introduction 2.2.1.2). These have been obtained using 
isolated MBT domain modules. However, few data exist on the binding properties of 
full length MBT proteins that potentially differ from the ones of isolated MBT modules. 
In line with this, there is a discrepancy between the specificity of the isolated four MBT 
domains of L3MBTL2 and the corresponding full-length protein in in vitro binding 
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assays. While the 4MBT region bound, similarly to the three MBT domains of 
L3MBTL1, specifically to mono- and di-methylated histone peptides (Guo et al., 2009), 
full-length L3MBTL2 recognised H4K20 preferentially in its un- and mono-methylated 
state (Trojer et al., 2011). In addition, Trojer et al. (2011) demonstrate a binding of 
L3MBTL2 (full length) to unmethylated H3 (aa 1-21) regardless of H3K4 or H3K9 
mono- or di-methylation. In addition to the potential differences of the binding 
selectivity of MBT domains and full length MBT proteins, one should consider that the 
binding specificities of MBT domain proteins in vivo very likely also depend on many 
other factors, such as associated proteins influencing binding affinity and specificity to 
chromatin. 
Role of MBT domain binding to H4K20 methylation 
In human mono-methylation of H4K20 enhances chromatin association and promotes 
the repressive activity of L3MBTL1 (Trojer et al., 2007; Kalakonda et al., 2008). In fact 
the association of L3MBTL1 at the cyclin E promoter was shown to be reduced upon 
PR-SET7 knockdown, concomitant with an increase of the cyclin E mRNA levels 
(Kalakonda et al., 2008). Therefore, in this study the question was addressed whether 
loss of H4K20me1 has an impact on LINT repression. In agreement with dPR-Set7 
being the sole methyltransferase in Drosophila (Nishioka et al., 2002), H4K20me1 
levels were significantly reduced in a global manner (Figure 4.31 B). However, 
transcription levels of LINT target genes were unaffected (Figure 4.31 C). In agreement 
with this ChIP analysis suggests that the H4K20me1 modification is absent from 
promoters of LINT target genes swa and nos (Figure 4.32 A). This indicates that even 
though dL(3)mbt bound H4K20me1 with a higher affinity than unmethylated H4 
peptide in vitro (Figure 4.30 B; Scharf et al., 2009) that the interaction between 
dL(3)mbt and H4K20me1 is not part of the repression mechanism of LINT.  
There is one major difference between the L3MBTL1/H4K20me1 regulated cyclin E 
gene (Kalakonda et al., 2008) and the LINT target genes that were investigated in this 
study. While cyclin E is a cell cycle-dependent gene that needs to be dynamically 
regulated, the germline-specific LINT target genes are required to be constantly 
silenced in somatic cells. For this reason, it might well be that H4K20 methylation 
contributes to the modulation of other dL(3)mbt target genes in response to cell cycle 
progression or other biological pathways.  
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However, by using somatic Kc167 cells as a system, an associated drawback is that the 
repression of germ cell-specific LINT target genes is naturally already established. 
Therefore, it cannot be excluded that H4K20 mono-methylation plays an important role 
during the establishment of stable repression of germline-specific target genes. 
In addition to mono-methylated H4K20, the MBT domains also specifically recognised 
H4K20me2 in vitro (Figure 4.30 B). Even though the H4K20me2 mark was present at 
LINT target gene promoters, the levels were not elevated in comparison to control 
regions (Figure 4.32 B). This observation was not surprising since two previous 
publications reported that 85-90% of all chromatin associated histone H4 molecules are 
di-methylated at lysine 20 (Schotta et al., 2008; Yang et al., 2008). This might implicate 
that the H4K20me2 mark is uniformely high along the chromosomes. Therefore, this 
modification is unlikely to recruit the LINT complex in a specific manner to its target 
genes. However, it is still conceivable that upon targeting of LINT by other means, a 
binding of dL(3)mbt to H4K20me2 contributes to transcriptional repression. 
Role of MBT domain binding to alternative histone modifications 
To explain the function of MBT domain proteins, such as Sfmbt, in the Polycomb 
system, it has been speculated that the MBT module could act as a so termed ‘grappling 
hook’ (Klymenko et al., 2006). Hence, in the untranscribed state H3K27, H3K9 and 
H4K20 are extensively tri-methylated throughout the Ubx locus, except for the 
promoter and the 5’-coding region (Papp and Müller, 2006). Given the specificity of 
MBT domains for mono- and di-methylated histone lysines Klymenko et al. (2006) 
favour a model, in which MBT proteins bound to PREs scan the neighbouring 
chromatin for lower methylated lysine residues. By tethering H3K27 to E(z)/PRC2 the 
MBT domains can then function like a ‘grappling hook’ to ensure that this histone mark 
becomes tri-methylated. However, in case of LINT regulated target genes this paradigm 
is difficult to envisage, since the binding peaks of LINT subunits and E(z) localise at 
diverging regions of target genes, at promoter and ORF, respectively. Therefore, a 
prerequisite for the functional interaction between dL(3)mbt and E(z) on chromatin 
would be the formation of a chromatin loop to bring dL(3)mbt and E(z) in close 
proximity. In order to test such a model, more sophisticated experiments would be 
necessary. 
However, it is also tempting to speculate that dL(3)mbt within the LINT complex can 
bind specifically to the low-methylated state of activating histone modifications, such as 
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H3K4. In vitro binding assays of the three MBT domains of human L3MBTL1 revealed 
that the affinity towards H3K4me1 is a magnitude higher compared to H3K4me2 (Li 
et al., 2007b). In order to gain a better insight into the methylation status of H3K4 at 
LINT target promoters, it would be interesting to include an H3K4me1-specific 
antibody in ChIP analysis to investigate changes of H3K4me1 levels upon LINT 
disassociation.  
 
5.5 LINT repression is independent of histone-modifying activities  
Changes of H3K4 methylation levels at LINT target genes 
The derepression of LINT target genes is accompanied by changes in histone 
modification patterns. It correlates with a modest increase of H4 acetylation at the 
promoter and a significant elevation of H3K4 di-methylation at the promoter and the 
ORF (Figure 4.33). Both histone marks are characteristic for active chromatin (see 
introduction). Although the LINT core complex does not contain any histone-modifying 
enzymes, dL(3)mbt and dLint-1 interact with the deacetylase dRpd3 and dLint-1 
associates with the H3K4-specific demethylase dLsd1. The enzymatic activities of both 
proteins could have offered an explanation for the observed histone modification 
changes. However, depletion of the dLint-1 interacting dLsd1 and dRpd3 enzymes did 
not relieve the repression of LINT target genes (Figure 4.39). Moreover, knockdown of 
dLsd1 did not suppress repression of a reporter gene mediated by dL(3)mbt- and dLint-
1-LexA fusion proteins (Figure 4.41). Also TSA-treatment of cells to inhibit HDAC 
activity did not reduce repressive potential of dL(3)mbt in the same reporter assay 
(D. Pagliarini, diploma thesis, 2008). These results suggest that the maintenance of 
germline-specific LINT target genes does not require these repressive histone-
modifying enzymes. In contrast to loss of LINT from the promoter, a depletion of 
dLsd1 does not lead to an increase of H3K4me2 levels. Therefore it is most likely that 
the detected changes in histone modifications are a consequence of active transcription 
rather than a loss of histone-modifying enzymes that are associated with LINT target 
genes.  
When discussing the relevance of histone modifications it seems indispensable to 
distinguish whether a certain modification pattern is cause or consequence of a specific 
biological event, such as transcription (Henikoff and Shilatifard, 2011). For instance, 
methylation of the H3K4 residue correlates highly with active transcription on a 
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genome-wide level (Schübeler et al., 2004; Roh et al., 2006). In most cases the 
modification of H3K4 by mono-, di- and tri-methylation is interpreted as a consequence 
of active transcription. In yeast it was demonstrated that the Set1 methyltransferase is 
recruited to sites of active transcription by the RNA Polymerase II elongating 
machinery (Krogan et al., 2003; Ng et al., 2003).  
Even though LINT is devoid of histone-modifying enzymes, it is still conceivable that 
the dLint-1 interacting proteins dRpd3 and dLsd1, as well as other chromatin ‘writers’, 
are initially required to establish repressive chromatin patterns at LINT target genes. 
The data in this study indicate, however, that once gene silencing is established, the 
presence of LINT at the promoter is sufficient to protect repressive histone marks. 
Changes of H3K27 methylation levels at LINT target genes 
A third histone modification that was significantly affected by derepression of LINT 
target gene derepression was the repressive histone mark H3K27me3. Upon loss of 
LINT, the levels of tri-methylated H3K27 that is set by the PRC2 integral histone 
methyltransferase E(z) (Cao et al., 2002; Czermin et al., 2002; Kuzmichev et al., 2002; 
Müller et al., 2002) decreased significantly in the transcribed region (Figure 4.34). In 
accordance with the presence of H3K27me3, E(z) was detected specifically in the open 
reading frame of LINT target genes (Figure 4.36). In general high levels of H3K27me3 
correlate with transcriptional silencing of Polycomb targets, such as the Hox genes 
(Nekrasov et al., 2007; Sarma et al., 2008). The repressive effect of this mark is in line 
with germline-specific genes targeted by LINT being turned off in somatic tissues. As 
described above, H3K4me2 levels were unaffected by dLsd1 knockdown. In contrast, 
H3K27me3 levels were indeed reduced upon depletion of E(z) (Figure 4.34). However, 
the expression levels of LINT target genes were also not significantly changed (Figure 
4.38), arguing that the reduction of a single repressive mark is not sufficient for gene 
induction.  
Surprisingly, although H3K27me3 levels strongly decreased upon derepression of target 
genes (Figure 4.33), E(z) was not displaced from the open reading frame (Figure 4.36). 
Hence, another mechanism must take effect to inhibit the enzymatic activity of PRC2.  
A recent publication demonstrated that the enzymatic activity of E(z) in the PRC2 
complex is inhibited by active chromatin modifications, such as methylated H3K36 and 
H3K4, in an allosteric manner (Schmitges et al., 2011). On the other hand PRC2 was 
shown to be stimulated by H3K27me3, the same mark that is deposited by its 
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catalytically subunit (Hansen et al., 2008; Margueron et al., 2009). This positive feed-
back loop is thought to be involved in the efficient creation and epigenetic maintenance 
of H3K27me3 positive domains. The direct inhibition of PRC2 through active histone 
marks offers now a paradigm of how spreading of methylated H3K27 into active 
chromatin regions can be prevented (Schmitges et al., 2011).  
With regard to this study the same mechanism may be responsible for a decrease in 
H3K27me3 despite the presence of E(z). Since the derepression of LINT target genes is 
accompanied by elevated levels of methylated H3K4 both in the promoter and the ORF 
(Figure 4.33), it is conceivable that this increase in active histone marks is efficient to 
inhibit the catalytic activity of E(z).  
An alternative explanation for the decrease in the amount of H3K27me3 is that the 
enzymatic activity of E(z) is overcome by the counteracting H3K27me2/3 specific 
demethylase dUTX (Smith et al., 2008; Herz et al., 2010). Previously, Smith et al. 
(2008) demonstrated an interaction between dUTX and RNA polymerase II (RNA Pol 
II), as well as a co-localisation with the elongating form of RNA Pol II on polytene 
chromosomes. Using the heat shock gene Hsp70 as a model for inducible gene 
activation, dUTX was shown to be recruited to the transcribed region upon heat shock 
induction of Hsp70. In conclusion, there are at least two mechanisms, which both occur 
on a co-transcriptional level, that could account for the H3K27me3 loss upon LINT 
target gene derepression.  
 
5.6 Model of LINT-mediated gene repression 
The data presented in this thesis favour the following model for target gene repression 
by the LINT complex (Figure 5.3).  
The LINT core complex, consisting of dL(3)mbt, dLint-1 and dCoREST, stably 
represses genes, whose expression is normally restricted to the germline. All three 
subunits of LINT are crucial for the maintenance of stable silencing (Figure 4.39). The 
LINT complex binds specifically close to transcription start sites of target genes, 
suggesting that LINT might prevent transcription by restricting the access of RNA Pol 
II and activating transcription factors to promoters (Figures 5.1 and 5.2). In favour of 
this mechanism, recruitment of LINT subunits to the promoter region of a reporter gene 
is sufficient for repression even under conditions when repressive histone-modifying 
enzymes are depleted (Figure 4.41).  
5 DISCUSSION 
164 
 
The derepression of target genes is accompanied by changes in histone modification 
patterns. Upon loss of LINT the levels of repressive H3K27me3 decrease, while active 
histone marks (H3K4me2 and H4 acetylation) increase. These changes are likely to 
occur as a consequence of active transcription (see 5.5).  
In contrast to LINT, repression of mammalian CoREST/LSD1 complexes is considered 
to be triggered via histone demethylation and deacetylation, while the major repression 
mechanism of the mammalian L3MBTL1 complex is thought to be nucleosome 
compaction (Figure 5.1). 
 
 
Figure 5.3: Model of LINT-mediated transcriptional repression. Upper panel: The LINT 
complex is associated with the promoter regions of repressed genes, such as the MBTS 
germline-specific genes, which precludes the access of RNA polymerase II (RNA Pol II) and/or 
activating transcription factors to the promoter. Lower panel: Inactivation or depletion of LINT 
complex subunits allows the binding of RNA Pol II and/or activating transcription factors to the 
promoter, facilitating transcription initiation and elongation. The derepression of LINT target 
genes is accompanied by a loss of repressive (H3K27me3) and a gain in active (H3K4me2) 
histone marks that are likely to occur co-transcriptionally.  
 
In the future, further experiments are required to decipher the mechanism of LINT 
repression in more detail and determine the contribution of each LINT subunit, as well 
as of single protein domains of dL(3)mbt, dLint-1 and dCoREST. 
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5.7 Potential recruitment mechanisms of LINT to target genes 
Although the LINT complex appears to bind directly to the promoter regions of target 
genes, the model presented here (Figure 5.3), does not imply that LINT features a DNA 
sequence-specific mode. About how LINT gets recruited to its binding sites can only be 
speculated and the exact mechanism of targeting remains to be elucidated in future 
experiments.  
Like other repressor complexes (such as PRC1: Shao et al., 1999; PRC2: Czermin 
et al., 2002; Müller et al., 2002; and dNuRD: Kunert et al., 2009; Reddy et al., 2010), 
LINT lacks a DNA-sequence specific transcription factor as an integral subunit. 
Therefore, one possible mechanism for LINT targeting is that a transcriptional repressor 
specifically binds to its recognition site in the promoter of target genes and recruits 
LINT directly on the DNA as a co-repressor complex to silence transcription. As a 
candidate approach the promoter regions of genes, which were deregulated upon 
dL(3)mbt and dLint-1 depletion, were analysed statistically for the enrichment of 
known transcription factor binding motifs (F. Finkernagel). However, this analysis did 
not yield a significant result.  
Correlation between dL(3)mbt binding sites and insulator sequences 
A DNA motif search among the dL(3)mbt binding sites by Richter et al. (2011) led to 
the identification of four consensus sequences that matched consensus motifs of the 
chromatin insulators bound by CP190 (Negre et al., 2010), BEAF-32 (Zhao et al., 
1995), CTCF (Holohan et al., 2007) and Su(Hw) (Adryan et al., 2007). Of these the 
latter three can directly bind to sequence-specific recognition sites. Insulator proteins 
have been implicated in the regulation of chromatin organisation and gene regulation by 
mediating the formation of chromatin loops (Yang and Corces, 2011). In agreement 
with an enrichment of insulator consensus sequences within dL(3)mbt-associated 
regions, binding sites of dL(3)mbt overlapped largely with bound CP190, BEAF-32, 
CTCF and to a lesser extent with Su(Hw) (Richter et al., 2011). The correlation between 
dL(3)mbt and insulator protein binding is particularly high within the Hox gene cluster 
of the Bithorax complex (Richter et al., 2011). Given that dLint-1 and dL(3)mbt ChIP-
Seq peaks overlap to a great extent (approximately 80%, see 5.3.2) there is a high 
likelihood that also LINT shares a plethora of binding sites with insulator proteins. The 
statistical analysis to quantify this overlap remains to be done. However, questions that 
also need to be addressed in the future are for instance whether there is a biological 
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relevance for this overlap and whether insulator proteins can be involved in the 
targeting of dL(3)mbt to insulator sequences. Therefore, to term dL(3)mbt an insulator 
protein (Richter et al., 2011) seems premature at presence. Also one should keep in 
mind that ChIP data are always obtained from a cell population. Therefore the 
identification of regions that are positive for the binding of different factors does not 
necessarily imply that these sites are actually bound by all these factors concomitantly. 
Transcription factors as potential candidates to recruit LINT to target genes 
During the purification of the Myb-MuvB complex dL(3)mbt co-purified in a sub-
stoichiometric manner from embryo extracts (Lewis et al., 2004). This led to the 
conclusion that dL(3)mbt is an optional subunit of Myb-MuvB. On the contrary the 
isolation of the dREAM complex, also from embryo extract, which is identical to the 
Myb-MuvB complex in its core subunit composition, was devoid of dL(3)mbt 
(Korenjak et al., 2004). Moreover, in this study the bulk of dL(3)mbt and RBF2 (a Myb-
MuvB/dREAM subunit) clearly separated upon gel filtration analysis (Figure 4.4), 
arguing against a stable interaction and supporting an independent association of 
dL(3)mbt in the LINT complex. Nevertheless, gene expression analysis of Kc167 cells 
revealed an significant overlap within different gene classes, regulated by both Myb-
MuvB and dL(3)mbt (Georlette et al., 2007). The fact that Myb-MuvB and dL(3)mbt 
share target genes and a probable proximity on the DNA might provide an explanation, 
why dL(3)mbt co-purified with Myb-MuvB in a sub-stoichiometric manner. If the Myb-
MuvB complex with its two integral sequence-specific transcription factors E2F and 
dMyb is involved in the recruitment of dL(3)mbt and the LINT complex to common 
target genes, needs to be further investigated in the future. 
In case of CoREST a recruitment mechanism has been elucidated for a certain set of 
target genes. In the mammalian system, as well as in Drosophila, the co-repressor 
CoREST, as part of a dLsd1-HDAC complex, is recruited by the transcription factors 
REST (repressor element I silencing transcription factor; in vertebrates) and Ttk88 
(Tramtrack88; in Drosophila) (Andrés et al., 1999; Dallman et al., 2004), respectively. 
These transcription factors do not share a discernable homology, but in cooperation with 
CoREST-Lsd1-HDAC complexes, they both hinder the expression of neuronal-specific 
genes in non-neuronal cells. However, none of the neuronal genes, that were identified 
to be regulated by the Ttk88-dCoREST complex (Dallman et al., 2004), were up-
regulated in dL(3)mbt depleted Kc167 cells (microarray analysis in this study, data not 
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shown), arguing against co-regulation of these genes by LINT. It is noteworthy, 
however, that the dCoREST-dLsd1-HDAC complex executes a similar function as the 
LINT complex by repressing the transcription of tissue-specific genes. While the 
dCoREST-dLsd1-HDAC complex silences neuronal-specific genes in non-neuronal 
cells, LINT represses germline-specific MBTS genes in somatic cells. Given that the 
same protein in two distinct chromatin-related complexes co-regulates different sets of 
target genes, it is tempting to speculate that one of the residual subunits determines the 
specificity for certain target genes, for instance by interacting with a sequence-specific 
transcription factor, while dCoREST fulfils a general repressive function.  
To sum up, to unravel the exact mechanism of recruitment of LINT to target genes, 
more elaborate experimental and bioinformatical approaches are needed. For instance, a 
comparison of the microarray data upon depletion of dL(3)mbt or dLint-1, gained in this 
study, with dL(3)mbt (Richter et al., 2011) and dLint-1 (E. Mathieu, unpublished data) 
ChIP-Seq analysis could dismiss all indirectly deregulated genes. Accordingly, a DNA 
motif search within the promoter regions of direct target genes might be more 
meaningful and more likely result in an enrichment of LINT-bound consensus 
sequences. In this study I focused on identifying stoichiometric dL(3)mbt and dLint-1 
complexes. However, the interaction with a targeting protein, like a transcriptional 
regulator, would probably be weak, especially in solution. Therefore, in order to isolate 
sub-stoichiometric interaction partners of the LINT complex, it would be reasonable to 
analyse the identity of all co-precipitating proteins in FLAG petide eluates from affinity 
purifications via mass spectrometry.  
 
5.8 Chromatin compaction as a repressive mechanism 
The compaction of chromatin is an appealing mechanism for gene silencing. In fact, 
transcriptional repressors that have been linked to chromatin compaction belong to 
Polycomb and MBT protein families.  
Recently, human L3MBTL1 (Trojer et al., 2007) and L3MBTL2 (Trojer et al., 2011) 
have been shown to impact chromatin structure by compacting nucleosomal arrays 
in vitro. In these cases the ability to influence chromatin structure was attributed 
specifically to the MBT domains (Trojer et al., 2007 and 2011). In this context it is 
remarkable that both MBT proteins interact with HP1γ, a member of the 
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heterochromatin protein family (Eissenberg and Elgin, 2000). A prerequisite for 
L3MBTL1 compaction has been suggested to be mono- and di-methylation of histone 
H4K20 or H1bK26 (Trojer et al., 2007), whereas L3MBTL2 compacted chromatin in a 
modification independent manner (Trojer et al., 2011). However, one should take into 
account that results for L3MBTL1 were obtained using the isolated MBT module, while 
L3MBTL2 was studied as a full length protein.  
Among the PcG proteins, the PRC1 complex has been revealed to induce packaging of 
oligo-nucleosomal arrays in vitro, thereby antagonising the remodelling activity of 
SWI/SNF-class chromatin remodelers (Shao et al., 1999; Francis et al., 2004). Evidence 
for this compaction by PRC1 in vivo has been provided in embryonic stem cells using a 
FISH 2D approach (Eskeland et al., 2010). Surprisingly, the ability to compact 
chromatin has been conserved in diverse PRC1 subunits in Drosophila and mammals, in 
Psc and the Drosophila Pc mouse homologue M33, respectively (Grau et al., 2011). The 
capability of chromatin compaction appears to require a region with a high positive 
charge. In addition to PRC1, the PcG family contains two more MBT domain proteins, 
namely Scm and Sfmbt, that are implicated in the formation of higher-order chromatin 
structures. Thus, MBT domain proteins and PRC1 subunits seem to have evolved 
independent modes of packaging chromatin.  
Certainly, chromatin compaction by LINT mediated by dL(3)mbt would be a 
conceivable mechanism to explain access restriction of target gene promoters for RNA 
Pol II. As a consequence of chromatin compaction one might expect a local increase in 
nucleosome occupancy at the promoter regions of LINT target genes. However, H3 
ChIP experiments have demonstrated that these promoters are generally depleted of 
nucleosomes (Figure 4.29) and that the content of H3 in the transcribed region of for 
instance swa is not elevated compared to neighbouring active genes (see 4.3.1 and 
Figure 4.29 B). These findings do not rule out the possibility that there is a local 
compaction that hinders transcription and is undetectable by H3 ChIP analysis. 
Nevertheless, the results obtained in this thesis favour a simpler model, namely that 
LINT association with promoter sequences prevents binding of activating transcription 
factors and RNA Pol II (see Figure 5.3). This hypothesis does not exclude a local 
impact on the chromatin structure by LINT mediated by dL(3)mbt. To get a first 
glimpse of how LINT influences chromatin structure one could investigate the effect of 
LINT and its single subunits on oligo-nucleosomal arrays by electron microscopy, as it 
has been done for the PRC1 complex (Francis et al., 2004). Furthermore, one might 
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gain a deeper insight by a nucleosome mapping analysis (Gévry et al., 2009) in the 
presence and absence of LINT, while blocking transcription, which itself induces 
chromatin structure changes like replication-independent histone turnover 
(Schwartz and Ahmad, 2005; Dion et al., 2007).  
Even in terms of the intensively studied Polycomb/Hox gene system, the role of 
chromatin compaction is still difficult to envisage in vivo (Müller and Verrijzer, 2009). 
The PREs, bound by PcG proteins are depleted of nucleosomes and hypersensitive 
towards nuclease treatment (Mohd-Sarip et al., 2006; Papp and Müller, 2006). These so-
called ‘nucleosome-free regions’ (NFRs), even though not completely devoid of 
nucleosomes, are suggested to be sites of high histone replacement, implying a 
continuous eviction and re-assembly of nucleosomes (Mito et al., 2007). Therefore it 
appears more feasible that PRC1 acts on chromatin in the flanking regions of PREs, 
such as promoters or coding regions of Hox genes, to create a lesser accessible 
chromatin structure. The exact location of chromatin compaction of Polycomb and 
MBT domain proteins remains to be elucidated in the future in more detail.  
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7 Appendix 
 
Microarray results: dL(3)mbt and dLint-1 deregulated genes  
 
Table 7.1: Overlap of dL(3)mbt and dLint-1 co-regulated genes: List of genes identified by 
microarray analysis that are co-regulated in both dL(3)mbt and dLint-1 depleted Kc167 cells 
(log2 FC: ≥ 0.5 and ≤ -0.5). Genes were put in order according to decreasing log2 fold changes 
(log2 FC) in dLint-1 RNAi-treated cells. Deregulated MBTS genes are labelled with a grey 
background. 
Affy_ID dL3MBT 
RNAi 
log2 FC 
dLint1 
RNAi 
log2 FC 
Gene Symbol Gene Title 
1634302_s_at 7.6925 7.9155 CG14516 CG14516 
1639028_a_at 8.8067 7.2829 CG30296 CG30296 
1641305_at 7.6564 6.5804 piwi P-element induced wimpy testis 
1630749_at 8.9467 6.4546 CG11052 CG11052 
1627235_at 6.8328 6.0472 CG17207 CG17207 
1635163_at 7.1200 5.9691 CG5731 CG5731 
1638729_at 6.7737 5.9535 CG8589 / tej CG8589 / tejas / anon-fast-
evolving-1D11 
1625450_at 7.1608 5.7951 mthl14 methuselah-like 14 
1628036_at 5.9196 5.7478 hdm hold'em 
1633137_at 6.1735 5.7432 eIF4E-6 eIF4E-6 
1640031_at 5.9197 5.7306 Acer Angiotensin-converting enzyme-
related 
1636899_s_at 5.4052 5.6217 CG1623 CG1623 
1640961_at 5.9902 5.4461 CG32313 CG32313 
1626251_at 5.9181 5.4130 Rh4 rhodopsin 
1631174_at 5.9198 5.2046 CG9875 CG9875 
1632490_at 5.3525 5.1476 CG8008 CG8008 
1636591_at 6.3343 5.0894 skpB skpB 
1629597_a_at 5.1300 5.0775 Asph Aspartyl beta-hydroxylase 
1637913_at 5.3428 5.0032 CG11638 CG11638 
1627272_at 6.9354 4.9460 CG30380 CG30380 
1633920_at 5.4937 4.9150 CG5715 CG5715 
1635470_at 5.3212 4.9113 GNBP3 Gram-negative bacteria binding 
protein 3 
1640025_at 5.1533 4.7864 osm-6 osm-6 
1631125_at 5.0375 4.7619 CG15737 CG15737 
1625697_at 5.2593 4.7415 Cyp6g1 CYP6-like 
1625454_at 4.8588 4.6507 Gbeta5 Gbeta5 
1641390_at 6.3524 4.6145 dpr19 dpr19 
1633696_at 5.3490 4.5591 TM4SF Transmembrane 4 superfamily 
1641053_s_at 4.9014 4.5371 tok Tolkin 
1633126_at 7.0239 4.5360 CG4596 CG4596 
1630191_at 4.5037 4.4814 CG32436 CG32436 
1640104_at 6.4902 4.4284 RpS5b Ribosomal protein S5b 
1632600_at 4.8760 4.4245 CG34232 --- 
1624989_s_at 6.0270 4.4083 Ef1alpha100E elongation factor 1-alpha F2 
1633458_at 4.8220 4.3879 swa swallow 
1638866_at 4.0106 4.3443 CG9542 CG9542 
1622940_at 4.5716 4.3269 CG12698 CG12698 
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1638484_at 4.3197 4.3132 Hsp67Bc Gene 3 
1624467_a_at 4.8002 4.1979 CG8046 CG8046 
1638121_at 3.8750 4.1362 CG9961 CG9961 
1627645_at 4.3139 4.1208 CG9427 CG9427 
1640846_at 4.5030 4.0802 CG2887 CG2887 
1628925_at 3.7627 4.0513 CG17625 CG17625 
1632713_at 5.6229 3.9161 nos nanos 
1633377_at 4.8050 3.9145 --- --- 
1625582_at 3.5798 3.9020 CG32187 CG32187 
1624856_at 5.7646 3.8970 c(2)M crossover suppressor on 2 of 
Manheim 
1636063_at 5.1226 3.8716 CG34355  CG34355 
1639353_at 3.9377 3.7828 CG17032 CG17032 
1625639_at 3.3813 3.7066 CG6737 CG6737 
1624763_at 3.9457 3.7051 CG2556 CG2556 
1624628_at 3.8907 3.6745 CG10396 CG10396 
1634464_at 3.7449 3.6591 RpS19b Ribosomal protein S19b 
1629468_at 3.8971 3.6231 CG9372 CG9372 
1624197_a_at 3.9959 3.6002 CG6652 CG6652 
1627051_at 4.0280 3.5358 Lcp9 Larval cuticle protein 9 
1641534_at 4.1092 3.4932 CG11842 CG11842 
1623971_at 3.5584 3.4924 CG9150 CG9150 
1624310_s_at 3.6255 3.4857 CG4753 CG4753 
1623712_at 4.1017 3.4756 CG10132 CG10132 
1635980_s_at 4.0331 3.4009 CG12991 CG12991 
1634933_s_at 4.0823 3.3741 CG17207 CG17207 
1634882_at 3.6649 3.3395 Acp63F Accessory gland protein 63F 
1634402_at 3.7653 3.3319 Scgbeta Sarcoglycan beta 
1626271_at 4.2489 3.2746 CG9634 CG9634 
1629015_a_at 3.8365 3.2697 DAAM Dishevelled Associated Activator 
of Morphogenesis 
1624377_s_at 3.9682 3.2369 CG32594 E protein 
1625688_at 3.3574 3.2159 CG6293 CG6293 
1634788_at 3.1321 3.2107 CG4872 CG4872 
1639936_at 3.0000 3.1957 Sas N-acetylneuraminic acid phosphate 
synthase 
1632321_a_at 3.6488 3.1907 mthl7 Mth-like 7 
1623961_at 4.0643 3.1483 Arpc3B Arpc3B 
1633615_at 3.9173 3.1320 CG15330 CG15330 
1635940_at 4.2164 3.1297 CG5367 CG5367 
1626044_at 3.9587 3.1234 CG7628 CG7628 
1633893_at 4.4560 3.1130 CG31217 predicted gene W 
1635256_s_at 3.3079 3.0822 CG1275 CG1275 
1626600_at 3.0082 3.0711 CG30016 CG30016 
1623613_at 2.9774 3.0336 CG13762 CG13762 
1634733_at 2.3848 3.0270 CG3831  CG3831  
1630366_at 3.9608 3.0228 CG31149 CG31149 
1635831_at 2.6828 2.9702 CG14036 CG14036 
1637463_a_at 3.5252 2.9489 Nrg neuroglian 
1636961_a_at 2.6571 2.9429 CG9027 CG9027 
1629430_s_at 2.5436 2.9006 regucalcin regucalcin 
1636510_a_at 2.9620 2.8945 Lsd-1 Lipid storage droplet-1 
1637256_at 2.9847 2.8847 CG34349 CG11819 
1632688_s_at 2.3021 2.8663 CG11594 CG11594 
1630585_s_at 2.8297 2.8602 --- --- 
1633227_s_at 2.7559 2.8324 CG14945 CG14945 
1628146_at 2.9076 2.8184 --- --- 
1636247_at 2.9029 2.8181 CG32354 CG32354 
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1637404_at 3.9025 2.8141 CG10262 CG10262 
1638885_at 4.1302 2.8099 --- --- 
1625572_s_at 2.2315 2.7891 Dbi diazepam binding inhibitor 
1627619_at 3.2158 2.7844 CG15332 CG15332 
1632873_at 2.4292 2.7824 MtnA metallothionein N 
1634093_at 5.0666 2.7729 CG32017 CG32017 
1639406_at 2.7197 2.7548 lbm Late Bloomer 
1630239_at 5.0973 2.7534 --- --- 
1629119_at 4.9504 2.7373 CG33221 CG33221 
1622906_at 2.4611 2.7151 CG9027 CG9027 
1622990_at 3.4265 2.6872 CG5381 CG5381 
1629889_s_at 2.3878 2.6823 regucalcin regucalcin 
1624718_a_at 4.2700 2.6630 CG42299 / CG42300  CG42299 / CG42300 
1634557_at 2.8743 2.6478 Rhp Rhophilin 
1636785_at 3.2313 2.6424 --- --- 
1624720_s_at 3.1794 2.6289 CG6043 CG6043 
1635643_at 2.8349 2.6285 Rab23 Rab23 
1641657_s_at 3.8622 2.6213 CG12424 CG12424 
1639867_at 2.7898 2.5923 ea Easter 
1624982_s_at 2.4759 2.5496 CG5080 CG5080 
1634739_a_at 2.6202 2.5257 Pfk 6-phosphofructokinase 
1639478_at 3.9344 2.5253 CG5091 / CG5096 CG5091 / CG5096 
1635313_at 3.1816 2.5227 CG10405 CG10405 
1626228_a_at 3.1972 2.5176 CG6967 CG6967 
1630476_s_at 3.2214 2.5130 nahoda nahoda 
1630217_at 2.8464 2.5019 CG13650 CG13650 
1624706_at 3.1450 2.4996 CG34349 CG11819 
1633710_at 2.4035 2.4704 ChLD3 CG17905 
1626559_s_at 2.0116 2.4630 CG13148 CG13148 
1638368_at 1.8948 2.4301 CG31674 CG31674 
1627799_at 2.5016 2.4246 CG12161 CG12161 
1638417_at 2.3389 2.4203 CG31373 CG31373 
1636410_at 1.9583 2.4176 CG3505 CG3505 
1634993_at 3.2603 2.4151 CG40498 CG40498 
1624846_at 3.9166 2.4093 CG10764 CG10764 
1637538_s_at 2.3126 2.4056 CG9485 CG9485 
1623347_at 2.4913 2.4006 CG11674 CG11674 
1636733_at 1.2546 2.3887 CG32135 CG32135 
1639396_s_at 2.4471 2.3853 CDase Ceramidase 
1622970_at 2.8858 2.3515 form3 formin 3 
1641009_at 3.2860 2.3504 --- --- 
1632011_at 3.0630 2.3463 CG31274 / MESK4 CG31274 / Misexpression 
suppressor of KSR 4 
1633572_at 2.4569 2.3373 CG42336 CG42336 
1628298_at 1.9390 2.3342 Dox-A3 prophenoloxidase 
1626524_at 3.1284 2.3173 CG16996 CG16996 
1635591_at 2.1484 2.2841 NijA ninjurin A 
1629010_at 3.1712 2.2816 rho-5 rhomboid-5 
1638778_at 2.8726 2.2605 CG10352 CG10352 
1636146_at 3.4896 2.2570 Nrg neuroglian 
1640972_at 2.8721 2.2541 CycJ Cyclin-dependent kinase interactor 
5 
1623746_a_at 2.1906 2.2513 PICK1 PICK1 
1637794_at 2.6981 2.2450 CG4927 CG4927 
1630140_at 2.5242 2.2351 CG14931 CG14931 
1632019_s_at 2.2408 2.2335 CG9008 CG9008 
1637632_at 4.4942 2.2246 CG12194 CG12194 
1635416_at 4.1936 2.2031 CG31100 CG31100 
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1636564_at 2.1022 2.1974 CG14757 CG14757 
1622959_at 1.9383 2.1821 CG12928 CG12928 
1638220_at 2.0355 2.1761 CG16888 CG16888 
1641265_at 3.4615 2.1571 tty tweety 
1633645_at 1.0967 2.1498 CG13512  CG13512  
1632574_at 2.0238 2.1463 CG6574 CG6574 
1640097_at 1.2798 2.1460 Pxn peroxidasin 
1627537_at 1.7860 2.1458 CG3085 CG3085 
1628579_at 2.4513 2.1189 --- --- 
1639251_at 2.2301 2.1136 CG17462 CG17462 
1630085_s_at 1.6529 2.1127 Peritrophin-A peritrophin A 
1635300_at 4.0608 2.1121 CG1268 CG1268 
1626152_at 2.6932 2.1093 Ror Ror 
1624849_at 2.0905 2.0891 Prosap Prosap 
1623769_at 1.9746 2.0651 CG7322 CG7322 
1637654_at 3.0555 2.0647 CG10566 CG10566 
1633982_at 1.8321 2.0484 CG32088 CG32088 
1626268_at 2.6959 2.0469 Klp54D Kinesin-like protein at 54D 
1634036_at 1.7296 2.0226 CG8788 CG8788 
1637003_at 2.1031 2.0156 CG6927 CG6927 
1636906_s_at 2.1338 2.0073 Sans Sans 
1634756_at 2.7443 2.0007 nAcRalpha-80B Dalpha4 
1626552_at 2.7830 1.9997 CG3568 CG3568 
1629572_a_at 2.3165 1.9996 fat-spondin fat-spondin 
1631076_at 2.1885 1.9533 CG13771 CG13771 
1623342_at 1.6430 1.9505 CG8369 CG8369 
1626897_at 4.3727 1.9459 HisCl1 Histamine-gated chloride channel 
subunit 1 
1631228_a_at 1.8773 1.9425 sPLA2 secretory Phospholipase A2 
1635930_at 2.3549 1.9402 btn buttonless 
1640477_at 2.3338 1.9401 tilB touch insensitive larva B 
1637561_at 2.0999 1.9359 lectin-33A lectin-33A 
1625292_at 2.3665 1.9070 CG12200  CG12200  
1633998_s_at 2.5724 1.9046 --- --- 
1636255_s_at 1.8152 1.8599 CG7997 CG7997 
1641530_s_at 2.5070 1.8508 CG2264 CG2264 
1634336_at 2.2068 1.8426 bam bag-of-marbles 
1624744_a_at 2.4766 1.8346 nuf nuclear-fallout 
1641304_s_at 2.1563 1.8215 CG9801 CG9801 
1629802_at 1.7213 1.8206 CG15484 CG15484 
1632525_at 3.7480 1.8164 CG9925 CG9925 
1633880_s_at 2.0468 1.8043 CG8533 CG8533 
1634553_at 1.8404 1.7957 CG13602 CG13602 
1640845_at 1.7952 1.7936 CG10581 CG10581 
1637806_at 1.9534 1.7926 Ada Adenosine deaminase 
1629804_s_at 1.8722 1.7888 CG6329 CG6329 
1640281_s_at 1.4613 1.7884 CG17129 CG17129 
1634325_a_at 2.4876 1.7828 MESK2 Misexpression suppressor of KSR 
2 
1626079_a_at 2.4727 1.7705 CG2201 CG2201 
1627301_s_at 2.9443 1.7640 CG7208 CG7208 
1630999_at 2.1925 1.7565 CG7724 CG7724 
1629831_at 2.0082 1.7555 CG17801 CG17801 
1624425_at 2.1987 1.7545 CG7384 CG7384 
1632070_at 1.5302 1.7543 Ugt58Fa lectin-58Fg 
1628197_at 3.3645 1.7468 CG13177 CG13177 
1623312_s_at 1.5794 1.7163 CG11836 CG11836 
1633167_s_at 1.8986 1.6907 CG32496 / CG6788 CG32496 / CG6788 
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1630797_at 1.8675 1.6899 CG32582 CG32582 
1632345_at 1.2979 1.6831 CG8353 CG8353 
1637000_at 1.9552 1.6755 Vha68-1 Vha68-1 
1627862_at 2.8946 1.6709 CG15267 CG15267 
1631098_at 1.7104 1.6706 CG7194 CG7194 
1641204_at 1.5659 1.6660 CG14864 CG14864 
1631756_at 1.4518 1.6574 CG10859 CG10859 
1633994_at 3.8917 1.6513 CG34402 CG17793 
1634310_at 2.0130 1.6359 TpnC4 TpnC4 
1624568_at 1.6605 1.6350 CG7985 CG7985 
1635223_at 2.4339 1.6339 CG30285 / rap CG30285 / fizzy-related 
1629444_at 2.0608 1.6339 CG11756 CG11756 
1627176_at 1.8279 1.6333 CG31431 CG31431 
1630811_at 2.2517 1.6324 CG31624  CG31624  
1628964_at 2.0401 1.6160 CG4804 CG4804 
1628493_at 1.4035 1.6152 kal-1 Kallmann 
1627837_at 1.4916 1.6107 CG5527 CG5527 
1631606_at 1.4311 1.6102 CG14285 CG14285 
1637843_at 2.0446 1.6075 --- --- 
1627574_at 1.4728 1.6011 CG4623 CG4623 
1636535_at 1.5538 1.5889 CG15912 CG15912 
1627420_s_at 1.1387 1.5840 CG7702 connectin-like 
1626640_at 1.9760 1.5741 CG4565 CG4565 
1639640_at 1.3630 1.5701 CG32485 CG32485 
1626619_at 1.7740 1.5663 CG9919 CG9919 
1622932_s_at 1.7280 1.5651 sn fascin 
1628918_at 1.7860 1.5646 CG17478 CG17478 
1641722_at 0.9268 1.5632 Reg-2 rhythmically expressed gene 2 
1638882_at 1.2924 1.5539 ry Xanthine DH 
1628143_a_at 1.3147 1.5445 --- --- 
1640303_a_at 1.8083 1.5437 pst pastrel 
1631638_at 1.1820 1.5388 Pvf1 PDGF- and VEGF-related factor 1 
1641232_s_at 1.3519 1.5381 CG32706 / CG6999 CG32706 / CG6999 
1629160_s_at 1.4012 1.5376 --- --- 
1625835_at 1.4442 1.5286 yellow-f2 yellow-f2 
1631377_a_at 1.4367 1.5256 Adk1 Adenylate kinase-1 
1631179_s_at 1.9973 1.5251 CG6680 CG6680 
1631782_at 1.3786 1.5023 CG14312 CG14312 
1638587_at 2.7113 1.4902 tor torso 
1630605_at 1.5638 1.4876 CG16947 CG16947 
1626886_at 1.0778 1.4765 CG3663 CG3663 
1625817_at 1.1744 1.4549 CG14868 CG14868 
1636244_s_at 1.5558 1.4545 CG5191 CG5191 
1624466_a_at 1.6443 1.4492 CG15117 CG15117 
1628567_at 2.4824 1.4483 CG13565 CG13565 
1640291_at 1.8280 1.4472 CG11848 CG11848 
1633483_a_at 1.2973 1.4390 CG14207 small heat shock protein hsp20 
family 
1641339_at 1.3219 1.4380 CG10137 CG10137 
1629536_at 1.3796 1.4366 CG14079 CG14079 
1636997_at 1.8946 1.4342 CG18528 CG18528 
1640747_s_at 1.4610 1.4290 CG8547 CG8547 
1629778_s_at 1.6725 1.4273 CG5130 CG5130 
1639956_at 1.4849 1.4168 CG17760 CG17760 
1639210_at 1.9836 1.4126 Fcp3C Follicle cell protein 3C 
1624884_at 1.2211 1.4073 CG32712  CG32712  
1630985_at 2.3281 1.4000 CG30441 CG30441 
1629916_at 1.3714 1.3994 debcl deborg 
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1636925_at 1.2928 1.3892 CG31477 CG31477 
1638064_a_at 1.4324 1.3817 dgo diego 
1635541_s_at 1.8664 1.3783 MESK2 Misexpression suppressor of KSR 
2 
1626027_at 1.7218 1.3734 Sr-CII Scavenger Receptor 
1633741_at 1.0550 1.3707 CR31032 CR31032 
1626255_at 1.4224 1.3654 Gr61a Gustatory receptor 61a 
1636603_a_at 2.1410 1.3583 CG9297 CG9297 
1630145_s_at 1.5324 1.3518 Tsp42Ea tetraspanin 42E 
1639996_at 2.2390 1.3482 tomb tombola 
1631486_at 1.5572 1.3468 p38c p38c 
1630285_at 1.6143 1.3445 RhoGAP100F RhoGAP100F 
1634125_at 1.7975 1.3385 CG30440 CG30440 
1623065_at 1.5462 1.3368 CG13692 CG13692 
1641268_at 1.0779 1.3304 CG13313 CG13313 
1635813_at 1.4092 1.3292 mia TBP-associated factor 60kD-2 
1627900_at 1.0563 1.3193 Dim1 CG3058 
1639431_at 2.0115 1.3132 synaptogyrin synaptogyrin 
1634890_at 0.8249 1.3006 UK114 UK114 
1627593_at 1.5743 1.3004 CG2678 transcript B 
1630370_at 1.5367 1.2965 CG9796 CG9796 
1640729_s_at 1.8725 1.2850 nrv3 Nervana 3 
1641294_a_at 0.9992 1.2816 CG3625 CG3625 
1625617_at 0.8711 1.2767 Roc2 Roc2 
1635131_at 1.1470 1.2737 CG4525 CG4525 
1637056_s_at 0.9761 1.2700 CG11200 CG11200 
1635969_at 0.9613 1.2654 CG11590 CG11590 
1637826_at 1.2098 1.2550 CG10623 selenocysteine methyltransferase 
1631933_at 1.2150 1.2490 CG8526 CG8526 
1634738_s_at 1.5436 1.2364 --- --- 
1632119_s_at 1.6804 1.2353 ltd lightoid 
1623957_s_at 1.4071 1.2222 GstS1 glutathione-S-transferase 
1625543_s_at 1.7272 1.2181 CYLD CYLD 
1639516_at 1.4649 1.2171 CG30187 CG30187 
1626721_at 1.5259 1.2157 CG11762 CG11762 
1623743_at 1.5368 1.2143 CG3191 CG3191 
1633630_at 1.8354 1.2114 CG4324 CG4324 
1635473_at 0.5887 1.2110 Apf diadenosine tetraphosphate 
hydrolase 
1635765_at 1.5564 1.2091 CG31161 CG31161 
1628251_at 0.8961 1.2057 CG33054 CG33054 
1625756_at 1.2641 1.1969 CG6656 CG6656 
1639059_s_at 1.2054 1.1927 exu exuperantia 
1635527_at 1.0549 1.1908 CG5039 CG5039 
1626953_at 1.6009 1.1900 Fmo-1 Flavin-containing monooxygenase 
1 
1637737_at 1.0061 1.1885 l(1)G0230 lethal (1) G0230 
1625280_at 1.4362 1.1714 amon amontillado 
1631608_at 1.3086 1.1691 CG6954 CG6954 
1629546_at 0.7178 1.1501 CG7054 CG7054 
1632717_a_at 0.9283 1.1463 CG14341 CG14341 
1634608_at 1.3113 1.1353 CG30383 CG30383 
1634631_at 1.3295 1.1319 CG3105 CG3105 
1625568_a_at 0.9706 1.1165 CG15111 CG15111 
1636313_at 1.4472 1.1162 CG4914 CG4914 
1628547_at 1.3606 1.1083 CG5167 CG5167 
1629568_at 0.8775 1.1079 CG33276 CG33276 
1625443_a_at 1.0438 1.1044 CG33054 CG33054 
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1624357_at 1.7099 1.0993 cona corona 
1632882_at 1.2841 1.0977 CG11671 CG11671 
1624012_at 0.6105 1.0946 mRpL10 mitochondrial ribosomal protein 
L10 
1625947_at 1.1923 1.0897 GLaz Glial Lazarillo 
1631077_at 1.1094 1.0862 CG16957 CG16957 
1627826_s_at 0.7295 1.0840 CG12744 CG12744 
1622943_s_at 1.1225 1.0813 CG2371 CG2371 
1624663_a_at 1.6417 1.0755 vis vismay 
1631173_at 0.9835 1.0681 dob CG5560 
1632373_s_at 0.7834 1.0676 CG34015 CG34015 
1635684_a_at 1.5764 1.0627 unc-13 lethal (4) ry16 
1628959_at 0.8346 1.0503 gatA benedict 
1628738_at 0.8338 1.0447 CG31251 CG31251 
1625345_at 1.4776 1.0427 CG18508 CG18508 
1640059_at 1.1107 1.0411 CG6040 CG6040 
1628290_s_at 0.8950 1.0308 CG17292 CG17292 
1639597_at 0.7868 1.0292 Obp44a Odorant-binding protein 44a 
1627354_at 1.2959 1.0270 CG11779 / CG5835  CG11779 / CG5835  
1639133_at 0.9355 1.0163 CG1939 CG1939 
1624813_s_at 0.6618 1.0149 CG34008 CG34008 
1626186_at 1.1790 1.0109 CG18193  CG18193  
1631867_at 0.9300 1.0099 Idgf5 Imaginal disc growth factor 5 
1636089_at 1.4318 1.0091 comm commissureless 
1640492_at 0.6652 1.0080 CG10672 CG10672 
1637691_at 0.9938 1.0069 CG4570 CG4570 
1624937_at 1.0582 1.0055 CG12288 CG12288 
1623560_at 0.7475 1.0053 CG18048 CG18048 
1635964_at 1.0943 1.0002 niki nimA-like kinase 
1629625_at 0.8187 0.9958 CG42336 CG42336 
1623238_at 1.0007 0.9948 CG5618 CG5618 
1639944_at 1.4167 0.9889 Cyp9f2 Cyp9f2 
1630624_s_at 1.1325 0.9867 CG10151 CG10151 
1640842_at 0.8324 0.9831 CG34159 / CG5739 CG34159 / CG5739 
1639109_a_at 1.3128 0.9799 CRMP dihydropyrimidine amidohydrolase 
1628802_at 0.7372 0.9754 CG32554 CG32554 
1626023_at 0.7280 0.9726 CG14932 CG14932 
1630421_at 1.0434 0.9622 CG33170 CG33170 
1624203_s_at 1.3174 0.9620 Gli gliotactin 
1633059_at 1.8217 0.9490 CG6357 CG6357 
1627884_at 0.7830 0.9404 CG5281 CG5281 
1636943_s_at 0.9788 0.9339 Spn5 serpin 5 
1629977_at 0.7650 0.9281 CG9921 CG9921 
1639848_at 0.5809 0.9281 topi matotopetli 
1632762_s_at 0.9794 0.9272 CG3176 / CG32817 CG3176 / CG32817 
1635687_at 0.6087 0.9250 CG8490 CG8490 
1627105_at 2.0793 0.9221 TrxT thioredoxin 
1635517_at 1.6207 0.9168 CG1667 CG1667 
1638564_at 0.6142 0.9162 CG12279 CG12279 
1623216_s_at 0.5910 0.9159 CG9629 CG9629 
1641066_s_at 0.6191 0.9101 fbp fructose-1,6-bisphosphatase 
1629492_s_at 1.3919 0.9095 CG31626 CG31626 
1625857_at 0.8688 0.9094 CG8451 CG8451 
1632855_at 1.0483 0.9039 CG7352 CG7352 
1635486_at 1.1470 0.9038 CG33468 CG33468 
1624435_at 1.0526 0.9016 Tsp42Ej CG12143 
1641714_at 0.8110 0.8983 CG12338 CG12338 
1623257_a_at 0.8429 0.8949 CG17665 CG17665 
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1629906_s_at 0.8802 0.8922 --- --- 
1623883_at 0.9842 0.8906 CG18661 CG18661 
1634621_at 0.8731 0.8848 CG13599 CG13599 
1640775_a_at 1.0662 0.8802 Nmdmc NAD-dependent methylene-
tetrahydrofolate dehydrogenase 
1626928_at 1.0227 0.8800 CG13190 CG13190 
1637236_at 1.5189 0.8795 CG41284 --- 
1639645_at 0.7682 0.8776 CG9740 CG9740 
1636788_a_at 1.0261 0.8700 loqs loquacious 
1629732_at 1.2308 0.8648 CG8791 CG8791 
1625370_s_at 1.0431 0.8631 gem persephone 
1634351_at 0.6280 0.8578 CG7860 CG7860 
1633861_at 0.7575 0.8554 CG8145 CG8145 
1629879_at 0.7383 0.8553 Nnf1a CG13434 
1628500_at -1.0267 0.8519 CG32483 CG32483 
1639257_s_at 0.8172 0.8512 CG11739 CG11739 
1635203_at 1.1550 0.8488 Dip2 dorsal interacting protein 2 
1636718_s_at 1.1097 0.8443 CG4502 CG4502 
1631363_at 0.6649 0.8405 Nuf2 CG8902 
1641648_at 0.6621 0.8386 CG3939 CG3939 
1638543_at 1.7135 0.8386 CG33775 CG33775 
1630754_at 0.6252 0.8355 ORMDL ORMDL 
1638265_s_at 0.5893 0.8354 --- --- 
1637469_at 0.8568 0.8347 pen-2 presenilin enhancer 
1632646_at 1.0586 0.8328 Ptth prothoracicotropic hormone 
1630845_at 0.6978 0.8320 Sod superoxide-dismutase 
1632613_at 0.6510 0.8239 Spn6 serpin 6 
1626417_at 0.8895 0.8226 --- --- 
1635638_s_at 0.6773 0.8215 tomosyn tomosyn 
1634620_a_at 0.5989 0.8165 stl stall 
1639111_at 0.7052 0.8160 CG15362 CG15362 
1631030_at 0.6092 0.8123 Dbp80 Helicase 80 
1637727_at 0.6420 0.8091 CG7049 CG7049 
1630768_s_at 1.1435 0.8070 achi / vis achintya / vismay 
1631984_at 0.6514 0.8061 CG3639 CG3639 
1635887_at 0.6640 0.8051 CG30094 CG30094 
1631775_at 0.5949 0.8014 CG11137 CG11137 
1633272_at 1.1451 0.7974 CG9090 CG9090 
1625750_at 0.6010 0.7931 CG17272 CG17272 
1624183_a_at 0.7878 0.7907 Fas1 fasciclin I 
1639868_at 0.7530 0.7902 CG1702 CG1702 
1638652_at 0.9863 0.7857 CG40006 CG40006 
1626918_at 0.7079 0.7848 CG13879 CG13879 
1640430_s_at 0.6031 0.7833 CG15881 CG15881 
1639485_at 0.6089 0.7832 CG3893 CG3893 
1626304_at 0.6753 0.7805 CG32446 CG32446 
1625973_a_at 1.0785 0.7774 CG3038 CG3038 
1637645_at 0.8068 0.7741 miple2 miple2 
1641235_at 0.6687 0.7675 CG14102 CG14102 
1633870_at 0.5929 0.7671 CG9436 CG9436 
1626227_at 1.0515 0.7631 CG5337 CG5337 
1624725_at 1.7151 0.7619 CG9626 CG9626 
1624901_at 0.8564 0.7590 CG9272 CG9272 
1641408_at 0.9901 0.7583 --- --- 
1638052_at 0.8957 0.7537 CG41128 CG41128 
1631456_at 0.6634 0.7502 CG6812 CG6812 
1641733_a_at 0.8135 0.7497 cerv CG15645 
1629666_at 0.6347 0.7350 dgt4 CG4865 
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1638801_at 0.7555 0.7350 CG14229 CG14229 
1641603_s_at 0.9578 0.7330 CG9611 gp150-like 
1640778_at 0.7835 0.7306 --- --- 
1626052_at 0.7410 0.7166 MP1 Melanization Protease 1 
1628097_at 0.7495 0.7166 elk eag-like K[+] channel 
1632979_at 0.6159 0.7148 CG11784 CG11784 
1631536_at 0.8597 0.7124 Dip3 Dorsal interacting protein 3 
1639856_at 0.9450 0.7119 CG5727 CG5727 
1624617_at 0.6042 0.7095 CG1665 CG1665 
1638278_s_at 0.5917 0.6880 Myo61F myosin61F 
1635074_s_at 1.1320 0.6832 --- --- 
1623508_at 1.0617 0.6813 CG30466 CG30466 
1633626_at 0.6136 0.6798 CG14104 CG14104 
1627843_at 0.7257 0.6793 CG12253 CG12253 
1634570_at 1.7582 0.6760 CG5375 CG5375 
1628445_at 0.9610 0.6736 CG33213 CG33213 
1631101_at 0.6639 0.6711 CG6480 CG6480 
1630730_at 0.7513 0.6617 CG6808 CG6808 
1628453_at 0.6171 0.6609 l(1)G0289 lethal (1) G0289 
1637461_at 0.6535 0.6595 CG9527 CG9527 
1638344_at 0.7893 0.6569 CG5287 CG5287 
1626615_at 0.7644 0.6532 CG31156 CG31156 
1631183_at 0.7454 0.6477 RhoL Rho-like 
1627302_at 0.6820 0.6410 Fmo-2 Flavin-containing monooxygenase 
2 
1636730_at 0.6045 0.6345 CG13373 CG13373 
1623904_a_at 0.8428 0.6306 Rpt3R Rpt3R 
1623022_at 0.8046 0.6210 CG15820 CG15820 
1641117_a_at 0.8063 0.6153 CG17600 CG17600 
1627854_at 0.6181 0.6115 CG9914 Enoyl-CoA hydratase 
mitochondrial 
1623887_at 1.2932 0.6097 Pimet CG12367 
1623271_a_at 0.5912 0.5977 janA janus A 
1641455_at 0.8489 0.5862 CG6762 CG6762 
1637815_s_at -0.8570 -0.5859 Cka connector of kinase to AP-1 
1629835_at -0.8112 -0.5990 CG5048 CG5048 
1637928_at -0.9457 -0.5999 gb / Oatp58Db CG6070 / Organic anion 
transporting polypeptide 58Db 
1625992_s_at -0.6284 -0.6025 CG34413 CG32836 
1638171_s_at -0.7851 -0.6311 CG1753 CG1753 
1635399_s_at -0.6195 -0.6435 CG11006 CG11006 
1632963_at -0.6514 -0.6515 CG4963 anon-fast-evolving-2H5 
1627888_at -0.7302 -0.6554 CG6672 CG6672 
1632098_at -0.8236 -0.6626 CG4364 CG4364 
1637703_a_at -0.8560 -0.6723 Socs36E Suppressor of cytokine signaling at 
36E 
1640905_at -0.9685 -0.6741 wibg within bgcn 
1628807_at -1.0074 -0.6779 CG5205 CG5205 
1641576_a_at -1.2820 -0.6917 CG5205 CG5205 
1622909_at -0.5917 -0.7065 Pi3K21B dPI 3-kinase 
1631006_a_at -0.7350 -0.7123 CG10171 CG10171 
1636149_at -1.0581 -0.7165 CG31705 CG31705 
1625791_s_at -0.9043 -0.7240 --- --- 
1627704_a_at -0.7820 -0.7267 Traf4 TNF Receptor Associated Factor 1 
1641059_at -0.9559 -0.7268 Ca-P60A organellar-type Ca-ATPase 
1626606_at -2.2609 -0.7288 CG10630 CG10630 
1631527_at -0.6813 -0.7290 CG5642 CG5642 
1627454_a_at -0.6859 -0.7301 cora Coracle 
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1625744_at -0.7559 -0.7317 GstE6 Glutathione S transferase E6 
1637055_s_at -0.8695 -0.7421 --- --- 
1637612_at -0.5893 -0.7424 Hip14 htt-interacting protein 14 
1639048_a_at -0.7242 -0.7444 CG8229 CG8229 
1636745_at -0.7040 -0.7478 Art4 Drosophila arginine methyl-
transferase 4 
1638274_s_at -0.8298 -0.7541 pix pixie 
1637510_s_at -1.2060 -0.7718 Hexo1 Hexosaminidase 1 
1639215_at -0.6561 -0.7748 Csat D.melanogaster nucleotide sugar 
transporter 
1629324_at -0.7689 -0.7782 CG6870 cytochrome B5 
1633252_at -0.6522 -0.7819 CG31714 CG31714 
1630515_s_at -1.4784 -0.7957 Glt glutactin 
1626563_at -0.7008 -0.7984 Taf6 Suppressor of Ras85D 3-4B 
1625856_at -0.8156 -0.8035 dm diminutive 
1640884_at -0.6817 -0.8105 CG15784 CG15784 
1630091_at -0.8239 -0.8191 CG31296 CG31296 
1626621_at -0.6774 -0.8338 CG1407 CG1407 
1640567_at -0.7926 -0.8441 CG7337 CG7337 
1627142_at -1.0690 -0.8621 CG2943 CG2943 
1625885_at -0.8182 -0.8723 betaTub97EF beta tubulin 
1636302_s_at -0.7759 -0.9000 Su(dx) Suppressor of deltex 
1640065_at -0.8571 -0.9041 GstE7 Glutathione S transferase E7 
1636968_at -0.9213 -0.9088 CG5559 CG5559 
1637060_a_at -0.6527 -0.9190 Nopp140 Nopp140 
1625945_a_at -0.9598 -0.9214 CG1233 CG1233 
1629846_at -1.0410 -0.9276 CG11619 CG11619 
1622926_at -0.7760 -0.9277 CG5776 CG5776 
1637370_at -1.3887 -0.9389 yellow-f yellow f 
1623320_at -0.9114 -0.9456 CG3711 CG3711 
1632465_s_at -0.7436 -0.9702 CG6424 CG6424 
1633473_s_at -1.0151 -0.9733 Ald aldolase 
1633641_a_at -1.0767 -0.9955 CG15611 CG15611 
1640489_at -1.7766 -1.0064 CG18522 CG18522 
1634167_a_at -0.9641 -1.0177 sage salivary gland-expressed bHLH 
1625489_at -0.9037 -1.0191 --- --- 
1641548_at -0.7579 -1.0342 CG10289 CG10289 
1629776_a_at -0.9815 -1.0560 CG6643 CG6643 
1641068_a_at -1.4281 -1.0614 spz Spaetzle 
1623415_at -1.0754 -1.0749 dl dorsal 
1634731_at -1.0202 -1.0949 Cyp4p3 Cyp4p3 
1637188_s_at -1.5477 -1.0986 CG30492 CG30492 
1637936_at -1.0374 -1.1062 CG32512 CG32512 
1633237_at -1.8793 -1.1713 Idgf1 Imaginal disc growth factor1 
1628613_a_at -1.3817 -1.1746 CG30492 / CG30494 CG30492 / CG30494 
1635714_s_at -0.6911 -1.1825 fdl fused lobes 
1623663_a_at -1.5868 -1.1854 CG18063 CG18063 
1638708_s_at -0.8571 -1.2593 gpp grappa 
1635028_s_at -1.3175 -1.2859 Fuca alpha-L-fucosidase 
1635462_at -1.2174 -1.3364 rho rhomboid 
1634048_a_at -1.6744 -1.3394 bgm bubblegum 
1627312_at -0.8411 -1.3682 RpL12 Ribosomal protein L12 
1635512_at -1.4638 -1.3778 CG11893 CG11893 
1633964_at -0.7880 -1.3994 CG3626  CG3626  
1636323_at -1.3718 -1.4120 CG2249  CG2249 
1635630_a_at -1.4942 -1.4349 spir spire 
1627513_at -0.9962 -1.4363 --- --- 
1633905_at -1.6198 -1.4666 RpL28 Ribosomal protein L28 
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1629484_s_at -1.0079 -1.4769 chinmo Chronologically inappropriate 
morphogenesis 
1630412_at -1.4859 -1.4805 nimB5 CG16873 
1637347_at -2.0855 -1.6057 CG34164 / CG5317  CG34164 / CG5317 
1631123_at -1.7171 -1.6778 Corin DCorin 
1633459_a_at -1.7201 -1.6862 fau fau 
1629771_at -1.2399 -1.7365 Cyp12a5 Cyp12a5 
1625388_at -1.6575 -1.7661 CG4893 CG4893 
1638859_at -2.0157 -1.7806 CG14741 CG14741 
1634002_at -2.1558 -1.7817 CG13315 CG13315 
1640856_at -1.8191 -1.8016 CG14755 CG14755 
1631222_at -2.5403 -1.8303 pdm3 pou domain motif 3 
1628890_at -1.6279 -1.9595 CG11873 CG11873 
1639495_at -2.4164 -1.9655 Cyp9b1 Cytochrome P450-9b1 
1639321_s_at -2.0132 -2.0115 Tl toll 
1639692_s_at -2.0482 -2.0473 dl dorsal 
1639834_at -2.0699 -2.0838 CG14291  CG14291  
1637012_at -2.2272 -2.1204 m2 E(spl) region transcript m2 
1625873_at -2.7727 -2.4568 CG15661 CG15661 
1637962_at -1.5755 -2.5169 spir spire 
1631701_a_at -3.1035 -2.5682 Cpr49Ac CG8502 
1626048_at -2.7214 -2.5741 HLHmgamma split locus enhancer protein mB 
1640202_at -3.4350 -2.7265 Idgf2 Imaginal disc growth factor 2 
1639637_a_at -3.9943 -3.1120 CG3376 CG3376 
1640654_at -5.7820 -5.7820 He Hemese 
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Abbreviations and acronyms 
Amino acids are abbreviated with the common single or three letter code. The 
nucleotides Adenine, Guanine, Cytosine, Thymine and Uracil are abbreviated with A, 
G, C, T and U, respectively. Posttranslational modifications of histones are referred to 
with the abbreviation of the corresponding histone (H1, H3, H4, H2A or H2B), the 
amino acid residue in the single letter code including its position within the amino acid 
sequence and the modification status (e.g. me1, me2, me3, ac, ph). Therefore histone 
modifications are abbreviated for instance as H4K20me1 or H3K27me3.  
 
α anti 
aa amino acid 
Ab antibody 
ac acetyl/acetylated 
Acf1 ATP-dependent chromatin assembly factor 1 
ADP   adenosine diphosphate 
AKT murine thymoma viral oncogene or protein kinase B 
AML acute myeloid leukemia  
Ash1 Absent, small, or homeotic discs 1 
ATP adenosine triphosphate 
BD binding domain 
BEAF-32 Boundary element-associated factor 32 
BHC80 BRAF-histone deacetylase complex 80 
BLAST basic local alignment search tool 
bp base pair 
53BP1 p53 binding protein 1  
BPTF Bromo domain PHD finger transcription factor 
c Caenorhabditis 
C- carboxy-/carboxyl- 
Caf1 Chromatin assembly factor 1 
cDNA complementary DNA 
del deletion 
C. elegans Caenorhabditis elegans 
CG x computed gene x 
CG cancer-germline 
ChIP chromatin immunoprecipitation 
ChIP-Seq ChIP sequencing  
CoREST REST corepressor  
CP190 Centrosomal protein 190 
cpm counts per minute 
Ct cycle threshold 
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CT cancer-testis 
CTCF CCCTC-binding factor 
CTD C-terminal domain  
d Drosophila 
D. melanogaster Drosophila melanogaster 
da daughterless 
Da dalton 
DAPI 4',6-diamidino-2-phenylindole 
DDR DNA damage response 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
DNMT deoxyribonucleic acid methyltransferase 
dNTP deoxyribonucleotide triphosphate 
DP Dimerisation partner 
dREAM Drosophila RBF, dE2F2, and dMyb-interacting proteins 
DRM  DP, RB and MuvB 
DSB double strand break 
dsRNA Double-stranded ribonucleic acid 
DTT dithiotreithol 
EtBr ethidium bromide 
E. coli Escherichia coli 
Esc Extra sex combs 
Escl Esc-like 
EDTA ethylene diamine tetra acetic acid 
EED Early embryonic death  
EGFP Enhanced green fluorescent protein  
EGTA ethylene glycol tetra acetic acid 
EMS ethyl methane sulfonate 
Epo erythropoietin  
Ets E-26 transforming specific 
E(z) Enhancer of zeste 
FBS fetal bovine serum 
FC fold change 
FCS fetal calf serum 
FOXO Forkhead box O-class 
fw forward 
g gram 
Gcn5p General control of amino acid synthesis 5 protein 
G0-phase gap phase 0 
G1-phase gap phase 1 
GMC ganglion mother cell 
GST glutathione-S-transferase 
h human 
HAT histone acetyltransferase 
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HDAC histone deacetylase 
Hepes 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HKMT histone lysine methyltransferase 
Hox  Homeobox-containing  
HP1 Heterochromatin protein 1 
HPLC high performance liquid chromatography 
hr hour 
HRP horseradish peroxidase  
Hsp70 Heat shock protein 70 
HSPC hematopoietic stem/progenitor cells 
IEX ion exchange chromatography 
Ig immunoglobuline 
INP intermediate neural progenitor  
IP immunoprecipitation 
IPTG iso-propyl-ß-D-thiogalactopyranoside 
ISWI Imitation switch 
ITC  isothermal titration calorimetry 
ivT in vitro transcription 
JmjC  Jumonji C  
JMJD Jumonji domain containing  
kDa kilo dalton 
KDM2 Lysine-specific demethylase 2  
LB lysogeny broth 
Lid Little imaginal discs 
Lint-1  L(3)mbt interacting 
L(3)mbt Lethal 3 malignant brain tumour 
L3MBTL Lethal 3 malignant brain tumour-like 
Lsd1 Lysine-specific demethylase 1 
M molar 
MAPK Mitogen-activated protein kinase 
MBT malignant brain tumour 
MBTS MBT signature  
MDa mega dalton 
MDS myelodysplastic syndromes  
me methyl/methylated 
Mec  MEP-1-containing complex 
MES 2-(N-morpholino)ethane sulfonic acid 
Mi-2 Mitchell-2 
min minute 
MLL mixed-lineage leukemia 
mRNA messenger ribonucleic acid 
MPD myeloproliferative disorders 
M-phase mitosis phase 
MS mass spectrometry 
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Muv multivulva 
N- amino- 
NB neuroblast  
NCBI National Center for Biotechnology Information 
NE nuclear extract 
NFR nucleosome free region 
NMR nuclear magnetic resonance 
NuRD Nucleosome remodelling and histone deacetylase 
NURF Nucleosome remodelling factor 
Nurf55 Nucleosome remodelling factor 55 
OL optic lobe 
ORF open reading frame 
PAA polyacrylamide 
PADI peptidylarginine deiminase 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate buffered saline 
Pc Polycomb 
Pcl Polycomb-like  
P/CAF p300/CBP-associated factor 
PcG Polycomb group 
PCR polymerase chain reaction 
pdb protein data base 
Pen/Strep penicillin/streptomycin  
PEV positional-effect variegation  
ph phosphate/phosporylated 
Ph polyhomeotic 
PHD plant homeo domain 
Pho Pleiohomeotic 
PhoRC Pho-repressive complex 
PMSF phenylmethylsulfonyl fluoride 
Pol polymerase 
pRB retinoblastoma protein 
PRC1 Polycomb repressor complex 1 
PRC2 Polycomb repressor complex 2 
PRE Polycomb response element  
PRMT protein arginine methyltransferase 
PR-Set7 PR/SET domain-containing 
Psc Posterior sex combs  
PTM post-translational modification 
PV polycythaemia vera  
PVDF polyvinyl difluoride 
qPCR quantitative PCR 
RBF Retinoblastoma family protein 
RNA ribonucleic acid  
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RNAi RNA interference 
RNA Pol II RNA polymerase II 
Rpd3 Reduced potassium dependency 3 
rpm revolutions per minute 
RSCB Research Collaboratory for Structural Bioinformatics 
RT room temperature 
RT-qPCR real time-quantitative PCR 
rv reverse 
s second 
SAH S-adenosyl-L-homocysteine 
SAM S-adenosyl-methionine 
SAM domain sterile alpha motif domain 
Sce Sex combs extra  
S. cerevisiae Saccharomyces cerevisiae 
Scm Sex comb on midleg 
SDS sodium dodecyl sulphate 
sec second 
SET  Su(var)3-9, E(z) and Trx  
Sfmbt Scm-related gene containing four mbt domains  
sgs salivary gland-specific 
Sp3 Specificity protein 3  
S-phase DNA synthesis phase 
SPM domain Scm, Ph and MBT homology domain 
STAT5 Signal transducer and activator of transcription 
SUMO Small ubiquitin-like modifier 
Su(Hw) Suppressor of Hairy-wing 
Su(var) Suppressor of variegation 
Su(z)12 Suppressor of zeste 12 
synMuv synthetic multivulva 
SWH Salvador-Warts-Hippo 
SWI/SNF Switch/Sucrose NonFermentable 
Temed tetramethylethylenediamine 
Tris tris(hydroxyl-methyl)aminomethane 
Trx Trithorax 
trxG trithorax group 
ts temperature sensitive 
TSA  trichostatin A 
UTX Ubiquitously transcribed tetratricopeptide repeat on X chromosome 
VDRC Vienna Drosophila RNAi Center 
VNC ventral nerve cord 
v/v volume per volume  
w/v weight per volume 
Zn zinc 
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